Purification and characterisation of a mutant form of pyruvate kinase from Saccharomyces cerevisiae produced by site-directed mutatgenesis by Collins, Richard A.
THE PURIFICATION AND CHARACTERISATION OF A




BSc (Hons), MSc, CChem.MRSC




I HEREBY DECLARE THAT THIS THESIS HAS BEEN COMPOSED BY ME, THAT IT HAS
NOT BEEN ACCEPTED IN ANY PREVIOUS APPUCATION FOR A DEGREE, AND THAT
THE WORK OF WHICH IT IS A RECORD HAS BEEN CARRIED OUT BY ME.
RICHARD A. COLLINS
ACKNOWLEDGEMENTS
I would like to thank my supervisors Dr. L. A. Fothergill-Gilmore and
Dr. I. R.Bowman for advice and encouragement. I would also like to thank various
colleagues who have provided help and useful discussions throughout the course of
this project, particularly Dr.Malcolm White, Dr.Fiona Stuart, Dr.Gary Paterson,
Dr.Jacqueline Nairn and Dr.Teresa McNally. I would also like to thank Dr.Simon
Potter, Daniel Rigden, Nantana Fugtong, Rebecca Walter and Thalles Rocha for
friendship and support.
Particular thanks to Gillian Smith at the Student Advice Place, Professor
C.Edwards and Professor A.Miller. The author was in receipt of a William Thynne
Centenary Fellowship Award and is grateful to the family and trustees for financial
assistance.
I would like to thank Douglas Lamont, Shona Cunningham and Stella Bury
for technical assistance. Thanks are due to Prof.W.C.Plaxton, Dr.S.Blakeley and Dr.
P.Michels for supplying me with the DNA and protein sequences of several plant,
bacterial and protozoa pyruvate kinases and allowing me to use them ahead of
publication. Sequence analysis and construction of phylogenetic trees was performed
by I.Ernest at the International Institute of Cellular and Molecular Pathology,
Research Unit of Tropical Disease, Brussels, Belgium. CD spectroscopy facilities
were provided by Dr. N.C.Price and S.M.Kelly at the University of Stirling. I would
like to express my thanks to members of other labs who have helped me with various
aspects of my project particularly Dr. A. Boyd and Dr. N.Bryant, Dr. D. Apps and
Dr. A. Ryle and Prof. Al. Matheson.
I would like to thank Kay Bowles and Katrina Pfahlsberger for their
friendship in troubled times.
To my parents whose love and hard cash has kept me going-words are not
enough.
















































































m milli (10~3), metre
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PCR polymerase chain reaction
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SDS sodium dodecyl sulphate
SDS-PAGE polyacrylamide gel electrophoresis in the presence
of sodium dodecyl sulphate
SDW sterile distilled water






TBS Tris -buffered saline
TE Tris-EDTA
TEMED N, N, N\ N'-tetramethylethylenediamine
TPA Tetrapropylammonium hydroxide
Tris Tris[hydroxymethyl] aminomethane




v/v volume in volume
w/v weight in volume
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A variant form of the glycolytic enzyme pyruvate kinase (E.C 2.7.1.40)
in which the serine residue at position 384 of the polypeptide chain has been
mutated to proline has been overexpressed in the yeast Saccharomyces
cerevisiae. The mutant protein has been purified to homogeneity and has been
characterised by a number of physical, kinetic and chemical techniques. The
properties of the mutant enzyme have been compared to those of the native wild
type enzyme overexpressed from the same organism. The wild type enzyme is
activated by the allosteric effector fructose-1,6-bisphosphate. The mutant
enzyme was found to be dependent upon the presence of this effector for
catalytic activity and was inactive in its absence. The mutant enzyme became
50% activated at 1.9 + 0.1 mM Fru-1,6-P2- In the absence of the effector the
kcat of the mutant enzyme was reduced by a factor of 250. The fully activated
mutant enzyme had a 68% of that of the the wild type enzyme.The mutation
introduced into the enzyme was proposed to be at a site critical for the transfer of
the allosteric effect across the enzyme upon effector binding. This hypothesis is
demonstrated to be correct, and can be extended to invoke additional
conformational changes at the active site, as the mutant enzyme displayed
different kinetic properties to the wild type enzyme in the presence of the
allosteric effector fructose-1,6-bisphosphate. The Sq 5PEP and Sq 5ADP of the
wild type enzyme were 0.15mM and 0.39mM respectively. In the mutant
enzyme, these kinetic parameters increased to 0.69 and 0.94mM respectively.
The cooperativity between binding sites also increased significantly in the
mutant enzyme. The mutant also displayed altered monovalent and divalent
cation specificities and an altered pH profile in the presence and absence of
saturating concentrations of effector. In the presence of effector, the mutant
enzyme had a narrower pH profile than the wild type enzyme although both
enzymes displayed maximal activity at pH 6.5.
The conformations of the mutant and wild type enzymes were examined
by circular dichroism (CD) spectroscopy and fluorimetry in the presence and
absence of a number of ligands. The secondary structure of the mutant appeared
to be little different from that of the wild type enzyme indicating that they both
adopt the same overall conformation in solution. The addition of substrates and
effectors did not not alter the CD spectrum of either enzyme. The tertiary and
quaternary structures of the wild type and mutant enzymes appear to be
significantly different when thermostability, tryptophan fluorescence,
susceptibility to trypsin digestion and thiol group reactivity were examined.
An improved purification procedure has been devised that allows large
quantities of enzyme to be prepared rapidly. The enzyme produced in this
manner is essentially homogeneous, as analysed by SDS-PAGE, and free from
contaminating proteins. The enzyme is produced in a high yield and exhibits a
specific activity comparable to recent, more laborious, techniques. The
reproducibility of the improved protocol was maintained throughout the duration
of the project.
The amino acid sequences of 31 pyruvate kinases from a number of
organisms have been collected and compared. This represents the most
comprehensive set of sequences yet analysed and provides interesting data on
residues essential for catalysis and regulation. Likely targets for future
mutagenesis experiments can be identified. Available secondary structure
prediction programs have been used to compare the predicted structure of the
wild type and mutant enzymes and to reconcile the different properties of the
enzymes observed during the various studies undertaken throughout this
project.
1.0 INTRODUCTION
1.1 THE IMPORTANCE OF PYRUVATE KINASE
Pyruvate kinase is ubiquitous to all living organisms yet studied from the
Archeae to higher eukaryotes. Its expression is regulated according to tissue type and
cellular requirements by a variety of means. The enzyme activity can also be regulated
in a variety of ways from phosphorylation/dephosphorylation, allosteric interactions
and by association/dissociation of subunits. Its overexpression has been detected in
carcinomas from a variety of tissue types indicating that it may have a primary role in
other cellular functions such as cell division and tumorigenesis. Further investigation
may determine whether pyruvate kinase expression in this situation is diagnostically
useful.
An indication of the importance of pyruvate kinase can be obtained by
examining the number of nucleotide and protein sequences available and the variety of
their sources. As can be seen from Table 1, thirty-one complete protein sequences are
known (four bacterial, five fungal, three trypanosomal, nine plant and ten vertebrate),
making pyruvate kinase one of the most studied enzymes.
A further indicator of the importance of pyruvate kinase in an active research
environment can be determined from a database search of the number of research
publications in which pyruvate kinase is mentioned (Fig 1). As can be seen, the
number of publications has remained consistently high over the past decade,
indicating that study of the enzyme is still yielding important information on all
aspects of its biochemistry.
Yeast pyruvate kinase can be considered as a model enzyme for studying
allosteric interactions in eukaryotes. Its nucleotide and protein sequence are known.
Its three-dimensional structure has been interpolated, by computer analysis, by
superimposing its polypeptide chain on to the coordinates of the cat muscle enzyme
which were determined by X-ray crystallography (Clayden, 1987; Murcott, 1990).
From detailed analysis of these structures, important residues involved in both
catalysis and intersubunit communication can be inferred. The growing application of
molecular biological techniques to protein structure-function problems can be used to



































































SO SLHFSPNLTF AKQPFPKLPL PFPTSNSRYP VNNYKSLSIK
SQALNFFVSS SSRSPATFTI SRPSVFPSTG SLRLLVKKSL RTLWEASSA
LSP NGGSASTRSD KFLKPASFRV KVLGNEAKKS
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brasG TITTSTEMP. . ..PNLGQAF
tobacG SLQKSTS.S. . . .PSQSAAY
ecoll VM. ..NSRLE FNNDNRKLR.
bacste AL. . .EHRDI LSQRTKESQT
lactolac ML. ..KEYGR L.HPERYDKS
brasl SL. . .DYNTI FKEMIRATPL
bras2 SL. . .DYNTI FKEMIRATPL
potat SL. ..DNEAI FKEMIRCTPL
tobacc TI. . .DYPDV FKRIMSNAPV
asnig AI. . .PHFNV LDELRNLAPR
asnid AI. . .PHFNV FDELRNLAPR
trire TI. ..PYVSH FEEMCTLVKR
Scere AI. ..AYLPN YDDMRNCTPK
yarli AI. ..AYAPL FNEMRTLTVR
trybl AT. ..HDTVM FNSIKNLQKI
tryb2 AT. ..HDTVM FNSIKNLQKI
leish AL. ..NEYVF FNSIKKLQHI
ratL AV. ..YHRQL FEELRRAAPL
ratR AV. ..YHRQL FEELRRAAPL
humanL AV. ..YHRQL FEELRRAAPL
humanR AV. ..YHRQL FEELRRAAPL
humanMl AI. ..YHLQL FEELRRLAPI
humanM2 AI. ..YHLQL FEELRRLAPI
catMl AM. ..FHRKL FEELVRGSSH
ratMl AV. ..FHRLL FEELARASSQ
ratM2 AI. ..YHLQL FEELAAWRPL
chickMl AM. ..FHRQQ FEEILRHSVH
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. I. . TEAVCR GAVETAEKLD A.PLIWATQ
TI..TDAIGQ SVAHTALNLD V.AAIVTPTV
































































































GGSTANLVAK YRPAVPILSV WPVMTTDTF DWSCTDESPA
GGTTAKLVAK YRPAVPILSV WPVFTSDTF NWSCSDESPA
GGSTAKLVAK YRPAVPILSV WPVLTTDSF DWSISDETPA




















































bb aaaaa aaaaaaaaa aaaa
PFRLS FADDM ESNLNKTFSL LKARGMIKSG DLVIAV
PFRLS FADDM ESNLNKTFSL LKARGMIKSG DLVIAV
PFRLS FSDDM ESNLNKTFSL LKARGMIKSG DLIIAV
PIYME FSDDA EDTFTKALAT LLKQGMVKKG EEIAIVQSGS
PIYME FSSDA EETFSRAIKL LLSKSLVKDG QYVTLVQSGA
PQLVKEIT ST DDFYRLGKEL ALQSGLAHKG DVWYGFWCT
TKEAPHVN TT DEMLDVAVDA AVRSGLVKHG DLWITAGVP
PMMTEKPA ST DDMFEVAEKV ALASGLVEAG DNIIIVAGVP
PMLAEGSAKA TD SEST EVIIEAALKS ATQRGROJVG DAWALH...
PVLAEGSAKA TD NEST EEIIESALKQ ATEKGLCNHG DAWALH...
PLLGEGSAKA TD SEST EVILEAALKS AVTRGLCKPG DAWALH...
PVLHAGSARA SH EEST EEALDFALQH AKTKGLCKQG DSWALH...
PFLFPEKKPD FNVKVWQEDV DRRLKWGINH ALKLGIINKG DNIVCVQGWR
PFYFPEKKPD FNVKIWQEDV DRRLKWGINH GLKLGIINKG DNIVCVQGWR
PFLYPEQKPD FDTVNWQEDV DKRIKWAVTR AIELKTLTAG DTWWQGWK
PFVF.EKEP. ..VSDWTDDV EARINFGIEK AKEFGILKKG DTYVSIQGFK(485)
PFIY. HKARA SNPAEWQHDV EERLKWGMDE AVALGILNKG DVWAIQGWT
SVFY.DAAKS GEDKDK EKRVKLGLDF AKKEKYASTG DVWWHADH
SVFY. DAAKS GEDKDK EKRVKLGLDF AKKEKYASTG DVWWHADH
SVFF.DADKL GHDEGK EHRVAAGVEF AKSKGYVQTG DYCWIHADH
PLLYREPPEA IWADDV DRRVQFGIES GKLRGFLRVG DLVIWTGWR
PLLYREPPEA IWADDV DRRVQFGIES GKLRGFLRVG DLVIWTGWR
PLLYREPPEA IWADDV DRRVQFGIES GKLRGFLRVG DLVIWTGWR
PLLYREPPEA IWADDV DRRVQFGIES GKLRGFLRVG DLVTWTGWR
PVLCKDPVQE AWAEDV DLRVNFAMNV GKARGFFKKG DWIVLTGWR
PVLCKDPVQE AWAEDV DLRVNFAMNV GKARGFFKKG DWIVLTGWR
PWCKDPVQE AWAEDV DLRVNLAMNV GKARGFFKHG DWIVLTGWR(515)
PVLCKDAVLD AWAEDV DLRVNLAMNV GKARGFFKKG DWIVLTGWR
PVLCKDAVLD AWAEDV DLRVNLAMNV GKARGFFKKG DWIVLTGWR
PVLCKQPAHD AWAEDV DLRVNLGMNV GKARGFFKTG DLVTVLTGWR








bacste VG. .ETGSTN LMKVHVISDL
lactolac VG. ..TGRTN TMRIRTVK
brasl .R. ..IGAAS VIKICLVK
bra32 .R. ..IGAAS VIKICWK
potat .R. ..IGSAS VIKICWK
tobacc .R. ..VGTAS VIKIVTVK
asnig GG. ..MGHTN TVRWPAE.E
asnid GG. . .MGHTN TVRWPAE. E
trire GG. ..MGNTN TLRIVRADPD
See re AG. . . AGHSN TLQVSTV
yarli GG. ..LA.TP TLSEFSSVSK
trybl SV. ..KGYPN QTRLIYLP
tryb2 SV. ..KGYPN QTRLIYLP
leish KV. ..KGYAN QTRILLVE
ratL PG. ..SGYTN IMRVLSVS
ratR PG. ..SGYTN IMRVLSVS
humanL PG. ..SGYTN IMRVLSIS
humanR PG. ..SGYTN IMRVLSIS
humanMl PG. ..SGFTN TMRWPVP
humanM2 PG. ..SGFTN TMRWPVP
catMl PG. ..SGFTN TMRWPVP
ratMl PG. ..SGFTN TMRWPVP
ratM2 PG. ..SGFTN TMRWPVP
chickMl PG. ..SGYTN TMRWPVP
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Number of references in which pyruvate kinase is mentioned against the
year of publication.
Number of references generated by Medline CD-ROM database search using
the key words "pyruvate kinase'.
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1.2 THE IMPORTANCE OF PYRUVATE AND
PHOSPHOENOLPYRUVATE
Pyruvate and phosphoenolpyruvate (PEP) play essential roles in the
metabolism of virtually all organisms from bacteria to higher eukaryotes. The three
carbon a-keto structure of pyruvate serves as a major metabolic intermediate in a
number of important cellular pathways. In eukaryotes, pyruvate is derived from
glucose-6-phosphate, alanine and lactate. The reduction of pyruvate catalysed by
lactate dehydrogenase serves to regenerate NAD+, enabling glycolysis to proceed
transiently under anaerobic conditions. Lactate formed in active tissues is
subsequently oxidised back to pyruvate, primarily in the liver. Another readily
reversible reaction in the cytosol is the transamination of pyruvate, an a - keto acid,
to alanine, the corresponding amino acid. Several amino acids can be synthesised
from carbohydrate precursors by this route. A third fate of pyruvate is its
carboxylation to oxaloacetate inside mitochondria. This reaction, and the subsequent
conversion of oxaloacetate into PEP, bypass an irreversible step of glycolysis and
hence enable glucose to be synthesised from pyruvate. The carboxylation of pyruvate
is also important for replenishing intermediates of the citric acid cycle. A fourth fate
of pyruvate is its oxidative decarboxylation to acetyl CoA. This irreversible reaction
inside mitochondria is a decisive reaction in metabolism: it commits the carbon atoms
of carbohydrates and amino acids to oxidation by the citric acid cycle or to the
synthesis of lipids. The pyruvate dehydrogenase complex, which catalyses this
irreversible funnelling, is stringently regulated by multiple allosteric interactions and
covalent modifications. Pyruvate is rapidly converted into acetyl CoA only if ATP is
required or if two-carbon fragments are needed for the synthesis of lipids.
Phosphoenolpyruvate also serves as an important intermediate in aromatic
amino acid biosynthesis in bacteria and also in the transport of sugar molecules into
the cell via the phosphotransferase system (PTS). An unusual feature of the bacterial
phosphotransferase system is that PEP, rather than ATP or another nucleoside
triphosphate, is the phospho donor.
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The overall reaction carried out by the phosphotransferase system is:
Sugar (outside) + PEP —PTS/Mg2+ —> Sugar-phosphate (inside) + pyruvate
In tropical plants, PEP is formed from pyruvate via the C4 pathway. The
reaction is catalysed by pyruvate orthophosphate dikinase:
Pyruvate + ATP + Pj > PEP + AMP +PPj + H+
As can be seen from the brief outline described above, pyruvate and PEP
occupy often pivotal roles in the metabolism of many organisms and it is essential that
cells can respond rapidly to varying intracellular concentrations of these compounds.
As a result it is often the case that enzymes utilising either of these compounds as
substrates are under stringent control.
1.3 A COMPARISON OF YEAST AND VERTEBRATE PYRUVATE
KINASES
Yeast pyruvate kinase is between 49-51% identical at the amino acid
level with the vertebrate pyruvate kinases so far sequenced (Tables 1 and 16).
The enzyme from cat skeletal muscle has been sequenced and a high resolution
crystal structure has been elucidated (Muirhead et al., 1986). The X-ray
crystallographic studies on pyruvate kinase have tended to use the Ml
isoenzyme as it can easily be prepared in large quantities in a relatively stable
form. It is sometimes possible to crystallise alternative forms of an enzyme,
corresponding to different conformational states. The T (tense) state is the less
active form and is usually characterised by having a low affinity for substrate.
The R (relaxed) form is often the more active form of an enzyme, and has a
higher affinity for substates. The three-dimensional image produced from X-ray
crystallographic studies of the cat muscle enzyme, in the presence of NH4 ions
(which would bind at the potassium site), is almost certainly that of the R
quaternary structure. This is supported by the fact that the binding of substrates
to the crystalline form gives rise to only small conformational changes
(Stammers & Muirhead, 1975).
The enzyme from the majority of sources is a tetramer of identical
subunits (Fig.2). Each subunit is composed of four domains; a small N-terminal
domain and domains A, B and C (Fig. 3). Domain A is composed of an eight-
stranded alpha/beta barrel, a structural motif found in a number of other,
seemingly unrelated, proteins e.g. triosephosphate isomerase. The domain
structure found is assumed to be a general feature of the other vertebrate
enzymes and is probably very similar to the other, non-vertebrate, enzymes.
This is demonstrated by the ability of the yeast sequence to be modelled into a
structure that can be readily superimposed on to the cat structure (Clayden,
1987; Murcott, 1990).
The main difference between the yeast and the vertebrate enzymes is the
larger size of the N-terminal domain in the latter. In the non-allosterically
regulated enzymes so far sequenced (human, cat, rat and chicken skeletal muscle
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Fig. 2 Yeast pyruvate kinase tetramer.
Each subunit is coloured separately.
The Cal and Ca2 helices are labelled.
N = N-terminal domain.
The structure shown is the yeast sequence that has been modelled to
fit the coordinates of the cat muscle enzyme determined by X-ray
crystallographic studies (Muirhead et al., 1987).
Note how the Ca2 helices and (to a lesser extent) the Ca 1 helices of
adjacent subunits he close to one another.
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Fig. 3 Yeast pyruvate kinase monomer.
Ribbon diagram showing the domain structure of the enzyme.
Domains are labelled A, B, C and N.
Green - alpha helix, Red - beta strand, Blue - random coil
The arrow indicates the cleft between domains A and B leading to the
active site. Black spheres represent space filling models of the
substrates PEP and ADP.
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Ml isoenzymes), the N-terminus is 23 residues longer than the yeast enzyme in
each case. The allosterically regulated enzymes (human and rat muscle M2
isoenzymes), and those regulated by phosphorylation (human and rat liver,
human and rat red blood cell isoenzymes), show an even larger difference in the
size of the N-terminal domain. These enzymes are between 23 and 67 residues
longer than the yeast enzyme at the N-terminus. It is thought that the N-terminal
domain interacts with the other domains in the enzyme, particularly the C-
domain, and hence may subtly influence enzyme activity and intersubunit
communication.
A region considered to be essential in the transmission of the allosteric
effect upon effector binding is the C-domain, especially two alpha helices (Cal
and Ca2) which form close contacts with the other subunits. Both helices
contain 13 amino acid residues (Table 2). On comparing the known vertebrate
sequences with each other, the two alpha helices appear to be very similar in
terms of identical or conserved residues. This suggests that only slight changes
in sequence are required to significantly alter the enzyme's response to the
presence of another molecule such as an allosteric effector. Such a change could
arise simply by random mutation of certain key residues over the course of
evolution. A comparison of the Ca 1 and Ca2 helices between yeast and
vertebrate enzymes shows that the yeast Cal sequence is most similar to the
allosterically regulated isoenzymes and the yeast Ca2 sequence is most similar
to the non-regulated isoenzymes. The pronounced differences in the Ca2
sequences may indicate that this region may be more important than Cal in
contributing to the allosteric effect. Three of the 13 residues of Ca2 are identical
between the yeast and the regulated isoenzymes, with a further six residues
being conserved. By comparison, there are no identical residues between the
















YEAST LPNYDDMRNCTPK PTST TETVAASAVAAVF
HUt*<2 LQLFEELRRIAPI TSDP TEATAVGAVEASF
RATM2 LQLFEELAAHRPL PATP QKLPPWVPWRPPS
HUML RQLFEELRRAAPL SRDP TEVTAIGAVEAAF
RATL RQLFEELRRAAPL SRDP TEVTAIGAVEASF
HUMR RQLFEELRRAAPL SRDP TEVTAIGAVEAAF















Table 2: Comparison of yeast and vertebrate Cal and Ca2 regions and
putative effector binding regions.
* indicates identical residues,. indicates conserved residues
A) upper box- yeast Cal/Ca2 region compared to the equivalent
region from vertebrate non-allosterically regulated enzymes,
lower box- yeast Cal/Ca2 region compared with the equivalent
region from vertebrate allosterically regulated enzymes.
B) upper box- yeast putative effector binding site compared with the
equivalent region from vertebrate non-allosterically regulated
enzymes.
lower box- yeast putative effector binding site compared with the
equivalent region from vertebrate allosterically regulated
enzymes.
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The site proposed to be involved in effector binding in the regulated
forms of the enzyme is also located in the C-domain and lies adjacent to the
important alpha helices in the amino acid sequence. Contacts with the N-domain
may also be important in defining the effector binding site. This sequence
contains 16 residues and forms a small beta strand (C(3l) and part of another
alpha helix (Ca3). A comparison of the yeast enzyme (which is regulated by
the effector fructose-1,6-bisphosphate) and the non-regulated vertebrate
enzymes show that they are very similar. Five of the 16 residues are identical
and a further eight are conservative changes with only three residues being
completely different. The regulated vertebrate enzymes share no identical
residues with the yeast enzyme in this region. Eight residues are conservative
changes and eight residues are completely different. This region was identified
in X-ray crystallographic studies using the non-regulated cat muscle enzyme
(Muirhead et al., 1986) and by inhibition-protection studies using the regulated
E.coli enzyme (Speranza et al., 1990).
The active site lies in a cleft between domains A and B and the residues
involved in binding and catalytic activity are conserved in all known sequences
(Table 1). A more detailed comparison of the 31 sequences in Table 1 is given in
the Discussion (Section 4.13).
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1.4 THE REACTION MECHANISM
The pyruvate kinase reaction mechanism has been elucidated by studying
almost exclusively the enzymes derived from rabbit and cat skeletal muscle and the
yeast Saccharomyces cerevisiae. Fortunately, studies have shown that the sequence
identity between these enzymes and those derived from other eukaryotic sources are
sufficiently similar for meaningful parallels to be drawn regarding both the interaction
of substrate(s) with the enzyme and the actual mechanism of catalysis.
Early work concentrated on determining the nature of the phospho transfer
reaction. Indeed, as early as 1955 (Harrison et al.) it had been shown by isotope
studies that various kinases could transfer phospho groups without exchange of the
phospho oxygens with water or substrates. These studies also showed that phospho
transfer occurred directly from donor to acceptor molecules without the formation of a
covalent phospho-enzyme intermediate. This was confirmed for pyruvate kinase in
particular in later studies using 32p labelling experiments (Hass et al., 1961).
In a direct transfer mechanism, ADP and ATP would be expected to share one
binding site, whilst pyruvate and PEP would be expected to share another binding
site on the enzyme, with a further provision that the binding occur so that the
transferable phospho group of ATP and PEP occupied a common position on the
enzyme. These properties were confirmed for the rabbit muscle enzyme by direct
binding studies of the substrates PEP and ADP (Reynard et al., 1961). A simple
schematic illustrating the relations between substrates and
a transition state for the enzyme are shown in Fig 4.
1.4.1 NMR SPECTROSCOPY AND THE REACTION MECHANISM
Nuclear magnetic resonance spectroscopy (NMR) has been used to determine
the location and disposition of substrates and effectors during catalysis.
Molecular contact between the partially positive phosphorus atom of the y- phospho
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Schematic illustration of relations among substrates and a transition state
for pyruvate kinase
(from Reynard et al, 1961).
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polarization and enolization of pyruvate. This is consistent with direct phospho
transfer from PEP to ADP (Mildvan et al., 1976).
A tentative reaction mechanism for the rabbit muscle enzyme was proposed
(Mildvan & Cohn, 1966). This is illustrated in Figs. 6, 7 and 8. In the first step, Fig.
6, the divalent activator (Mn2+) is shown to combine with an imidazole group and
another ligand Y, which may either be an e-amino group or an atypical sulphydryl
group. The ligands for the divalent cation have since been identified as Glu 271, Ala
292 and Arg 293 (Muirhead et al., 1987). The combination of cation and ligand
results in a conformational change of the protein and yields a binary complex in
which the rotational motion of water molecules remaining in the coordination sphere
is considerably hindered. The substrate ADP combines with the Mn2+-enzyme
complex (Fig. 7) and donates one ligand to the bound Mn^+. The substrate PEP
donates a ligand to the Mn^+ and also causes a further conformational change which
may "open up" the site. The group designated X-H in Fig. 7 is in a position to
protonate the vinyl carbon atom of PEP. The structure of the quaternary
E-Mn^+ ADP-PEP complex (Fig. 8) is merely the superposition of the structures of
the two ternary complexes of Fig. 7. Preceding or during the phospho transfer from
PEP to ADP, the group X-H protonates the vinyl carbon atom of PEP, converts it to
a methyl group, and thus effects the keto-enol tautomerization (Rose, 1960). The
product complex in Fig. 8 indicates that ATP donates two ligands to the bound
Mn2+ The ligand X-H may be the residue Lys 269 as determined by X-ray
crystallographic studies (Muirhead et al., 1987).
These mechanistic speculations were designed as a working hypothesis to
guide future experimentation. The role of the required monovalent activator was
omitted in the formulation although it was shown that the monovalent ion controls the
conformation of the ternary complexes. The chemical basis for this control was then
not clear.
The use of NMR spectroscopy has also been applied to the study of the
function of K+ in the pyruvate kinase reaction mechanism. The binding of PEP and
PEP- analogues to Mn2+-complexes of muscle pyruvate kinase was investigated
(Nowak & Mildvan, 1972). Their results suggested that coordination of the carboxyl
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Fig. 5 A) Hypothetical complex of rabbit muscle pyruvate kinase, monovalent (K+)
and divalent (Mn2 + or Co2 +) cations, CrATP and PEP consistent with NMR
data and the observed competition between ATP and PEP.
B) Active complex of rabbit muscle pyruvate kinase, monovalent (K+) and
divalent (Mn2 + or Co2 +) cations, CrATP and pyruvate consistent with NMR
data and the model above.
The group labelled B is is probably involved in deprotonation of pyruvate.
Cr3 +, Mn2 + and Co2 + are used for their paramagnetic properties.
(from Mildvan et al, 1976).
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The formation of the binary (E-Mn2 +) complex in the pyruvate kinase
reaction.
Y represents an e-amino group or an atypical sulphydryl group.
X-H represents an unidentified proton donor.
€
T - 20
Postulated ternary complexes in the pyruvate kinase reaction.
A =* ADP, B = PEP.




Fig. 8 Mechanism of the conversion of the substrate complex (E-Mn2 +-ADP-PEP)
to the product complex (E-Mn2 +-ATP-pyruvate) in the pyruvate kinase
reaction.
Note the deprotonation of the group X-H during the reaction.
(from Mildvan & Cohn, 1966).
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group of PEP and its analogues by enzyme-bound K+ changed the conformation of
the enzyme-Mn2+-PEP complex to its catalytically active form.
The nature of the phospho group transfer can be probed more deeply by using
substrates labelled with various isotopes that can be resolved by NMR spectroscopy.
This procedure helped elucidate the phospho transfer mechanism as more likely to
occur by an associative mechanism than by a dissociative mechanism (Hassett et al.,
1982). In the associative mechanism, bond-making precedes bond-breaking, and the
attack of the acceptor group on phosphorus occurs in a transition state in which the
central phosphorus is pentacovalent and has trigonal bipyramidal geometry. In the
dissociative reaction, bond-breaking leads, and monomeric metaphosphate is formed
as a discrete intermediate before it collapses on to the acceptor nucleophile.
If the reaction catalysed by pyruvate kinase were dissociative, one should
expect that each of the phospho group donors (PEP in one direction and ATP in the
other) would, on binding to the enzyme, dissociate partly or wholly to produce
enolpyruvate and metaphosphate or ADP and metaphosphate. In the absence of the
cosubstrate acceptor, these enzyme-bound species would simply collapse back to the
intact donor molecules. There is no evidence, from positional isotope exchange nor
racemization at the y-phosphorus of ATP, to suggest that the phospho transfer
reaction of pyruvate kinase proceeds by a dissociative mechanism (Hassett et al.,
1982). Phospho transfer has indeed been found to proceed with inversion of
configuration at phosphorus- indicating that the reaction proceeds by an associative
mechanism in which the metal ion might be imagined to stabilise the pentacovalent
phosphorus transition state via electrostatic interactions (Blattler & Knowles, 1979).
These stereochemical approaches provide an access to the otherwise cryptic events
that are involved in phospho group transfer within the ternary complexes of pyruvate
kinase and its substrates. A study of a number of enzyme-catalysed phosphorus
reactions other than that of pyruvate kinase suggest that a mechanism involving
simple , direct in-line transfer of the phospho group between the two participating
substrates is mechanistically more economic than reactions involving putative
phospho-enzyme intermediates (Blattler & Knowles, 1979).
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1.4.2 PEP ANALOGUES AND THE REACTION MECHANISM
Evidence from the use of PEP analogues, such as phosphoglycolate and
phosphoenolketobutyrate, indicated that the enzyme preferentially binds the trianionic
form of the compound over the dianionic form. This is consistent with the idea that
the phospho group must be fully ionized so it can enter the coordination sphere of the
metal during turnover (Dougherty & Cleland, 1985).
The reaction mechanism of yeast pyruvate kinase, particularly the proton
transfer reactions, were studied and compared with those of the rabbit muscle enzyme
(Ford & Robinson, 1976). They found no difference between the two reactions
catalysed i.e. the transfer of a phospho group from PEP to ADP preceded the transfer
of a proton from water to enolpyruvate. Two lines of experimental evidence
supported this conclusion. First, as no proton transfer from PEP to water occurred in
the absence of a functional phospho acceptor (ADP) this suggested that phospho
transfer was required for proton transfer from PEP. This did not prove that phospho
transfer preceded proton transfer, but was a necessary consequence of such a
mechanism. Second, the rate of enolization of pyruvate was 1-2 orders of magnitude
faster than the rate of phospho transfer from ATP to form PEP in the reverse reaction.
The faster rate would be observed if proton transfer occurred before phospho
transfer in the reverse reaction. Therefore, in the forward reaction, proton transfer
must follow phospho transfer.
The binding site for PEP must consist of at least two subsites (Mildvan et al.,
1971); a phospho binding site and a carboxyl binding site. The bound monovalent
cation was thought to bind at the carboxyl binding site as K+ was found to decrease
the affinity of the E-Mn2+ for PEP analogues lacking a free carboxyl group (Nowak
& Mildvan, 1972).
In other studies (Cottam et al.,1972) where water proton relaxation rate
measurements and kinetic studies of ternary complexes were used, it was concluded
that the reaction mechanism of pyruvate kinase from S.cerevisiae suggested that an
ordered addition of substrates to the enzyme was likely. This was confirmed when it
was found that in the fructose-1,6-bisphosphate and K+-activated pyruvate kinase
from S.cerevisiae , the reaction mechanism was an ordered type with PEP binding
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first, followed by ADP and Mg2+ (MacFarlane & Ainsworth, 1972). Pyruvate
release also took place before MgATP. It was suggested that Mg^+, by binding
separately, bridged the two substrates. Pyruvate kinase is unusual in that it requires
two distinct divalent cations. One binds at a site on the protein and the other interacts
primarily with the nucleotide phospho acceptor (Fig. 10).
The theory that the essential divalent metal ion did not bind at the active site
until after both PEP and ADP were bound was supported by the work of independent
groups (MacFarlane & Ainsworth, 1972; Fell et al., 1974). In this respect the yeast
enzyme differed from the rabbit muscle enzyme as the latter displayed random order
binding of PEP, ADP and Mg2+.
Tritium exchange and trapping experiments (Robinson & Rose, 1972)
suggested that product release was rate-limiting with regard to both the forward
reaction as well as the enolization (back) reaction, and that phospho transfer preceded
protonation. These authors also suggested that the catalytic mechanisms of the muscle
and yeast enzyme were highly similar.
1.4.3 SECONDARY REACTIONS CATALYSED BY PYRUVATE
KINASE
It has long been known that pyruvate kinase also catalyses a number of
secondary reactions (Boyer 1962). These reactions were studied in some detail
(Leblond & Robinson, 1976). The secondary reactions identified were the
ATP-dependent phosphorylations of fluoride, hydroxylamine and glycolate. All of
these secondary reactions occur at the same site on the enzyme as the phospho
transfer. The study of these reactions allowed some inferences to be made regarding
the active site of the enzyme and the mechanism of the reaction. Each of the three
secondary reactions can be considered to be a nucleophilic attack on the terminal
phosphorus of ATP.
Bicarbonate, an essential cofactor for the fluoride and hydroxylamine
reactions, may act by occupying a carboxylic subsite normally occupied by PEP or
pyruvate, and inducing conformational changes essential for catalysis. The
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Fig. 10 Schematic drawing of the active site of rabbit muscle pyruvate kinase with
oxalate, ATP and the three inorganic cofactors present.
X and Y are likely to be two of the three originally proposed ligands
i.e. the carboxyl group of Glu 271 or the carbonyl groups of Ala 292 or
Arg 293.
M1 and M2 are divalent cations (usually Mg2 +)
M3 is a monovalent cation (usually K+).
(from Lodato & Reed, 1987).
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reactions is illustrated schematically in Fig. 9. Subsequently, a further secondary
reaction catalysed by pyruvate kinase has been discovered, the decarboxylation of
oxaloacetate (Creighton & Rose, 1976).
1.4.4 OTHER STUDIES
A mechanism for the reverse reaction of pyruvate kinase was postulated
(Lodato & Reed, 1987). They suggested, from analysis of electron paramagnetic
resonance (EPR) data, that a divalent cation at a protein-based site (distinct from the
ADP-bound cation) activated the keto-acid substrate through chelation and promoted
phospho transfer by simultaneous coordination to the enolate oxygen and to the
remaining non-coordinated oxygen from the y-phospho group of ATP (Fig 10).
Electron spin echo envelope modulation (ESEEM) studies suggested a function for
the protein-based divalent cation, namely that it coordinated to the phospho group that
was transferred from PEP to MgADP during catalytic turnover (Tipton et al., 1989).
The ESEEM technique of pulsed EPR spectroscopy resolves superhyperfine
interactions that are obscured by the intrinsic line width of the continuous wave EPR
signal. As a result, paramagnetic metal cation probes such as Mn^+ can provide
information on the nuclei of atoms not directly bound to the probe.
In the normal reaction, the inorganic cations together with the proton that adds
to the enolate of pyruvate, balance the net negative charges carried by the substrates at
neutral pH.
PEP^- + H+ + ADP^- — 2M2+,M+—> ATP^" + pyruvate"
Extensive isotope trapping studies by a number of workers over many years
have now revealed details of the pyruvate kinase reaction (Rose, 1960; Rose & Kuo,
1989; Kuo & Rose, 1978). The catalytic reaction occurs in separate phosphate and
proton transfer stages:-
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K+, Mg2+ and MgADP are required for the phospho transfer steps, and K+ and
Mg2+ with allosteric stimulation by MgATP are important for proton transfer.
The use of isotope methods with ^H-labelled water have been used to
identify the proton donor and determine when in the sequence of the catalytic cycle it
was generated (Rose & Kuo, 1989).
1.4.5 DISSECTING THE REACTION
The pyruvate kinase reaction is best described by the succession of two
reactions:
H+ + ADP + PEP > ATP + enolpyruvate
enolpyruvate > pyruvate
The evidence for this was as follows:
1) 3h exchange between pyruvate and water occurred in the absence of nucleotides
(Rose,1960).
2) The enzyme catalysed the stereospecific ketonization of added enolpyruvate and
phosphorylated a variety of acceptors (Kuo & Rose, 1978).
3) Significant amounts of enolpyruvate bound to the enzyme have been detected
(Seeholzer et al., 1991).
4)The equilibrium constants for both proposed half reactions have been determined
(Seeholzer et al., 1991).
Previous studies (Rose & Kuo, 1989) showed that:
1) The enzyme, not the medium, was the immediate source of protons for the
ketonization step.
2) The proton donating group was fully formulated prior to the kinase step.
3) The donor group was an e-amino group of a lysine residue, probably the lysine
269 suggested by Muirhead (1987).




When D2O was used as the solvent for the enzyme it had a profound effect on
the kinetics of the reaction. The effect of D2O on kcat in the steady state suggested
that the forward rate was determined by hydrogen transfer to the enzyme (Rose et al.,
1991). Further evidence indicated that the kinetically important proton in question
was the proton used for ketonization of enolpyruvate i.e. the substrate proton.
The ketonization half-reaction was believed to occur within the domain of the
eight alternating helix and strand sequences, the alpha/beta barrel, that constitutes
about half the mass of each of the four identical subunits of the enzyme.
The pyruvate kinase reaction, as measured by pyruvate production, has long
been known to show a large D2O inhibition (Kayne & Suelter, 1968). The broad pH
range over which this effect is seen would seem to rale out some general medium
effect acting to alter the distribution of conformational states (Rose & Kuo, 1989). Its
magnitude, greater than five-fold, would imply a primary kinetic effect.
This isotope effect was shown to derive from the reprotonation of the product
form of the enzyme:
EB- > EBH
In fact, this step may be the rate-limiting step in the steady state.
The assignment of lysine 269 as the donor was made from a crystal of cat
muscle pyruvate kinase infused with PEP since no other prototropic amino acid
residue seemed suitably located in the region designated as the active site (Muirhead et
al., 1986). Note that the molecule on which the donor will act is not PEP but
enolpyruvate and that the process of getting to enolpyruvate from PEP might
produce significant changes in the PEP binding site. A lysine residue with a pKa of
9.1 in the free enzyme was assigned as being the catalytic base responsible for
enolization (Dougherty & Cleland, 1985). From other studies (Seeholzer et al., 1991)
it can be shown that the pKa of this lysine remains unchanged by pyruvate binding.
Despite many studies suggesting the role of enolpyravate as a bound
intermediate in the pyruvate kinase reaction, direct evidence for its occurrence was
lacking until its isolation as a bromine derivative (Seeholzer et al., 1991). The
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technique used exploited the high reactivity of enolpyruvate with bromine compared
with the slow rate of ketonization to pyruvate or spontaneous generation of
enolpyruvate from pyruvate. Bromine in acid was therefore used to trap enolpyruvate
which could be liberated and measured upon denaturation of the enzyme.
1.4.7 SUMMARY
A summary of the findings to date allow a catalytic mechanism for pyruvate
kinase to be proposed (Muirhead, 1986). Pyruvate kinase catalyses the transfer of the
phospho group of PEP to MgADP via an enolate intermediate that is then protonated
to form pyruvate. The enzyme is unique among kinases for its absolute requirement
for enzyme-bound cations, Mg^+ and K+. The divalent cation coordinates substrates
in the large active site pocket. PEP possibly only binds correctly in the presence of
the divalent cation. The binding of Mg2+ also enhances the binding of the phospho
group. Thus Mg2+ assists in orientating the phospho groups of ATP and ADP to
allow phospho transfer between ATP and pyruvate and between ADP and PEP,
respectively. The nucleotide-bound Mg^+ serves to reduce the electrostatic repulsion
between the phospho donor (y-phospho, or PEP) and the nucleophile ((3-phospho or
enolate), as well as to postion the a and (3 phospho groups at the active site. The
phospho donor and acceptor bind at sites such that phospho transfer can occur
directly from donor to acceptor without a conformational change in the enzyme being
necessary to bring the two sites closer together. The phospho transfer reaction
probably occurs by an in-line associative mechanism, with inversion of
configuration. The monovalent cation may also be involved in phospho transfer by
polarizing the phospho group to be transferred. The enolization reaction is brought
about by the interaction of a base, possibly lysine 269, with the methyl group.
A sequence of events for the overall reaction can be postulated (Fig 11).
Step 1: PEP and ADP bind (not shown in Fig. 11).
a) A phospho group is essential for the correct binding of pyruvate.
b) K+ binds to glutamate 363, glutamine 328 and to a carboxyl group on PEP.
c) A phospho group binds near serine 242, arginine 72 and arginine 293.
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d) PEP displaces a molecule of water from the inner coordination sphere of Mg2+.
e) The phospho group is transferred to ADP.
Step 2: An ATP-enolate intermediate is formed
a) Enolate is stabilised by Mg2+.
b) Enolate of pyruvate and ATP are formed.
Step 3:
Lysine supplies a proton leading to the formation of pyruvate and ATP.
Step 4:
Water enters and outer sphere complexes are formed.
Step 5:
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1.5 THE ACTIVE SITE
The residues important in catalysis, and substrate binding and orientation, in
many forms of pyruvate kinase, have been determined by a variety of techniques.
Chemical modification with substrate analogues or compounds that react specifically
with a certain type of amino acid residue were once the only way of determining
residues essential for activity. These techniques have now largely been superceded by
spectroscopic studies which have the advantage of not altering the enzyme during
measurement and so can relay information about the actual events that are occurring at
the active site. More detailed information has been obtained by the use of X-ray
crystallography of the cat skeletal muscle enzyme (Muirhead et al., 1987). From these
studies it was found that the active site was located in a cleft between domains A and
B. The active site was found in electron density maps by soaking crystals of pyruvate
kinase in solutions containing divalent metal ions and PEP at pH8. This section is
followed by chapters on substrate specificity (1.6), the divalent cation (1.7) and the
monovalent cation (1.8).
1.5.1 EARLY STUDIES
The first attempt to describe an active site for pyruvate kinase was by Reynard
et al. (1961) in which they diagramatically represented the active site as two adjacent
overlapping sites; one for pyruvate/phosphoenolpyruvate and another for ADP/ATP,
with the overlap being most pronounced at the site of phospho transfer (Fig 2). A
tentative role for the metal ions, Mg2+ and K+, was also suggested although they
indicated that K+ may not be needed in the catalytic reaction at all but may simply be
required for the protein to adopt its proper conformation. Indeed, K+ or other
monovalent cations have been found not to be a necessary requirement for full
catalytic activity in many pyruvate kinase enzymes, particularly those from bacterial
sources. This may reflect differences in the three dimensional conformations adopted
by eukaryotic and prokaryotic forms of the enzyme (Benzimen,1969; Ozaki & Shiio,
1969; Chuang & Utter, 1979). The susceptibility of the terminal phospho group to
nucleophilic attack may be enhanced by the presence of Mg^+ (Reynard et al., 1961).
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1.5.2 INHIBITION-PROTECTION STUDIES
One of the earliest ways in which information about the active site was
obtained, prior to the widespread use of X-ray crystallography and site-directed
mutagenesis, was inhibition/protection studies. This technique relies on incubating
the enzyme of interest with a compound known to react only with certain specific
amino acid sidechains to produce a covalendy bound, usually inactive,
inhibitor-enzyme complex. By including substrates, individually or in various
combinations, prior to the addition of inhibitor and determining how much protection
from inhibition these treatments afforded, residues essential for binding substrates
and products or essential for catalytic activity could be identified. This approach has
been used with pyruvate kinase from various sources with varying degrees of
success.
Tanaka et al. (1967) used the sulphydryl inhibitor p-chloromercuribenzoate
(p-CMB) and found that the allosteric isoenzyme from rat liver was thirty times more
sensitive to inhibition by this reagent than the non-allosteric rat muscle enzyme.
However, Jacobsen and Black (1971) found no significant difference in the reactivity
of the allosteric human red blood cell enzyme and non-allosteric rabbit muscle enzyme
to iodoacetamide. If the kinetic similarity of the rat liver and human erythrocyte
enzymes is a reflection of structural similarity, this suggested that differences exist in
the environment of the reactive group of the isoenzymes in the absence of substrates
or cations. These differences can be detected with the relatively large p-CMB
molecule, but are insufficient to have any effect on reaction with the much smaller
iodoacetamide molecule. The rabbit muscle enzyme can be protected against p-CMB
inhibition by PEP, ADP and Mn^+ (Mildvan & Cohn, 1965; 1966). Jacobsen and
Black however, found that PEP, ADP and Mg2+ alone offered no protection against
iodoacetamide inhibtion of the rabbit muscle enzyme but that K+ and MgADP did
protect. These experiments demonstrate the difficulty of interpreting what is actually
occurring within the enzyme. Conflicting data are often produced in chemical
modification experiments. However, it appears to be the case in these experiments
that certain substrates and effectors can protect the enzyme from chemical
modification and hence a flexible environment at the active site can be inferred. That
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identical data are not produced from all the isoenzymes studied means that differences
in the isoenzyme active site do occur upon substrate/effector binding.
2,4,6-trinitrobenzene-l-sulphonic acid (TNBS, picrylsulphonic acid) has
been used to inactivate lysine sidechains in the active site of rabbit muscle pyruvate
kinase (Hollenberg et al., 1971). They observed protection against inactivation by
ADP, Mg2+ and K+ separately. TNBS has also been used to inactivate four lysine
residues essential for the activity and cooperativity of the enzyme from
S.carlsbergensis (Roschlau & Hess, 1972). Protection against inactivation was given
by PEP, ADP and Mg2+. Fructose-1,6-bisphosphate did not protect against
inactivation.
Lysine sidechains have also been inactivated in the rabbit muscle enzyme with
pyridoxal 5'-phosphate, due to Schiff base formation (Johnson & Deal, 1970).
Protection against inactivation was afforded by PEP, ADP and ATP. Two ionisable
groups susceptible to inhibition and deduced to be involved in Mn^+ binding were
identified (Mildvan & Cohn, 1966). Jacobsen and Black (1971) argued that if these
groups are also those found to be susceptible to inhibition by iodoacetamide in then-
study then they can justifiably be included within the active site as these sidechains
are protected from inhibition by substrates and cations. Subsequent X-ray
crystallographic studies suggest that the ligands for the divalent cation are Glu 271,
Ala 292 and Arg 293 (Muirhead et al., 1987).
Data from TNBS inhibition of rabbit muscle pyruvate kinase (Hollenberg et
al., 1971) suggested that the four lysyl-e-amino groups inhibited by this compound
were essential for catalytic activity and that these groups were involved in the binding
of ADP by the enzyme. Of the ligands identified by X-ray crystallographic studies as
being involved in ADP binding, only residue 114 is a lysine. Lysine 269 however, is
implicated as the proton-donating catalytic residue (Muirhead et al., 1987). It should
also be noted that three arginine residues (Arg 72, 119 and 293) were also implicated
as being important for ADP binding, and these could have been labelled by TNBS
and mistaken for the other lysine residues.
Thallium and manganese NMR binding studies indicated that the Mg^+ and
K+ binding sites are close together in the rabbit muscle enzyme (Kayne & Reuben,
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1970). The possibility that K+ and MgADP protect against inactivation is more likely
due to a shielding effect or a minor conformational change in the vicinity of the active
site.
Flashner et al.(1972) confirmed the findings of other workers when they
stated that pyruvate kinase has four active centres and that modification of the enzyme
with 5,5-dithiobis (2-nitrobenzoic acid)(DTNB) did not appreciably alter the active
site despite it becoming otherwise catalytically inactive. The reagent used appeared
only to react with eight sulphydryl groups per tetramer, four not being required for
activity and four being essential for activity.
Inhibition studies with DTNB and iodoacetamide on the pyruvate kinase from
Saccharomyces carlsbergensis allowed the identification of thiol groups that, when
chemically altered, affected the catalytic and allosteric properties of the enzyme
(Wieker & Hess, 1972). They produced a model in which they identified three
cysteine residues per subunit (labelled XI-3 in Fig 12) as essential for activity. The
model presents the enzyme after substitution at the most reactive of the three cysteine
residues studied, XI. The group XI is localised outside the active and allosteric site,
but is close enough to the active site such that substitution by a group R can influence
the binding of the substrate depending upon the size and/or charge of R. The group
X2 is part of the active site, together with one other amino acid residue or a group of
several amino acid residues, A. The pH dependence of the pyruvate kinase reaction
revealed that a group with pKa=9.0 is involved in substrate binding and that this
group becomes more acidic in the enzyme-substrate complex, pKa=8.4 i.e. this
group is ionised both in the free enzyme and the enzyme-substrate complex. Since
these pKa values are consistent with those of cysteine residues, it can be assumed that
the binding of substrates occurs at the group A and that the binding properties of
group A are determined by the state of protonation of X2, probably via a hydrogen
bond between A and X2.
The group X3 is part of the allosteric site together with another amino acid
residue or group of several amino acid residues, B. The substitution at X3 may cause
an inhibition by allosteric interactions changing the properties of the active site. This
inhibition can be overcome by fructose-1,6-bisphosphate, and therefore, the direct
binding of the activator has to occur at an additional group other than X3. This group,
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(otlostcric site)
Fig. 12 Schematic presentation of the functional thiol groups of one subunit of
pyruvate kinase (for explanations see text)
(from Wieker & Hess, 1972)
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B, may be attached to X3 by a hydrogen bond. As the sequence of the
S.carlsbergensis enzyme is not known, it is impossible to know precisely the location
of the cysteine residues referred to. It is probable that chemical modification of any
residue will result in a decrease in activity due simply to steric hindrance. From what
is known of the seven cysteine residues per subunit in the S.cerevisiae enzyme, as
revealed by computer modelling based on a knowledge of the X-ray crystal structure,
none of these residues are well placed for an essential catalytic role.
In separate experiments, using inhibition-protection of S.carlsbergensis
pyruvate kinase with TNBS, (Bornman et al., 1972; Roschlau & Hess, 1972) lysine
and histidine residues and the carboxyl groups of either glutamic acid and/or aspartic
acid were found to be essential for enzymatic activity. Thus, the groups A and B may
be composed of these amino acid residues.
1.5.3 NMR AS A PROBE OF THE ACTIVE SITE
The powerful technique of NMR spectroscopy has been applied to the study
of the muscle pyruvate kinase active site since the early 1970s (Nowak & Mildvan,
1972). These authors used competitive analogues of PEP and measured the
longitudinal and transverse relaxation rates of their protons and phosphorus atoms to
analyze reactions at the enzyme active centre. They concluded that substrates become
more tightly bound as the reaction centre phosphorus is approached (i.e. the
phosphorus atom destined to take part in the phospho transfer reaction). Such
immobilization would allow orientational or entropic effects to operate in enzyme
catalysis. They also described diagramatically a composite model of the ternary
analogue and normal substrate complexes of pyruvate kinase, indicating likely
conformations around the active site (Fig 13). A role for K+ is also noted. The
geometry of the composite model is based on kinetic and binding data and on
distances calculated from nuclear relaxation data on the Mn2+-activated enzyme.
Motion of the analogues (and by implication, the natural substrate PEP) is hindered at
the reaction centres where protonation and phospho transfer are taking place.
An early consensus as to the likely structure of the active site suggested a
relatively rigid conformational arrangement of the two substrates and two activating
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Fig. 13 Upper figure- a composite model of the ternary analogue complex of
rabbit muscle pyruvate kinase (E-Mn2 +-phospholactate-K+) based on
NMR data. The van der Waals radius of the methyl group of phospholactate
is shown to interact with the group BH which protonates PEP.
Lower figure- ternary complex as above except that the substrate PEP
replaces the substrate analogue.
(from Nowak & Mildvan, 1972).
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cations (Kayne, 1973). Accessibility to the solvent was assumed to be good due to
the high turnover number (250s~l), the report of the stereospecific reduction of
pyruvate and the results of tritium exchange experiments discussed elsewhere. In
contrast however, an exclusion of solvent (H2O ) is implied by the limited amount of
H2O in the Mn^+ coordination sphere measured by proton relaxation rate
enhancements of the binary complex, and by the fact that H2O would make an
excellent phospho acceptor if available to the group undergoing transfer. Further
NMR studies indicated that the metal-y phosphate distance of 5A (Sloan & Mildvan,
1976) for pyruvate kinase-bound ATP was equal to that found for the phosphorus
atom of PEP and Co2+ on pyruvate kinase (Melamud & Mildvan, 1975) which was
consistent with the overlap in space of the PEP phosphorus and the y-phospho group
of ATP at the active site.
1.5.4 ADP ANALOGUES AS PROBES OF THE ACTIVE SITE
The ADP analogue 5'-p-fluorosulphonylbenzoyladenosine (FSBA) reacts
with the active centre of the S.carlsbergensis pyruvate kinase and also at a secondary
site (probably the other nucleotide binding site on the enzyme) to produce an inactive
complex (Likos et al., 1980). The reagent reacted with both lysine and tyrosine
residues and these have therefore been considered to be important residues in the
nucleotide binding site.
Other ADP and ATP analogues have also been used in an attempt to further
characterise the nucleotide binding site in pyruvate kinase. Rabbit muscle pyruvate
kinase was inhibited by 8-thiocyano-ATP (Scheiner-Bobis et al., 1992).
Use of the ADP analogue 2',3'-dialdehyde-ADP has also been demonstrated (Bezares
et al., 1987). Studies using the ATP analogue 8-(4-bromo-2,3-dioxobutyl)thiol-
adenosine 5'-triphosphate resulted in the inactivation of the rabbit muscle enzyme due
to covalent modification of cysteines 48, 62 and 151. Protection against inactivation
was given by PEP, K+ and Mn^+ to cysteines 48 and 151 only, indicating that these
two residues are involved in the maintenance of enzyme activity, possibly through
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substrate binding (Vollmer & Colman, 1990). According to Muirhead et al. (1987),
the primary residues involved in binding the phosphate groups of ADP in the cat
muscle enzyme are Cys 455, Lys 114, Arg 119 and possibly Arg 72 and Arg 293.
Residues involved in binding the adenine ring of ADP are lie 118, Val215,Val 220
and Phe 243. All of these residues are conserved in the yeast enzyme except Val 220
which is changed to leucine. The fact that three cysteine residues have reacted with
the ADP analogue does not mean that they are necessarily involved in ADP binding.
The sulphydryl groups are the most reactive sidegroups in proteins (Scopes, 1987)
and would be expected to react with any reactive ADP-analogue under the conditions
of the assay.
1.5.5 OTHER SPECTROSCOPIC STUDIES OF THE ACTIVE SITE
Studies by Lodato and Reed (1987) exploited the intrinsic selectivity of the
protein-based site for Mn^+ and of the nucleotide-based site for Mg^+ for analysis by
electron paramagnetic resonance spectroscopy (EPR) of the ligands for Mn^+ at the
protein-based site. They used oxalate, a structural analogue of the enolate form of
pyruvate, as a surrogate for the reactive form of pyruvate in complexes with enzyme,
Mn2+, Mg2+ and ATP. The results showed that oxalate is bound at the active site as
a bidentate chelate with Mn2+. Further experiments revealed that ATP bridges Mn^+
and Mg2+ at the active site. The authors were able to postulate a mechanism for the
reverse reaction of pyruvate kinase by analysis of the structure of the
enzyme-Mn2+-oxalate-Mg2+-ATP complex. They also described a model of the
conformation of substrates at the active site (Fig 10).
The essential lysine residue present in the active site of the cat skeletal muscle
pyruvate kinase (Muirhead et al., 1986) has also been identified in bovine and rabbit
sources (Johnson et al., 1969; Bezares et al., 1987) and in S.cerevisiae (Imarai et al.,
1988) by modification with TNBS. Protection experiments suggested that these
residues were related to the nucleotide-binding site of the enzyme. The lysine residue
in question was identified by peptide analysis as lysine 337 in S.cerevisiae (see Table
1).
Electron spin echo envelope modulation (ESEEM) spectroscopy studies of
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rabbit muscle pyruvate kinase in the presence of substrates, products and cofactors
indicated that ATP was directly coordinated to Mn^+ at the protein based site (Tipton
et al., 1989). Furthermore, the close proximity of the monovalent cation and the
protein based divalent cation was also demonstrated. From the ESEEM studies a
picture of the active site emerged in which it appeared to be a flexible and dynamic
environment. In addition to observing coordination of ligands to the protein based
metal ion, the authors determined that the position of the catalytic lysine in the active
site was sensitive to the nature of the monovalent cation and to the presence of other
species in the active site. Furthermore, the monovalent cation appeared to play a role
in determining active site geometries.
The high density of negative charge carried into the active site by the anionic
substrates is balanced by the triad of inorganic cations that specifically activate the
enzyme.
Recent data on the pyruvate kinase catalysed decarboxylation of oxaloacetate
indicated that metal coordinated water was displaced during the binding of substrates
and effectors (Kiick & Cleland, 1989).
Knowledge of the conformations and arrangement of substrates bound at the
active sites of enzymes can yield valuable information as to the mechanism of enzyme
action. Although the active site and mechanism of action of pyruvate kinase have been
a subject of study for many years, geometric information on the active site has thus
far been incomplete. X-ray crystallographic studies have been able to unambiguously
locate the binding sites of the two substrates. The thermodynamic and kinetic
properties of complexes detected in the crystallographic state are difficult to
determine, leaving open the possibility that they are not functional in catalysis.
Information from NMR studies (Mildvan et al., 1976) using information from two
paramagnetic probes, allowed the construction of the total substrate geometry at the
active site of the rabbit muscle pyruvate kinase enzyme (Figs 8 and 10).
1.5.6 SUMMARY
A variety of studies have identified many residues important in catalysis and
substrate binding. Early studies utilised residue-specific modifying agents to identify
45
ligands important in catalysis. These studies were limited largely to the identification
of highly reactive residues such as lysine, arginine, histidine and cysteine. Later
studies exploited more sensitive spectroscopic techniques. This allowed highly
sensitive measurements to be made and resulted in the determination of the total
geometry of the active site. X-ray crystallographic studies have identified the specific
ligands involved in substrate binding and catalysis.
Analogues of the substrates ADP and PEP, and the metal cations Mg2+ and
K+, allowed theories of the structure and disposition of ligands at the active site to be
postulated and tested.
In summary, ADP appears to be coordinated to an enzyme-bound divalent
cation and to another divalent cation not linked to the enzyme. The PEP molecule is
coordinated to the monovalent cation by its carboxyl group. As a result, the phospho
group of PEP is sufficiently close to undergo transfer to ADP to form ATP and
pyruvate. A proton is donated to the enol-form of the product, which is postulated to
exist in a transition state complex with the enzyme, via lysine 269. The proton is
ultimately derived from the solvent and is transferred to the active site by a proton
relay mechanism probably involving Glu 271. This results in the formation of the
keto-form of the product, which is subsequently released.
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1.6 SUBSTRATE SPECIFICITY
Early studies on the enzyme revealed that pyruvate kinase has a broad
specificity towards the nucleotide substrate of the reaction (Boyer, 1962). Specific
activities and Michaelis constants for several diphosphates have been determined
(Plowman & Krall, 1965). The maximum velocities at pH 7.5 were in the order: ADP
= GDP > IDP > dADP > UDP > CDP > dCDP with CDP having 30% and dCDP
having 0.3% the activity of ADP. However, the Km ADP was a factor of four lower
than for GDP or any of the others. This suggests that the nucleotide binding portion
of the active site does not have very stringent steric (or catalytic) requirements.
Studies on ADP analogues shows that the phosphate ester portion of the molecule
does have some structural restrictions (Setondji et al., 1971). Reversible inhibitors of
PEP-utilising enzymes have been used to characterise the substrate binding properties
of these enzymes. Useful compounds include 1-hydroxy-1-cyclopropane carboxylic
acid phosphate (O'Leary et al.,1981), phosphoglycolate, phospholactate and
phosphoenol-a-ketobutyrate (Rose, 1970).
Work using PEP analogues indicated quite a high degree of specificity
towards the phosphate donor component of the reaction. There is no carbon
asymmetry in the enolpyruvate or pyruvate, but the introduction of deuterium and
tritium into the molecule allowed a determination of any stereospecificity in the
reaction. By using phosphoenol-a-ketobutyrate as the substrate, and studying the
stereochemistry of the product, it was discovered that proton addition to PEP occurs
from a specific direction i.e. the 2-si face of the molecule (Rose, 1970).
Dead-end inhibition of the pyruvate kinase catalysed decarboxylation of
oxaloacetate by the physiological substrate PEP indicated that PEP binds only to the
enzyme-metal ion complex and not to the free enzyme (Kiick & Cleland, 1989).
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1.7 THE DIVALENT CATION
The necessity for a divalent cation in the pyruvate kinase reaction has long
been known (Boyer et al., 1954). It is now known that two divalent cations are
required for catalysis of the enolization of pyruvate in the presence of ADP. One
divalent cation is bound directly to the enzyme and interacts with the bound ATP
through an intervening water ligand (site 1). The second divalent cation is directly
coordinated to the phospho groups of ATP and does not interact with the enzyme (site
2) (Gupta et al., 1976). A requirement for two divalent cations per active site has
previously been suggested for PEP carboxylase (Foster et al., 1967). A dual divalent
cation requirement for pyruvate kinase is consistent with all of the early and more
recent structural and binding data on this enzyme (Mildvan, 1974).The interaction of
the metal ions and the substrates are shown in detail in Fig 10, derived from NMR
studies and model building.
In vivo, Mg2+ serves as the divalent metal ion. In vitro however, Mn2+,
Co2+ and Ni^+ can all serve (Robinson & Rose, 1972; Melamud & Mildvan, 1975;
Kwan et al., 1975).
The role of the enzyme-bound metal is probably to adjust the protein
conformation and to orientate water ligands near the phospho groups of the substrate
(Suelter & Melander, 1963). More specifically, the enzyme-bound M^+ serves to
position the substrates and influences the electronic distribution at the C2-0 bond of
pyruvate and the acidity of the C3-H. The nucleophilic C2-0 of the enolpyruvate
carries out the in-line displacement of the bg bridge oxygen of ATP to form PEP and
ADP, in the reverse reaction (Hasset et al., 1982). The enxyme-based divalent cation
has also been implicated in the cooperative binding of PEP to the enzyme-Mn^+
complex (Nowak & Lee, 1977).
The role of the nucleotide-bound metal is probably to adjust the
polyphosphate conformation and to polarise, and thereby increase the electrophilicity
of, the y-phospho group of ATP which is in molecular contact with the carbonyl
oxygen of pyruvate, as determined by NMR spectroscopy (Mildvan et al., 1976).
The nucleotide-bound metal has no direct role in adjusting the protein conformation,
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since its role can be filled by Cr3+ which is substitution inert and therefore cannot
acquire ligands from the enzyme. Another role of the nucleotide-bound metal is to
activate the base which deprotonates pyruvate in the reverse reaction (Robinson &
Rose, 1972).
It was found that Ca^+ is an activator of the enzyme at low Mg^+ and Ca^+
concentrations; otherwise it is an inhibitor at the protein-based site (Boiteux et al.,
1983). These effects can be explained by assuming that Ca^+ has the same binding
properties as Mg2+ but does not allow a catalytic turnover.
Crystallographic studies have identified the M^+ binding sites as oxygen
atoms of the protein and substrates (Muirhead et al., 1986). These are contained in an
alpha/beta barrel domain of the enzyme. The residues involved were found to be the
carboxyl group of Glu 271, and the carbonyl oxygens of Ala 292 and Arg 293. A
charged lysine 269 is believed to be well-placed for transfer of a proton to the 2-si
face of enolpyruvate (Rose, 1970).
A variation in the rate of the enolization reaction was seen when different
divalent cations were used to activate the enzyme. The rates decreased in the order
Co2+ > Ni^+ = Mn^+ > Mg2+ which correlated with the increasing pKa of the water
ligands of these divalent cations indicating that the electonegativity of the
nucleotide-bound, rather than that of the enzyme-bound metal, determined the rate of
enolization.
25Mg2+-NMR has recently been adapted as a useful spectroscopic tool in the
study of Mg2+ interactions with macromolecules. Such studies of magnesium-
binding proteins can provide valuable information, such as pKa values for binding-
site ligands, binding constants and exchange rates for the Mg2+-protein complexes,
and Mg2+ binding to genetically altered enzymes. Such studies have also been
applied to rabbit muscle pyruvate kinase, although the results in this instance were
inconclusive due to experimental difficulties which resulted in the precipitation of the
enzyme (Lee & Nowak, 1992).
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1.8 THE MONOVALENT CATION
Pyruvate kinase was the first enzyme which was shown to require a
monovalent cation for activity (Boyer et al., 1942). A monovalent cation requirement
has since been found for many different classes of enzyme e.g. acetate kinase (EC
2.7.2.1), oxaloacetate decarboxylase (EC 4.1.1.3) and threonine dehydratase (EC
4.2.1.16) (Suelter, 1970). The mode of action of the monovalent cation has yet to be
fully elucidated for any of the systems studied. The general role proposed for
monovalent cations has been to induce a conformational change in the enzyme
yielding the active form (Kachmer & Boyer, 1953; Evans & Sorger, 1966; Happold
& Beechey, 1958). The primary bases for this suggestion were the correlation of
enzymatic activity with the ionic radii of the ions, and the high concentrations of
monovalent cations required for maximal effect (5-100mM). These findings were
confirmed by others who also found that activating cations could change the
spectroscopic (Suelter et al., 1966) and immunoelectophoretic (Sorger et al., 1965)
properties of an enzyme or the NMR spectral properties of an
enzyme-Mn2+-substrate complex (Mildvan & Cohn, 1966).
From a survey of enzymes requiring monovalent cations a direct role for K+
in stabilizing an enolate intermediate formed during catalysis was proposed (Suelter,
1970). Further, a direct role for K+ in the pyruvate kinase reaction was obtained by
T1+ NMR studies indicating that the monovalent activator binds within 8A of the
Mn^+ binding site (Kayne & Reuben, 1970). This was confirmed in ESEEM
spectroscopic studies of the rabbit muscle enzyme (Tipton et al., 1989).
The observation that K+ decreased the affinity of enzyme-Mn^+ for PEP
analogues which lacked a free carboxyl group, and the evidence that Mn^+ binds the
phospho group being transferred (Mildvan et al., 1976) suggested that the carboxyl
group of PEP and its analogues were coordinated by the enzyme-bound K+. This
would allow the proper alignment of its phospho group for nucleophilic attack.
Indeed, it has been proposed that this single event may be sufficient to activate the
enzyme.
NMR relaxation techniques provided evidence that the monovalent cation has
a specific binding site on the enzyme near the PEP/pyruvate binding site (Rauschel &
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Villafrancha, 1980).
Studies have revealed that NH4"1" also activates pyruvate kinase in the
absence of K+. It also appears that activating NH4+ and K+ facilitate one another's
binding, but do not appear to compete for binding at a single site (Rhodes et al.,
Studies on the pyruvate kinase catalysed decarboxylation of oxaloacetate
indicated that there is no change in the initial velocity patterns or the kinetic
parameters in the presence or absence of K+, indicating that this cation is not required
for this reaction. It has been noted that monovalent cations are often not required for
the normal pyruvate kinase reaction in several bacterial forms of the enzyme and that




1.9 BINDING OF FRUCTOSE-1,6-BISPHOSPHATE
Very little is known about the details of Fru-1,6-P2 binding to pyruvate
kinase. A second nucleotide binding site was identified in X-ray crystallographic
studies (Muirhead et al., 1987). It was postulated that this site could also function as
an effector binding site in the allosterically regulated enzymes. As the muscle enzyme
is not regulated by allosteric effectors, any indication of a binding site must remain
tentantive until a crystal structure of an allosterically regulated form of the enzyme in
the presence of effector is determined. Three peptides purporting to define the effector
binding site in E.coli were isolated and sequenced (Speranza et al., 1989) and
supported this earlier work. Differences between these regions and those of various
plant pyruvate kinases have been indicated as the explanation for the non-binding of
Fru-1,6-P2 to these enzymes. (Blakeley et al.,1990). A direct relationship between
the Fru-1,6-P2 binding region and hydrophobic regions on the enzyme surface
emerged from studies of the binding of the fluorescent probe 8-anilino-l-naphthalene
sulphonate to the enzyme. The effector was observed to displace the bound probe
from approximately half the sites, indicating the apolar character of the Fru-1,6-P2
specific region (Kapoor, 1976).
Studies on Fru-1,6-P2 binding to the pyruvate kinase from E.coli
demonstrated that this effector binds to the enzyme via its phospho groups. This was
deduced by examining the effect of increased ionic strength of the assay media on the
extent of Fru-1,6-P2 activation (Speranza et al., 1989). Hydrogen bonds between
enzyme and effector are also implicated. Potential ligands for the sugar moiety of
Fru-1,6-P2 have been identified in computer modelling studies of the yeast enzyme
(Clayden, 1987). The effect of Fru-1,6-P2 on the E.coli enzyme can be modified by
the hydrogen bond-disrupting agent formamide (Speranza et al.,1989).
The importance of phospho groups in the binding of Fru-1,6-P2 had also
been suggested for the yeast enzyme some time earlier (Haeckel et al., 1968). Other
workers (Fell et al., 1974) observed that Fru-1,6-P2 affected the thiol group
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reactivity and cold lability of the yeast enzyme suggesting a significant conformational
change occurs on the binding of this molecule.
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1.10 CONFORMATIONAL CHANGES IN PYRUVATE KINASE
The major conformational change that occur in allosteric proteins, that is of
interest to kineticists, is the R to T transition. Allosteric proteins are assumed to adopt
two extreme conformations. The inactive T state is characterised by a low affinity for
substrate, whilst the active R state is characterised by a higher substrate affinity. The
change from T to R is assumed to occur upon binding an allosteric activator.
Conversely, allosteric inhibitors favour the adoption of the T state over the R state,
and decrease the activity of the enzyme. The allosteric pyruvate kinase enzymes
appear broadly to follow this pattern of two extremes of possible conformation. The
non-allosteric muscle enzyme can be made to adopt a less active conformation in the
presence of non-physiological amounts of the allosteric inhibitor phenylalanine,
otherwise it appears to be permanently locked in the active R state. The finding that
two conformations can be induced in the rabbit muscle enzyme has made this protein
a model for studying allosteric transitions. This may be more to do with the
availability and stability of muscle enzyme preparations than the physiological
relevance of the results. The kinetic properties of the various pyruvate kinase
isoenzymes can be explained by the existence of several different conformational
states for the tetrameric enzyme ranging from a T-state with a low affinity to an
R-state with high affinity for the substrate. The high affinity state is stabilized by
PEP, Fru-1,6-P2 and low pH. The low affinity T-conformation is stabilized by ATP,
alkaline pH, gluconeogenic amino acids such as alanine and the phosphorylation of a
serine residue near the N-terminus (present only in the R and L isozymes from
vertebrates)
Sequence variability in the intersubunit contact areas may affect the
equilibrium between the R and T quaternary structures and give rise to the different
kinetic properties observed.
A variety of techniques can be used to study conformational changes
occurring in proteins upon the binding or release of substrates, products and
effectors. Experimental techniques such as fluorescence quenching and relaxation,
phosphorescence and NMR spectroscopy point to a rather fluid, dynamic structure
54
for globular proteins involving rapid conformational fluctuations which allow
relatively easy, if somewhat transient, accessibility of interior groups to solvent and
molecular probes.
On the other hand, data from X-ray crystallographic studies indicated that the
packing densities of groups within globular proteins are as high as those found for
solid, crystalline amino acids and small organic compounds suggesting a rather rigid
and static view of these proteins.
Although it is difficult to conceive macroscopic systems having both fluid and
solid-like behaviour at one and the same time, these properties are perfectly
compatible with the microscopic nature of individual protein molecules.
1.10.1 FLUORESCENCE MEASUREMENTS
One of the earliest techniques to be used in this way on pyruvate kinase was
analysis of fluorescence quenching of tryptophan residues in the enzyme from
S.cerevisiae (Kuczenski & Suelter, 1971). This technique had been used successfully
to show that binding of cations to the rabbit muscle pyruvate kinase resulted in
relatively low tryptophan fluorescence quenching and thus minor changes in
conformation (Suelter, 1970). More extensive changes in conformation in the yeast
enzyme were recorded after the addition of Mg2+, K+, PEP, ADP and also after
raising the temperature of the enzyme solution from 0°C to 30°C. The results
suggested that the conformation adopted in the presence of Mg2+, K+ and PEP is an
intermediate on the path to the kinetically active conformer. The nucleotide, ADP, is -
required to complete the transition. However, an alternative explanation, arising if
ADP does not provide the driving force to complete the conformational transition,
argues for the existence of two different active conformers controlled by fructose-1,6-
bis- phosphate or K+. This alternative was supported by the antagonistic effect of K+
on the binding of Fru-1,6-P2 and further suggested a dual role for K+:
1) as a required cation for catalysis in the presence and absence of Fru-1,6-P2
2) in producing a unique active conformer in the absence of Fru-1,6-P2
Such a dual role is consistent with the observation that Na+ can substitute for K+
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only in the presence of Fru-1,6-P2 (Hunsley & Suelter, 1969). The similar
fluorescence changes seen in the rabbit muscle enzyme and the yeast enzyme as the
temperature is lowered indicated a common conformational transition in both
proteins. The similarity of the responses in the Fru-1,6-P2- activated enzyme to those
of the muscle enzyme further suggested a similar active conformer for each,
especially when one considers that the rabbit muscle enzyme is considered not to be
allosterically activated whereas the yeast enzyme is typical of the allosteric
isoenzymes activated by Fru-1,6-P2
Many allosteric enzymes contain metal ions or require the addition of metal
ions for activity. Hence, an approach to the understanding of the mechanism of
allosteric interactions is to compare the binding of metal ions and substrates to
allosteric and non-allosteric enzymes which catalyse the same reaction. Such a
comparative study has been undertaken for pyruvate kinase (Cottam et al., 1972).
They used water proton relaxation rate measurements and kinetic studies of ternary
complexes in the analysis of rabbit muscle and yeast pyruvate kinase. Their results
indicated that similar structures exist for the ternary complexes
enzyme-Mn2+-substrate of the yeast and muscle enzymes. They suggested that, as
with the muscle enzyme, the yeast enzyme may bind the phospho group of PEP
through a Mn^+ bridge. Fructose-1,6-bisphosphate appeared to increase the affinity
of the yeast enzyme for PEP, perhaps by adjusting the structure of its proposed
carboxyl binding site. Fructose-1,6-bisphosphate appeared to have no effect on the
binding of ADP but abolished the homotropic effect of PEP.
A variety of different techniques have been developed over the years to detect
and measure the extent of conformational changes in pyruvate kinase derived from
many different sources, such as ultraviolet difference spectroscopy (Suelter &
Melander, 1963), tryptophan fluorescence (Suelter, 1967), ultraviolet circular
dichroism spectra (Wildes et al., 1971), sedimentation velocity and optical rotatory
dispersion studies (Kayne & Suelter, 1968). Thermodynamic data obtained from
equilibrium studies of the conformational changes could apparently be described
adequately by a model in which the yeast enzyme existed in two conformations, the
equilibrium between which were strongly temperature dependent (Kayne & Suelter,
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1968).
Electron paramagnetic resonance (EPR) studies of enzyme-Mn^+ binary
complexes have given direct evidence for the muscle enzyme existing in more than
one conformational state (Reed & Cohn, 1972).
Study of E.coli pyruvate kinase (Markus et al., 1980) allowed an extension of
the concerted model of allosteric interaction between enzymes and effector molecules
(Monod et al., 1965). The extension proposed consisted of three conformational
states and four protomers. Only one conformational state forms the catalytically active
complex with PEP, ADP and Mg2+. A second conformational state binds ADP and
Mg2+ In the absence of ligands, most of the enzyme is in a third state that can bind
ADP at the active site and ATP at an allosteric site. Fructose-1,6-bisphosphate is
assumed to exert its effect by binding exclusively to the allosteric site of the
conformational state that forms the active complex (Fig. 14A).
Binding of substrates to the enzyme in solution causes a reduction in the
radius of gyration of the tetramer such as might occur as a result of a substrate-
induced closure of the cleft of the active site (Consler et al., 1988).
Some studies on the nature and conformation of pyruvate kinase have
produced unusual results. Rabbit muscle pyruvate kinase was correctly identified as a
tetramer with a monomelic subunit size of 57.2kD (Steinmetz & Deal, 1966).
However, it was suggested that the enzyme existed as two identical catalytic particles
(or protomers) each 115kD in size, with each protomer consisting of two polypeptide
chains. It was erroneously thought that the two polypeptides within each protomer
were not identical due to the incorrect finding that only one Mn2+ and one PEP
molecule bound to each protomer. This study did however, confirm the lack of any
covalent linkages between subunits as it was found that complete dissociation of the
enzyme occurred in 4M urea.
Protein difference spectroscopy has been used to measure the dissociation
constants for the interaction of monovalent cations, divalent cations and substrates
with the yeast enzyme (Suelter at al, 1966). The difference spectrum was found to be
due to a change in the environment of the tryptophanyl residue brought about by a
change in the conformation of the protein molecules (Kayne & Suelter, 1968). A












Fig. 14 Different conformations of E.coli pyruvate kinase induced by
various ligands.
A) Data from Markus et al., 1980
B) Data from Speranza et al., 1989
See text for details.
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or non-activated enzyme although no significant difference spectrum was observed
when ADP or ATP was titrated with either enzyme form.
Studies on Neurospora pyruvate kinase revealed several ligand-induced
conformational changes by measuring the intrinsic protein fluorescence of the native
enzyme and variously ligated complexes. Ultraviolet difference spectroscopy,
chemical modification of exposed residues, interaction with fluorescent probes,
differential proteolysis and inactivation by protein denaturants showed similar results
(Kapoor, 1976). As a result it was concluded that the two state model based on the
symmetry model of Monod et al. (1965) was clearly inadequate to describe the
conformational changes induced in the protein upon ligand binding.
Thermodynamic analyses tell us little of the nature of the fluctuations or their
kinetics that occur within proteins. Presumably the majority of the fluctuations
involve small, rapid changes in the bond lengths and angles of individual groups in
the polypeptide chain, but these may readily combine to give gross changes in
conformation. It was apparent from studies involving relaxation processes (Grinvald
& Steinberg, 1974) that sizeable conformational fluctuations are possible and cover a
time range from nanoseconds, or less, up to minutes or hours (Cooper, 1976).
Studies of the interactions of monovalent and divalent cations with rabbit
muscle pyruvate kinase by a variety of techniques indicated that the metal-enzyme
complex had a conformation that was different from that of the free enzyme. As a
result of this conformational transition, a blue shift in the protein spectrum was
observed, which could be interpreted as meaning that one or more tryptophanyl
residues were brought into an aqueous environment. A similar spectral shift was
observed when the temperature of an aqueous solution of pyruvate kinase was
lowered from 30°C to 0°C. The fluorescence emission difference spectrum has a
broad maximum between 330-350nm. Such emission is characteristic of tryptophanyl
fluorescence, confirming the perturbation of such residues during a conformational
transition, suggesting a transfer from a non-aqueous to an aqueous environment. The
correspondence between the spectrophotometric and fluorimetric observations
confirmed the existence of at least two different enzyme forms.
Pyruvate kinase is a model regulatory enzyme as demonstrated by its extreme
flexibility, witnessed by the array of conformational transitions detectable in
59
interaction with a range of ligands- e.g. metal ions (Nowak, 1976), substrates
(Reubens & Kayne, 1971) and allosteric effectors (O'Brien & Kapoor, 1975). The
effects of ligands on the quaternary structure of Neurospora pyruvate kinase was
evaluated by means of intersubunit cross-linking utilizing diimidoesters,
dimethylsuberimidate (DMS) and dimethyladipimidate (DMA) (Kapoor, 1976). The
results of these cross-linking experiments indicated that the binding of Fru-1,6-P2
leads to an alteration of the interprotomeric distance between crucial lysine residues,
involved in the cross-linking reaction. This conclusion was based on the following
evidence: DMS reacts with the unligated enzyme to form primarily monomers and
cross-linked dimers whereas DMA treatment resulted in the formation of cross-linked
dimers, trimers and tetramers. On repeating these experiments using pyruvate kinase
preincubated with Fru-1,6-P2, the cross-linking pattern was dramatically altered:
DMS treatment now led to the formation of cross-linked trimers and tetramers which
could be prevented by addition of the allosteric inhibitor valine. This suggested that in
the enzyme-(Fru-l,6-P2) complex the e-amino groups of the lysyl residues
participating in the interprotomeric cross-linking are situated further apart allowing the
longer DMS molecule to "fit" between them. The conformational change promoted by
Fru-1,6-P2 results in a significant alteration of the geometrical arrangement of the
subunits in the pyruvate kinase tetramer.
1.10.2 TEMPERATURE-INDUCED CONFORMATIONAL CHANGES
Low temperature instability in proteins (such as that observed in certain forms
of pyruvate kinase) indicate that associations between apolar groups, significantly
weakened at low temperature, are important in such proteins (Kauzmann, 1959). An
examination of the kinetics of dissociation of S.cerevisiae pyruvate kinase, produced
by low temperature incubation of the enzyme in the absence of activating metal
cations, suggested the existence of two types of subunit interaction (Kuczenski &
Suelter, 1970). Hydrophobic forces are assumed to predominate between the dimers
whilst electrostatic forces predominate between subunits of the dimer. The
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dissociation at low temperature was promoted by Fru-1,6-P2- This is taken as direct
evidence that this ligand produced an alteration in the quaternary structure of yeast
pyruvate kinase and supports the contention that allosteric ligands affect
conformational transitions from one enzyme form to another. These authors
concluded their report by postulating the existence in solution of an equilibrium
between two or more tetrameric forms of the enzyme, and that both forms exist in the
absence of Fru-1,6-P2- Inactivation in the absence of Fru-1,6-P2 would depend on
the equilibrium distribution, and addition of Fru-1,6-P2 would merely produce a shift
in equilibrium concentration of the two forms.
1.10.3 SUBSTRATE-INDUCED CONFORMATIONAL CHANGES
A mechanism of protection by a shielding effect or a minor conformational
change in the vicinity of the active site is an interesting theory. It could be brought
about by the binding of substrates, with the result that a group susceptible to
inactivation is no longer exposed (Jacobsen & Black, 1971).
A significant role for ADP in the determination of enzyme conformation in
S.cerevisiae pyruvate kinase was suggested from analysis of the fluorescence
quenching data (Kuczenski & Suelter, 1971), although this was contrary to the
kinetic data reported earlier (Hunsley & Suelter, 1969).
After an investigation into the mechanism of reaction of kidney (M2) and
muscle (Ml) pyruvate kinases by kinetic, equilibrium and structural measurements
(Consler et al., 1989), the simplest model which seemed to rationalize the
experimental data was a concerted, allosteric model analogous to the two-state model
of Monod, Wyman & Changeux (1965). It was found that at pH 7.5 and 23°C, the
kidney enzyme existed mostly in an inactive form whilst the muscle enzyme was
present almost exclusively in the active conformation.
The conformational transition underlying the regulation of pyruvate kinase
activity involves a contraction and expansion of the global structure of the enzyme
regulated by the presence of metabolites. The change in the hydrodynamic properties
was characterised by a rotation of one domain (domain B) relative to the remainder of
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the subunit. PEP, Mg2+ and K+ are the ligands that facilitate the domains to move
closer to each other, "priming" the enzyme for catalytic activity. However, these
domain movements only affect the local region around the active site of each subunit.
From X-ray crystallographic data (Stammers & Muirhead, 1977) it was
shown that the inter-domain region which was involved in cleft closure did not
participate directly in intersubunit contacts: thus it was highly unlikely that this
structural region was responsible for the intersubunit contact that led to the
cooperative nature of the structural change. Hence, additional conformational changes
must accompany the domain movement, and these must involve intersubunit contact
sites so that conformational communication exists among the four subunits.
The fluorescence excited state lifetimes of tryptophan residues has been used
as a probe for conformation in the Ml and M2 isozymes from rabbit muscle. Studies
on the rabbit muscle Ml and M2 isozymes imply that in the absence of allosteric
effectors these two isozymes may normally exist in different distributions between
conformational states and that interconversion between alternate conformers occurs.
The abolition of the sigmoidicity by Fru-1,6-P2 observed in the E.coli
enzyme, suggested that this ligand binds to the allosteric site of the catalytically active
state (Rl) more strongly than it does to the other conformational states of the enzyme.
The addition of Fru-1,6-P2 thus displaces the various conformations towards the
state Rl.
1.10.4 THEORETICAL CONSIDERATIONS ON CONFORMATIONAL
CHANGE
Abrupt transitions in spectroscopic properties of proteins are conventionally
ascribed to conformational change. This may be misleading, because spectral
properties can be affected by other processes not necessarily associated with
discernable changes in polypeptide geometry (Cooper, 1981).
A general model whereby ligand induced changes in protein dynamics could
produce allosteric communication between distinct binding sites, even in the absence
of a macromolecular conformational change, has been produced (Cooper & Dryden,
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1984). The effect arises out of the possible changes in frequencies and amplitudes of
macromolecular thermal fluctuations in response to ligand attachment. Long range
influence of kinetic processes at different sites might also be mediated by a similar
mechanism.
Allosteric effects, involving communication between distant ligand binding
sites on biological macromolecules, are central to many physiological control and
receptor processes. Conventionally, these effects are ascribed to ligand-induced
conformational changes transmitted through the macromolecule and across subunit
boundaries.
It was shown that it was possible to explain cooperative ligand binding in
terms of the frequency and amplitude of atomic motions about fixed mean positions
i.e. without a conformational change in any sense that could be determined
structurally.
It would appear that high concentrations of Fru-1,6-P2 (greater thanlmM)
loosen the structure of pyruvate kinase, simultaneously destroying the basis for
inter-site interaction and releasing the constraints that limit substrate affinity in the
unmodified enzyme (Morris et al., 1986).
As the observed enzymic activity is the sum of a series of different reactions
e.g. substrate and effector binding, protein isomerization, etc, any change in the
primary sequence might affect a specific equilibrium e.g. isomerization, which would
ultimately lead to a change in the regulatory behaviour of the enzyme. Also, sequence
changes might exert a global effect on the enzyme, leading to changes in most if not
all of the equilibria characterising the enzyme reaction (Consler et al., 1989).
A non-physiological T to R state conformational change can be induced in
rabbit muscle pyruvate kinase by high concentrations (12mM) of phenylalanine. This
system has acted as a model for the allosteric transition in some studies.
Through intensive kinetic and structural analysis, rabbit muscle pyruvate kinase was
shown to be well described by a simple two state model (Consler et al., 1989). All
kinetic behaviour of the enzyme could be explained by changes in distribution
between the T and R states caused by ligand and substrate binding. The T to R
transition was shown to involve global conformational change. A general equation
63
was derived to express the kinetic data in terms of equilibrium constants for the
binding of substrates and ligands, rate constants for catalysis, and the isomerization
constant for the R to T equilibrium. In this way it was possible to predict the
distribution between R and T states. For example, the distribution of pyruvate kinase
from 91% R to almost 100% T could be achieved by the addition of 12mM
phenylalanine. It was also possible to predict the distribution of the T state as a
function of phenylalanine concentration in the presence or absence of the substrate
PEP.
The pyruvate kinase-phenylalanine complex exhibited a larger Stokes radius
i.e. it was more asymmetric or expanded, which is an observation that is in total
agreement with that from a study using neutron scattering (Heyduk et al., 1992).
Crystallographic data showed that for a number of protein systems, transition
between the allosteric states involved a significant rotation of the subunits with
respect to each other (Evans, 1992). Furthermore, in all the crystalline structures, all
subunits assumed the same structure i.e. structural symmetry was always preserved,
regardless of the specific conformational state that the protein was in. Hence, it seems
that systems exhibiting a positive cooperative mechanism undergo a concerted global
structural change as is the case with pyruvate kinase (Heyduk et al.,1992).
1.10.5 FRUCTOSE-l,6-BISPHOSPHATE-INDUCED
CONFORMATIONAL CHANGES
Studies on the Fru-1,6-P2 activated pyruvate kinase from E.coli indicated that
Fru-1,6-P2 formed ionic bonds with the enzyme through its two phosphate groups
and also that hydrogen bonding played a critical role in stabilizing both the inactive
and active enzyme conformers (Speranza et al.,1990).
By using NaCl and formamide to disrupt ionic and hydrogen bonding
respectively it was found that formamide weakened hydrogen bonds peculiar to the
inactive enzyme conformation, which predominated at low substrate concentrations,
thus facilitating the transition to the active conformation. Also, formamide hampered
the formation of new alternative hydrogen bonds which stabilized the active
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conformation. Thus, the transition from the inactive to the active conformation of the
enzyme mainly depends on the breaking and formation of sets of hydrogen bonds
peculiar to each of the conformers (Speranza et al„ 1990).
By comparing the crystallographic structures of the different conformational
states, it is possible to glean better insights into the molecular mechanisms of
allostery. At present only six protein systems have crystallographic data on their
respective different conformational states. These include haemoglobin, E.coli
aspartate transcarbamylase, porcine kidney fructose-1,6-bisphosphatase, glycogen
phosphorylase, bacterial phosphofructokinase and Bacillus stearothermophilus
glyceraldehyde-3-phosphate dehydrogenase. A common feature among the
conformational states exhibited by these protein systems is the rearrangement of
subunit-subunit contacts, resulting in a change in the global structure of the proteins
(Evans, 1992).
Studies on the Fru-1,6-P2 activated form of pyruvate kinase from E.coli
demonstrated the existence of different conformational states of the enzyme produced
by the addition of the substrates and effectors. By analysing the thermostability and
resistance to tryptic digestion in the presence and absence of effectors, three distinct
conformations were detected. The first "basal" conformational state, generated in the
absence of both PEP and Fru-1,6-P2, is highly resistant to trypsin digestion and is
also moderately thermostable. Binding of Fru-1,6-P2 induced a "loosening" of the
enzyme structure observed in the second conformational state, resulting in a more
easily digested form of the enzyme. In the presence of PEP and Mg2+ the third
conformation is produced and is characterised by a remarkable thermal stability (Fig.
14B).
Thus, the mechanism of the allosteric activation by Fru-1,6-P2 may be due to
the fact that it switches the enzyme from its "basal" to its "loose", more accessible,
conformation. The third "highly stable" conformation may conceivably reflect the
"closing-up" of the enzyme on the substrates, to ensure the exclusion of water from
the active site during phospho transfer (Fothergill-Gilmore, 1986).
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1.10.6 OTHER CONFORMATIONAL STATES OF PYRUVATE
KINASE
It has been shown that Fru-1,6-P2 caused the association of monomelic
pyruvate kinase M2 subunits into the active tetrameric form of the enzyme. This
association was demonstrated in vivo. At physiological levels of glucose (4-6mM)
30-35% of the pyruvate kinase existed as monomer. When cells were deprived of
glucose tetrameric pyruvate kinase M2 was rapidly converted to monomer. On the
subsequent addition of glucose tetramer formation increased. The levels of
Fru-1,6-P2 decreased concomitantly with that of glucose. These results indicated that
monomer-tetramer interconversion is a major in vivo cellular regulatory mechanism in
response to changes in the extracellular concentration via Fru-1,6-P2 (Ashizawa et
al., 1991). This mechanism was demonstrated on the M2 isozyme and may also
occur with the L and R isozymes.
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1.11 ALLOSTERY
Allostery can be defined as a change from one conformation of a protein,
possessing two or more different receptor sites, to another conformation when one of
the receptor sites is occupied by a compound other than the substrate or product. This
definition does not require the two receptor sites to interact with each other in any
way, nor does it imply that the protein must be composed of more than one
polypeptide chain.
Allosteric interactions and their effects are now widely accepted as being of
fundamental importance in metabolic regulation. In a period of a few years, in the
early and mid-1960s, papers by Monod, Changeux and Jacob (1963), Monod,
Wyman and Changeux (1965) and Koshland, Nemethy and Filmer (1966) attempted
to explain a host of previously inexplicable results (from the studies of numerous
enzyme reactions by many different authors) by developing new theories on how
enzymes interact with small molecules, both substrates and other compounds, that
appeared to modulate enzyme activity. By defining new terms they interpreted
established findings in a new and challenging fashion which emphasised the subtlety
of the enzyme's interactions with itself and other molecules. The "symmetry" or
"concerted" model of Monod, Wyman and Changeux and the "sequential" model of
Koshland, Nemethy and Filmer have become yardsticks by which to interpret enzyme
kinetic data in an attempt to define the precise nature of the intersubunit
communication and the effect on this of the binding of various molecules.
The biological activity of many proteins is controlled by specific metabolites
which do not interact directly with the substrates or products of the reactions. The
effect of these regulatory agents appeared to result exclusively from a conformational
alteration (allosteric transition) induced in the protein when it bound the agent. It was
suggested that this mechanism played an essential role in the regulation of metabolic
activity. In other words, certain proteins, acting at critical metabolic steps, were
endowed with specific functions of regulation and coordination. Thus, a biochemical
reaction could be controlled by a metabolite acting as a physiological signal rather
than as a chemically necessary component of the reaction itself.
Briefly then, the properties of such systems can be described as follows. The
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functional structures of controlling proteins are assumed to possess two, or at least
two, stereospecifically different, non-overlapping receptor sites. One of these, the
active site, binds the substrate and is responsible for the biological activity of the
protein. The other, or allosteric site, is complementary to the structure of another
metabolite, the allosteric effector, which it binds specifically and reversibly. The
formation of the enzyme-allosteric effector complex does not activate a reaction
involving the effector itself: it is assumed only to bring about a discrete reversible
alteration of the molecular structure of the protein or allosteric transition, which
modifies the properties of the active site, changing one or several of the kinetic
parameters which characterise the biological activity of the protein.
An essential feature of this model is that the allosteric effector, since it binds at
a site altogether distinct from the active site and since it does not participate in any
stage of the reaction activated by the protein, need not bear any particular chemical or
metabolic relation of any sort with the substrate itself. The specificity of any allosteric
effect and its actual manifestation is therefore considered to result exclusively from
the specific construction of the protein molecule itself, allowing it to undergo a
particular, discrete, reversible, conformational change, triggered by the binding of the
allosteric effector.
Direct evidence of reversible conformational alterations provoked by the
binding of a "regulatory" metabolite have been obtained with several proteins of
higher organisms . I shall consider a few of them briefly here.
MUSCLE GLYCOGEN PHOSPHORYLASE (EC 2.4.1.1)
Reaction catalysed: (l,4^-D-glucosyl)n + orthophosphate >
(1,4-<-D-glucosyl)n_ i + cc -D-glucose-1 -phosphate
This was probably the first allosteric enzyme mechanism to have been
discovered and analysed in detail (Helmreich & Cori, 1964). The enzyme was
isolated in two forms; phosphorylase a and phosphorylase b. Muscle phosphorylase
b is a dimer (Mr 2 x 97.3k) and is active only in the presence of high concentrations
of AMP or IMP, which act allosterically- they bind to a nucleotide binding site and
alter the conformation of phosphorylase b. ATP and ADP act as a negative allosteric
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effectors by competing with AMP. Glucose-6-phosphate also inhibits phosphorylase
b, primarily by binding to the AMP site. Under most physiological conditions,
phosphorylase b is inactive because of the inhibitory effects of ATP and
glucose-6-phosphate. In contrast, phosphorylase a is fully active, irrespective of the
levels of AMP, ATP and glucose-6-phosphate. However, at low levels of Pi, its
activity is stimulated by AMP. Glucose is an allosteric inhibitor. Phosphorylase b can
be converted to phosphorylase a by a MgATP-requiring enzyme termed
phosphorylase kinase (Krebs & Fischer, 1956) which catalyses transfer of the y-
phospho group of ATP to a unique serine hydroxyl located close to the N-terminus of
the protein (Titani et al., 1975). This is accompanied by a further dimerization to give
a tetramer (Mr 4 x 97.4k). The proportion of active enzyme is determined primarily
by the rate of phosphorylation and dephosphorylation. In resting muscle, nearly all
the enzyme is in the inactive b form. Thus, this system shows that a reversible
non-covalent interaction between an allosteric effector and a protein may mimic the
effects of an irreversible stable modification of protein structure involving a covalent
reaction. Indeed, differences between the a and b forms of this enzyme have been
directly determined from comparison of the X-ray crystallographic patterns of the
isolated enzyme (Sprang & Fletterick, 1979).
GLUTAMATE DEHYDROGENASE (EC 1.4.1.2)
Reaction catalysed: glutamate + NAD+ + H2O > NH/j."1" + a-ketoglutarate +
NADH + H+
The activity of this enzyme is allosterically regulated. The vertebrate enzyme
consists of six identical subunits, which can polymerise further. GTP and ATP are
allosteric inhibitors, whereas GDP and ADP are allosteric activators. Numerous other
metabolites have been found to act on this enzyme causing either activation or
inhibition. Activation by leucine and diethylstilbestrol both show evidence of
cooperative effects. The complex allosteric reactivity of glutamate dehydrogenase
reflects its multivalent role in cellular metabolism. The effectors which activate or
inhibit the activity of this enzyme act by inducing a conformational alteration as does
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the binding and release of the cofactor NAD+/NADH (Engel & Dalziel, 1969).
HAEMOGLOBIN
Haemoglobin is an example of a non-enzymic protein whose specific
regulatory competence has long been recognised. As is well known, the dissociation
curve of oxyhaemoglobin as a function of oxygen tension is sigmoid, demonstrating
cooperativity in the binding of oxygen. By contrast, the dissociation of oxygen from
myoglobin is a simple adsorption isotherm. An empirical equation designed by Hill
(1910), y = kpn / (l+kpn), gave a reasonable approximation to the haemoglobin data
with n=2.6. Adair (1925) obtained a closer fit using a four constant equation in which
the constants related the successive affinity constants of oxygen to the haem groups
of haemoglobin. Adair's equation did not provide any theoretical explanation for the
changing affinity constants, but it was capable of fitting the data quite accurately.
Pauling (1935) made the first attempt to relate the change in these constants to the
geometry of the protein by assuming a single affinity constant and an interaction term
which depended on the geometry of the four subunits. This functional difference
between haemoglobin and myoglobin is now known to depend upon the tetrameric
structure of the former and the monomelic state of the latter.
Adult haemoglobin consists of two types of subunit (a and p) arranged in an
a2p2 tetrameric array. Haemoglobin can be dissociated into its constituent chains.
The properties of the a chain are very much like those of myoglobin. The a chain by
itself has a high oxygen affinity, a hyperbolic oxygen dissociation curve and oxygen
binding characteristics that are insensitive to pH, carbon dioxide concentration and
2,3-bisphosphoglycerate levels. The isolated P chain readily forms a tetramer (P4,
also called haemoglobin H). Like the a chain and myoglobin, P4 entirely lacks the
allosteric properties of haemoglobin and has a high oxygen affinity. In short, the
allosteric properties of haemoglobin arise from interactions between the two types of
subunit.
It was demonstrated by X-ray crystallography (Perutz,1960) that in
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haemoglobin the four haem groups are actually quite far apart, excluding the
possibility of direct interaction and implying that any interaction is indirect,
presumably due to a conformational alteration.
Haemoglobin exhibits three kinds of allosteric effects. First, the oxygen
binding curve of haemoglobin is sigmoidal, which means that the binding of oxygen
is cooperative. Second, H+ and carbon dioxide promote the release of oxygen from
haemoglobin, an effect that is physiologically important in enhancing the release of
oxygen in metabolically active tissues. Conversely, oxygen promotes the release of
H+ and carbon dioxide in the alveolar capillaries of the lungs. These allosteric
linkages between the binding of H+, carbon dioxide and oxygen are known as the
Bohr effect. Third, the affinity of haemoglobin for oxygen is further regulated by
2,3-bisphosphoglycerate, a small molecule with a high density of negative charge.
This molecule can bind to deoxyhaemoglobin but not to oxyhaemoglobin and as a
result lowers the affinity of haemoglobin for oxygen.
The allosteric properties of haemoglobin arise from interactions between its a
and (3 subunits. The T (tense) quaternary structure is constrained by salt links
(electrostatic interactions) between different subunits, giving it a low affinity for
oxygen. These intersubunit salt links are absent from the R (relaxed) form, which has
a higher affinity for oxygen. On oxygenation, an iron atom moves into the plane of
the haem group, pulling a proximal histidine with it. This motion cleaves some of the
salt links, and the equilibrium is shifted from T to R. The deoxy (T) state is stabilised
by 2,3-bisphosphoglycerate binding to positively charged groups surrounding the
central cavity of haemoglobin.
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THE CONCERTED AND SEQUENTIAL MODELS OF ALLOSTERIC
INTERACTION
A) THE CONCERTED MODEL
The ligand binding properties of various proteins led Monod, Wyman and
Changeux to propose a model for allosteric interactions. Their scheme imagines the
binding of ligand at one site to have no direct effect on the affinity of the other sites,
but to alter the conformational equilibrium between the two alternative quaternary
conformations of the protein: one having low intrinsic affinity for the ligand at all its
sites, was designated T (for "tense", since it was imagined to be constrained in some
manner); the other, having high affinity for the ligand, was designated R (for
"relaxed"). These two forms with i ligand molecules bound are often referred to as Ti
and Ri. According to the model, these two conformations coexist even in the absence
of ligand, with an equilibrium constant L between TO and RO. The TO form is
favoured, and the protein has relatively low affinity for the first ligand molecule.
Since the R conformation has the higher affinity by a factor c, ligand molecules will
be bound to it preferentially. This will pull the conformational equilibrium toward the
R state, since the conformational change and ligand binding are linked functions, and
the conformational equilibrium between the two conformations with one ligand
molecule bound will be cL. The other vacant sites on the Rl molecule will then be in
the high affinity form; therefore the average affinity of the vacant sites of the entire
population will be increased, giving positive cooperative homotropic interactions.
In this model, called the concerted model, heterotropic interactions arise by
the preferential binding of other ligands to either of the two states. Affinity is
decreased by molecules that bind preferentially to the T state, since they pull the
conformational equilibrium back toward T. Affinity is increased by any molecule that
binds preferentially to the R state. Different ligands control the apparent affinity
simply by shifting the equilibrium between the two states.
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B) THE SEQUENTIAL MODEL
Allosteric interactions can also be accounted for by a sequential model
(Koshland, Nemethy & Filmer, 1965). The simplest form of the model makes three
assumptions:
1) There are only two conformational states (R and T) accessible to any one subunit.
2) The binding of ligand changes the shape of the subunit to which it is bound.
However, the conformation of the other subunits in the protein molecule is not
appreciably altered.
3) The conformational change elicited by the binding of ligand in one subunit can
increase or decrease the ligand-binding affinity of the other subunits in the same
protein molecule.
Ligand binding is cooperative if the affinity of the RT conformational state for
ligand is greater than that of the TT states.
DIFFERENCES BETWEEN THE TWO MODELS
The two models differ in terms of protein conformation primarily with respect
to the conformations of the partially ligated states. Both models imply that ligand
binding has effects on the protein conformation; in the sequential model, such effects
extend directly to the other binding sites; affecting their ligand affinity. In the
concerted model they need extend only to the interface between subunits to alter the
conformational equilibrium between the R and T quaternary states. The concerted
model envisages the two conformations to be present even in the absence of ligand,
RO and TO, whereas in the sequential model the R conformation is induced only upon
ligand binding. The sequential model predicts that the conformational change upon
ligand binding should parallel the extent of ligand binding, whereas the two need not
coincide with the concerted model, since conformational change should tend to occur
at one stage of ligand binding at each molecule. Thus, hybrid RT intermediates are
allowed in the sequential model but excluded in the concerted model. The concerted
model proposes that symmetry is essential for the interaction of subunits in
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oligomeric proteins and therefore requires it to be conserved in allosteric transitions.
In contrast, the sequential model assumes that subunits can interact even if they are in
different conformational states.
The concerted model is much more restrictive than the sequential model. The
only parameters that may be varied are L, the conformational equilibrium constant in
the absence of any ligand, and the affinities of the two states for each ligand; the
relative affinities of the two states specify the allosteric parameter c. Also, the
parameters L and c are not independent. Alteration of one also changes the other. This
interdependence probably reflects the linkage between the conformational change and
the change in affinity for the ligand in state T.
The greatest restriction of the concerted model is that it does not predict
negative cooperativity, since the ligand can pull the conformational equilibrium only
toward the high affinity form (Creighton, 1984).
OTHER MODELS ARE COMPATIBLE WITH THE OBSERVED DATA
Contrary to the model proposed by Monod et al. (1965), it is not necessary
for a tetramer of identical subunits to maintain a symmetrical arrangement on
undergoing a conformational change to adequately describe the ligand binding data
observed. Atkinson et al. (1966) proposed an important model for ligand binding that
differed significantly from the model of Monod et al. (1965). This model explained
complex data obtained from substrate and modifier interactions with
phosphofructokinase and isocitrate dehydrogenase by assuming progressive changes
in ligand site interactions. In this model, binding of ligand at one site could either
increase or decrease the affinity of ligand at a second site, which could in turn affect
the binding at a third site, etc.
Several kinds of cooperative models have been used to explain sigmoidal
relationships between velocities and substrate concentrations observed with
regulatory enzymes e.g. allosteric interactions between subunits and multiple binding
site models. Even though cooperative models can explain sigmoid data, cooperativity
is not essential. Models requiring single, independent active sites with multiple
reaction pathways by which the binding sites are occupied can also explain sigmoid
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data. It appears that sigmoid data can only eliminate ordered sequence models (i.e.
those with a single reaction pathway) which involve the binding of only one molecule
of each substrate to one molecule of enzyme (Sweeny & Fisher, 1968). These
authors presented a series of models that did not require cooperativity or binding of
more than one molecule of substrate to each catalytic site at a given time in order to
exhibit sigmoidicity.
The classical oxygen binding curves of haemoglobin have served most
usefully in bringing out the importance of cooperative effects in the binding of ligands
to proteins. These results have led to the association of sigmoidicity with
cooperativity which has been applied to enzymes as well as to proteins that only bind
ligands. The models developed by Sweeny and Fisher (1968) took into account all
the low molecular weight components in the system, did not require the presence of
subunits (although their presence was not excluded), and were readily amenable to
further kinetic approaches. It should have been possible to test these models using
isotope exchange techniques and other related experimental approaches. To the
knowledge of the author these possible experiments have not been performed.
Changes in the allosteric properties of an enzyme by heating or other
techniques involving changes in the conformation of the enzyme have been used as
evidence for cooperativity in the enzyme system. If it can be assumed that changes in
the conformation of the enzyme could result in changes in the magnitude of the rate
constants involved in the mechanism, then these non-cooperative models can explain
the data equally well. In many of the models described by Sweeny and Fisher (1968),
a change in one of the rate constants induced or eliminated sigmoidicity. It seems
reasonable to expect that changing the conformation of an enzyme could indeed
change the relative magnitude of rate constants and thereby change its kinetic
characteristics. In a similar way an added inhibitor or other effector could modify the
relative magnitude of terms in the rate expression in such a way as to change the
observed relationships between velocity and substrate concentration.
The crystal structures of the six allosteric enzymes that have so far been
crystallised in both their R and T states suggests that the symmetry model of Monod
et al. (1965) is the most consistent in terms of explaining the data produced. In all of
the crystal structures a symmetrical arrangement of subunits is found. This symmetry
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is preserved in both the R and T forms. It should be noted that the RO and TO
structures are the two extremes of a range of possible structures available to the
enzymes. Some intermediate structures would be compatible with either the symmetry
or sequential model, and so the absence of certain structures does not rule out the
sequential model on these grounds.
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1.12 COOPERATIVITY IN PYRUVATE KINASE
It was observed in many enzyme systems that at substrate concentrations
below half maximal saturation, the reaction velocity increased faster than the substrate
concentration, while at low inhibitor concentrations the rate decreased faster than the
inhibitor concentration. This implies that the enzyme molecule is able to bind more
than one substrate or inhibitor molecule at a time and that in the native enzyme there is
some sort of cooperative interaction between the homologous binding sites. Further,
interaction could enhance or diminish the binding of further substrate or effector
molecules i.e. that cooperativity could be positive or negative. Also, binding of one
type of molecule could affect either the binding of the same type of molecule or the
binding of a different molecular species entirely i.e. cooperativity could be
homotropic or heterotopic. A plot of reaction velocity against substrate concentration
typically shows a sigmoidal relationship when cooperativity between ligands occurs
(Fig 15A).
How is cooperativity measured? If the interaction of ligand A to an enzyme is
measured by some function fy and this interaction is also measured in the presence
of ligand B, giving fA/B> we have a quantitative measure of the extent of interaction
of A. If A interacts with the protein independent of ligand B, f^\ = fyg
If the presence of B affects the interaction of A to the protein, then fyg - f^\ is a
measure of the extent of interdependence or cooperativity, which can either be in a
positive or negative sense. The apparent free energy of binding (AG^) was used
(Nowak and Lee, 1977) as a parameter to measure the extent of interaction of the
substrates and cations with the enzyme. More usually however, the data obtained
when initial reaction velocity is determined as a function of substrate concentration are
used. A Hill plot is constructed (Hill, 1925) where logjo (v/Vm-v) is plotted against
logio [S]. A typical plot is shown in Fig 15B. The slope is taken as njq, the Hill
coefficient, which is usually interpreted as a measure of the cooperativity of a given





Fig. 15 A) Comparison of a hyperbolic binding curve with a sigmoid curve.
B) A Hill plot.
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hyperbola is usually found. A value greater than 1 indicates positive cooperativity and
a value less than 1 indicates a negative cooperative interaction between ligands.
A brief review of the types of cooperative interactions found in pyruvate
kinase follows. The consequence that each ligand has on the binding of other ligands
is summarised in Table 3.
1) COOPERATIVE EFFECTS INVOLVING
PHOSPHOENOLPYRUVATE
In pyruvate kinase from S.cerevisiae positive homotropic effects were
observed in the binding behaviour of PEP (Morris et al., 1984). Sigmoidal kinetics
were transformed to hyperbolic in the presence of fructose-1,6-bis phosphate.
Using the calculated apparent free energy of binding as a parameter to
measure the extent of interaction of substrates and cations with pyruvate kinase it was
shown that PEP had four binding sites per mole of enzyme (Nowak & Lee, 1977).
This value was in contrast to the 2.4 reported by Renard et al. (1961) but in accord
with a value of 3.8 + 0.3 reported by Kayne (1973) and now known to be correct
from more detailed analysis.
The direct heterotropic interaction between PEP and ADP was reported to be
small and negative (Morris et al., 1984), but the overall interaction between these
substrates became positive when their positive interactions with Mg2+ were taken
into account. The affinity of the enzyme for Mg^+ increases by over 70-fold in the
presence of PEP. The coupling free energies were rather large in a negative direction,
indicating a strongly positive cooperative interaction (Nowak and Lee, 1977). The
heterotropic interactions of the substrates are comparable with those revealed by the
rabbit muscle enzyme and it was suggested that they have a common origin in charge
interactions within the active site (Morris et al., 1984). Different conformations of the
enzyme affect substrate binding in a significant manner. On studying differences
between the rabbit Ml and M2 isoenzymes it was found that in each case PEP binds
to the active R state by at least one order of magnitude more tightly over the inactive T
state (Consler et al., 1989).
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2) COOPERATIVE EFFECTS INVOLVING ADP
Positive homotropic effects in the binding of ADP to pyruvate kinase from
S.cerevisiae were reported by Morris et al. (1984). This is in contrast to other
workers (Hunsley & Suelter, 1969) who reported that ADP did not display any
cooperativity in binding and also appeared not to be strongly affected by Fru-1,6-P2.
The lack of cooperativity in ADP binding was confirmed in further experiments
which also implicated possible conformational changes in the enzyme-M2+-substrate
complex as being important in mediating the altered binding properties.
3) COOPERATIVE EFFECTS INVOLVING M2+ AND M+
Cooperative binding of Mg2+, Mn2+, K+ and NH44" to pyruvate kinase was
observed in S.cerevisiae (Hunsley & Suelter, 1969).
From an analysis of the kinetic data it was shown that Mn2+ increased the
binding affinity of the enzyme for PEP by more than two orders of magnitude
(Nowak & Lee, 1977). The coupling free energies were rather large in a negative
direction, indicating a strongly positive cooperative interaction.
In the formation of the ternary enzyme-M2+-ADP complex, there was little, if
any cooperativity involved.
Magnesium displayed positive homotropic interactions in its binding
behaviour (Morris et al., 1984). The binding of univalent and bivalent cations was
mutually cooperative (Rhodes et al., 1986) but appeared not to involve competition at
a single site in the case of the univalent ions. The cooperative effects calculated for the
bivalent-monovalent cation interactions with pyruvate kinase suggested that no
ligand-ligand interaction takes place.
Cooperativity was also observed in the binding of Mn2+ and pyruvate. The
extent of cooperativity was significantly less than that observed with PEP and
substantial evidence exists to suggest that no direct coordination of these substrates
occurs (Fig. 10 and 13). The binding of Mn2+ to the enzyme-PEP-ADP complex
was also observed to be cooperative.
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4) COOPERATIVE EFFECTS INVOLVING Fru-1,6-P2
Fructose-1,6-bisphosphate binding, which yielded positive homotropic
cooperative kinetics, transformed the sigmoidal kinetics of K+, Mg2+, NH4+ and
PEP to hyperbolic and lowered the apparent for each variable. ADP was reported
not to be strongly affected by Fru-1,6-P2 (Hunsley & Suelter, 1969). On changing
from sigmoidal to hyperbolic kinetics in the presence of 1.2mM Fru-1,6-P2, the
affinity of the enzyme for ADP increased 1.2-fold, the affinity for PEP increased
12-fold and the affinity for Mg^+ increased 7-fold (Morris et al., 1986).
Data clearly indicated that in pyruvate kinase from S.cerevisiae, Fru-1,6-P2
acted solely by changing the affinity of the enzyme for its substrates. Low
concentrations of Fru-1,6-P2 appeared to mediate enzyme activity while leaving the
substrate interactions of both kinds (heterotropic and homotropic) largely the same.
By contrast, high effector concentrations seemed to exert their major effect on the
homotropic interactions of PEP and Mg^+ both decreasing their magnitude and
causing a compensatory increase in the affinity of the enzyme for these substrates.
The heterotropic interactions remained relatively unaffected. It appeared therefore,
that high effector concentrations loosen the structure of pyruvate kinase, destroying
the basis for inter-site interaction and releasing the constraints that limit substrate
affinity in the unmodified enzyme. This conclusion is supported by the observation
that the reactivity of the enzyme towards pyridoxal-5'-phosphate is increased in the
presence of Fru-1,6-P2 (Valentini et al., 1991). Fell et al. (1974) reported that the
reactivity of the thiol groups and cold inactivation of the yeast enzyme was increased
in the presence of Fru-1,6-P2, indicating a different conformation for the enzyme
could be adopted.
The cooperative binding of the allosteric activator Fru-1,6-P2 to yeast
pyruvate kinase was investigated by equilibrium dialysis and fluorescence quench
titration. The results showed that yeast pyruvate kinase binds four molecules of
Fru-1,6-P2 per tetramer (Murcott et al., 1992). When Fru-1,6-P2 is titrated into yeast
pyruvate kinase the resulting binding behaviour is compatible with a model whereby
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the enzyme molecule acts as a dimer of dimers with two steps in the heterotropic
cooperative transition of the enzyme from the low affinity T state to the high affinity
R state. A two-step model for the cooperative binding of Fru-1,6-P2 to yeast
pyruvate kinase was proposed. The first ligand binds to the quaternary T state and
induces a conformational change to an intermediate state, R', which has increased
affinity for ligand. Binding of the second ligand is to this R' state. Binding of the
third ligand induces a further conformational change to the full R state, which has the
greatest affinity for the ligand. These data suggested to the authors that the
cooperative binding of Fru-1,6-P2 to yeast pyruvate kinase could be best described
by the model of Eigen (1967) in which a concerted and a sequential element in the
transition are proposed.
5) COOPERATIVE EFFECTS INVOLVING H+
Binding of H+ to S.cerevisiae pyruvate kinase shows positive homotropic
cooperativity and the protonated enzyme is catalytically inactive. It was also found
that H+ interacts positively with PEP but negatively with both ADP and Mg2+. This
suggested that H+ was bound in a position that enhanced the binding of PEP through
its negatively charged carboxylate group while repelling the positively charged
magnesium ion. The negative interaction between H+ and ADP may also be caused
by the repulsion of Mg2+, for it has been suggested that the nucleotide depends on
Mg2+ for one of its links to the enzyme (Kinderlerer, 1986).
SUMMARY
From data gathered from a variety of sources there is substantial evidence to
suggest that there is no requirement for direct ligand-ligand interaction to be necessary
for cooperative effects to occur. Cooperative effects can occur by the first ligand
inducing a conformational change in the enzyme, affecting the binding site for the
second ligand to increase (or decrease) the binding affinity for the second ligand. The
heterotropic interactions of pyruvate kinase may originate in charge interactions at the
active site and homotropic interactions may reflect intersite events (Ainsworth &
MacFarlane, 1973). Table 3 summarises the data presented in this chapter.
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TABLE 3 COOPERATIVITY BETWEEN SUBSTRATES AND EFFECTORS IN
S.CEREVISIAE PYRUVATE KINASE
PEP ADP M2+ K+ H+ FBP NH4




M2+ +(2) -(6) +(1,3) +(4) +(4)
K+ + (7) + (4) + (3) + (4)
H+ + (5) - (5) - (5) + (5)
FBP -(1,3) "(3) "(3) +(3) -(3)
NH4 + (4) + (4) + (3)
+ increase in cooperativity
decrease in cooperativity
o no change in cooperativity
References: 1) Morris et al, 1984
2) Nowak & Lee, 1977
3) Hunsley & Suelter, 1969
4) Rhodes et al, 1986
5) Kinderlerer, 1986
6) Cottam et al, 1972
7) Nowak & Mildvan, 1972
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CAVEAT: SIGMOIDICITY WITHOUT COOPERATIVITY
Cooperative effects can arise in a simple way without the need for special
assumptions about the quaternary structure of the protein. Apparent cooperative
effects can arise in reactions involving a pair of substrates if a random non-
equilibrium addition of the substrate to the enzyme occurs (Ferdinand, 1966).
Conformational relaxation might give rise to cooperative protein-ligand interactions
although it is not clear if this model is thermodynamically possible (Atkinson, 1966).
The model of Rabin (1967) requires neither an allosteric site nor a second
substrate. It postulates instead two conformational states of the enzyme, E and F, E
being preferred in the absence of substrate (Fig 15). Both forms can bind the
substrate, but only F catalyses the reaction. Product release yields the free enzyme in
the F form. At high substrate concentrations, this is immediately reconverted to
FS-the enzyme-substrate complex. At lower substrate concentrations, however, F has
a lower chance of isomerising to E. A significant portion of the flow then proceeds
via ES, the rate of product formation being limited by the isomerisation of ES to FS.
Another possible non-cooperative explanation for kinetic, or binding curve,
data that departs from the simple classical pattern is the presence of non-identical sites
for the substrate or ligand. A mixture of two isoenzymes, for instance, will not give
"linear" kinetics unless the two forms have the same Kjyj.
Non-identity may also arise in more subtle ways: proteins may have identical
subunits arranged in non-equivalent positions. There might be, for instance,
distinguishable "top" and "bottom" sets of subunits; the behaviour of one set might be
altered by the mere presence of the other set, if, for example, one set of binding sites
were near the interface between the two sets of subunits. However, the sites with
greatest affinity would bind the ligand preferentially, and thus non-identical sites can
only be invoked in cases of apparent "negative cooperativity"- i.e where initial
binding appears to impede subsequent binding (Engel, 1981).
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Fig.16 Rabin's model to
explain substrate cooperativity
without postulating allosteric sites.
1.13 ALLOSTERY AND CONFORMATIONAL CHANGE IN THE
GLYCOLYTIC PATHWAY
The enzymes usually described as the key regulatory steps in glycolysis -
hexokinase, phosphofructokinase (PFK) and pyruvate kinase- are all known to be
regulated in vivo by a number of molecules. Yeast hexokinase is an excellent example
of an enzyme that exhibits conformational changes upon ligand binding (Dela Feunte,
1970). Phosphofructokinase has been found to be regulated by as many as 28
different compounds in vitro. Pyruvate kinase from a number of sources is also
known to be regulated allosterically. The number and type of effectors and their
efficacy depends upon the source of the enzyme as it is a direct reflection of the
importance to the organism in being able to switch rapidly from glycolysis to
gluconeogenesis and back again.
I shall briefly describe how allosteric interactions affect the activity of
hexokinase and PFK as it is interesting to note that three kinase reactions are
important regulatory steps in the glycolytic pathway and all three enzymes appear to
undergo significant changes in protein conformation upon substrate and effector
binding. The topic of allostery and conformational changes in pyruvate kinase has
been extensively covered in the previous sections of Chapter 1 and is , of course, the
subject matter for the rest of this thesis. It is important to note that conformational
changes probably occur in all enzymes to some extent upon ligand binding and that
these changes will also be present in the other enzymes of the glycolytic pathway but
that not all of these enzymes are endowed with the specific regulatory features that
have made hexokinase, PFK and pyruvate kinase the subject of such intense study.
HEXOKINASE (EC 2.7.1.1)
Reaction catalysed: glucose + MgATP > glucose-6-P + MgADP
Of the kinase structures known to date many have very similar structural
features i.e. many appear to have bilobed structures of two domains, with a marked
cleft between them containing the active site. This common structural feature probably
reflects the need for conformational changes upon substrate binding and catalysis, as
has been shown quite dramatically for hexokinase (Bennett et al., 1980). Upon
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binding its substrate, glucose, the two lobes of hexokinase rotate, essentially as rigid
bodies, by 12° relative to each other, resulting in relative movements of as much as
8A. Ligands that bind but do not produce this conformational change are not
substrates; such movement therefore is probably essential for catalysis. Following
rotation of the lobes, the glucose molecule is almost engulfed by the enzyme, so that
it cannot enter or leave the active site; dissociation of product from the enzyme is quite
slow and rate- limiting, probably being limited by the opening of the cleft. X-ray
diffraction studies show that the binding of both the sugar and the nucleotide cause
extensive changes in tertiary structure (Fig 17).
As a consequence of glucose binding and the conformational change, the
apparent affinity for ATP increases 50-fold. It also binds within the cleft, interacting
with both domains, in a way that is favoured by the conformational change. That the
conformational change involves rotation of otherwise unchanged domains, rather than
rearrangements within them, is suggestive of a relatively rigid architecture for each.
Another function of this conformational change may be to permit the enzyme to
embrace totally the substrate in the transition state, placing functional groups in the
proper orientation all around the substrate and providing them with the appropriate
environment e.g. a hydrophobic environment would be expected to facilitate the
electrostatic interactions between enzyme and substrate believed to be of prime
importance for catalysis. A conformational change would be necessary simply to
permit products to dissociate and substrates to bind.
Further conformational changes probably take place in hexokinase after binding the
second substrate ATP, since the glucose-6-hydroxyl and ATP y-phospho groups are
observed to be 6A apart, too far for the reaction to occur in one step. The detailed
nature of these changes is not yet known.
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Fig. 17 The conformational changes induced in hexokinase by glucose binding.
The solid line shows the a-carbon backbone in the presence of glucose.
The dotted line shows the backbone of the part of the enzyme that is




Reaction catalysed: fructose-6-P + MgATP > fructose-1,6-bisphosphate
+ MgADP
The reaction catalysed by PFK is essentially irreversible under physiological
conditions (principally because of the high for F-T6-P2), and the reverse
reaction is catalysed by a different enzyme, fructose-1,6- bis phosphatase. The PFK
reaction is considered the principal regulatory step in glycolysis. The enzyme is
regulated in most species and tissues, but its regulators vary, depending on
physiological requirements. The enzymes from the bacteria E.coli and Bacillus
stearothermophilus have been best characterised to date (Evans, 1992). Four different
crystal structures have been deduced, representing both the active R-state and the
inhibited T-state conformations. This has greatly increased knowledge about the
catalysis and regulation of this enzyme. E.coli PFK shows strongly sigmoidal
kinetics with respect to fructose-6-P, but not to ATP. It is activated by the reaction
product MgADP, and inhibited by PEP. Recent studies of E.coli PFK have shown
that the allosteric behaviour is rather more complicated than was at first thought. In
particular, although the kinetics with respect to ATP are hyperbolic, ATP does
nevertheless behave as an allosteric inhibitor at low fructose-6-P concentrations, and
binding of fructose-6-P in the absence of ATP is non-cooperative.
The bacterial PFKs are tetramers, each subunit containing about 320 residues.
As was observed in hexokinase, and is common with most other kinases, each
subunit consists of two domains. The large domain binds ATP and the smaller binds
fructose-6-P. Each subunit makes contact with two other subunits, a close contact
within the dimer and a smaller contact between dimers. The tetramer is a dimer of
dimers.
Of particular importance in understanding the allosteric behaviour of PFK is
the location of the substrate and effector binding sites in the tetramer. Each monomer
contains three binding sites, two forming the active site and binding the substrates
fructose-6-P and MgATP, and one allosteric effector site, which binds both the
activator MgADP and the inhibitor PEP. It is typical of enzymes catalysing a
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bimolecular reaction that each substrate should bind to a different domain of the
enzyme, with the catalytic site between the domains. This allows some adjustment of
the relative orientation of the two substrates by movement of the domains. In PFK
such domain flexibility appears to be important, and three of the important catalytic
residues lie on a polypeptide loop (residues 125-129) linking the two domains. The
position of the binding site for the cooperative substrate ffuctose-6-P lies in the
interface between dimers. Thus the dimers are linked by the fructose-6-P sites. The
two subunits within the dimer are linked by the allosteric effector site, which is buried
in the interface.
Conformational changes occurring during catalysis have been deduced by
comparison of crystals of PFK in the active R-state grown from a mixture of reaction
products (F-l,6-P2 and MgADP) and the same crystals soaked in a substrate mixture
(fructose-6-P and MgATP analogue and the activator MgGDP). The effect of the
observed conformational change is to bring the two substrates together. In the "open"
subunit, the distance between the y-phospho of ATP and the phospho acceptor of
fructose-6-P, is just over 4A, too far for a direct nucleophilic attack. In the "closed"
subunit, this distance is reduced to just under 3A, positioning the two substrates
perfectly for the reaction to take place. All other structures of PFK resemble the
"open" subunit conformation and this therefore appears to be the normal
conformational state.
Analysis of mutant forms of PFK produced by site-directed mutagenesis have
identified residues important in regulating the allosteric transition. As a result it was
observed that it is interactions with the g-phosphate of ATP which are important for
ATP acting in effect as an allosteric inhibitor, leading to the cooperative kinetics
observed with respect to fructose-6-P. From kinetic studies on bacterial PFKs, it
appears that the regulation of activity is achieved primarily through the modulation of
activity for the substrate fructose-6-P. The most important physiological effect in
bacteria is likely to be inhibition by PEP causing inhibition of fructose-6-P binding.
Fluorescence data suggest that the enzyme exists in two major conformational
states, differing in their affinities for fructose-6-P, consistent with allosteric models
and with the structures observed in crystals. The major conformational states, the
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active high affinity R state and the inactive low affinity T state are best considered as
families of conformations. All protein structures are altered to a greater or lesser
extent by the binding of ligands, and comparison of the structures of R-state PFK
crystals with different ligands bound show conformational changes around the
binding sites, in some cases remote from the binding sites, but it is the large shift of
conformation between the R-state and T-state families which causes the allosteric
behaviour (Fig 18).
The structural characterisation of the allosteric transition comes from a
comparison of two structures of B.stearothermophilus PFK; an R-state structure and
a T-state structure. Comparison of these two structures shows a major change in the
quaternary structure which can be most simply described as a rotation by about 7^
around the molecular p-axis (Fig 18). This conformational change removes the
sidechain of arginine 162 from the active site, where it binds the phospho group of
fructose-6-P, and replaces it in space by glutamate 161. The removal of a positive
charge and its replacement by a negatively charged or neutral residue is probably
sufficient to account for the low affinity of the T-state for fructose-6-P, although there
may be additional steric hindrance to binding, since the active site is somewhat more
constricted in the T-state. The two subunits make approximately the same number of
contacts in both the R and T-states, but they are different. The change in
conformation of a loop formed from residues 156-162 is intimately linked to the
quaternary structure change, such that change in the loop will tend to trigger the
quaternary structure change, and conversely the quaternary change will force the loop
change on all four subunits in the tetramer, thus favouring concerted change. The
four active sites are effectively linked by their position in the interface between rigid
dimers.
The effector site binds both allosteric activators such as MgADP, MgATP and
Pi, and the allosteric inhibitors PEP and 2-phosphoglycolate. These ligands bind in a
deep cleft, with the phosphate or ^-phosphate in a common position. When the cleft
is fully closed the enzyme takes up its T-state conformation. Mutations affecting this
cleft closure e.g. serine 159 to asparagine, lock the enzyme in the T-state with a
concomitant decrease in affinity for fructose-6-P.
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(a) (b)
Fig. 18 General view of the allosteric transition between inactive T state (solid




1.14 ISOENZYMES OF PYRUVATE KINASE
According to the recommendations of the Commission on Biological
Nomenclature of IUPAC-IUB (1977), isoenzymes are defmed as,"multiple molecular
forms of an enzyme occurring within a single species, as a result of the presence of
more than one structural gene."
Isoenzymes of pyruvate kinase have been best described from various
vertebrate species but they are also found in fish, plants, bacteria, fungi, protozoa and
algae. A brief description of the properties of pyruvate kinase isoenzymes from some
of these different sources is given in the following pages.
VERTEBRATE PYRUVATE KINASE ISOENZYMES
In vertebrate tissues four different isoenzymes of pyruvate kinase are found.
These isoenzymes are tissue specific, have kinetic properties reflecting the different
metabolic requirements of the tissues and differ in the regulation of gene expression.
The Ml type is the major form of adult skeletal muscle, heart and brain and
shows predominantly hyperbolic Michaelis-Menten kinetics. The M2 type is the only
form detected in early foetal tissues and is present in most adult tissues. The R type is
expressed only in erythrocytes and the L type is the major form in adult liver. In
contrast to Ml, the M2, R and L types are all allosterically regulated and show
sigmoidal kinetics with respect to the substrate phosphoenolpyruvate. In addition, R
and L are regulated by reversible protein-kinase mediated phosphorylation of a
specific serine near the N-terminus (reviewed by Muirhead, 1990).
The crystal structure of an Ml isoenzyme is known (Muirhead et al.,1986)
and amino acid sequences are available for Ml, M2, R and L isoenzymes. Alignment
of these sequences shows them to be highly conserved and implies that the tertiary
and quaternary structures of all isoenzymes are very similar.
Genetic studies have suggested the presence of only two structural genes in
mammals: one coding for both the Ml and M2 and another coding for both R and L.
The R and L type enzymes are produced from a single L gene by the use of
differential promoters (Noguchi et al., 1987). The mRNAs are identical except in the
5'-terminal region. The L gene is composed of twelve exons and eleven introns. The
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first and second exons encode the 5'-terminal sequence specific for the R and L types
respectively. The remaining downstream exons encode common sequences (Fig 19).
In contrast, Ml and M2 are produced from the same gene transcript by alternative
RNA splicing (Noguchi et al., 1986). The M gene contains two adjacent exons, one
which codes for residues 380-435 in Ml and the other for the corresponding residues
in M2. Apart from this region coded by alternative exons, the sequences in Ml and
M2 are identical (Fig. 20).
Pyruvate kinase isoenzymes are different only due to small perturbations at
key structural locations, which in turn lead to changes in not one specific equilibrium
constant but in a majority of the equilibrium constants governing the basic behaviour
of the enzymes. As a consequence of these changes, the isoenzymes exhibit
quantitatively different kinetic behaviours under the same experimental conditions.
The structural elements which are responsible for the change in chemical
equilibrium and which are most likely involved in subunit contacts were identified by
X-ray crystallographic studies as the N-terminal domain (residues 10-40, cat muscle
numbering) and helices 1 and 2 of domain C (residues 385-425). It can be shown that
these elements of structure do differ among the isoenzymic forms of pyruvate kinase
(Table 1). It can be imagined that these structural units play an important role in
intersubunit communication and thus are responsible for the transmission of
information between the subunits. They probably participate in the switching between
the alternative conformations of pyruvate kinase. If this structural region plays an
important role in conferring specific allosteric behaviour in pyruvate kinase, then one
might expect that this region will be sensitive to mutation (i.e. mutation of individual
residues within this region would significantly affect the allosteric behaviour of the
enzyme- as has been shown to be the case in bacterial phosphofructokinase). Indeed,
a change in the allosteric properties of the human R isoenzyme has been found as a
result of a naturally occurring threonine to methionine point mutation at position 384
within the first alpha helix of domain C (Kanno et al., 1991). Other natural mutations
detected in the human L type isoenzyme have also been studied. For example, an
arginine 132 to cysteine mutation resulted in altered allosteric properties whereas a
threonine 353 to methionine mutation did not severely affect allosteric interactions.
Both enzymes however showed an increased thermolability and reduced specific
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Fig.19 Schematic representation of expression of the pyr¬
uvate kinase L gene. Exons R and L are indicated by closed and
hatched boxes, respectively. The exons common to both mRNAs are
shown by open boxes. CAAT, CAT box; TATA, TATA box; AATAAA,
polyadenylation signal; LPK, L-type pyruvate kinase; RPK, R-type
pyruvate kinase.
(from Inoue et al., 1986)
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Fig.20 Schematic representation of expression of the pyr¬
uvate kinase M gene. The M! exon is indicated by the hatched box
and the M2 exon by the closed box. The exons common to both
mRNAs are shown by open boxes. TATA, TATA box; AATAAA,
polyadenylation signal; M,PK, Mrtype pyruvate kinase; M2PK, M2-
type pyruvate kinase.
(from Noguchi et al., 1986)
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activity (Neubauer et al., 1991).
The differences between rat Ml and M2 isoenzymes are located solely in the
Cal and Ca2 regions mentioned earlier. The different properties of rat L and R
isoenzymes may also be due to a limited difference in amino acid sequence in a
localised region. In this case the region of structure that is affected is the N-terminal
domain. This structural element is in close contact with the Cal and Ca2 helices and
helps to form the network of subunit interactions between the four identical subunits
of the tetramer (Table 1, Fig. 2). In addition, the catalytic activity of the L isoenzyme
is known to be allosterically regulated by phosphorylation. The site of this covalent
modification is serine 12, which is precisely in the N-terminal domain of the enzyme.
The fact that Ml and M2 lack that sequence extension in the N-terminus explains why
these two isoenzymes are not phosphorylated and are not regulated by this
post-translational modification.
It is becoming clear that differences in a localised region in the sequence and
structure of pyruvate kinase, the intersubunit contact region, confer characteristic
properties on each of the four vertebrate isoenzymes. The perturbation of this subunit
interface by amino acid substitution, by covalent modification, or by alteration of
solution conditions leads to an allosteric transition between conformers of the
enzyme. These states each have characteristic catalytic properties and thus allow for
precise regulation of pyruvate kinase activity in a tissue specific manner. A unifying
working hypothesis is therefore proposed for the regulation of pyruvate kinase, based
upon the existence of a characteristic allosteric transition between alternate states of
the enzyme. Changes in primary sequence affect the various equilibrium reactions in
spite of the fact that there is also a great deal of sequence identity among these
isoenzymes.
PLANT PYRUVATE KINASE ISOENZYMES
Different pyruvate kinase isoenzymes are found in the cytosolic and plastidic
compartments of several plant tissues (Plaxton, 1989). Their occurrence within these
compartments may be a reflection of the proposed origin of certain plant organelles
i.e. chloroplasts are thought to have arisen by an invasion of a primitive eukaryotic
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cell by a cyanobacterial progenitor (Alberts et al., 1983). As a result, these
isoenzymic forms of pyruvate kinase can differ markedly in their structure and
function.
Sequence information on plant pyruvate kinase isoenzymes is not well
reported in the literature and I am indebted to Prof.W.C.Plaxton and Dr.S.Blakeley
for their permission to use sequences determined in their laboratories in advance of
publication.
There appear to be at least three distinct plastidic forms of pyruvate kinase in
plants. These have been termed PKpA, PKpB and PKpG. The genes for these
plastidic variants have been cloned and sequenced from several different plants
(S.Blakeley, pers.comm). Import data into chloroplasts suggests that the G
isoenzyme is stromal and the A isoenzyme may be located in the plastid envelope. It
was originally thought that PKpA and PKpB were different subunits in a
heterotetrameric isoenzyme but they are now considered to form distinct
homotetramers themselves. The plastid isoform of plant pyruvate kinase is as distinct
from the cytosolic enzyme as it is from other eukaryote pyruvate kinases. In contrast,
the cytosolic plant enzyme is closely related to eukaryote pyruvate kinases and quite
dissimilar to the plastid form (Blakeley et al., 1991). This can be more clearly seen by
reference to the matrix of differences presented in Table 16 (Section 3.11).
Five complete plastidic isoenzyme DNA and deduced amino acid sequences
are known. Castor bean isoenzymes PKpA and PKpB appear to be produced from
the same gene by the use of alternative mRNA splicing in a manner analogous to the
Ml and M2 mammalian isoenzymes. Tobacco plastidic forms PKpA and PKpG have
also been sequenced. The A form is the largest pyruvate kinase yet found (593
residues). The G isoenzyme is shorter at 562 residues. Most of the difference appears
to be located in the N-terminus. The G isoenzyme gene from Brassica napus has also
been sequenced. It encodes a protein of 567 residues. The plastidic forms are all
much larger than their cytosolic counterparts (with the exception of PKpB from castor
bean) and more variable in size. The reasons and implications of these differences
have yet to be explained. However, the increased size of the plastidic forms may be
related to their importation into intracellular organelles.
Four cytosolic pyruvate kinase genes have been cloned from three different
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plant species. All the cytosolic enzymes are approximately the same length, 508- 510
residues. This is much shorter than the reported lengths of the plastidic isoenzymes
and may reflect a real difference in properties, the precise nature of which remains
elusive. The difference in length between the cytosolic and chloroplastic enzymes
appears to be mainly localised to the N-terminus, and may therfore be related to the
mechanism of import into the chloroplast. Some of the plant enzymes are affected by
allosteric effectors. The differences between the plant enzymes in the crucial Cal and
Ca2 helices and in the N-terminus may be sufficient to explain these different
properties (Table 1).
Expression of pyruvate kinase and the organisation of genes for this enzyme
in plants is complex. Castor bean PKc is apparently expressed both as a homo- and a
hetero- tetramer while PKp from the same species is apparently expressed as a
heterohexamer (Blakeley et al., 1991). From an analysis of the genomic DNA, potato
tuber PKc is encoded by at least three genes. Much work remains to be done on plant
pyruvate kinases. Information on enzyme structure and regulation of enzyme activity
remains poor but is progressing rapidly.
FISH PYRUVATE KINASE ISOENZYMES
Isoenzymic forms of pyruvate kinase have been detected in fish tissues but
information about their different physical and kinetic properties is very scant. Two
isoenzymes from the white muscle and liver of the rainbow trout have been identified
(Somero & Hochachka, 1968). The muscle isoenzyme appears to be activated by
fructose-1,6-P2 whereas the liver isoenzyme is not affected. This is the opposite
situation to mammalian tissues and may reflect the different metabolic stresses
undergone by these tissues in these different organisms. Studies of pyruvate kinase
from the skipjack tuna (Euthynnus pelamis) resulted in the isolation of heart muscle
and skeletal muscle forms of the enzyme (Guppy & Hochachka, 1979). The
Michaelis constant for the substrate PEP appeared to exhibit temperature dependence
in the skeletal muscle but not in the heart muscle isoenzyme. The Michaelis constant
for the other substrate ADP displayed temperature independence in both forms of the
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enzyme. Both enzymes were inhibited by alanine and ATP. This inhibitory effect was
abolished in the presence of Fru-1,6-P2-
Fish pyruvate kinase isoenzymes are notable in having quite acidic pH optima
and this may be of physiological advantage allowing the enzyme to work maximally
under conditions of severe muscular exertion (as in catching prey/ avoiding predators)
or in conditions of anoxia (oxygen depletion due to depth of habitat or due to ice
cover in winter) (Zamora et ah, 1992).
BACTERIAL PYRUVATE KINASE ISOENZYMES
Several different bacterial species have been identified as possessing
isoenzymic forms of pyruvate kinase, although none have been well characterised to
date.
E.coli has been reported to contain two distinct pyruvate kinase isoenzymes
(Malcovati & Kornberg, 1969). Genes encoding both have been cloned and
sequenced (Bledig et al., 1991; Dorit et al., 1989). One isoenzyme (PKI) is activated
by Fru-1,6-P2 resulting in a thirty-fold increase in the affinity for the substrate
phosphoenolpyruvate. This form is also inhibited by ATP. The other isoenzyme
detected in this species, PKH, is not affected by Fru-1,6-P2 but is activated by AMP.
PKII is not inhibited by increases in ATP.
Streptococcus faecalis has also been reported to possess two isoenzymes of
pyruvate kinase (PKI and PKII). Information about these forms is poor. PKI is not
affected by allosteric activators, whereas PKII appears to be activated by Fru-1,6-P2-
The PKH form has been reported as having a molecular mass of lOOkD and so the
possibility of PKII being a degradation product of PKI cannot be excluded
(Wittenberger et al., 1973).
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FUNGAL PYRUVATE KINASE ISOENZYMES
Study of the filamentous dimorphic fungus Mucor rouxii has identified three
distinct isoenzymes of pyruvate kinase (Passerson & Roselino, 1971). The
expression of the different isoenzymes depends on the life-cycle of the organism and
the carbon source of the growth media. Ungerminated sporagiospores contain only
PKI. This form has a molecular mass of 180-190kD, a K\jPEP of 2.5mM and is
allosterically activated by Fru-1,6-P2. Extracts of fungal mycelia grown with amino
acids as the carbon source contain PKHI. This form also has a molecular mass of
180-190kD. The Kj^PEP is reduced to ImM but is still activated by Fru-1,6-P2.
During the aerobic germination of spores and the conversion of yeast-like cells to
mycelium, PKH appears. This form appears to be a hybrid of types I and HI. Similar
in size to both PKI and PKIII it has a Kj^PEP of 2.5mM and is activated by
Fru-1,6-P2.
PROTOZOAN PYRUVATE KINASE ISOENZYMES
Of the three isoenzymic forms of pyruvate kinase detected in Entodiniwn
species only one has been characterised (Wakita & Hoshino, 1989). This form is
activated by AMP and Fru-1,6-P2 and inhibited by ATP and so appears to be
analogous to the PKI isolated from E.coli.
Two pyruvate kinase isoenzymes have been isolated from the parasitic
protozoan Leishmania mexicana amazonensis (Ponte-Sucre et al., 1993). One enzyme
(PYK1) displayed hyperbolic kinetics and was inhibited by
fructose-2,6-bis-phosphate (Fru-2,6-P2), whereas the other enzyme (PYK2) showed
sigmoidal kinetics for the substrate PEP and was activated by Fru-2,6-P2- The
apparent molecular size of PYK1 from gel filtration chromatography was 200kDa
whilst that of PYK2 was 55kDa. The observation that the monomelic PYK2 displays
sigmoidal kinetics with respect to its substrates gives support to the theory of Rabin,
that cooperativity between active sites is not necessary to explain sigmoidicity. An
alternative explanation is that the conditions of purification have caused the
dissociation of PYK2 into its constituent monomers, and that under physiological
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conditions it too exists primarily as a tetramer.
Genes encoding two isoenzymes of pyruvate kinase have been cloned and
sequenced from the protozoan Trypanosoma brucei (stock 427). Each isoenzyme was
found to consist of 498 amino acid residues and have molecular masses of 54,378
and 54,363 Daltons respectively. These isoenzymes are 41-51% identical at the amino
acid level to pyruvate kinases from other sources. The two isoenzymes differed from
each other in only five positions. The sequence differences were clustered in domain
C, supposedly involved in the regulation of enzyme activity (Allert et al., 1991).
ALGAL PYRUVATE KINASE ISOENZYMES
Isoenzymes of pyruvate kinase from these organisms have been best
described from the green alga Selenastrum minutum. Two isoenzymes were isolated
corresponding to chloroplastic (PKI, PKp) and cytosolic (PKH, PKc) forms
respectively (Lin et al., 1989). Both isoenzymes showed hyperbolic substrate
saturation kinetics and both were activated by DHAP and inhibited by ATP, citrate,
oxalate, Pj and Fru-1,6-P2. However, they differed in other respects. PKp appeared
to be heat labile and very sensitive to inhibition by the thiol reagent N-ethylmaleimide
(NEM), whereas PKc was heat stable and only slightly sensitive to NEM inhibition.
Furthermore, PKp appeared to be a homotetramer of Mr 240k whilst PKc appeared to
be a homodecamer of Mr 590k. The great size of the PKc isoenzyme is unusual and
may be due to the formation of high molecular wieght precipitates during purification.
Also, PKp was uniquely inhibited by ribose-5-phosphate, malate,
ribulose-l,5-bisphosphate and 2-phosphoglycerate and PKc was inhibited
specifically by glutamate. The Michaelis constants for the substrates PEP and ADP
were 0.18mM and 0.2mM for PKp and 0.09mM and 0.05mM for PKc respectively.
The two isoenzymes also displayed different pH optima with PKp showing greatest
activity at pH 6.5 and PKc most active at pH 7.0.
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OTHER PYRUVATE KINASE ISOENZYMES
Monomelic pyruvate kinase has been isolated as a thyroid hormone binding
protein from human epidermoid carcinoma A431 cells (Kato et al., 1989). This
protein (p58) shows 91% sequence identity to the rat M2 isoenzyme at the nucleotide
level and 97% identity at the amino acid level. The monomer is in equilibrium with
the tetrameric enzyme in vivo and in the absence of Fru-1,6-P2 the formation of the
tetramer is inhibited and the monomer stabilised. The tetramer does not bind thyroid
hormone whereas the monomer does. As far as is known, this form of regulation has
only been found in mammalian cell cultures and, as a result, may not be
physiologically relevant.
In vivo hybidisation of the M2 and L subunits has been confirmed in
mammals by the generation of additional isoenzymes from a presumed (M2)2L2 band
isolated from bovine kidney. The hybrid had first been denatured with urea and then
allowed to renature following removal of the urea by dialysis (Cardenas et al.,1977).
Hybridisation of subunits has been confirmed in human tissue by the observation of
M2-L hybrids in hepatomata and their host livers (Hammond and Balinsky, 1978)
and the discovery of a five-membered hybrid set in foetal brain resulting from the
hybridisation of Ml and M2 subunits.
The possibility of many more hybrid varieties of pyruvate kinase being
discovered in different tissues or cell cultures in the future is highly likely and can
only shed more light on to the fascinating subject of enzyme regulation, particularly
as it occurs in vivo.
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1.15 GENE STRUCTURE OF YEAST PYRUVATE KINASE
Pyruvate kinase is encoded by a single gene (PYK1) in S.cerevisiae. The
gene is located on chromosome 1 (Fig. 21). This locus has also been identified as
being important in cell division and has been designated cell division cycle 19
(cdcl9).
Like many other glycolytic enzymes, pyruvate kinase is regulated at the
transcriptional level in response to carbon source, increasing 10-20 fold when
glucose is added to yeast cultures growing on non-fermentable carbon sources.
Pyruvate kinase is one of the first glycolytic enzymes to be induced during the switch
from non-fermentative to fermentative growth (Maitra & Lobo, 1971). The pyruvate
kinase gene contains two Upstream Activating Sequences (UAS) located between
-811 and -634 relative to the initiation codon, one Upstream Repressible Sequence
(URS) between -468 and -344 (Nishizawa et al., 1989), and a putative Downstream
Activation Site (DAS) located within the coding region (Purvis et al., 1987), all of
which contribute to transcriptional activity. The UAS1 (which contains a
RAP1/GRF1 binding site, Nishizawa et al., 1989), UAS2 and DAS are all required
for high level transcription on glucose, but the role of these sequences in carbon
source regulation is not clear. The URS partially represses PYK1 transcription in
glucose-grown and glycerol-ethanol grown cultures (Nishizawa et al., 1989). A
second URS, located between -868 and -854, has been proposed (Luche et al.,
1992). Conventional eukaryotic transcription and translation regulatory signals are
also found eg TATA boxes, ATG translation initiation codon, TAA translation
termination codon, and polyadenylation signals, as well as yeast-specific signals eg
CT rich regions, CAAG high expression box and an adenine at -3. A comprehensive
list of such regulatory signals is given in Fig.22.
The PYK1 gene encodes a protein of 499 amino acids (excluding the
N-terminal methionine) in a single open reading frame with a monomer molecular
weight of 54,544. The N-terminus is blocked, probably with an acetyl group as is the
case in the similar enzyme from S.carlsbergensis. The amino acid sequence of yeast
pyruvate kinase is specified by a highly restricted set of codons. Only 39 of the



























































Fig.22UpstreamanddownstreamgulatoryregionsofPYK1f S.cerevisiae. Fordetailsseefac ngpage.
subset of only 26 codons. The amino acid composition is very similar to the average
for a cross section of unrelated proteins (Fig. 23; Klapper, 1977).
The non-coding strand of PYK1 also contains a large open reading frame with
the potential to encode a 326 residue protein. This sequence begins and ends with
conventional initiation and termination codons and also contains some sequences
typical of eukaryotic upstream sequences, particularly TATA boxes and the adenine at
-3. No strong candidates for 3' transcription termination sequences are found. The
putative protein is distinctly atypical by the criteria of Klapper (1977) and does not
contain any similarities to existing proteins as determined by a database search of
current primary sequences. The large open reading frame probably originated through
the introduction of silent mutations in PYK1 destroying stop codons in the
non-coding sequence that usually prevent the formation of alternate reading frames.
The alternate explanation, that PYK1 encodes two distinct proteins on separate
strands of the same gene is difficult to reconcile with traditional concepts of gene
expression and evolution. However it is important to note that similar open reading
frames may exist in other genes and may represent a considerable source of error as
future genome sequencing projects generate large amounts of data which may lead to
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Fig. 23 Occurrence of amino acid residues in yeast pyruvate kinase
compared with other proteins.
PYK = % frequency of each amino acid residue occurring in
the yeast pyruvate kinase coding sequence.
Ex = % frequency of each amino acid residue occurring in a cross-
section of 207 unrelated proteins of known sequence (data from
Klapper, 1977).
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1.16 CLONING AND OVEREXPRESSION STRATEGY
The plasmid used for overexpressing the various forms of pyruvate
kinase was pMA91-pyk. This was designed and constructed by Mellor et al.
(1985) and is used in this project with their permission.
The size of the PYK1 gene necessitated a complex mutagenesis and
subcloning strategy to be devised. This was done entirely by the author's
predecessor, T.McNally, as part of her PhD thesis, with assistance from
Dr.I.Purvis at the University of Glasgow.
The mutagenesis protocol is outlined below. The entire wild-type
pyruvate kinase gene from S.cerevisiae was cloned into the plasmid pAYE434
as a 5kbp Hind HI fragment (Fig. 24A). A 2kbp EcoRI fragment, containing
most of the pyruvate kinase coding region and a large non-coding upstream
region, was excised and 'force-cloned' into the vector pSP65. This vector had
been cut with EcoRI and SaH. The forcible ligation of EcoRI and SaH termini in
this way caused in the resulting site to be resistant to either EcoRI or Sail
cleavage, due to the loss of the requisite recognition sequences. The PYK1
encoding region could then be simply cloned into the vector pK19 via the EcoRI
and Hind III sites (Fig. 24B).
A 0.9kbp Bglll-Hind HI fragment containing the regions of PYK1 that
were to be mutated was excised from pSP65-pyk and cloned into M13abl for
the site-directed mutagenesis reactions. The method of Kunkel et al. (1985) was
the mutagenesis protocol of choice. Due to the instability of large insertions into
Ml3, the entire PYK1 sequence could not be incorporated into this vector, thus
complicating the mutagenesis strategy. After the various mutagenesis reactions
had occurred successfully, the modified BglH-Hind ni fragments were excised
and cloned back into pK19-pyk vectors that had themselves been cut with the
same two enzymes. This allowed the construction of a series of pK19-pyk
plasmids containing the majority of the PYK1 coding sequence each with a
single engineered point mutation at a specific known site.
In a separate experiment, a 7.5kbp Hind IH fragment containing the
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genomic S.cerevisiae DNA, was cloned into the vector pUC18 to generate the
plasmid pPYK20 (Fig.25 A).
The various pK19-pyk plasmids were digested with the restriction
enzymes Bgin and BstEII and the resultant 0.75kbp fragments containing the
modified PYK1 sequences were purified and cloned into similarly digested
pPYK20 plasmids. This allowed the generation of a series of pPYK20 vectors
each containing the complete PYK1 coding sequence and each containing a
single point mutation of interest.
After propagation of these pPYK20 plasmids in E.coli, a Bglll-Sstl
fragment was excised and cloned into the vector pMA91-pyk that had been
similarly digested. This final stage resulted in the entire PYK1 coding sequence
being reconstituted in an E.coli/S.cerevisiae shuttle vector, in either its wild-type
or mutated form, linked to the highly active phosphoglycerate kinase promoter
(Fig. 25B). This routinely allowed overexpression of protein up to 5-10% of the
total cellular contents.
Obviously, this complex scheme is very time-consuming and prone to
losses of product and contamination at every subcloning stage and it would be
very much more beneficial for an easier mutagenesis protocol to be devised. A
system based on the phagemid pVT-U/L (Vernet et al., 1987) may be a suitable
alternative. A preliminary investigation into the feasibility of this method was
undertaken, and samples of pVT vectors were kindly provided by Dr. Vernet. It
was felt that this particular avenue of investigation, although very promising in
its scope for rapid mutagenesis and overexpression of recombinant protein,
would be too time-consuming to initiate at such a late stage of these
investigations. Such studies would, however, make an ideal component of any





















1.17 AIMS OF THE PROJECT
This project involves the overexpression, purification and
characterisation of a mutant form of the glycolytic enzyme pyruvate kinase from
the yeast Saccharomyces cerevisiae.
The enzyme is a tetramer of identical subunits, each about 55kDa in size
(Fig. 3). From an analysis of a computer model of the yeast enzyme, it was
observed that the residue serine 384, present in the middle of an alpha helix, lay
in an important intersubunit contact zone. As a result, it was thought that this
residue may have a role in contributing to the communication of conformational
changes, induced by ligand binding, to the other subunits. The quaternary
structure of the enzyme can be likened to a dimer of dimers (Fig.3), where
serine 384 of one subunit lies in close proximity to the equivalent residue in its
neighbouring subunit. The effect of any mutation involving serine 384 is,
therefore, likely to be enhanced by the close proximity of these residues to each
other.
Serine 384 was replaced by a proline residue by site-directed
mutagenesis (McNally, 1989). This substitution would have a significant effect
on the alpha helix into which it was introduced. It was hoped that this would
have measurable effects on the interaction of the enzyme with substrates and
effectors, and also on the physical properties of the enzyme such as its stability.
The various different properties of the mutant enzyme can be characterised by a
number of techniques. Traditional enzyme assay methods provides information
on catalytic activity, substrate and effector binding affinities, and cooperativity
between binding sites. The mutation was also expected to change the
conformation of the enzyme. This aspect can be addressed by a number of
techniques such as spectroscopy (uv absorption, CD, and fluorimetry), chemical
modification, protease susceptibility, and physical methods such as thermal
stability.
As the effects of the point mutation could not be predicted in advance,
antibodies against wild type pyruvate kinase will be raised and purified from
rabbit serum. These will be useful for purifying any catalytically inactive forms
113
of the enzyme that may be produced. It is also considered necessary to modify
the purification protocol to allow rapid reproducible production of large amounts
of enzyme suitable for kinetic and physical characterisation.
As many complete pyruvate kinase amino acid sequences as possible will
be collected and compared in an attempt to further characterise the enzyme in
terms of residues essential for catalysis, substrate and effector binding,
conformational stability and intersubunit communication. It is hoped that future
targets for mutagenesis can be identified in this way. A phylogenetic analysis
might provide information about the origin and evolution of the various pyruvate
kinase enzymes.
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2. MATERIALS AND METHODS
2.1 MATERIALS
All chemicals were of the highest grade available and were purchased mainly
from Sigma Chemical Co Ltd, Poole, Dorset; Aldrich Chemical Co Ltd, Gillingham,
Dorset; BDH Laboratory Supplies, Lutterworth, Leicestershire and Boehringer
Mannheim UK, Lewes, East Sussex. Major exceptions were solvents and reagents
for molecular biological applications which came from IBI Ltd, Cambridge, UK;
DNA purification and sequencing kits from Promega, Madison, USA; and enzyme
chemiluminescent kits, radiochemicals and autoradiography film from Amersham
International pic, Amersham, UK. Restriction enzymes and lambda Hind 111 DNA
molecular size markers were from a variety of sources mainly Boehringer Mannheim
UK; Amersham International pic; Pharmacia Biosystems Ltd, Milton Keynes, UK
and Northumbria Biologicals Ltd, Cramlington, UK. Growth media were from
Unipath Ltd, Basingstoke, UK and Difco Laboratories, East Molesey, Surrey.
Equipment and other important reagents not reported here are mentioned throughout
the text where appropriate.
2.2 STRAINS AND PLASMIDS USED
2.2.1 STRAINS
Escherichia coli TGI K12 A(lac-pro, supE, thi-1, hsdD5/F'traD36, proA+B+, laclq,
lacZAM15).
Saccharomyces cerevisiae SF747 Apyk9 mata, leu2, ura3, trpl, gallO, pykl::ura3
(constructed by McNally, 1989).
2.2.2 VECTORS
pK19 (Pridmore, 1987)












The pK19pyk and pMA91pyk derivatives were also created by McNally (1989).
The nomenclature S384X, used above, indicates that serine 384 of the yeast pyruvate
kinase protein has been mutated to the residue X by site-directed mutagenesis.
2.3 PYRUVATE KINASE ASSAY
Many different methods are available for analysing the catalytic activity of
pyruvate kinase. These include monitoring the loss of pyruvate from the reaction
media spectrophotometrically (Pon & Bondar, 1967), determining the amount of
l^C-pyruvate as it is formed from ' ^C-phosphoenolpyruvate (Kaslow & Garrison,
1983) and recording the loss of NADH as it is converted to NAD+ in a coupled
enzyme assay with lactate dehydrogenase (Bucher and Pfleiderer, 1955). By far the
most commonly used technique is the latter, i.e coupling the reaction:
PEP + MgADP + H+ > Pyruvate + MgATP
to the simultaneous reaction:
Pyruvate + NADH > Lactate + NAD+
Conditions are chosen such that the pyruvate is converted to lactate as soon as it is
produced via the first reaction. The stoichiometry is such that the rate of the second
reaction, determined by the rate of decrease of absorbance at 340nm, is equivalent to
the rate of the first reaction (assuming that the coupled reaction is never limiting).
Throughout the work described in this thesis, pyruvate kinase was assayed by
the method of Bucher and Pfleiderer (1955) with some slight modifications.
The reaction mixture contained: 5.61 (imoles phosphoenolpyruvate
monocyclohexylammonium salt, 2.4 pinoles ADP di(monocyclohexylammonium)
salt, 0.4 pmoles nicotinamide adenine dinucleotide (reduced form) as the trisodium
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salt (NADH), 1.1 Units rabbit muscle lactate dehydrogenase, 100 (imoles KC1,15
(imoles MgCl2, 0.5(imoles EDTA, 100 pinoles MES-TPA, pH 6.5. The reaction
was started by the addition of phosphoenolpyruvate. The MES-TPA, KC1, MgCl2
and EDTA were mixed together and termed the "assay buffer". The EDTA was
present to chelate traces of divalent cations present in the solutions in experiments
where different divalent cations were being tested. TPA was chosen as the counter-
ion to MES as KOH and NaOH would interfere with the concentration of monovalent
cations present in tha assay mixture.
The constituents were dissolved in assay buffer and stored on ice until
required. The assay mixture was allowed to warm to 25°C before the addition of
enzyme. The temperature was maintained with a thermostatically controlled water
bath accurate to + 0.1°C. The total reaction volume was 1ml.
In other assays, e.g. in which allosteric effectors were added, or in which the
concentrations of substrates were altered over a certain specified range, the reaction
volume was kept constant at 1ml by adjustments in the volume of assay buffer used.
The rate of decrease in absorbance at 340nm of NADH was followed
electronically on a Philips PU8400 uv/visible spectrophotometer. This device greatly
increased the number of samples that could be analysed in a given time and allowed
statistically meaningful interpretation of data.
Results could be plotted on a graph automatically and rates could be calculated
to + 0.001 AU/min.
2.3.1 CALCULATION OF SPECIFIC ACTIVITY
The spectrophotometer calculated reaction rates in absorbance units per minute
(AU min~l). The Beer-Lambert law A = E.c.l, where A is the absorbance at 340nm,
E is the molar extinction coefficient of NADH (6220 M'lcm~l), 1 is the pathlength of
the incident light beam (1cm) and c is the concentration of the species of interest in the
cuvette (M), can be used to calculate the specific activity of any pyruvate kinase
sample.
If A = E.c.l, then c = A/E.l
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as 1 = 1cm, this simplifies to c = A/E (units of mol L~1 min~l)
The amount of NADH consumed in the cuvette is determined by multiplying by the
volume of the reaction mixture in the cuvette (0.001 L) and dividing by the amount of
enzyme present (mg). This gives the specific activity of the preparation in terms of
mol min~lmg~l. This will usually be an extremely small value and so correction to
(imol min"lmg"l is made by multiplying by 10^. For the purposes of this thesis, a
unit of pyruvate kinase activity is defined as the amount of enzyme that converts one
mmol of phosphoenolpyruvate to pyruvate per minute under the standard conditions
used in the assay (described in section 2.2).
2.4 MEASURING INTRACELLULAR METABOLITES
The measurement of the intracellular concentrations of various glycolytic
intermediates requires the rapid lysis of cells. Various methods for disrupting yeast
cells have been devised. However, the purpose of these protocols was usually the
recovery of genomic or plasmid DNA and so employed compounds such as phenol or
SDS that would severely compromise any attempt to assay intracellular metabolites
enzymatically. The following method avoids these problems.
2.4.1 YEAST CELL LYSIS
At specific time points after inoculation, 1.5ml culture medium was aseptically
removed from the culture flask into eppendorf tubes and centrifuged (6500rpm x 5
min, 5000g) to pellet the yeast cells. The pellet was washed twice with distilled water
and drained thoroughly. The pellet was resuspended in 0.1ml assay buffer and glass
beads (100 mesh) were added to the level of the meniscus. The tubes were vortexed
vigorously for one minute followed by incubation on ice for one minute. This process
was repeated three times. The base of the tubes were pierced with a needle and seated
in a glass test tube inside a bench top centrifuge. The cell contents were separated
from the glass beads by centrifugation (2000rpm x 30 sees). The contents of the glass



















The reaction was followed by monitoring the decrease in absorbance at 340nm due
to oxidation of NADH. The reaction was followed until the loss of NADH reached a
plateau.
2.4.3 FRUCTOSE-l,6-BISPHOSPHATE ASSAY
(from Murcott et al. 1992)
In a lml cuvette were added the following:
NAD+ 0.5mM
Triosephosphate isomerase (TIM) 2 units
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 2 units
Aldolase (ALD) 1.0 unit
Buffer (0.1M Tris-HCl, pH7.5) 0.93ml
Yeast cell lysate 0.05ml
Potassium arsenate ImM
The constituents were mixed and allowed to react for 24hrs at room temperature.
The potassium arsenate reacts with glyceraldehyde-3-phosphate and prevents
equilibration of the reaction.
The reactions occurring are:
Fructose-1,6-bisphosphate —ALD—> Dihydroxyacetone phosphate +
Dihydroxyacetone phosphate -—TIM—> Glyceraldehyde-3-phosphate
Glyceraldehyde-3-phosphate + NAD+ + Pj —GAPDH—> 1,3-bisphosphoglycerate
The net reaction therefore is:
Fructose-1,6-bisphosphate + 2 NAD+—> 2 1,3-bisphosphoglycerate + 2NADH
2.5 PROTEIN DETERMINATION
The amount of protein in a sample was determined using a modification of
the method of Bradford (1976). This involved incubating the sample in an acidic
solution of a dye (Bradford solution) whose spectral properties vary when it has













The dye was dissolved in the ethanol. To this solution was added the phosphoric
acid. The resulting solution was diluted to 1 litre with distilled water and filtered
to remove undissolved particles of dye. The final solution was copper brown in
colour. The solution was stored at room temperature in a dark bottle.
The samples to be analysed were pipetted into clean glass test tubes. The
volume of the sample was less than 0.1ml and the protein content was between
0-50mg. The samples were made up to 0.1ml with distilled water. To this was
added 0.9ml Bradford reagent. The tubes were vortexed and allowed to stand at room
temperature for ten minutes. The absorbance of the samples was measured at 595nm
and read against a suitable reference blank. A calibration curve was constructed
using known amounts of bovine serum albumin in the range 0-50|lg. The amount
of protein in the test samples was calculated by interpolation from the calibration
curve.
2.6 PURIFICATION OF PYRUVATE KINASE
The basic protocol for the large scale purification of pyruvate kinase was as
follows:
2.6.1 HARVESTING YEAST CELLS
One litre of overnight culture of the appropriate strain of S.cerevisiae was
harvested by centrifuging, in 250ml pots, for ten minutes at 5000rpm in a JAM rotor
in a Beckman J2/21 centrifuge. The supernatant was discarded, the pellets
resuspended in extraction buffer and pooled into one of the pots and recentrifuged as
above.
EXTRACTION BUFFER




The supernatant was again discarded. The pellet was resuspended in the
120
minimum of extraction buffer (5ml).
2.6.2 INHIBITING ENDOGENOUS PROTEASES
To this mixture, a cocktail of protease inhibitors was added.
PROTEASE INHIBITORS
1,10-phenanthroline (lOOmM in DMSO; inhibits metalloenzymes)
Dichloroisocoumarin (DCIC, 50mM in DMSO; inhibits serine proteases)
E64 (50mM in methanol; inhibits thiol proteases)
Benzamidine hydrochloride (lOOmM in methanol)
PMSF (lOOmM in methanol)
The volume of each stock solution used in each preparation was dependent
upon the volume of the cell/buffer mixture. A final concentration of 0. ImM
1,10-phenanthroline, ImM DCIC, E64 and PMSF, and 50mM benzamidine
hydrochloride were required prior to cell lysis.
2.6.3 CELL LYSIS
A sufficient quantity of 100 mesh acid-washed glass beads was added to the
cell suspension to form a thick slurry. The mixture was then homogenised using a
Teflon pestle mounted on a power drill, firmly attached to a retort stand, for six
minutes. During lysis the slurry was cooled by an ice bath. The mixture was then
cooled on ice for five minutes and the process repeated. The resultant lysed cell-glass
bead mixture was washed with 200ml extraction buffer in 25ml aliquots. The
washings were transferred to a clean beaker whilst the glass beads were cleaned to
enable reuse.
2.6.4 CLEANING GLASS BEADS
The glass beads were extensively washed in dH20 to remove cell debris and
buffer. In a large beaker, the glass beads were stirred vigorously for an hour in a
large volume of (IH2O to which had been added l-2ml concentrated nitric acid. The
beads were then rinsed extensively in dH20 and dried in an oven.
2.6.5 CONFIRMING CELL LYSIS
The bead washings were centrifuged for 20 minutes at 5000rpm to remove
cell debris and extraneous glass beads. The supernatant was transferred to a fresh
beaker. A sample of the pellet was examined under high power (400x magnification)
on a light microscope to assess the extent of cell lysis. If a large proportion of intact
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yeast cells were observed, the pellet was resuspended in buffer and protease
inhibitors and relysed with fresh glass beads as described above. Usually, only one
lysis step was required.
2.6.6 AMMONIUM SULPHATE PRECIPITATIONS
Finely powdered solid ammonium sulphate was added to the supernatant from
the centrifuged bead washings (after a small sample was removed for Bradford and
enzyme activity assays) to bring it to 40% (w/v) saturation. The amount of solid to
add to the solution can easily be calculated from readily available saturation tables.
This solution was stirred continuously, at room temperature, for two hours, avoiding
frothing. The solution was then centrifuged in thick-walled tubes (13,000rpm x 30
min). This step removed a large proportion of the relatively insoluble proteins found
in cells. The supernatant was decanted and saved whilst the pellet was discarded.
To the supernatant, more solid ammonium sulphate was added to bring the
solution to 70% (w/v) saturation (again after saving a sample for protein and activity
assays). The solution was stirred for two hours and centrifuged exactly as described
above. The resulting pellet was saved for gel filtration whilst the supernatant was
discarded.
2.6.7 GEL FILTRATION
The pellet from the previous step was resuspended in a minimum volume of
extraction buffer (typically 5-6ml) and applied to a Sephacryl S200 HR column (90 x
1.6 cm) equilibrated in identical buffer. The flow rate was kept constant by the use of
a Gilson Minipuls 2 peristaltic pump and 5ml fractions were collected automatically
via a fraction collector (ISCO model 1850). The pyruvate kinase was barely retained
by the matrix and eluted soon after the void volume. The fractions were assayed for
activity and those found to contain pyruvate kinase were pooled. The addition of solid
ammonium sulphate to 75% (w/v) saturation, followed by centrifugation in a
benchtop microcentrifuge (13,000rpm x 10 min) resulted in the precipitation of the
protein.
2.6.8 ION EXCHANGE CHROMATOGRAPHY
The surface of the pellets from the previous step were gently rinsed several
times with extraction buffer to remove as much ammonium sulphate as possible. This
process reduced the ionic strength sufficiently to enable maximal binding of
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impurities to the ion-exchange matrix. The pellets were pooled and resuspended in
2ml of extraction buffer and then applied to a Whatman DE52 (DEAE-cellulose) anion
exchange column (10 x 2.6cm). The remaining impurities bound to this column and
the pyruvate kinase eluted in the void volume. Fractions (2.5ml) were collected
automatically as before. The fractions were assayed for activity as described in
section 2.3. Active fractions were pooled.
2.6.9 STORAGE OF ACTIVE FRACTIONS
Enzyme was precipitated with ammonium sulphate as described above and
stored at 4°C as a slurry in a sterile glass test tube sealed with Nesco film. Enzyme
stored in this way remained active for at least one month.
2.7 CONFIRMATION OF HOMOGENEITY
To confirm that the enzyme preparation was homogeneous polyacrylamide gel
electrophoresis in the presence of the detergent sodium dodecyl sulphate
(SDS-PAGE) was carried out, followed by staining of the gel with Coomassie blue
dye. The resultant gel was scanned with a densitometer.
2.7.1 SDS-PAGE
The apparatus for pouring and running the gel (Tall Mighty Small, Hoeffer
Scientific Instruments, San Francisco, USA) was wiped with methanol to remove
traces of grease and other dirt and assembled according to the manufacturer's
instructions. The base of the assembly that was to hold the gel-forming solution
whilst it was polymerising was sealed with 0.5% (w/v) molten agar solution. Whilst
the agar was setting the gel-forming solution was prepared. The resolving capability
of the gel depends approximately on the concentration of polyacrylamide that it
contains. The % polyacrylamide of the gel can be calculated from the following
formula:
(a + b)/m
where a= acrylamide (g), b= N\ N-bismethyleneacrylamide ("bis"), m= total volume
of the solution.
Thus a 9% polyacrylamide gel would contain:




3.40ml buffer (1.0M Tris-HCl, pH 8.8; 1.0% SDS)
0.055ml 10% (w/v) ammonium persulphate
0.015ml TEMED
The solutions were mixed together in a clean beaker. The ammonium
persulphate and TEMED were added last as they cause the initiation and
polymerisation reactions which lead to the formation of the gel. The mixture was
rapidly pipetted into the space between the glass plates of the assembled apparatus.
The apparatus was set aside for about 15 minutes for the gel to set. The meniscus of
the solution was flattened by the addition of about 0.1ml butanol.
Whilst the separating gel was setting, the stacking gel mixture was prepared in
another clean beaker. The stacking gel mixture consisted of:
0.4ml acrylamide stock solution
1.05ml dH20
1.50ml buffer (0.5M Tris-HCl, pH 6.8; 1.0% SDS)
0.04ml 10% (w/v) ammonium persulphate
0.01ml TEMED
This mixture produced a 4% stacking gel after polymerisation was complete.
When the separating gel had set, the butanol was poured off and the top of the gel
rinsed with dH20. The stacking gel mixture was quickly pipetted in and the
appropriate well-forming comb inserted. The gel was left to set for a further 15
minutes.
When the gel had set the comb was removed and the whole apparatus
assembled ready to run. Electrode buffer (diluted from a lOx stock solution) was
prepared and poured into the chambers of the apparatus.




The pH was adjusted to 8.3 with concentrated HC1.
The volume was then adjusted to 1L.
250ml lx electrode buffer was sufficient for each gel. The samples were
loaded into the wells, one sample per well. Each well (for a 10-well comb) could
accept a maximum of 20 |il of sample. Along with the samples to be analysed,
molecular size standards were also applied in order to determine the size of bands of
interest and to compare gels ran on different days. The gel assembly was connected
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to a transformer and run at constant current to minimise heating effects. A current of
20-25mA (variable voltage 75-400V) was used. Electrophoresis was considered to be
complete when the dye front reached the bottom of the separating gel. This usually
took about 1.5 hours. The current was then switched off and the gel apparatus
disassembled. The gel was either stained or used directly for electrophoretic blotting
onto a nylon membrane (Western blotting).
2.7.2 SAMPLE PREPARATION
The sample to be analysed was mixed with an equal volume of SDS boiling
mix in an eppendorf tube and heated for 15 minutes in a bath of boiling water. The
tube was sealed to prevent evaporation of the sample but the top was pierced with a
needle to allow the expanding air to escape.
SDS BOILING MIX






After electrophoresis, the gel had to be stained in order to detect any proteins
that were present. The stain solution contained:
70% (v/v) dH20
8% (v/v) glacial acetic acid
22% (v/v) methanol
0.25% (w/v) Coomassie Brilliant Blue G250
The gel was incubated with about 50ml stain for as long as possible (more
than two hours and preferably overnight) in a sealed plastic box at room temperature
on a shaking platform. After staining was complete the gel had to be destained. This
process removed excess stain from the gel, leaving the proteins visible as blue bands
against a colourless background.
2.7.4 GEL DESTAINING
The destaining solution was identical to the stain solution except that it lacked
Coomassie blue dye. The staining solution was poured from the gel and saved for
reuse. After rinsing the gel with distilled water to remove excess stain, 100ml
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destaining solution was added. The gel was incubated, as for staining above. Two
pieces of sponge were added to the destaining gel to absorb particles of stain as they
were released during the destaining process to prevent redeposition onto the gel. The
destain solution was replaced with fresh solution at frequent intervals to ensure a clear
background. Destaining was usually complete within two hours. For a permanent
record, the gel was mounted onto a damp piece of blotting paper and dried under
vacuum using a commercial gel-drying apparatus (Atto AE-3700 gel dryer and
processor, Atto Corp, Tokyo, Japan).
2.7.5 DENSITOMETER SCANNING
The homogeneity of protein preparations could be further confirmed by the
use of a densitometer. This device scans the gel and records how much of the
scanning beam of light is absorbed by the densely-stained protein bands.
The gel was removed from the destain solution and rinsed in dF^O. It was
essential that the background was as clear as possible. The wet gel was placed onto a
clean glass platform mounted in the machine and smoothed out to remove any trapped
air bubbles. The width of the beam was controlled by choice of aperture and the path
to be followed by the beam was carefully adjusted by controls mounted on the
platform. The device (Joyce Loebl Chromascan 3) then scanned the gel automatically
and provided a linear plot of peaks, the size of which corresponded to the density of
staining. The number, and area, of all peaks able to be resolved were presented
graphically or as a table. The molecular size of unknown proteins could be calculated
by first scanning a lane of the gel in which a series of molecular size standards was
run. The Rf values of these standards could then be plotted against the log 10 of their
molecular size to obtain a calibration curve from which the size of unknown proteins
could be interpolated.
2.8 WESTERN BLOTTING
2.8.1 TRANSFER OF PROTEIN TO MEMBRANE
The usual procedure for the transfer of proteins to a membrane used in our
laboratory was semi-dry electrophoretic transfer. The polyacrylamide gel, fresh from
SDS-PAGE, was soaked in buffer A to remove excess salts which would interfere in
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protein transfer and subsequent steps.
BUFFER A
0.4M 6-amino-n-caproic acid
0.025M Tris-HCl, pH 9.4
20% (v/v) methanol
A nylon membrane (Hybond N+, Amersham International pic, Amersham,
UK) was cut to the same size as the gel, rinsed in 100% methanol and stored in
buffer B until required.
BUFFER B
0.025M Tris-HCl, pH 10.4
20% (v/v) methanol
The blotting apparatus was assembled as follows:
Two layers of filter paper cut to the same size as the gel and soaked in buffer C were
placed onto the surface of the lower half of the blotting apparatus (BioRad). This
lower half was composed of a slab of graphite and formed the anode of the apparatus.
BUFFER C
0.3M Tris-HCl, pH 10.4
20% (v/v) methanol
On top of these layers were placed two layers of filter paper soaked in buffer
B. The nylon membrane was placed on top of these layers followed by the gel, care
being taken to exclude any trapped air bubbles. On top of the gel were placed four
layers of filter paper soaked in buffer A. The upper half of the transfer unit, forming
the cathode, was placed on top of the assembled filter paper/gel/membrane stack and
connected to the power supply. A constant current (0.8mA/cm2) was applied for one
hour. After this time, the power was switched off and the transfer unit carefully
disassembled. The gel was stained with Coomassie Blue as described earlier to assess
the extent of transfer to the membrane. The membrane was rinsed in water and stored
wrapped in clingfilm until required.
2.8.2 DETECTION OF IMMOBILISED PROTEIN
After transfer, the membrane was placed in a clean plastic tray containing
about 100 ml of blocking buffer and incubated (all incubations described in this
section occurred at room temperature on a gently shaking platform) for two hours to
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block any remaining protein binding sites.
BLOCKING BUFFER




The mixture of 150mM NaCl and lOmM Tris-HCl is known as Tris- buffered
saline (TBS). When Tween 20 was also added it was known as TBST.
After blocking, the membrane was rinsed in a little TBST and incubated in




0.3ml purified rabbit anti-PK IgG (1:1500 dilution of antisera)
After incubation with primary antibody, excess IgG was removed by washing the
membrane three times, for ten minutes each time, in 100ml aliquots of washing
buffer. The buffer was discarded between washes.
WASHING BUFFER
TBS
0.05% (v/v) Tween 20





0.03ml goat anti-rabbit IgG conjugated to horseradish peroxidase
After this secondary antibody incubation, the membrane was rinsed in three changes
of washing buffer (100ml per wash, each for ten minutes) before incubation with the
colour development solution.
2.8.4 COLOUR DEVELOPMENT REACTION
The horseradish peroxidase activity conjugated to the secondary antibody was
utilised in order to locate specific protein bands. The specificity of the conjugated
enzyme for substrate is quite broad and a number of dye precursors have been used
for localisation reactions. The reaction described here used 4-chloro-l-naphthol
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which could be oxidised to give a purple precipitate that was deposited onto the
membrane. The composition of the development mixture was as follows:
0.1ml 4-chloro-l-naphthol (lOOmg/ml in methanol)
0.07ml H202 (30% v/v)
8ml TBS
The development mixture was poured onto the membrane and agitated
constandy to ensure even wetting of the surface. Colour development began
immediately and lasted up to 30 minutes. When the colour had developed to the
required level the reaction was stopped by rinsing the membrane in an excess of
distilled water. The membrane could be photographed or stored damp in a sealed
plastic bag. Once the reaction had ended the membrane had to be kept in the dark to
prevent fading of the purple colour. On prolonged incubation with the reaction
mixture the dye became olive green in colour.
2.8.5 IMMUNODIFFUSION
Combination of antibody (Ab) and antigen (Ag) in a restricting gel
environment causes Ab-Ag precipitates to become visible as pale precipitin lines.
A number of clean glass microscope slides were coated with a film of molten
agarose-buffer solution which was allowed to cool and solidify.
AGAROSE-BUFFER SOLUTION




Wells were cut into the gel with a scalpel in identical positions on all the slides. The
wells were cut so that six wells surrounded a single central well, all an equal distance
apart. In the central well was placed 3.5|il undiluted pre-immune, or anti-pyruvate
kinase, serum. The other wells contained 3.5jil of solutions of the following:
BSA (O.lmg/ml), rabbit muscle pyruvate kinase (lmg/ml), yeast wild type pyruvate
kinase (lmg/ml), E.coli cell extract, Bacillus subtilis cell extract, Staphylococcus
aureus cell extract and Thermophilus acidophilum cell extract (all aproximately
lmg/ml). The slides were laid on tissue paper moistened in buffer and incubated in a
closed container at 4°C for 24 hours. The slides were stained for protein as described
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in Section 2.13. The agar strips could be preserved by mounting them on mats of
filter paper and compressing them with a heavy weight. The filter paper was changed
at regular intervals until the agar strip was completely dry.
2.8.6 IMMUNOTITRATION
Immunoremoval of pyruvate kinase activity was tested by mixing 2.5pg wild
type pyruvate kinase with 25mM Hepes-NaOH, pH 7.5, containing 10% (v/v)
glycerol, ImM dithioerythritol, and varying amounts of rabbit anti-yeast wild type
pyruvate kinase antiserum, or pre-immune serum, diluted in the same buffer.
Dilutions of antiserum or pre-immune serum were in the range 1:50 to 1:1000. The
reactions occurred in a total volume of 0.1ml. The mixtures were incubated at room
temperature for one hour, followed by two hours incubation on ice. Precipitates were
removed by centrifugation (13,000rpm x five mins). The residual pyruvate kinase
activity in a 5jil aliquot of supematent was assayed as described earlier (Section 2.3).
2.9 IMMUNISATION
2.9.1 ADVANTAGES OF USING RABBITS FOR IMMUNISATION
Polyclonal antisera can be raised in a large variety of laboratory animals. The
rabbit is generally considered to be one of the most useful as it can be made to
produce considerable quantities of antisera (up to 20ml per fortnight) of high affinity
and titre. These antisera are predominanantly of the IgG type. Other advantages of
using rabbits are their docility, the ease with which they can be housed and handled
and the relatively low cost of their upkeep.
The introduction of yeast-derived protein presented no difficulties with respect
to toxicity or reduced antigenicity due to species relatedness. The best yield and titre
of polyclonal antisera is obtained via a series of injections of the antigen. Two female,
3kg (4-5 months old), New Zealand White rabbits were purchased (City Farms, West
Lothian) and housed in the Faculty Animal Area. All antigen injections and
subsequent bleedings were performed by trained staff and not by the author himself.
2.9.2 IMMUNISATION PROTOCOL
Yeast pyruvate kinase (2mg/ml) in 70% (w/v) saturated ammonium sulphate
was kindly provided by Dr. Toby Murcott, University of Bristol. The ammonium
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sulphate was reduced by overnight dialysis against assay buffer at room temperature.
Before inoculation, a 5-10 ml sample of blood was taken from each rabbit and
a serum fraction prepared from it to act as a control blank in subsequent experiments.
The primary injection consisted of 0.5ml antigen solution and 0.5ml Freund's
complete adjuvant (FCA) thoroughly mixed to form a stable emulsion. FCA consists
of a mineral oil mixed with heat-killed bacillus and an emulsifier and acts to increase
the immune response to injected antigens. Equal volumes (0.5ml) were injected into
each rabbit sub-cutaneously at multiple sites.
After two weeks a further injection was made. This consisted of 0.1 mg
antigen in 0.2ml FCA:antigen emulsion. The mode of injection was as before.
After a further seven weeks a third injection was made. This consisted of
0.15ml antigen solution mixed with an equal volume of Freund's incomplete adjuvant
(FTA). FIA is identical to FCA except that it does not contain a heat-killed bacillus
fraction and so reduces the possibility of granuloma formation at the site of injection.
Four weeks after the final antigen injection 5-10ml whole blood was removed
from each animal and the antisera prepared as descibed in the next section. A
simplified version of the immunisation schedule is shown in table 15 (Section 3.9).
2.9.3 PREPARATION OF ANTISERA
A sample of blood (5-10ml) was removed from each animal by a qualified
technician and stored in sterile, plastic, screw-capped containers. The blood was
allowed to clot at 37°C for one hour. The clot was then detached from the walls of
the tube, until it was moving freely, by a sterile wooden cocktail stick. The clot was
allowed to retract at 4°C for 24 hours. After this process, a layer of straw-coloured
clear fluid could be seen above a dense mass of cells that lay at the bottom of the tube.
The clotted blood was centrifuged (4000rpm x 10 min) to fully separate the serum
from the blood cells. The upper serum layer was pipetted into a length of freshly
prepared dialysis tubing sealed at one end by a watertight plastic clamp. As much air
as possible was gently squeezed out of the tubing before the other end was sealed
with another plastic clamp. The sealed tubing was immersed in a beaker containing
200ml phosphate buffer (20mM KH2PO4 - NaOH, pH 7.2). Dialysis continued at
4°C for 24 hours with frequent replacement of the buffer.
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PREPARATION OF DIALYSIS TUBING
A 10cm length of Visking dialysis tubing (Medicell International Ltd,
London, UK) was boiled in 500ml 2% (w/v) sodium bicarbonate, ImM EDTA
solution for lOmin. The tubing was rinsed in a large volume of distilled water and
boiled for a further ten minutes. After further rinsing, the tubing was ready for use. It
was handled with gloves at all times and was kept submerged to prevent drying.
After dialysis, the serum was removed to a sterile tube and an equal volume of
anion exchange resin (Whatman DE52, DEAE-cellulose) equilibrated in dialysis
buffer was added. The mixture was allowed to stand for one hour at room
temperature with occasional mixing. The antisera/resin slurry was then poured into
the barrel of a 5ml sterile syringe and the antisera expressed through a sterile 0.2mm
filter unit (Millipore S.A, Molsheim, France)) into sterile eppendorf tubes. Aliquots
of lml were stored at -20°C until required.
2.10 DNA PURIFICATION
Plasmid DNA purification can be done on many scales depending on the
quantity and quality of the required material. Smaller quantities (l-5pg) are sufficient
for most uses eg restriction enzyme digests but higher quality preparations may be
needed for transformation or mutagenesis experiments. Small scale preparations
(minipreps) have the advantage of being rapid but care must be taken to prevent
contamination with endogenous RNAses. Large scale preparations (maxipreps) do
not suffer from RNAse contamination but as a result are much more time consuming
to perform.
2.10.1 PLASMID MINIPREPS
The protocol outlined below is basically the same as that described by
£cL<i\brcol<.et al. in "Techniques in Molecular Biology" vol. 1,4.15-4.19, Cold Spring
Harbor, 1989.
Sterile apparatus and solutions were used and gloves were worn throughout
the procedure.
A 10ml overnight culture of the bacteria containing the plasmid of interest was
aliquoted into eppendorf tubes and the cells pelleted by spinning them in a benchtop
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centifuge (MSE Microfuge, Fisons.UK) for four minutes at 13,000rpm. The










To this mixture 0.3ml solution 3 was added. This deproteinated the nucleic acid,
facilitating its solubilisation.
SOLUTION 3
17.4ml glacial acetic acid
10.8g KOH
The KOH was dissolved in 30ml dH20 to which the acetic acid was then added. A
large amount of heat was liberated and care was taken during the mixing process. The
volume was adjusted to 60ml with CIH2O.
On addition of solution 3 a large amount of protein was precipitated. The
resulting mixture was centrifuged at 13,000rpm for ten minutes in a benchtop
microcentrifuge. The supernatant was transferred to a fresh tube whilst the pellet was
discarded. To the supernatant, 1/10 of the volume of 3M sodium acetate and two
volumes of absolute ethanol were added. The solution was incubated at -20°C for
two hours. After incubation, the plasmid DNA was precipitated by centrifugation at
13,000rpm for ten minutes. The supernatant was discarded, the pellet dried in a
vacuum desiccator and resuspended in 50ml lxTE.
lx TE
lOmM Tris-HCl, pH 8.0
ImM EDTA
To each fraction of plasmid DNA, 2ml ribonuclease A solution was added and
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the tubes incubated at 37°C for 30 minutes. This resulted in the degradation of any
RNA contaminants copurifying with the plasmid DNA.
RIBONUCLEASE A PREPARATION
lOmg bovine pancreatic ribonuclease A (Boehringer Mannheim GmbH,
Germany) was dissolved in 1ml 0.01M sodium acetate (pH 5.2). The mixture was
heated to 100°C for 15 minutes and then allowed to cool slowly to room temperature.
The mixture was dispensed in 50|il aliquots into sterile eppendorf tubes and stored at
-20°C until required.
After ribonuclease treatment, an equal volume of phenolrchloroform was
added to each tube. The mixture was shaken until an emulsion formed. After brief
centrifugation (13,000rpm for 15 sees) the aqueous and organic layers separated. The
DNA partitioned to the upper aqueous layer whilst the ribonuclease remained in the
organic layer. The aqueous phases from separate tubes were pooled into one tube to
which an equal volume of chloroform was added. This removed traces of phenol.
The mixture was briefly centrifuged as before. The upper aqueous layer was removed
to a fresh eppendorf tube. The plasmid could be precipitated from this fraction by the
addition of 1/10 volume of 3M sodium acetate and two volumes of absolute ethanol
followed by a two hour incuabation at -20°C and a high speed centrifugation step
(13,000rpm for 10 mins). The supernatant was discarded, the pellet dried under
vacuum and either stored at -20°C until required or resuspended in lxTE and used
immediately.
PHENOL PREPARATION
Phenol was stored in a dark glass bottle at -20°C. It was melted by immersing
the bottle in a water bath heated to 60°C for several minutes. A fraction was poured
into a 50ml Falcon tube and 8-hydroxyquinoline (0.1% w/v) was added. This
compound acts as a weak inhibitor of RNAase and its pale yellow colour serves to
easily identify the phenolic phase in mixtures of immiscible liquids. An equal volume
of 1M Tris-HCl, pH 8.0 was added and the two liquids mixed vigorously for a few
minutes. After the two phases separated, the upper buffer layer was removed and the
procedure repeated. The pH of the phenol layer was tested using pH indicator paper.
An organic phase pH of between 7.5 and 8.5 units was required. The phenol was
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stored under 0.1M Tris-HCl, pH 8 in a 50ml Falcon tube wrapped in aluminium foil
to prevent light- induced degradation. The tube was stored at 4°C. Under these
conditions the phenol remained stable for about one month. A pronounced darkening
of the phenol phase, from pale yellow to deep orange, was observed upon prolonged
storage and indicated that the phenol was no longer fit for use.
2.10.2 PLASMID MAXIPREPS
This follows basically the same procedure as for the miniprep method but on a
larger scale. All equipment was sterile and gloves were worn throughout the
preparation.
A bacterial culture was grown with vigorous shaking in a 37°C incubator to
the desired ceh density. The cells were pelleted by a brief centrifugation step
(5000rpm for 10 mins in 250ml capacity plastic pots in a Beckman J2-21 centrifuge
fitted with a JAM rotor). The supernatant was decanted and the pellet resuspended in
solution 1 (4ml per 100ml starting culture, Section 2.10.1). A sample of the
resuspended cells was removed and plated onto selective agar plates to confirm that
the culture contained only the transformed cells of interest. The plates were incubated
at 37°C and examined after 16-20 hours. To the resuspended cells solution 2 was
added (8ml per 100ml starting culture). After ensuring the complete lysis of the cells
by gentle mixing, solution 3 was added (6ml per 100ml starting culture). The mixture
was centrifuged in thick-walled tubes at 13,000rpm for 15 minutes in a Beckman
JA20 rotor. The supernatant was decanted into 50ml Falcon tubes. Sodium acetate
and absolute ethanol were added just as described for the miniprep. An incubation at
-20°C for two hours, followed by a further centrifugation at 13,000rpm for 15
minutes, resulted in the precipitation of the plasmid DNA. The supernatant was
decanted and the pellets washed in 80% (v/v) ethanol. The plasmid was repelleted by
centrifuging at 13,000rpm for ten minutes. The ethanol was poured off and the pellets
dried under vacuum for a few minutes. At this stage the pellet was a pale yellow in
colour due to RNA contamination. The pellets were resuspended in 4ml sterile lxTE.
Caesium chloride (lg/ml) was added and the tubes incubated at 50°C for a few
minutes to ensure the complete dissolution of the salt. To every 5ml of CsCl-DNA
solution, 0.4ml ethidium bromide (lOmg/ml) was added. The mixture was
centrifuged at 8,000rpm for ten minutes. This caused RNA to precipitate as a deep
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red pellet and also allowed the removal of extraneous protein as this formed a floating
scum layer. The clear red-coloured liquid was transferred to special
ultracentrifugation tubes (Beckman). The tubes were topped up with mineral oil and
sealed by melting the tops in a sealing device provided by the manufacturer of the
tubes. Before sealing, the mass of the plasmid-containing tubes were corrected to
within 0.5% of each other by the addition or subtraction of oil. The tubes were then
placed in a Beckman Ti70.1 rotor and centrifuged at 45,000rpm for 48 hours at 22°C
in a Beckman L60 ultracentrifuge. After this period the plasmid was visible as a pale
red band about halfway down the tube.
2.10.3 RECOVERING PLASMID FROM CsCl GRADIENT
The process is described diagrammatically in Fig.25. The tubes were carefully
removed from the rotor to prevent disturbing the CsCl gradient. The plasmid DNA
was visible as the lower of two pale red bands located about halfway down the tube.
The tube was carefully held in a clamp attached to a retort stand. A needle (21 gauge)
was used to pierce the top of the tube such that it penetrated the mineral oil layer.
Another needle was used to pierce the tube just above the plasmid band of interest. A
third large bore (18 gauge) needle was used to pierce the tube directly at the level of
the plasmid band. This needle was attached to a sterile 1ml syringe and the plasmid
band was carefully extracted. The large bore of the needle prevented shearing of the
DNA, especially high molecular weight species of plasmid. The needle was removed
from the syringe and the contents expressed into a sterile eppendorf tube.
2.10.4 REMOVAL OF ETHIDIUM BROMIDE FROM CsCl PURIFIED
PLASMID
To the solution of DNA an equal volume of 1-butanol saturated with water
was added. The two phases were mixed by gently shaking the tube. The phases were
separated by briefly centrifuging (6500rpm for 15 seconds). The upper butanol layer
was removed and discarded. Further water-saturated butanol was added and the
process repeated several times until all the pink colour disappeared from both the
aqueous and organic phase. The CsCl was removed by diluting the DNA solution
with three volumes of water and precipitating the DNA with two volumes of absolute
ethanol at 4°C for 15 minutes followed by centrifugation at 13,000rpm for ten
minutes at 4°C. The supernatant was removed and the plasmid pellets dried under
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Fig. 26 Collection of plasmid DNA from CsCl gradients
containing ethidium bromide.
(from Sambrook et al., 1989)
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vacuum for a few minutes. The plasmids were stored at -20°C until required.
2.11 BACTERIAL TRANSFORMATION
2.11.1 PREPARATION OF COMPETENT CELLS
Before transformation of bacterial cells can occur they must be made able to
take up foreign DNA i.e. made competent. This can be done in a variety of ways but
by far the quickest and easiest method is to incubate the cells in a solution of
alkali-metal salt, usually calcium chloride.
The following procedure is a modification of the method developed by Cohen
(1972) as described in "Molecular Cloning: A Laboratory Manual", 2nd edition,
(1989, Cold Spring Harbor Laboratory Press, NY, USA,) by Sambrook, Fritsch and
Maniatis, Volume 1, pp 1.82-1.84.
All equipment coming into contact with the bacterial cultures was sterile and
gloves were worn throughout.
A single colony of E.coli TGI, from a plate freshly grown for 16-20 hours at
37°C, was transferred to 10ml LB media and incubated at 37°C with vigorous
shaking for 16 hours. A portion of this culture (1ml) was used to seed 100ml SOB
media in a 1 litre flask. This culture was incubated at 37°C with shaking until the
ODgoo reached 0.3-0.4 (this usually took 3-4 hours).








The cells were then transferred to 50ml Falcon tubes and cooled on ice for ten
minutes. The cells were pelleted by centrifuging at 4000rpm for ten minutes. The
media was decanted and discarded. The tubes were inverted to allow as much fluid as
possible to drain away. The pellets were resuspended in 10ml 0.1M CaCl2 and stored
on ice for a further ten minutes. The cells were then pelleted as before. The
supernatant was decanted and the pellets resuspended in 2ml ice-cold 0.1M CaCl2.
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The cells were then ready for transformation.
2.11.2 TRANSFORMATION
Competent cells (0.2ml) were pipetted into sterile eppendorf tubes. The DNA
was added to each tube (no more than 50ng in 10ml lxTE). A control experiment in
which no DNA was added was included in each transformation experiment. The
tubes were incubated on ice for 30 minutes. The cells were then heat-shocked at 42°C
for 90 seconds to encourage them to take up the added DNA. The tubes were then
chilled on ice for two minutes. Growth media (0.8ml LB, Section 2.11.3) was added
to each tube and the cells incubated, without shaking, at 37°C for 60 minutes. This
allowed the cells to recover from the transformation and to begin to express the
antibiotic resistance encoded by the newly incorporated plasmid. The transformed
cells were pelleted by a brief centrifugation (6500rpm for 15 sees) and the excess
fluid removed. The pellets were resuspended in the residual media (100-150|il).
Equal volumes of transformed cells (50(il) were pipetted into the centre of selective
agar plates and the fluid spread evenly over the surface by a sterile bent glass rod.
The plates were incubated at 37°C for 16-20 hours, after which time single colonies
were visible.
The agar plates incorporated an antibiotic such that only successfully
transformed cells were able to grow. A negative control plate was also used. This
contained an antibiotic that transformed cells cannot grow in the presence of and
demonstrated that no unusual plasmid had been introduced. A positive control
consisting simply of rich media with no added antibiotics of any kind was also used.
Untransformed cells can grow on this and so colonies visible on these plates after












Kanamycin monosulphate (20mg/ml in CIH2O) to a concentration of 0.07mg/ml was








Ampicillin (sodium salt, 20mg/ml in dH20) was added to a concentration of
O.lmg/ml, after the media has cooled to below 50°C.
For non-selective rich media 2xTY plates were used without antibiotic
addition. To prepare one batch of twenty 90 x 12mm plates, 500ml of media was
required. For liquid growth media, the above recipes were prepared except that the
agar was omitted.
2.11.4 STORAGE OF BACTERIAL STRAINS
To enable a constant supply of viable cells of the correct genotype to be
available, frozen stocks of each strain were kept. These stocks consisted of the
relevant bacterial strain grown in a liquid medium, containing the appropriate selective
antibiotic, and supplemented with sterile glycerol (0.67ml culture grown to a density
of OD500 0.8-1.0 + 0.33ml sterile glycerol in a sterile 1ml eppendorf tube). After
vortexing, to ensure even mixing of the culture with the glycerol, the tubes were
labelled and stored in a freezer at -20°C where they remained viable for up to 24
months. The cells could be revived by taking a sterile loop and scraping the frozen
surface of the stock culture and spreading the cells onto the appropriate selective agar
plate and incubating for 16-20 hours at 37°C. The agar plates themselves could be
wrapped in clingfilm to keep them airtight and stored at 4°C for up to four months
before replating of the cells became necessary.
2.12 YEAST TRANSFORMATION
Like bacterial cells, yeast can be made competent to take up foreign DNA by
pretreatment with alkali metal salts. The method described here is a variation of the
lithium acetate pretreatment protocol of Ito et al. (1983). As with the transformation
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of bacteria, all solutions and glassware coming into contact with the yeast cells were
sterile. The yeast strain to be transformed had its native PYK1 gene disrupted by an
insertion of the URA3 gene (McNally, 1989).
A single colony of the recipient strain was picked from a freshly grown
selective plate and used to inoculate 10ml of selective media. The cells were grown at
30°C with shaking for 48 hours. The 10ml culture was used to seed 300ml of
identical media in a one litre flask , which was also grown at 30°C with shaking for
48 hours. A sample of the cells (2 x 50ml) were harvested by centrifuging in Falcon
tubes in a benchtop centrifuge for ten minutes at 2500rpm. The supernatant was
discarded and the cells resuspended in 10ml lxTE. The cells were pelleted exactly as




lOmM Tris-HCl, pH 8.8
ImMEDTA
Sterilised by filtration
The cells were pelleted exactly as before. The pellets were finally resuspended
in 1ml lithium acetate solution and incubated at 30°C with gentle shaking (lOOrpm)
for one hour. The yeast cells were now ready to be transformed.
Aliquots of competent cells (lOOpl) were pipetted into 1.5ml eppendorf tubes.
The DNA (l-10p.g) was dissolved in lxTE and added to the cells in a volume of
50|il. A control, in which no DNA was added to the cells was included in every
transformation experiment. The cells were incubated, without shaking, at 30°C for
30 minutes. To each tube 0.7ml PEG solution was then added and the cells
thoroughly mixed by pipetting up and down using a 200|il pipette.
PEG SOLUTION
40% (w/v) polyethylene glycol 3350
dissolved in lithium acetate solution.
Sterilised by filtration.
Following the addition of the PEG solution, the cells were incubated (without
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shaking) for 45 minutes at 30°C. The tubes were then placed in a water bath at 42°C
for five minutes. The cells were pelleted by briefly centrifuging at 6500rpm for 15
seconds. The supernatant was discarded and the cells resuspended in 1ml YEPD. The
cells were incubated at 30°C for one hour and then repelleted exactly as before. The
majority of the supernatant was poured off and the cells resuspended in about
100-200p.1 of the remaining fluid. The cells (50|ll per plate) were spread onto
selective plates using a sterile bent glass rod and incubated for upto 14 days at 25°C.
2.13 GROWTH AND MAINTENANCE OF YEAST STRAINS
One strain of yeast was routinely used throughout this project:
Saccharomyces cerevisiae SF747 (mataa leu2, ura3, trpl, gallO)
This strain was further modified by disrupting the PYK1gene by the insertion of the
ura3 gene. This prevented the expression of native pyruvate kinase protein. As a
result, this strain could be used as the recipient for expression vectors containing
native or modified versions of the PYK1 gene enabling the production and
subsequent purification of a variety of different forms of the enzyme. The disruption
of PYK1 also means that this strain cannot utilise glucose as a carbon source and so
must be grown on pyruvate-containing media which enables the pyruvate kinase step
in glycolysis to be bypassed.
The disrupted strain, designated Apyk9, was grown on the synthetic medium
Yo leu+ura~pyruvate.
Yo leu+ura"pyruvate
6.7g/litre yeast nitrogen base (without amino acids)
5.0g/litre ammonium sulphate
20g/litre pyruvate
lOml/litre lOOx amino acid stock
Sterilised by autoclaving
N.B. The pyruvate was added as a solution after the media has cooled. It was
sterilised by filtration through a 0.22mm pore diameter filter.
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Tryptophan was prepared separately as a lOOx stock solution at 2g/litre. It
was stored at 4°C in the dark. Leucine was also prepared as a lOOx stock solution at
6g/litre. It was stored at -20°C as were the other amino acid stocks.
For growth of transformed strains pyruvate was replaced with glucose
(which could be added before autoclaving) and leucine was omitted. Solid media
could be prepared from these solutions by the addition of 15g/litre agar prior to
autoclaving.
2.14 PLOTTING A GROWTH CURVE
Growth rate experiments were performed on all strains. All strains were
grown on the appropriate synthetic media as described in the last section. The strain
pykl::ura3 was grown on Yo leu+ura"pyruvate. Transformed strains were grown on
Yo leu'ura"glucose. A 10ml starter culture was inoculated with a single colony
aseptically transferred from a freshly grown plate of selective media. This was
incubated at 30°C with vigorous shaking for 16-20 hours. This starter culture was
used to seed 100ml selective media which was also incubated at 30°C with shaking.
At recorded times, 1ml samples were aseptically removed from the culture and the cell
density measured spectrophotometrically at 600nm. The measure of light scattering of
the culture is proportional to the cell density. At absorbances above 1.0, the culture
was diluted by a known amount and the optical density remeasured. The actual
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OD600 was then derived by back-calculation. This method obviated any deviation
from non-linearity observed at high cell densities. The results were plotted as OD5Q0
against time after inoculation (in hours) to give a growth curve for that particular
strain. A plot of log ODggo enabled the growth rate to be determined from the linear
portion of the resultant curve.
2.15 PLASMID RESCUE
To confirm that transformation had been successful, the plasmid was purified
from transformed yeast cells and compared with an original plasmid preparation.
Factors such as size, restriction digest patterns and selectable markers were compared
between the two plasmids.
A sample of yeast culture (1.5ml) was pelleted by brief centrifugation
(6500rpm for 15 seconds). The supernatant was discarded and the pellet resuspended
in the residual fluid (100- 150(il). To each pellet 0.2ml yeast lysis buffer, 0.2ml
phenol- chloroform (1:1) and 0.3g acid-washed glass beads were added.
YEAST LYSIS BUFFER





The mixture was vortexed for two minutes and then centrifuged (13,000rpm x
10 minutes) to pellet cell debris. The supernatant was transferred to a clean eppendorf
tube and 1/10 volume of 3M sodium acetate and two volumes absolute ethanol were
added, followed by incubation at -20°C for 20 minutes. Centrifugation (13,000rpm x
10 minutes) after the incubation pelleted the DNA. The supernatant was removed and
the pellet dried under vacuum. The pellet was dissolved in 10ml lxTE and used to
transform competent bacteria. After transformation, the bacteria were plated onto
selective agar plates and incubated at 37°C for 16-20 hours. Any colonies that grew
indicated that they were successfully transformed with the yeast-derived plasmid.
More plasmid could be obtained by maxi- or minipreps and the two compared by
restriction digest patterns.
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2.16 RESTRICTION ENZYME DIGEST
All restriction enzyme digests were performed in lx KGB buffer
(McClelland, 1987) as described in the paper. All incubations were carried out at
37°C for at least one hour except when BstEll was used. This is a heat stable
enzyme and the optimal temperature for use was 60-65°C. Digests were carried out in
a volume of 20|il and 0.5-2.0|ig DNA was digested at a time. When the digests were
performed for analysis by agarose gel electrophoresis the digestion was stopped by
the addition of 6|il gel-loading buffer.
GEL LOADING BUFFER
0.225ml dH20
0.1ml 500mM EDTA, pH8.0
0.5ml 2.5% (w/v)Bromophenol Blue
0.625ml Glycerol
2.17 AGAROSE GEL ELECTROPHORESIS
After restriction enzyme cleavage had taken place, the fragments were
separated by agarose gel electrophoresis.
A gel caster (85mm x 105mm) was washed and dried and the ends sealed
with autoclave tape to prevent the molten agarose from escaping. A 0.75% (w/v)
agarose solution was prepared.
AGAROSE SOLUTION
0.75g pure agarose (molecular biology grade)
100ml lxTBE
The agarose was melted by heating in a microwave oven (650W) on full
power for 30 seconds and was allowed to cool for a few minutes prior to the addition
of 5p.l lOmg/ml ethidium bromide to make a final concentration 0.5|Og/ml. The
ethidium bromide was added after a period of cooling to prevent the formation of
toxic vapour as it is relatively volatile. When the agarose was still molten it was
poured into the gel caster and a well-forming comb inserted. The gel was allowed to
cool thoroughly. This took 10-20 minutes. The gel appeared opaque when fully set.
When the gel was set the comb and the autoclave tape sealing were removed. The gel,
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still in its caster, was placed in a buffer tank (Gel Electrophoresis Apparatus
GNA100, Pharmacia, Sweden) which was filled with about 350ml electrode buffer
(lx TBE containing 0.5(ig/ml ethidium bromide)
ELECTRODE BUFFER STOCK (lOx TBE)
54.0g Tris base
27.5g Boric acid
20.0ml 0.5M EDTA, pH 8.0
dH20 to 1 litre
The pH was adjusted to 8.3 by the addition of concentrated HC1.
This stock was diluted for use, with dH^O, to a 0.5x working concentration.
The samples were carefully pipetted into the wells in the gel. Each well could
hold about 20|il sample. The coloured loading buffer enabled the sample to be seen,
making loading easier. The glycerol kept the sample from dispersing on loading. The
bromophenol blue migrated down the gel during electrophoresis and enabled the
approximate position of the bands to be monitored so that excessive electrophoresis
can be avoided. The lid of the buffer chamber was attached. The lid contained the
connections to the terminals. The leads from the terminals were attached to a
transformer (Shandon Southern Products Ltd,UK) and a constant voltage of about
50-80V was applied across the gel. The current was switched off when the
bromophenol blue had migrated about 80% of the way down the gel. Under these
conditions, electrophoresis was complete in about 1.5-2 hours.
The gel was removed from the caster and examined under ultraviolet tight on a
transilluminator. The ethidium bromide intercalates between the bases of the DNA
and causes fluorescence under uv illumination. In this way the position of the
fragments can be visualised. A permanent record of what the gel looked like could be
obtained by photographing the gel using uv-sensitive film (Polaroid 665).
2.18 SOUTHERN BLOTTING
Southern blotting is a method by which DNA present in an agarose gel can be
transferred and permanently bound to a solid matrix, usually a nylon membrane, and
then specific sequences detected using an oligonucleotide probe complementary to a
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sequence of interest.
2.18.1 TRANSFER OF DNA FROM GEL TO MEMBRANE
After electrophoresis, the gel was transferred to a small plastic tray. The
bottom left hand comer of the gel was trimmed off to orientate the gel in subsequent
steps. The double stranded DNA present in the gel was denatured by soaking in
several changes of 1.5M NaCl, 0.5M NaOH with constant agitation for 1-2 hours.
The gel was rinsed briefly in dH20 and neutralised by washing in several changes of
1.5M NaCl, 1M Tris-HCl (pH 7.5) for one hour. The gel was then transferred to the
blotting apparatus designed for the capillary transfer of DNA to membranes. The
apparatus consisted of a mat of filter paper, 10cm square and 6cm deep, placed into a
large plastic box and saturated with lOxSSC. Excess lOxSSC was poured into the
box to a level halfway up the side of the filter paper stack. The top layer of filter
paper was covered in an impermeable layer of clingfilm into which a hole, the same
dimensions as an agarose gel, had been cut. This ensured that buffer only passed




Dissolved in dH20, pH adjusted to 7.0 with concentrated HC1 and the volume made
up to 1 litre with dH20.
A nylon membrane (Hybond -N+, Amersham International pic, Amersham,
UK) was cut to exactly the same dimensions as the gel. It was wetted briefly with
dH20 and then soaked in lOxSSC for five minutes.
The gel was removed from the neutralising solution and inverted so that its
underside was uppermost and carefully placed onto a filter paper support. The gel and
filter paper was placed on top of the stack of saturated filter papers in the plastic box.
The membrane was laid on top of the gel. It also had a comer trimmed off and this
was aligned with that of the gel, again for orientation purposes. Two sheets of filter
paper, cut to just smaller than the membrane, were moistened in lOxSSC and placed
on top of the membrane. Paper towels, cut to just smaller than the size of the
membrane, were stacked 5-6cm high on top of the gel-membrane - filter paper
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assembly. Care was taken to ensure that buffer could only pass through the gel and
membrane into the paper towels. The transfer was allowed to proceed for up to 24
hours. During this period the denatured ssDNA was eluted from the gel and deposited
onto the nylon membrane. The paper towels above the gel became saturated with
buffer and were replaced when necessary to maintain the flow of buffer.
After transfer was complete the apparatus was disassembled. The positions of
the wells were marked on the membrane with a soft pencil.
2.18.2 BINDING DNA TO THE MEMBRANE
To prevent elution of the DNA from the membrane during subsequent
washing steps the DNA must be covalently linked to the support. This was achieved
by wrapping the membrane in clingfilm and exposing it to uv light from a
transilluminator for three minutes.
2.18.3 CONFIRMING TRANSFER OF DNA TO MEMBRANE
After the transfer, the gel was removed from the filter paper stack and soaked
in dH20 containing 0.5(ig/ml ethidium bromide for one hour on a rotating platform.
The gel was then examined under uv illumination. Any DNA that had not transferred
to the membrane would fluoresce. Usually no extraneous fluorescence was observed
after the transfer process.
2.18.4 DETECTION OF IMMOBILISED DNA
The immobilised DNA was detected using a commercially available
enzyme-linked chemiluminescent (ECL) kit (Amersham International pic, Amersham,
UK). The procedure involved labelling the specific oligonucleotide at its 3' end with
fluorescein-11-dUTP. This labelled oligonucleotide hybridised to target sequences on
membrane-immobilised ssDNA and was detected using anti-fluorescein antibodies
conjugated to horseradish peroxidase (HRP). The HRP catalysed the oxidation of
luminol present in the detection reagent to give an oxidised product. As the luminol
breaks down it passes through an excited intermediate stage and as this falls to the
ground state, light is emitted (tanax 428nm). This light output was detected on
blue-light sensitive film, providing a permanent hard copy result.
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2.18.4.1 LABELLING OF OLIGONUCLEOTIDE PROBE
A suitable oligonucleotide probe was chosen (five different probes were
available, corresponding to the five oligonucleotides used for the initial mutagenesis








The components were mixed by gently tapping the tube. The reaction mixture
was incubated at 37°C for 90 minutes. After incubation the reaction mixture was
either used immediately or stored at -20°C until required. A 10cm x 10cm membrane
required only 16(il labelled oligo for most detection purposes.
2.18.4.2 PREHYBRIDISATION
Prior to the addition of labelled oligonucleotide, the nylon membrane was
prehybidised for 2-3 hours in a shaking water bath set at the temperature at which
hybridisation was to occur. The membrane was sealed into a plastic bag containing




0.1 % (w/v) hydridisation buffer component
0.02% (w/v) SDS
0.5% (w/v) blocking agent
The hybridisation temperature was 37°C.
2.18.4.3 HYBRIDISATION
After prehybridisation, 16(il labelled oligo was added to the buffer in the




The blot was removed from the hybridisation solution and placed in a clean
container. It was covered with 100ml 5xSSC, 0.1% (w/v) SDS and incubated at
room temperature for five minutes. The buffer was discarded and the process
repeated. This buffer was also discarded and replaced with 100ml stringency wash





The membrane was incubated at 42°C, in a shaking water bath, for 15
minutes. The buffer was discarded and the process repeated.
2.18.4.5 MEMBRANE BLOCKING
The following procedures were all performed at room temperature and all
required conatant agitation of the blots.




0.10M Tris-HCl, pH 7.5
The wash solution was discarded and replaced with 25ml block solution and
incubated for 30 minutes.
BLOCK SOLUTION
0.5% (w/v) blocking agent in buffer 1.
After incubation in block solution the membrane was rinsed for one minute in
buffer 1.
2.18.4.6 ANTIBODY INCUBATION
The anti-fluorescein HRP conjugate stock was diluted by a factor of 1250x






The blots were then placed in a clean container and washed for five minutes in
buffer 2. This was repeated a further three times to ensure complete removal of any
non-specifically bound antibody.
2.18.5 SIGNAL GENERATION AND DETECTION
Equal volumes of detection solutions 1 and 2 (provided in the Amersham ECL
kit) were mixed immediately prior to use to give a final volume of 12ml. Once made
up, the detection solution could be reused 4-5 times if stored in the dark at 4°C. The
blot was incubated in this solution for exactly one minute. The blot was then removed
from the solution, briefly dried on filter paper and wrapped in clingfilm, care being
taken to smooth out the wrinkles as much as possible. In a dark room the blot was
placed into a light-tight film exposure cassette and covered with a piece of blue-light
sensitive film (Hyperfilm-MP, Amersham international pic, Amersham, UK) cut to
approximately the same dimensions as the membrane. The cassette was firmly sealed
and the film exposed to the blot for exactly one hour at room temperature. Exposure
for longer than one hour greatly increased the background signal. The cassette was
opened in a dark room and the film developed in an automatic developer (X-ograph
X2, Fuji). The film provided a permanent record of the blotting experiment and
allowed judgements about washing stringency and exposure times to be made in
order to optimise conditions for future experiments. The membrane could be stored
damp, wrapped in clingfilm, at 4°C.
2.19 SEQUENCING OF DNA
In order to support the contention that the altered physical properties of any
enzyme produced was actually due to the single point mutation introduced it was
necessary to sequence the plasmid DNA extracted from cells producing the mutant
enzyme.
2.19.1 AMPLIFICATION OF DNA
In order to produce sufficient template for sequencing it was decided to
amplify a short stretch of DNA by the polymerase chain reaction (PCR) and subject it
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to PCR sequencing via the chain-termination method using a mixture of deoxy- and
dideoxynucleoside triphosphates. Two oligonucleotide primers were designed to be
exactly complementary to regions either side of the serine 384 that had been mutated.
The primers (a 19mer and a 22mer) were synthesised by the Oswel DNA Synthesis
Facility (Department of Chemistry, University of Edinburgh). The primers were
analysed for internal secondary structure using the UWGCG programs SQUIGGLES
and CIRCLES (Devereux, 1984). The mass of the primers and PCR product were
confirmed independently by the use of laser desorption mass spectroscopy at the
WELMET Protein Characterisation Facility (Department of Biochemistry, University
of Edinburgh). The PCR product was desalted by HPLC prior to analysis. The
oligonucleotide primers were analysed without prior purification. The analyses were
carried out by Ms. Shona Cunningham.
The target DNA sequence was a 253bp region encoding residues 334-419 of
the yeast pyruvate kinase subunit. The target was amplified from several sources,
either the 0.75kbp subcloned PYK fragments present in plasmid pK19 or the entire
PYK sequence present in the vectors pPYK20, pAYE434 and pMA91.
The PCR amplification reaction was prepared using the "fmol DNA
Sequencing System" (Promega, Madison, WI, USA) and consisted of the following
components:
template DNA (ds plasmid DNA, CsCl purified) 2|il
oligonucleotide primer lp.1
lOx PCR buffer 10|il
dNTP mix (2mM) 8(il




The reaction mixtures were prepared in 0.5ml eppendorf tubes. The mineral
oil was added last and formed a covering layer to prevent evaporation during the
various incubations. The PCR incubations were performed using a thermocycler
(Techne PCH2, USA) which allowed rapid alteration and stable maintenance of the
programmed incubation temperatures. The thermocycler was allowed to heat to 95°C
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before the tubes were placed in the heating block. The tubes were packed tighdy into
the spaces provided to prevent their expulsion by trapped air expanding during the
rapid heating steps. An initial incubation at 95°C for two minutes ensured that the ds
target DNA was sufficiently denatured to allow the annealing of the primer oligos
later. This initial heating was followed by 30 cycles of
denaturation/annealing/extension.
Denaturation 95°C, 1 min
Annealing 56°C, 1 min
Extension 72°C, 1 min
The annealing temperature was chosen to be 4-5°C lower than the melting
temperature of the oligonucleotides. The melting temperature was calculated from the
formula:
69.5 + (0.41 x %GC) - 650/length of oligonucleotide (bp)
After the 30 cycles were completed the thermocycler cooled the tubes to 15°C
where the activity of the Taq polymerase is effectively halted. The reaction mixtures
were stored at 4°C until required.
The size and amount of PCR product was determined by analysing a sample
of the reaction mixture by agarose gel electrophoresis (section 2.2.2.2). An agarose
concentration of 1.5% was necessary to detect the smaller DNA products generated
using the primers chosen for this reaction.
A theoretical maximum amplification of target DNA of 2^0 (1.07 x 10^) is
possible, although this is almost never practically achievable and a yield of 2^0 (1.05
x 106) is more usual.
2.19.2 DNA SEQUENCING METHODOLOGY
Several different DNA sequencing methodologies exist. The chain-
terminating reaction using dideoxynucleoside triphosphates (ddNTPs)(Sanger et al.,
1977) is generally considered the easiest and most convenient method and was the
method utilised in the present work.
2',3'-ddNTPs differ from conventional dNTPs in that they lack a hydroxyl
residue at the 3' position of deoxyribose. They can be incorporated by DNA
polymerases into a growing DNA chain through their 5'-triphosphate groups.
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However, the absence of a 3'-hydroxyl residue prevents the formation of a
phosphodiester bond with the succeeding dNTP. Further extension of the growing
DNA chain is therefore impossible. Thus, when a small amount of one ddNTP is
included with the four conventional dNTPs in a reaction mixture for DNA synthesis,
there is competition between extension of the chain and infrequent, but specific,
termination. The products of the reaction are a series of oligonucleotide chains whose
lengths are determined by the distance between the terminus of the primer used to
initiate DNA synthesis and the sites of premature termination. By using the four
different ddNTPs in four separate enzymatic reactions, populations of
oligonucleotides are generated that terminate at positions occupied by every A, C, G,
or T in the template strand.
2.19.3 THE SEQUENCING REACTION
The materials required for PCR sequencing were obtained from a commercial
kit, "fmol DNA Sequencing System" (Promega, Madison, WI, USA). The reaction
mixtures were prepared in 0.5ml eppendorf tubes. Four tubes were labelled A, C, G
and T and into each was pipetted 2(il of the appropriate dNTP/ddNTP mixture. In a
separate tube were mixed the following components:
ds template DNA (derived from PCR) 5(ll
primer 4jil
y.35s-dATP (lOOOCi/mmol) 0.5(ll
Taq polymerase (5000U/ml) 1 fil
5x sequencing buffer (0.25M Tris-HCl, pH9.0,10mM MgCl2) 5}il
dH20 1.5|il
Aliquots (4|il) of this mixture were then added to the dNTP/ddNTP
solutions in the four labelled tubes prepared earlier. After the reaction mixtures
had been prepared they were subjected to exactly the same PCR conditions as had
been used to generate the DNA template. The PCR was stopped by the addition of








The chain-termination reaction products were separated according to chain
length on a polyacrylamide gel and visualised by exposure to photographic film.
In other experiments, DNA sequencing was performed using the Sequenase
commercial kit (USB) exactly following the manufacturer's instructions.
2.19.4 PREPARATION OF THE SEQUENCING GEL
The sequencing gel was prepared from 100ml gel-forming solution.
GEL-FORMING SOLUTION
40% acrylamide solution 75ml
lOx TTE 50ml
urea 230g
The urea took several hours to dissolve completely. The volume was adjusted to




The components were dissolved in distilled water and the volume adjusted to





The components were dissolved in distilled water and the volume adjusted to
1000ml to produce a lOx stock solution. The stock solution was diluted to a lx
working solution with distilled water. To 100ml of the gel-forming solution in a
250ml flask, 0.14ml TEMED and 0.34ml 10% (w/v) ammonium persulphate
solution were added and swiftly poured between pre-assembled sequencing plates.
When DNA was sequenced via the Sequenase methodology, lxTTE was
replaced with lxTBE in both the gel-forming solution and the running buffer.
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2.19.5 ASSEMBLY OF SEQUENCING APPARATUS
A sequencing gel is typically 30 x 30 x 0.2 cm in dimension. Two glass plates
of slightly differing sizes (42 x 34 x 0.4 cm and 39 x 34 x 0.4 cm) were thoroughly
washed with hot water and detergent and dried. Both plates were then wiped with
ethanol and allowed to air dry. The smaller plate was coated on one side with
Sigmacote (a special silicone solution in heptane, Sigma Chemical Co Ltd, Poole,
Dorset, UK) and allowed to air dry under a fume hood. This coating acts to ease
separation of the glass plate from the gel at a later stage.
The larger plate was laid with the side to be in contact with the gel uppermost.
Two plastic spacers (42 x 1 x 0.2 cm) were laid lengthways along the sides of the
plate. The smaller plate was laid on top of the larger plate, its treated side innermost,
forming a sandwich. The plates were secured along the sides and base with electrical
tape (Scotch tape, 3M, St.Paul, MN, USA). Special care was taken to exclude air
bubbles beneath the tape to reduce the possibility of leakage of the polyacrylamide
solution.
2.19.6 POURING THE SEQUENCING GEL
The gel-forming solution was prepared as described in section 2.19.4. After
the addition of TEMED and ammonium persulphate the solution was rapidly poured
into the gap between the two plates. Any air bubbles that formed were removed by
alternately rocking and tapping the plate assembly, or scooping them out using a
sharks tooth comb. Sometimes it was impossible to remove all the air bubbles. If this
happened the gel solution could be quickly poured out and repoured or the bubbles
were left in position and lanes chosen so that they caused no interference in the
running of the samples. In extreme cases the apparatus had to be completely
disassmbled and reprepared from the beginning. After successfully pouring the gel,
the plate assembly was laid on the bench with the open end slightly raised, to prevent
seepage of the gel solution, and allowed to set overnight. The well-forming comb
was inserted into the top of the gel with its flat edge in contact with the gel solution.
This ensured the formation of a perfectly flat surface to the top of the gel facilitating
sample loading. The upper part of the plate assembly was wrapped in clingfilm to
prevent the top of the gel drying out. When polymerisation was complete, the comb
and tape were removed and the assembly rinsed with water to remove deposits of
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urea and polyacrylamide that may have accumulated. The plate assembly was
connected to the electrophoresis equipment, ensuring that the smaller plate was
towards the back, and checked to ensure that no leakage of buffer was possible. Any
small gaps were plugged with silicone grease. The gel was pre-run without samples
for one hour, at a constant power output of 50W, in order to warm the gel.
2.19.7 LOADING THE SEQUENCING GEL
After the pre-run, the power was switched off and a sharks tooth comb
inserted into the top of the gel so that the teeth just penetrated the surface. The
samples to be loaded were heated for two minutes at 80°C in a heating block. The
samples (3.0|il) were loaded into adjacent wells. The order of loading was always A,
C, G, T (i.e. alphabetically). Two sets of four samples were loaded, corresponding
to the two different primers used in the chain-termination reactions. The leads were
reconnected and the samples run at 50W constant power. To obtain maximal
sequence information the first samples were allowed to run for two hours before a
second loading of samples was applied to the gel, in different lanes from the first.
Electrophoresis was continued for a further 2-3 hours. This procedure allowed
sequence very close to, and quite distant from, the primer to be read.
2.19.8 AUTORADIOGRAPHY
When electrophoresis was complete the power was switched off and the leads
disconnected. The glass plates were prised apart with a spatula. The gel remained
attached to the non-silicone treated plate. The plate with attached gel was submerged
in a tray of fixing solution for five minutes.
FIXING SOLUTION
10% (v/v) methanol
10% (v/v) glacial acetic acid
80% (v/v) distilled water
This served to fix the gel and remove urea which would prevent the gel from
drying properly and cause it to stick to the autoradiography film. The plate was
removed from the fix solution and excess solution allowed to drain from the gel. A
piece of filter paper (3MM Chr, Whatman) slightly larger than the dimensions of the
gel was cut and carefully smoothed over the gel excluding any air bubbles. In a
continuous movement, the paper was peeled away from the glass plate. The gel
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adhered to the paper. A piece of clingfilm was laid over the gel, again care being
taken to exclude air bubbles. The gel was then transferred to a gel dryer and dried
under a vacuum at 80°C for several hours. When the gel was thoroughly dry the
clingfilm was removed and excess filter paper trimmed off. The gel was loaded into a
large film cassette and, in a dark room, a sheet of autoradiography film
(Hyperfilm-HP, Amersham International pic, Amersham, UK) laid in contact with
the gel. The film was exposed at room temperature for 48-72 hours. After exposure
the film was removed from the cassette and developed using an automatic film
developer (X-ograph Compact X2). The sequence was read from the bottom of the
gel up as the shortest terminated chains, corresponding to DNA sequence nearest the
3' end of the primer, migrated farther down the gel.
2.20 FLUORESCENCE MEASUREMENTS
All fluorescence measurements were produced on a Perkin-Elmer LS3B, or
LS50, fluorescence spectrometers with attached recorders (Perkin- Elmer Corp,
Norwalk, Connecticut, USA).
The sample, containing 30-50|ig protein, was loaded into a 0.5ml quartz
fluorimetry cuvette and placed in the appropriate cell holder inside the machine. The
excitation and emission wavelengths, monochromator slit widths and wavelength
scan speed were adjusted using controls on the fluorimeter panel. The chart speed and
sensitivity (mV gain) were set with controls located on the chart recorder.
Fluorescence was measured at right angles to the incident beam in a
pathlength of 1cm. The cuvette was kept at 25 ± 0.1°C with a thermostatted water
bath. The upper and lower limits of the chart recorder trace, corresponding to
maximum and minimum detectable fluorescence emission respectively, were set using
a reference cuvette containing buffer and unligated wild type pyruvate kinase. The
emission wavelength was set on the sample emission maximum. A sample of buffer,
without added protein, allowed calibration of the fluorescence minimum.
To take a measurement, the shutter was first closed to prevent excessive
illumination of the sample. The pyruvate kinase sample was loaded into the cuvette
and mixed thoroughly with the cuvette contents. The shutter was opened and the
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sample illuminated for 20 seconds prior to measurement (it was noted that severe
fluctuation occurred in the fluorimeter read-out in the initial few seconds following
illumination). After this pre-illumination period had elapsed, the average fluorescence
was calculated by a 15 seconds integration performed by the fluorimeter.
When ligands were added they were allowed to mix with the sample for one
minute in the unilluminated fluorimeter chamber before the pre-measurement
illumination. Volume changes on addition of ligands were kept to a minimum. For
consecutive additions of ligand to a sample, the shutter was closed, the ligand added
and incubated for one minute and then pre-illuminated for 20 seconds prior to
measurement.
Results were plotted as change in fluorescence between unligated and ligated
sample versus concentration of ligand. These data could also be transformed into
Hill-type plots.
2.21 PROTEIN SEQUENCING
In order to confirm that the protein being studied was indeed a mutated form
of yeast pyruvate kinase, the purified protein was chemically fragmented, the
individual peptides purified by HPLC and sequenced via automated Edman
degradation.
2.21.1 CYANOGEN BROMIDE CLEAVAGE
Cyanogen bromide (CNBr) is capable of cleaving thioethers, and thus
provides a method to cleave proteins specifically on the carboxy-side of methionine
residues.
The protein pellet from the ion-exchange chromatography step was washed
several times in distilled water and repelleted by centrifugation (13,000rpm x 15
mins). The excess fluid was removed by aspiration and the pellet dissolved in 0.5ml
90% formic acid. Aliquots (0.175ml) were transferred to sterile eppendorf tubes and
a small crystal of CNBr was added. The tubes were covered in aluminium foil and
incubated at room temperature in a fume cupboard for 24 hours. After this time,
0.2ml distilled water was added and the mixtures reduced to dryness in a vacuum
desiccator. A blank containing no added protein was also prepared.
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2.21.2 PURIFICATION OF PEPTIDES
The peptides generated by CNBr digest were separated by reverse phase
chromatography using a microbore HPLC system (model 130A, Applied
Biosystems). The column (2.1mm id x 30mm) contained a matrix of 7|im particles
coated in octadecylsilane (CI 8) with an effective pore size of 300A. Peptides were
eluted with a buffer gradient from 100:0 to 0:100 (buffer A : buffer B). Buffer A
contained distilled water and 0.1% trifluoroacetic acid (TFA). Buffer B contained
70% acetonitrile and 0.1% TFA. The flow rate was 0.2ml per minute. The peptide
mixture was resuspended in 0.18ml 4M guanidine hydrochloride and centrifuged to
remove any insoluble precipitate. The sample (0.17ml) was loaded onto the column
via a 0.2ml displacement loop. Each run took 65 minutes to perform. The eluant was
monitored at 220nm and the absorbance against time was displayed on a chart
recorder connected to the HPLC apparatus. Fractions were collected by hand.
2.21.3 SEQUENCING PEPTIDES
The peptides were sequenced in the Welmet Protein Characterisation Facility
(Department of Biochemistry, University of Edinburgh) by Mr.D.Lamont using an
Applied Biosystems 477A protein microsequencer. The method utilised automated
Edman degradation of the peptide followed by HPLC separation of the derivatised
amino acids and their identification by comparison of their retention time with
calibrated standards. The results were analysed by comparing the deduced order of
residues removed from the peptides with the known sequence of peptides likely to be
produced with CNBr.
2.22 ELECTRON MICROSCOPY
Yeast cells were grown in the appropriate selective media to late log phase and
samples (1.5ml) pelleted by centrifugation (13,000 rpm x three mins). The pellet was
resuspended in 1ml fixative solution.
FIXATIVE SOLUTION




The cells were then washed for two hours with three changes of buffer solution.
1 60
BUFFER SOLUTION
Sodium cacodylate, pH7.4 0.1M
Calcium chloride 2mM
The cells were then fixed for one hour in a second fixative solution.
SECOND FIXATIVE SOLUTION
Sodium cacodylate, pH 7.4 0.1M
Osmium tetroxide 1 % (w/v)
Calcium chloride 2mM
After the second fixing step, the cells were pelleted and resuspended in 0.05ml 2%
(w/v) molten low melting point agarose. Care was taken to ensure that the molten
agarose had cooled sufficiendy to avoid damaging the cells. The agarose blocks were
then trimmed into l-2mm square cubes and dehydrated by washing in increasing
concentrations of ethanol and water.









After the final ethanol wash, the cells were washed twice for 15 minutes each in
propylene oxide. The cells could now be embedded in araldite resin. A 50ml Falcon
tube containing 20ml araldite CY212 and 20ml dodecyl succinic anhydride was
incubated in a water bath until both were thoroughly mixed. When mixing was
complete, 0.8ml benzyldimethyamine was added and mixed in thoroughly. The
dehyrated agarose cubes were transferred to glass vials and infiltrated with a 1:1
mixture of propylene oxide and araldite mix for 30 minutes. The cells were then
transferred to 100% araldite mix and infiltrated overnight. The cubes were transferred
to fresh araldite mix and infiltrated for a further six hours. The cubes were placed into
embedding moulds. A slip of paper identifying each sample was added and the
moulds filled with fresh araldite mix. The resin was polymerised in an oven set to
60°C for 48 hours. The cells, now sealed in an araldite block, were removed from
the moulds and taken to the Department of Pathology where they were sectioned by
microtome, stained with uranyl acetate, and mounted onto copper microscopy grids.
These procedures were all performed by a qualified technician. The grids were
examined under an electron microscope housed in the Department of Biochemistry
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with the assistance of Mrs. S.Bury. The cells were examined under low
magnification (4000-8000x) and photographs taken via a built-in mounted camera.
2.23 ALIGNMENT AND PHYLOGENETIC ANALYSIS OF
PYRUVATE KINASE SEQUENCES
The multiple alignment of amino acid sequences was performed using
the program PILEUP of the GCG package (University of Wisconsin, USA).
The alignment was manually adjusted using the program SEQUENCES
APPLICATION. The percentage of identity between pairwise aligned sequences
was calculated after the exclusion of areas containing deletions and insertions.
The multiple alignments of amino acid sequences were converted to the
appropriate input format for the PHYLIP package (version 3.5; Felsenstein,
1993) using the program READSEQ (Gilbert, 1993). The number of
substitutions between sequences was measured using the program PRODIST
(PHYLIP package) correcting for multiple substitutions according to Kimura
(1993). Based on the distance matrix, a phylogenetic tree was constructed using
the least-squares method of the program FITCH (PHYLIP package; Fitch &
Maroliash, 1967). To test the reliability of the tree, the bootstrap method was
applied (Efron, 1982; Felsenstein, 1985). From the original data set 100
bootstrap replicates were obtained allowing the construction of the
corresponding distance matrices and phylogenetic trees using the program
SEQBOUT (PHYLIP package). The program CONSENSE (PHYLIP package)
was used to obtain a consensus tree as confidence levels for monophyletic
groups.
All phylogenetic analyses were carried out on a R4000 Silicon Graphics
Iris Indigo computer by I. Ernest (International Institute of Cellular and
Molecular Pathology, Research Unit for Tropical Diseases, Brussels, Belgium).
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3.1 MORPHOLOGICAL AND BIOCHEMICAL STUDIES ON THE
PARENT AND TRANSFORMED CELLS
One of the fundamental characteristics of transformed yeast cells that can
be measured is the growth rate and its comparison with the parent untransformed
strain. The log^Q of the optical density at 600nm against time of sampling is
shown for the parent strain and the strains transformed with wild type and
mutant enzyme-overexpressing plasmids (Fig. 27). The slope of the linear part
of the plots can be used to determine the doubting time of the cells. All the cells
are grown on the selective media appropriate for that strain.
The parent strain contains a disrupted genomic copy of the PYK1 gene
making it incapable of growth on glucose. The efficiency of utilisation of
various carbon sources by the parent strain was examined and the results
displayed in Fig. 28.
The external and internal morphology of the parent and transformed
strains was examined under the electron microscope. The results are shown in
Fig. 29. The author would tike to thank Mrs.S.Bury for assistance with using
the electron microscope.
The possibility of cells containing a disrupted gene for pyruvate kinase
or a deficient copy of the enzyme being able to utilise glucose as a carbon source
is rationalised by examining alternate pathways for glucose catabolism in yeast
(Scheme 1).
The effect of lOmM potassium cyanide on the growth of the parent and
transformed strains is shown in Fig. 30.
The intracellular amounts of the allosteric effector Fru-1,6-P2 in the
parent and transformed cells is shown in Fig. 31.
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Figure 27: Growth curves of parental and transformed yeast cells.
pyk:: ura3 Parent S.cerevisiae strain in which PYK1 gene has
been disrupted by an insertion of URA 3.
Grown on leu+ ura" glycerol-ethanol.
WT Parent strain transformed with plasmid
pMA91pyk(WT) overexpressing wild type
pyruvate kinase.
Grown on leu" ura" glucose.
S384P Parent strain transformed with plasmid
pMA91pyk(S384P) overexpressing mutant
pyruvate kinase.
Grown on leu" ura" glucose.





Figure 28: Growth of pyk:: ura3 on different carbon sources.
Minimal media as defined in section 2.13 was used and supplemented with
2% (w/w) indicated carbon source. Ethanol (EtOH), where present, added as
2% (v/v).
OD600 plotted against time of sampling.
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Figure 30: Effect of KCN on growth of parental and transformed yeast cells.
Arrow indicates point of addition of KCN solution to each culture.




























Figure 31: Intracellular fructose-1,6-bisphosphate levels in parent and
transformed cells at different stages of growth.
Metabolite levels determined as described in Section 2.3.1
mid-log = stage of cellular growth midway through exponential phase as
determined from a plot of log OD600 against sampling time.
late-log = stage of cellular growth still in exponential phase but immediately
prior to cells entering stationary phase.
stat = stationary phase.
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3.2 PEPTIDE SEQUENCING
In order to confirm the presence of the serine 384 to proline point
mutation in the mutant enzyme an attempt was made to determine the sequence
of a peptide containing the region of interest.
A sample of the purified enzyme was cleaved into peptides by overnight
incubation in the presence of cyanogen bromide. The peptides were separated by
HPLC on a microbore reverse phase column. The chromatogram obtained is
shown in Fig. 32A. A control sample, containing all the reaction components
but lacking enzyme, was also run. The chromatogram of this control sample is
shown in Fig. 32B.
The expected number of peptides, and the sequence of their first 15 N-
terminal residues, is shown in Table 4.
The peptides were sequenced by automated Edman degradation. The
peak isolated by HPLC chromatography, and subsequently sequenced,
contained a mixture of peptides, making detailed analysis difficult. The PTH-
derivatised amino acid residues were separated by HPLC. A standard
chromatogram, showing the retention times of the PTH-derivatised residues and
Edman reaction by-products, is shown in Fig. 33. An example of a typical
chromatogram produced during automated Edman degradation is shown in Fig.
34. The yield of each PTH-derivatised amino acid (pmol) is given in Table 5.
From this the peptide sequence can be deduced. The sequence of the peptides
detected is shown in Table 6.
A comparison of the peptide having the most prominent signal against








Theoretical CK'BR fragments from Pyruvate Kinase
1 . . 5 R L E
2 . . \ F S H
3 . . I F T T
4 . . Y V D V
5 . . V F A S
6 . . V A R G
7 . . L E S
8 . . T Y N P
9 . . L S G E
10 . . A E T A
11 . . R N C T
R L T S L
G S Y E Y
D D K Y A
K N I T K
F I R T A
D L G I E
R P T R A
T A K G N
V I A E Q
P K P T S
N V V A G S
H K S V I D
K A C D D K
V I S A G R
N D V L T I
I P A P E V
E V S D V G
Y P I N A V
A I A Y L P
T T E T V A
Table 4 Fragments expected from complete CNBr digest of pyruvate
kinase.
Fragments are listed according to their position in the protein,
from N-terminal to C-terminal. Only the first 15 residues of
each peptide are listed.
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- Applied Blosustdia -177H Protein Scaugncer Chriwiatooraii Report -
SAMPLE : RC FR17 CNBR
[ Initiated 21 Apr 993 11:51 an ]
CYCLE SUMMARY :
Reaction cycle : BE6IN-1








[ 21 Apr 1993 12:58pm I
0.0 to 29.0 nin
1.0 sec




1 r r t i j ■ v 1 t T i 1 f • 1 1 1 1 f 1
1.5 18.0 15.0 20.0 25.0
Retention Tine: Minutes
PEAK TABULATION : ( IMX injection > Calibration : D-6
Peak R. Tme C.Tine Height Pnol Peak R.Tine C.Tine Height Pnol
ID ( nin) < nin) (uAU) * ID < nin) < nin) < uAU >
4.83 ! 944 17.13 1 04~
5.02 « 19455 18.78 954
ASP 5.88 5.68 23556 75.00 PRO 19.62 1 9.62 10488 75.00
A5N 8.52 6.52 18231 75.00 CYS 19.92 19.92 3903 75.00
SER 7.85 7.65 8058 75.00 MET 20.52 20.52 14988 75.00
5LN 8.08 8.08 13371 75.00 UAL 20.87 20.87 13623 75.00
THR 9.67 8.67 10380 75.00 DPT 22.43 22 .43 10026 75.00
5LY 9.07 9.07 10692 75.00 TRP 23.78 23.78 17901 75.00
GLU 9.77 9.77 18306 75.00 PHE Z4.63 24.63 1 1274 75.00
DMP 10.23 10.23 2646 75.00 ILE 25.27 25.27 7596 75.00
HIS 1 1 .42 1 1 .42 9477 75.00 LYS 25.75 25.75 10209 75.00
ALA 12.97 12.97 10986 75.00 LEU 26. 17 26. 17 7734 75.00
15.02 2487 27.92 3291
ARG 15.75 15.75 4950 75.00
TYR 18.63 16.63 16335 75.00
Fig.3 3 Calibration chromatogram of PTH-derivatised amino acid
residues and reaction by-products.
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- Boolled Biogvateng i77R Protein Sequencer Chrowatooran Report -
SAMPLE : RC FR17 CNBR
[ Initiated 21 Apr 1993 11:51 am ]
CYCLE SUMMARY :
Reaction cycle : NORMAL-1 Data collect tine : 0.0 to 29.0 Bin
Conversion cycle : NORMAL-1 Data interval : 1.0 sec
Gradient : NORMAL-1 Inject volume : 50 of 150 uL











PEAK TABULATION : ( 1O0X injection ) Calibration : D-6
Peak R.Time C.Time Height Pmol I Peak R.Tlme C.Time Height Pmol
ID ( nin) (min) (uAU) ! ID
l
(min > (min) ( uAU >
4.93 22123
1
! UAL 20.83 20. S~ 1 3473 74 . l "
ASP 5.82 5.58 45963 146.34 l1 22.00 729
ASN 5.40 6.52 1860 7.55 1 DPT 22.42 22 .43 1 16064 863.22
SER 7.52 7.55 1272 1 1 .84 : TRP 23.78 23.78 4002 16.77
6LN 7.92 8.08 359 2.07 ! PHE 24.60 24.63 279 1 .36
THR 8.55 8.57 1644 1 1 .88 ! ILE 25.30 25.27 3168 31 .28
5LY 8.95 9.07 21 93 15.38 ! LEU 26.20 26. 17 3636 35.26
6LU 9.50 9.77 684 2.80 I< 27.95 2463
DMP 10.12 10.23 20766 588.51 11
HIS 1 1 .57 1 1 .42 60 0.47 l1
ALA 12.83 12.97 441 3 30. 13 1
ARG 15.52 15.75 1068 16.18 I1
TYR 15.53 15.53 7089 32.55 •1
PRO 1 9.55 1 9.52 354 2.53 I1
CYS 19.87 19.92 42 0.81 1l
Fig.34 Chromatogram from first round of automated Edman degradation
of peak 17 (as identified in Fig.32).
The residue identified as the first amino acid in the sequence is
indicated V, for valine.
176
- Applied 9J-osy?tgn5 Tabulation Report ~
SAMPLE : RC FR17 CNBR
Sample Amount : 1000 pmol
Date/Time of Run : Z1 April 1993 11:51an
Cycles Run : 1 STD, 15 AA
Raw Data Tabulation . . . (in pnols)
ft R H 0 C [ 0 e H I L I n F P S I li Y 0
ycle fllft ftRG ftSH ftSP CYS 6LU SIN SLY HIS ILL LEU LVS nn PHE PRO SER THR TRP IYR Ufil
I 30.1 16.2 7.7 116.3 0.8 2.8 2.1 15.1 0.5 31.3 35.3 0.0 0.0 1.9 2.5 11.8 11.9 16.8 32.5 71.2
2 23.3 3.0 30.6 3.8 0.2 20.9 1.7 7.3 0.9 1.3 9.0 0.0 0.3 59.3 2.1 5.1 1.5 5.8 11.6 36.1
3 35.1 9.1 17.1 23.6 0.9 5.4 1.3 8.1 0.7 3.3 6.1 0.0 0.9 7.7 2.3 12.0 21.1 1.3 3.3 8.9
3 16.1 2.5 9.3 6.6 0.3 1.0 1.6 22.0 1.1 2.9 5.3 0.5 0.9 1.3 15.1 12.1 35.3 3.1 23.8 5.1
5 5.2 6.1 2.3 19.8 0.0 3.7 0.8 11.8 0.5 3.3 6.9 12.7 0.5 16.9 27.9 4.1 11.0 3.7 4.7 12.4
6 5.9 5.0 19.8 17.2 1.6 3.0 1.7 7.1 1.9 29.8 30.4 3.9 0.2 4.8 17.9 1.4 5.8 13.8 4.b 8.2
1 13.0 13.1 11.5 10.6 1.7 3.1 2.1 19.2 0.5 30.1 10.1 8.9 0.6 1.6 28.0 1.6 9.0 1.2 4.1 6.0
8 8.5 10.6 1.8 b.5 0.0 10.9 1.9 12.8 8.3 25.1 8.3 3.9 0.3 1.7 23.9 3.5 33.6 2.3 9.4 7.0
9 30.0 9.9 1.4 1.9 0.6 11.7 8.9 9.1 0.7 9.6 5.8 12.8 0.1 2.2 13.0 7.2 11.8 2.1 6.6 6.8
10 24.1 6.7 14.3 6.3 0.2 12.8 4.2 3.9 ".3 18.9 6.5 8.6 0.2 2.9 ? i,; 6.7 13.7 0. ? 5.2 "4,1
11 17.1 1.7 6.3 11.9 0.0 6.8 3.1 9.5 i.5 30.5 b.6 5.2 0.2 2.0 22.2 6.1 14.1 1.8 3.0 16.3
12 30.1 11.2 5.0 7.0 0.3 8.1 2.2 9.3 1 7 13.9 6.3 3.0 0.6 2.! 13.2 13.5 10.3 1.5 2.5 19.5
13 23.6 6.7 1.4 10.1 0.0 5.5 it S 8.7 l.i 6.1 12.1 0.6 0.1 2.8 15.6 7.5 7.5 8.2 6.3 11.3
11 13.8 5.5 3.9 ■•1.5 0.2 9.1 2.5 15.3 0.7 b. 6 12.1 0.0 0.1 2.2 10.3 6.9 9.5 10.2 3.7 '4.1
15 12.5 11.4 1.0 9.7 0.2 7.3 7.4 13,7 1.1 9.3 6.1 0.6 0.9 ? ? 13.5 c 2 5.0 11.1 ?_ i 18.9




Sequence's detected from - RC FRIT CNBR






f) RN + TP-PTS-TE-V-
g) NFSH-S-E-H-S-I -
+ : No signal, possible unmodified cysteine residue.
- : No positive assignment for this residue, possibly
due to multiple signals.
Table 6 Sequence of peptides detected in peak 17 in order of positive







kpyk_yNLPGTDVDLPALSEKDKEDLRFGVKNGVHMVFASFIRTANDVLTIREVLGEQGKDVKIIV 1801902002 02230 Fig.35Comparisonfthepe tidegiv ngthemostpr inentsi n l withSwissprotdatabaseofproteinsequence .
3.3 DNA SEQUENCING
To confirm that the overexpressed pyruvate kinase under study contained
the desired serine to proline mutation a portion of the plasmid DNA containing
the region around the mutation was sequenced. The method used was PCR
sequencing using a commercially available kit (Promega, Madison, USA).
Two oligonucleotide primers were designed to be exactly complementary
to a short region 80-100bp either side of the site of the mutation. The relation of
the primers to the PYK1 insert are shown in Fig. 36. The sequence and other
properties of the primers are shown in Table 7.
The potential secondary structure of the oligonucleotides was checked
using the UWGCG programs SQUIGGLES and CIRCLES (Devereux et al.,
1984) and the results are displayed in Fig. 37. There appears, from these
figures, to be the potential for a significant amount of secondary structure to
form. Under the conditions in which the primers are used however, these
structures probably do not exist.
The size of the oligonucleotides was checked by laser desorption mass
spectrometry (LDMS) (Fig. 38)
The region of interest (residues 333 to 418 inclusive) was amplified
from a variety of different plasmid sources by the polymerase chain reaction
(Fig. 39). The resultant product was analysed by agarose gel electrophoresis
and its size deduced by comparing the distance it migrated against a calibration
curve derived from the distance migrated by DNA fragments of known sizes run
under identical conditions (Fig. 40). An attempt was also made to determine the
size of the PCR product by laser desorption mass spectrometry (Fig. 42). Prior
to LDMS the PCR product was purified by reverse phase chromatography (Fig.
41).
The PCR product was used directly, without further purification, as the
template for double-stranded PCR sequencing using Taq polymerase. The
sequence around the site of the engineered point mutation is shown in Fig. 43.






region of PYK1 encoding residues 333-418 inclusive
flanking regions of PYK1
— oligonucleotide primers
Figure 36: DNA amplification strategy
A portion oiPYKl present on the plasmid pMA91pyk was amplified
using the polymerase chain reaction (PCR) and two oligonucleotide primers
(961Y and 962Y).
The reaction details are described in Section 2.19
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PRIMER MASS (Da) MASS DIFFERENCE
CALCULATED ACTUAL Da %
961Y 7037±8 7280 243 3.3
962Y 5879 ±7 6154 275 4.5
Sequence: 961Y GGA CAG TTT GGT CTG TAC TTG G







Table 7: Properties of the oligonucleotide primers used in PCR product generation and sequencing.
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Figure 37: Primer self-complemenatarity calculated with the UWGCG programs CIRCLES
and SQUIGGLES.
The primer sequence is represented as an arc and a potential stem loop
respectively. Complementary base pairs are indicated by a connecting strand.
Bases are numbered from the 5'-terminus.
A) 961Y, B) 962Y
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Figure 38: Laser desorption mass spectra of the oligonucleotide primers.
A)961Y
B)962Y
The signal shown is an average of 21 separate determinations.
Calculated mass is shown in daltons.
Int = signal intensity (arbitrary units)
Analyses were carried out by S.Cunningham (Welmet).
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1 2 3 4 5
Figure 39: Amplification of PYK1 DNA by the PCR from pK19-l 17.
Different volumes of the reaction mix were mixed with 3|il loading buffer
and analysed on a 1.5% agarose gel in the presence of ethidium bromide.
Lane: 1) DNA size markers (Gibco lkb ladder)
2) l(il reaction mixture
3) 5(il reaction mixture
4) 10(il reaction mixture
5) DNA size markers (Gibco lkb ladder)





Figure 40: Calibration curve for calculating size of PCR product.
Distance migrated in mm by each of the bands in the marker lane in figure 39
plotted against the logjQ of their length in bp.
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Figure 41: HPLC purification of the PCR product from pK19-117.
68|il of PCR reaction mixture loaded onto CI8 reverse phase microbore
HPLC system (Applied Biosystems).
uv detection at 295nm.
Product eluted with 0-70% (v/v) acetonitrile (ACN) gradient.
Chart speed 1.2mm/min.
i - injection spike, P - PCR product peak, S - solvent front,
Ve - elution volume (ml)
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Figure 42: Laser desorption mass spectrum of the PCR product from pK19-117.
F1PLC purified product from Figure 40 subjected to LDMS.
Signal generated is an average of 11 separate determinations.
Int = signal intensity (arbitrary units)
Analyses were carried out by S.Cunningham (Welmet).
Although low molecular weight matrix material is observed, the PCR












T G C A T G C A
1101 ACATGAGAAA CTGTACTCCA AAGCCAACCT CCACCACCGA AACCGTCGCT
1151 GCCTCCGCTG TCGCTGCTGT TTTCGAACAA AAGGCCAAGG CTATCATTGT
Fig. 43 Autoradiographs of the DNA sequence of PYK1
A) wild type, B) Ser 384 Pro mutant
The DNA sequence is from the expression vector pMA91pyk carrying
the wild type or mutated PYK1 gene respectively. In both figures the DNA sequence
begins at base 1126 and ends at base 1173. The sequence runs in the 5'->3'
direction from the top of the figure. The sequence is numbered according to
McNally et al. (1989b). The serine 384 residue (sequence TCC) in the wild type
gene and the proline 384 residue (sequence CCA) in the mutated gene are indicated.
The underlined sequence below the figure shows the region indicated in the
autoradiographs.
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3.4 PURIFICATION OF THE WILD TYPE AND MUTANT
ENZYMES
The wild type and mutant pyruvate kinases were purified in exactly the
same manner using identical equipment and reagents (Scheme 2).
The elution profile of the wild type pyruvate kinase from the Sephacryl
S200 column is shown in Fig. 44A. It is identical in all major respects to the
elution profile of the mutant enzyme (Fig. 44B). Similarly, the elution profile of
the wild type enzyme from the DEAE ion-exchange column (Fig. 45A) is
identical to that of the mutant enzyme (Fig. 45B).
The purified enzymes were subjected to analysis by SDS-PAGE (Fig.
46). From the resultant gel it can be seen that the enzyme is essentially
homogeneous and free of contaminating proteins after the final ion-exchange
chromatography step.
Both enzymes demonstrated a linear relationship between initial velocity
and enzyme concentration (Fig. 47).
The purification process is summarised in Tables 8 and 9.
KINETIC CHARACTERISATION OF THE WILD TYPE AND
MUTANT ENZYMES
1) The effect of fructose-l,6-bisphosphate
It was discovered during the purification process that the mutant enzyme
was essentially inactive in the absence of the allosteric activator Fru-1,6-P2- In
contrast, the wild type enzyme is only slightly affected by the effector over the
same concentration range (Fig.48). Throughout this thesis the mutant form of
the enzyme was assayed in the presence of 5mM Fru-1,6-P2 unless otherwise
stated.
2) The effect of phosphoenolpyruvate
The purified wild type and mutant enzymes were assayed with varying
amounts of the substrate PEP. Plots of velocity against substrate concentration
are shown in Fig 49. The data from these experiments can be analysed via a Hill
plot (Fig. 50) From such a transformation, the Sq 5 for PEP can be calculated
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easily. The degree of cooperativity between binding sites is given by npj, the
Hill coefficient, and is equal to the slope of the line produced.
3) The effect of ADP
The pure wild type and mutant enzymes were assayed with varying
amounts of the other substrate ADP. A plot of velocity against substrate
concentration for each enzyme is shown in Fig. 51. Estimates of Sq 5 and n^
can also be calculated from Hill plots of these data (Fig. 52).
4) The effect of potassium
The effect of potassium (as the chloride salt) on the wild type and mutant
enzyme activity is shown in a plot of velocity against KC1 concentration in Fig.
53. As can be seen for both enzymes, the plot is weakly sigmoidal between 0-
lOOmM KC1. Above lOOmM, KC1 is inhibitory. Estimates of Sq 5 and n^,
obtained from Hill plots, are shown in Fig.54.
5) The effect of monovalent cations
The wild type and mutant enzymes were assayed in the presence and
absence of Fru-1,6-P2 with lOOmM various monovalent chlorides in a buffer
containing tetrapropylammonium as the counter ion. The data are normalised
with respect to potassium, the usual physiological ion bound to the enzyme. The
monovalent cations tested did not significantly affect the activity of the coupling
enzyme (Fig. 55).
6) The effect of divalent cations
The wild type and mutant enzymes were assayed in the presence and
absence of Fru-1,6-P2 with 15mM various divalent cations (Fig. 56). The
cations were present as the chloride salt except barium, which was used as the
acetate salt. The results are normalised with respect to magnesium, the usual
physiological cation bound to the enzyme. Zinc inhibited the coupling enzyme
and could not be tested. Apart from zinc, none of the other divalent cations
significandy affected the activity of the coupling enzyme (Fig. 57).
7) The effect of pH
The effect of varying the pH of the buffer on the activity of the wild type
and mutant enzymes is shown in Fig. 58. In the presence of the allosteric
activator Fru-1,6-P2, the pH optimum of the wild type and mutant enzymes is
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6.5. In the absence of the effector, the wild type enzyme activity profile is
unaltered whilst the mutant enzyme is virtually inactive except at pH 8.5 and
9.5. The activity of the mutant enzyme at high pH is much lower than in the
presence of effector. The pH profile of the mutant enzyme is much narrower
than the wild-type enzyme.
8) Determination of kcat
The catalytic constant gives an indication of the efficiency of the
enzyme in terms of the rate of breakdown of the enzyme-substrate complex to
products and free enzyme. For enzymes displaying hyperbolic kinetics, the
calculation of k^ is simply Vm/[e], where Vm is the maximum calculated
velocity for the reaction and [e] is the concentration of enzyme. Note that for
pyruvate kinase there are four active sites participating in the reaction and so [e]
is effectively four times the determined enzyme concentration. The protein
preparation needs to be free from contaminants and its concentration known to a
high degree of accuracy for k^ values to be accurately calculated. Table 10
gives a summary of the k^ values, and the other kinetic parameters determined
for both the wild type and mutant enzymes.
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SCHEME 2: PYRUVATE KINASE PURIFICATION PROTOCOL
Yeast overnight culture
Harvest cells (5k x 5 min)
▼
Lyse cells (glass beads/homogeniser)
Pellet cell debris (5k x 20 min)
40% (w/v) saturated ammonium sulphate cut
Stir 2hrs (RT)
Pellet protein (13k x 30 min)
70% (w/v) saturated ammonium sulphate cut
Stir 2hrs (RT)
Pellet PK (13k x 30 min)
▼
Resuspend pellet in minimum
volume of extraction buffer (5-6ml)
Apply to Sephacryl S200 column
(1.6 x 90 cm)
I
▼
Apply active fractions to
Whatman DE52 anion-exchange
column (2.7 x 9.5 cm)
I
T
Pyruvate kinase elutes in void volume.
Concentrate active fractions
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Figure 44: Elution of: A) wild type and B) S384P mutant pyruvate kinase
from Sephacryl S200 gel filtration column.
Fractions (5ml) were eluted and their absorbance at 280nm measured.
Some fractions were assayed for enzyme activity according to the method
described earlier (Section 2.3).
The elution buffer comprised: 50mM Tris-HCl, pH 7.5, 20% (v/v) glycerol,
3mM MgC^, ImM DTT, 0.04% (w/v) sodium azide.

















Figure 45: Elution of: A) wild type and B) S384P mutant pyruvate kinase
from DEAE-cellulose anion-exchange column.
Fractions (2.5ml) were eluted and their absorbance at 280nm measured.
Some fractions were assayed for enzyme activity according to the method
described earlier (Section 2.1.3).
The elution buffer comprised: 20mM Tris-FlCl, pH 8.5, 20% (v/v) glycerol
3mM MgCl2, ImMDTT.
The flow rate was 30ml/hr.
N.B. The first ten fractions from the wild-type enzyme preparation were discarded
The elution profile should therefore be shifted to the right, where it matches the
profile of the mutant enzyme preparation.
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Figure 46: Stages of purification of wild type pyruvate kinase.
Samples treated and analysed by SDS-PAGE as described in Section 2.7
Lanes 1) cell-free yeast extract: 2) supernatant from 40% fw/v) ammonium
sulphate precipitation; 3) pellet from 40% (w/v) ammonium sulphate precipitation:
4) supernatant from 70% (w/v) ammonium sulphate precipitation; 5) pellet from
70% (w/v) ammonium sulphate precipitation; 6) fraction from gel filtration step
showing highest pyruvate kinase activity; 7) fraction from ion-exchange step
showing highest pyruvate kinase activity; 8) sample of commercially available
rabbit muscle pyruvate kinase (Sigma).
Arrows indicate size (kDa) and position of molecular weight standards analysed
under identical conditions.
205 - rabbit muscle myosin; 116 - E.coli f3-galactosidase; 97 - rabbit muscle












Figure 47: Rate of reaction as a function of enzyme concentration.
A) wild type and B) S384P mutant pyruvate kinase
from ion-exchange step was assayed according to the method described earlier
(Section 2.3).
Standard assay mixture was used.
S384P mutant enzyme was assayed in the presence of 5mM Fru-1,6-P2-
Protein concentration was determined by measuring the absorbance at 280nm
and using a value of 0.51 for a lmg/ml solution (Yun et al., 1976).
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TABLE 8: PURIFICATION OF WILD TYPE PYRUVATE KINASE
FRACTION VOLUME PROTEIN TOTAL SPECIFIC TOTAL YIELD FOL
(ml) (mg/ml) PROTEIN ACTIVITY ACTIVITY (%)
(mg) (U/mg) (U)
C.E. 1 92 1.8 346 51 1 7650 1 00 1 .0
40S 213 1 .5 320 56 1 7920 1 00 1 .1
70P 7.5 1 0 75 94 7050 40 1 .8
S200 6 3 1 8 245 4410 25 4.8
IEX 5.5 1 .5 8.3 325 2670 1 5 6.4

















C.E 1 72 1.5 260 44 1 1 400 1 00 1 .0
40S 1 94 1.3 250 49 1 2300 1 00 1 .1
70 P 7 11.5 81 85 6890 60 1 .9
S200 6 2.75 16.5 225 3720 32 5.1
IEX 5.5 1.75 9.6 275 2640 23 6.25
C.E. - cell-free extract, 40S - supernatant from 40% saturated ammonium sulphate precipitation,
70P - pellet from 70% saturated ammonium sulphate precipitation, S200- pooled gel-filtration
fractions, IEX - pooled anion-exchange fractions.
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Figure 48: Activity of: A) wild type and B) S384P mutant pyruvate kinase
as a function of fructose-1,6-bisphosphate concentration.
The enzyme from the ion-exchange step was assayed according to the method
described earlier (Section 2.3).
The activity is expressed as a percentage of the maximal rate observed at the
highest effector concentration used.
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Figure 49: Rate of reaction as a function of the substrate PER
A) wild-type and B) S384P mutant pyruvate kinase.
Assay conditions: 50mM MES-TPA, pH 6.5, lOOmM KC1, 15mM MgCF),
2.4mM ADP, 1.1 units lactate dehydrogenase, 0.15mM NADH.
PEP was present as the mono(cyclohexylammonium salt).
Fru-1,6-P2 (where present) was 5mM.
A full description of how the assay was performed is given in Section 2.3.
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Figure 50: Hill plot of the data presented in Figure 49.
Vm was calculated from a Hanes plot of the same data (not shown).
A) wild type and B) S384P mutant pyruvate kinase.
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Figure 51: Rate of reaction as a function of the concentration of the substrate ADR
A) wild type and B) S384P mutant pyruvate kinase
from ion-exchange step was assayed according to the method described earlier
(Section 2.3).
ADP was present as the di(monocyclohexylammonium) salt.
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Figure 52: Hill plot of the data presented in Figure 51.
Vm was calculated from a Hanes plot (not shown).
A) wild type and B) S384P mutant pyruvate kinase.
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Figure 53: Rate of reaction as a function of the concentration of potassium.
A) wild type and B) S384P mutant pyruvate kinase
from ion-exchange step was assayed according to the method described earlier
(Section 2.3).
Potassium was present as the chloride salt.
Wild type enzyme assayed in the absence of Fru-1,6-P2.
S384P mutant pyruvate kinase was assayed in the presence of 5mM Fru-1,6-P2-
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Figure 54: Hill plot of the data presented in Figure 53.
Vm was calculated from a Hanes plot (not shown).






















Figure 55: Monovalent cation specificity of: A) wild type and B) S384P mutant pyruvate
kinase in the presence and absence of Fru-1,6-P2.
Enzymes from the ion-exchange step were assayed according to the method
described earlier (Section 2.3) except that 0.1ml 1M MCI was added separately.
Assay buffer comprised: 50mM MES-TPA, pH 6.5, lOOmM MCI, 15mM
MgCl2.
Values are expressed relative to K+, the usual physiological cation, which was
designated as giving 100% activity.



















Figure 56: Divalent cation specificity of A) wild-type and B) S384P mutant pyruvate kinase.
Assay conditions: 50mM MES-TPA, pH 6.5, lOOmM KC1, 15mM M2+, 2.4mM
ADP, 5.6mM PEP, 0.15mM NADH, 1.1 units lactate dehydrogenase.
Cations were added as the chloride salts, except barium, which was added as the
acetate salt.
FBP (where present) was 5mM.
Rates are expressed in arbitrary units relative to magnesium, which was
designated as giving 100 units of activity.




Fig. 57 Effect of divalent and monovalent cations on lactate dehydrogenase.
A) Lactate dehydrogenase (0.02 Units) was incubated in the
presence of 15mM of the indicated divalent cations (present as the
chloride salt, except barium, which was present as the acetate salt).
Other components: 0.14mM NADH-Naj, 13.7mM NaPyruvate.
B) Lactate dehydrogenase (0.09 Units) was incubated in the
presence of lOOmM of the indicated monovalent cations (present as
the chloride salt). Other components: 0.14mM NADH-Na2,
18.2mM NaPyruvate.












Figure 58: Activity of: A) wild type and B) S384P mutant pyruvate kinase as a function of
pH in the presence and absence of Fru- 1,6-P2-
Enzymes from the ion-exchange step were assayed according to the method
described earlier (Section 2.3) except that different pH buffers were used.
At pH values below 7.0, MES-TPA buffers were used.
Above pH 7.0, Tris-HCl buffers were used.
Assay buffer comprised: 50mM buffer, lOOmM KC1, 15mM MgC^-
Fru-1,6-P2, where present, was 5mM.
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TABLE 10 KINETIC PARAMETERS OF THE WILD TYPE AND S384P MUTANT PYRUVATE
KINASES DETERMINED BY ENZYME ASSAY
PARAMETER WILD TYPE MUTANT
Sq 5 PEP (-FBP) 3.34mM
nH 2.67
Sq 5 PEP (+FBP) 0.16mM 0.94mM
nH 1.00 1.69
So 5 ADP (-FBP) 0.39mM
nH 1.16
So 5 ADP (+FBP) 0.15mM 0.69mM
nH 1.04 1.46
Sq 5 KCI (-FBP) 41,5mM
1-80
So-5 KCI (+FBP) - 21.4mM
ri|_| - 1.36
pH optimum 6.5 6.5
kcat(-FBP)






3.5 FLUORESCENCE AND CIRCULAR DICHROISM
SPECTROSCOPY STUDIES
1) Fluorescence studies
The effect of saturating concentrations of the substrates PEP (5mM) and
ADP (2mM) on the fluorescence emission spectrum of both the wild type and
mutant enzyme emission spectra are shown in Figs. 59 and 60 respectively..
The effect of varying the concentration of the effector Fru-1,6-P2 on the
emission spectra of the wild type and mutant enzymes is shown in Figs. 61. The
data from these titrations were analysed in a variety of ways to obtain estimates
of the dissociation constant of the effector with the enzymes. A number of other
fluorimetric titrations with a variety of ligands were also performed. The data
from these experiments are summarised in Table 11.
The CD and fluorescence experiments were carried out in 20mM Tris-
HC1, pH 8.5, 20% glycerol, 3mM MgCl2 and ImM DTT.
2) Circular dichroism (CD) spectroscopy
The CD spectra of the wild type and mutant enzymes are shown in Fig.
62 . The data obtained from these spectra were analysed by the CONTIN
program (Provencher, 1981) to obtain values for the various secondary
structural elements (alpha helix, beta sheet and random coil). The values
obtained for both the wild type and mutant enzyme are shown in Table 12.
The effect of saturating concentrations of substrates PEP (5mM) and
ADP (2mM) and of the effector Fru-1,6-P2 (ImM) on the CD spectra of the
wild type and mutant enzymes are shown in Figs. 63, 64 and 65 (wild type) and
Figs. 66, 67 and 68 (mutant) respectively.
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nm
Fig. 59 Effect of 5mM PEP on the fluorescence emission spectra of yeast
pyruvate kinase.
A) wild type (0.137mg/ml), B) S384P mutant enzyme.
Upper trace in each figure - spectrum in absence of ligand.
Lower trace in each figure - spectrum in presence of ligand.
Excitation 295nm, emission 300-400nm.
Buffer: 20mM Tris-HCl, pH 8.5, 20% (v/v) glycerol, 3mM
MgCl2, ImM DTT.
int = fluorescence emission intensity (arbitrary units)
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Fig. 60 Effect of 2mM ADP on the fluorescence emission spectra of yeast
pyruvate kinase.
A) wild type (0.137mg/ml), B) S384P mutant enzyme (0.2mg/ml)
Other conditions exacdy as described in Fig. 59.
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Fig. 61 Effect of increasing concentrations of Fru-1,6-P2 on the
fluorescence emission spectra of yeast pyruvate kinase.
A) wild type enzyme (0.137mg/ml),
B) S384P mutant enzyme (0.2mg/ml)
A decrease in signal intensity upon each addition of ligand is
observed. Total ligand concentration at each measurement is: i) 0|iM,
ii) 27p.M, iii) 54^tM, iv) 78^tM, v) llO^iM, vi) 133}iM.
Other conditions as described in Fig. 59.
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TABLE 11
BINDING PARAMETERS OF THE WILD TYPE AND S384P MUTANT PYRUVATE KINASES
DETERMINED BY FLUORIMETRY
PARAMETER WILD TYPE MUTANT
SQgFru-1,6-P2 49.3^M 1 5. 6|iM
nH 1.23 1.80
Sq 5 Fru-1 ,6-P2 (ADP) 269.3^M 56.8^M
nH 1.08 1.40
Sq 5 Fru-1 ,6-P2 (PEP) 55.2^M 15.3^M
nH 1.76 0.95
So 5 ADP 3.02mM 2.49mM
nH 1.06 0.96
SggPEP 93.0|iM 1 7 0(iM
nH 1.06 1.00
TABLE 12
SECONDARY STRUCTURE CONTENT (%) OF THE WILD TYPE, S384P MUTANT AND CAT
MUSCLE PYRUVATE KINASES.
ENZYME ALPHA HELIX BETA SHEET RANDOM
WILD TYPE 29 ^ 0.51 29 ±.0.74 42 ±0.9
S384P 20 ±.1.0 45 + 1.0 35 ±1.8
CAT 4 0 2 2 3 8
Wild type and S384P mutant enzymes were determined by CONTIN analysis of data collected by CD spectroscopy.
Cat muscle values were derived by analysing X-ray crystallographic data and summing those structures that had been
assigned as forming alpha helices or beta strands.
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3.6 TRYPSIN DIGESTION OF WILD TYPE AND MUTANT
PYRUVATE KINASE
The effect of incubating samples of purified wild type and mutant
pyruvate kinase with trypsin, in the presence and absence of various substrates
and effectors, was examined. The protective effect of the various ligands on the
susceptibility of the wild type and mutant enzymes to trypsin is shown in
Figures 69 and 70 respectively. The time taken for the enzymes to lose 50% of
their activity (T^q) in the presence of each ligand is given in Table 13.
3.7 NEM INHIBITION OF WILD TYPE AND MUTANT
PYRUVATE KINASE
The effect of incubating purified samples of wild type and mutant
pyruvate kinase with 2mM NEM, in the presence and absence of various
ligands, was examined. The protective effect of the ligands on the two enzymes
is shown in Figures 71 and 72 respectively. The time taken for the enzymes to












Fig. 69 Effect of ligands on the susceptibility of wild type pyruvate
kinase to digestion by trypsin.
Pyruvate kinase and trypsin (1:1 w:w) were incubated in standard




Aliquots (5/xl) were removed and incubated in standard assay
buffer to which had been added ImM PMSF.
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Fig.70 Effect of ligands on the susceptibility of S384P mutant pyruvate
kinase to digestion by trypsin.




THE EFFECT OF LIGANDS ON THE SUSCEPTIBILITY OF WILD TYPE AND
MUTANT PYRUVATE KINASE TO DIGESTION BY TRYPSIN.
WT
ADDITION T5 o (min) FOLD
S384P
T50 (min) FOLD
NONE 1 9.4 1.0 23.5
1.0
ADP 99.1 5.1 84.8
3.6
FBP 1 6.5 0.85 1 8.3
0.78




Fig. 71 Effect of ligands on the susceptibility of wild type pyruvate
kinase to inhibition by NEM.
Enzyme was incubated in the presence of 2mM NEM in standard




Aliquots (5. ■ 1) were removed and incubated in standard assay
buffer.
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Fig. 72 Effect of ligands on the susceptibility of S384P mutant pyruvate
kinase to inhibition by NEM.




THE EFFECT OF LIGANDS ON THE SUSCEPTIBILITY OF
WILD TYPE AND MUTANT PYRUVATE KINASE TO
INHIBITION BY NEM.
WT S384P
ADDITION T50(min) FOLD T50 (min) FOLD
NONE 8.8 1.0 6.9 1.0
ADP 23.1 2.6 14.8 2.1
FBP 32.3 3.7 8.0 1.2
PEP 60.0 6.8 15.5 2.2
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3.8 THERMAL STABILITY STUDIES
The resistance of the wild type and mutant enzymes to thermal
denaturation are shown in Fig. 73. The enzymes were incubated in assay buffer
at the indicated temperature for three minutes. They were then cooled on ice for
five minutes before being centrifuged to remove denatured enzyme. Aliquots of
the supernatant were then assayed to determine residual activity.
The unfolding of the wild type and mutant enzymes as a function of
temperature were studied by incubating the enzymes in assay buffer at various
temperatures in a thermostatically controlled spectrophotometer and monitoring
the change in absorbance at 280nm (Fig. 74). The influence exerted by the
effector Fru-1,6-P2 on unfolding was also studied. The absorbance of any
protein at 280nm is due primarily to the presence of tyrosine and tryptophan
residues and any increase in this value would indicate the exposure to the
solvent of previously buried residues.
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Figure 73: Thermostability of wild-type (WT), mutant (S384P), and rabbit muscle (PKr)
pyruvate kinase enzymes.
Aliquots of enzyme were incubated at the indicated temperatures for 3 min,
followed by incubation on ice for 5 min. Samples were then centrifuged (13,000
rpm x 5 min) and the supernatants assayed for activity as described in Section 2.3.
The enzymes were assayed in the presence of 5mM Fru-1,6-P2.































Figure 74: Unfolding of: A) wild type and B) S384P mutant pyruvate kinase.
Aliquots of enzymes from ion-exchange step were incubated in a 1ml quartz
cuvette placed in a thermostatically contolled heating block inside a uv
spectrophotometer.
The change in absorbance at 280nm was monitored.




The polyclonal antiserum used in the following experiments was raised
by immunising two female New Zealand White rabbits with an emulsion of
antigen and Freund's Complete Adjuvant. The animals were housed in the
Faculty Animal Area (Department of Biochemistry, University of Edinburgh).
All the injections and blood sampling were performed by trained staff and not by
the author himself. I would like to thank Mr.D.Henderson in particular for his
help and advice during this period.
The full protocol for the raising of antiserum is described in Table 15.
The antiserum was used in Western blotting experiments to determine the affinity
of the preparation, in terms of the optimum dilution of antiserum to use, and the
extent of cross-reactivity with other antigens. A typical Western blot is shown in
Fig.75. The antiserum was also used in an attempt to precipitate wild type
pyruvate kinase from solution. A comparison of the efficacy of the polyclonal
antiserum and the pre-immune control serum in causing the precipitation of















1st immunisation 0.5 50:50 FCA : Ag
emulsion
22 2nd immunisation 0.1 0.2 50:50 FCA : Ag
emulsion





FCA Freund's complete adjuvant
FIA Freund's incomplete adjuvant
fig antigen (desalted, post-ion exchange, pyruvate kinase solution)
234
Fig. 75 Western blot.
Protein samples were separated by electrophoresis on a 10%
polyacrylamide gel in the presence of SDS and transferred to a
nylon membrane. The membrane was probed with a solution of
anti-wild type yeast pyruvate kinase antiserum diluted 1:400 in TBS.
Lanes: 1) molecular weight standards, 2) rabbit muscle pyruvate
kinase, 3) yeast wild type pyruvate kinase, 4) T.acidophilwn cell-
free extract, 5) B.subtilis cell-free extract, 6)E.coli cell-free extract,
7) S.aureus cell-free extract.
Arrows on left indicate position and size (kDa) of molecular weight
markers.
66 = bovine plasma albumin, 45 = egg ovalbumin, 36 = rabbit
muscle glyceraldehyde-3-phosphate dehydrogenase, 29 = bovine
carbonic anhydrase, 24 = bovine trypsinogen, 20 = soybean trypsin
inhibitor, 14 = bovine lactalbumin.
Arrow on right indicates position of yeast pyruvate kinase.
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Fig. 76 Immunoprecipitation of wild type yeast pyruvate kinase.
Wild type pyruvate kinase solution was incubated with either 1:20
diluted pre-immune serum (Cs) or immune serum (Ab) according to
the protocol given in Section 2.8.
After precipitation of Ab-Ag complexes, the activity of an aliquot of
the supematent was determined according to the protocol in Section
2.3. Activity of the samples is expressed as a % of the initial rate of a
control sample.
As can be seen, no precipitation of wild type pyruvate kinase is
observed, perhaps due to non-optimal incubation conditions.
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3.10 COMPUTER PREDICTIONS OF SECONDARY
STRUCTURE
Several programs are available for the determination of protein
secondary structure. The most accessible are those issued by the University of
Wisconsin Genetics Computer Group (UWGCG). Portions of the sequences of
the wild type and the mutant enzyme were compared by several well-known
secondary structure prediction programs.
Figure 77 shows a plot for a 30 residue stretch of the wild type enzyme.
The sequence is centred on serine 384. The upper section shows the sequence
with an indication of the nature of the amino acid residue present i.e. whether
they are acidic/basic or hydrophobic/hydrophilic. The upper panel shows a Chou
and Fasman secondary structure prediction. The middle panel shows a
hydrophobic moment plot and the lower panel shows a hydropathy prediction.
Figure 78 shows shows an identical set of panels based on the same stretch of
sequence but containing the proline 384 point mutation.
Figure 79 shows the Chou and Fasman secondary structure plot overlaid
with the hydropathy profile for a 51 residue portion of the wild type enzyme.
The sequence is centred on serine 384. Highly hydrophilic and hydrophobic
segments are indicated with different symbols. A distinction can been made
between beta coils, beta strands and alpha helical regions. Figure 80 shows an
identical plot for the mutant enzyme containing the serine 384 to proline point
mutation.
Figure 81 shows a plot from the program PREDICT for a 51 residue
stretch of the wild type pyruvate kinase surrounding the mutagenesis target
residue, serine 384. This program shows a consensus plot from eight different
methods of predicting the secondary structure of a polypeptide. As a result,
greater confidence can be placed in the output from these multiple plots than on
the output from a single method like PEPPLOT or PLOTSTRUCTURE. Figure
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Fig. 81 Output from program PREDICT for wild type pyruvate kinase.





TURN OR COIL PREDICTION
Lj i i- l 1 i l i j ! 1 i i 1 i l i 1 l .1 1. i.. j i .j. -i- j .4.-1
YI..P:; YDD^NCTPKPTSm" ETY AAS.V/S'A VFEQKAK/f? I VLSTSGTfr'SL
B-STRAND PREDICTION
" I—l f- 1 ;—• • ** ' •" 1
r" '—• '—" ~ ; r~J ~ > ; 1
U-l -J.-I i—i_L .Lj-.l-i L-L-L-i Ui 1 t I ! ! I i_L.L_-L i I I ! 1 llLLI III! J-i-J-J 1 I I I -1 1-1
V! DVYnin^3N'~7pV'p-T-C-2£-~--p. 'A Aq »•' '3?A\ ::~zrr\'<' AC A*9 T\M CTCqT^bo?i i— • i i i i—»IJ i i i i * ♦ O t i i \ J t <w t i L. I y AAs^A t AA ^ I ubr./w ,Aa i ^ uu i JU » i • « \
HELIX PREDICTION
iO
? * w ' r"i
x-.x .!—i 4 j i ! j-. j j 4 i i 4 ! ! x 1 i j 1 i i 1 i ! I x- I ~V~j l- xxx-ij
TPKPTS^EP.'AASAVfAVFEaKAK^IVLSTSGTfPRL
Fig. 82 Output from program PREDICT for S384P mutant pyruvate kinase.
A portion of the polypeptide sequence identical in length and position
to the wild type sequence was analysed.
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3.11 ALIGNMENT AND PHYLOGENETIC ANALYSIS OF
PYRUVATE KINASE SEQUENCES
The primary amino acid sequences listed in Table 1 were compared using
the program SeqAli. The percentage identities between sequences are shown in
Table 16.
A phylogenetic tree based on a calculated distance matrix was
constructed using the program FITCH (Fig. 83). A consensus phylogenetic tree
was constructed after bootstrap analysis using the program SEQBOUT (Fig.
84).
All computer analyses were performed by I.Ernest at the International
Institute of Cellular and Molecular Pathology, Research Unit for Tropical
Diseases, Brussels, Belgium.
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TABLE16 PERCENTAGEOFIDENTITYB TWEENSEQU C S: castab
casta100.094.1 castb94.1100.0 tobaa79.984 8 brasg39.643 1 tobag40.42 colil33.61 bacst36.24 3 lacto29.28 1 brasl31.90 8 bras230.929 7 soltu31.40 1 tobac31.80 emeni32.20 5 trire31.229 9 yeast31.80 1 yarli31.43 trybb32.71 3 tryb232.91 5 leish31.229 6 ratli30.91 6 ratre29.731 6 humli31.52 0 humre30.02 humml31.98 humm231.98 catml32.32 ratml32.34 ratm231.0 chick32.46 coli234.63 0
tobaabrasgb 79.93 640.4 84.843 12 4 100.039.78 8 39.7100.067 6 38.867 6100.0 32.99 54 35.37 741 2 28.5323 31.14 56 3 29.433 96 8 30.04 56 30.54 36 1 31.64 5 31.03.78 30.94 02 30.13 55 0 31.24 45 3 31.44 29 30.83 6 30.91 76 29.630 0.7 31.32 6 30.381.7 31.24 35 7 31.24 15 5 31.74 35 31.74 19 30.03 17 32.04 19 33.086 1
colilbacstlacto 33.66 229 31.64 328.1 32.95 328 5 39.57 72 39.441 23 5 100.051.54 51.5100.046.3 41.56 3100.0 47.14 738 6 45.84 737 1 47.54 93 6 46.35 73 45.037 1 44.30 536 7 43.11 536 9 44.21 337 44.51 036 7 44.51 236 43.82 136 9 45.06 13 3 44.75.836 1 46.37 13 5 46.37 13 5 48.27 33 1 48.57 33 48.5736 7 48.77 336 45.83 0 48.036 5 36.340 03
brasls2soltu 31.90 4 30.829 71 31.129 40 0 34.53 9 36.385 47.15 85 44.79 38.67 1 100.089.25 3 89.2100.03 3 85.33100.0 75.14 43 43.54 16 43.12 8 41.260 3 43.382 42.71 51 42.31 51 43.51 72 44.12 93 0 43.92 78 45.13 74 4 45.13 74 2 45.912 46.15 32 44.92 45.734 8 44.13 76 44.33 18 36.25 7
tobacemenirire 31.82 2 30.8529 9 30.51 60 34.363 7 36.14 53 8 46.35 04 45.700 5 36.37 17 75.143 5 74.44 13 75.343 62 8 100.044.52 2 44.5100.068 8 42.268 8100.0 40.766 83 4 42.565 20 9 43.37 06 8 43.37 40 42.57 88 2 42.950 77 42.750 57 9 43.651 37 9 43.651 37 9 46.8539 4 47.0549 4 45.6528 7 46.453 29 45.651 17 9 44.452 09 37.38 4




























































































































































































































humml 31.9 31.8 31.2 34.3 35.7 48.2 47.3 37.1 45.9 45.1 45.2 46.8 53.8 49.4 51.0 50.9 50.6 51.0 49.6 69.6 69.4 70.8 70.8 100.0 99.6 93.2 93.6 91.1 86.0 37.8
huinm2 31.9 31.8 31.2 34.1 35.5 48.5 47.3 37.3 46.1 45.3 45.2 47.0 54.0 49.4 51.2 50.9 50.8 51.2 49.8 69.6 69.4 70.8 70.8 99.6 100.0 93.2 93.6 91.1 86.0 37.8
catml 32.3 32.2 31.7 34.3 35.3 48.5 47.5 36.7 44.9 44.9 44.2 45.6 52.6 48.7 49.0 49.9 50.2 50.6 49.2 67.4 67.2 68.7 68.7 93.2 93.2 100.0 95.3 89.1 87.9 37.8
ratml 32.3 32.4 31.7 34.1 34.9 48.7 47.3 36.7 45.7 45.3 44.8 46.4 53.2 49.4 49.8 50.5 50.6 51.0 49.6 68.1 67.9 69.4 69.4 93.6 93.6 95.3 100.0 92.8 87.5 38.0
ratm2 31.0 31.0 30.0 33.1 33.7 45.8 45.8 35.0 44.1 43.7 43.6 45.6 51.1 47.9 48.2 48.3 49.2 49.6 48.0 64.5 64.3 66.0 66.0 91.1 91.1 89.1 92.8 100.0 83.2 35.2
chick 32.4 32.6 32.0 34.1 34.9 48.0 48.0 36.5 44.3 43.1 43.8 44.4 52.0 49.0 49.2 51.1 50.8 51.2 49.2 68.6 68.4 69.6 69.8 86.0 86.0 87.9 87.5 83.2 100.0 38.8
coli2 34.6 33.0 33.0 33.8 36.1 36.3 40.0 33.0 36.2 36.2 35.7 37.3 38.4 37.3 37.7 36.8 36.4 36.4 36.6 35.6 35.4 36.7 36.5 37.8 37.8 37.8 38.0 35.2 38.8 100.0
Fig.83 Phylogenetic tree for pyruvate kinase.
The tree was constructed using the program FITCH.
Distance between nodes is calculated in PAM units.
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Fig. 84 Consensus phylogenetic tree for pyruvate kinase.
The tree was constructed after 100 bootstrap analyses
according to the method described in Materials and Methods.
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4.0 DISCUSSION
4.1 Purification of pyruvate kinase.
4.2 Enzyme assay conditions.




4.6 Purification and kinetic characterisation of wild type and mutant forms of
pyruvate kinase.
4.7 Fluorescence and circular dichroism studies.
4.8 Trypsin digestion of wild type and mutant enzymes.
4.9 The effect of NEM on pyruvate kinase activity.
4.10 Thermal stability studies.
4.11 Antibody studies.
4.12 Computer predictions of secondary structure.
4.13 Sequence comparison of pyruvate kinases.
4.14 Alignment and phylogenetic analysis of pyruvate kinase sequences.
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4.0 DISCUSSION
4.1 PURIFICATION OF PYRUVATE KINASE
A large number of methods for the purification of pyruvate kinase, from
a number of species and tissues, to apparent homogeneity can be obtained from
a search of the literature.
Advances in our knowledge of yeast biochemistry and physiology and
the introduction of new techniques in molecular biology have identified several
areas leading directly to improved yields of enzymes during purification. For
example, several endogenous yeast proteases have been characterised (Jones,
1991) and specific inhibitors of them have been identified (Barrett et al., 1982;
Harper et al., 1985). Genetic engineering allows the overexpression of large
quantities of enzymes (or any other proteins) allowing smaller quantities of
starting material to be used with subsequent savings in time and reagents. Prior
to genetic engineering in yeast, the earlier methods of pyruvate kinase
purification were noted for their requirement for large quantities of yeast cells
(up to 4.5kg, Hunsley & Suelter, 1969) and the length of time necessary to
obtain an homogeneous enzyme preparation (up to 10 days). Often the enzyme
had degraded significantly or had reduced specific activities in these
preparations. Consequently, the determination of the characteristics of the
enzyme were strongly dependent upon the nature of the method used to isolate
the protein. As a result properties such as subunit molecular mass, native
molecular mass and values for the various substrates were often subject to
large errors and irreproducibility.
This project describes an improved purification of pyruvate kinase from
yeast in terms of speed, convenience, reproducibility, yield and specific activity.
The overexpression, purification and characterisation of a site-directed mutant
form of the enzyme and its comparison with a wild-type counterpart isolated by
the same methods are described. The results in Section 3.4, culminating in the
purification tables (Tables 8 and 9), demonstrate the convenience and high yield
of the new method. From cell lysis to use of the fractions obtained from the
ion-exchange step took approximately 36 hours and was readily reproducible
250
over the course of the project.
4.1.1 ISOLATION OF CELLS AND CELL LYSIS
The first stage in all preparations is the isolation of tissue from the host
organism and its lysis or rupturing to produce a cell-free homogenate. For yeast,
this first step is simple. Centrifugation of large volumes (1L) of growth media at
low speeds (5000rpm x 5min) results in the pelleting of sufficient cells for most
studies. However, the choice of method of cell lysis is much more varied. A
number of different methods have been described. A popular method in early
studies was autolysis or plasmolysis of the cells by incubation in toluene at
temperatures ranging from -20°C to 45°C for periods up to six hours (Roschlau
& Hess, 1972; Fell et al., 1974). This process resulted in the solubilisation of
the cell wall and the release of the intracellular contents. The effects of this
treatment on the enzyme being purified were not specifically mentioned. Other
methods of yeast cell lysis included high pressure homogenisation (Aust et al.,
1975), sonication (Hirai et al., 1975), incubation with ammonium hydroxide
(De La Morena et al., 1968) and homogenisation by a suspension of glass beads
(Murcott et al., 1991). Intracellular components have also been extracted directly
from dried cells with a 25% (v/v) glycerol solution (Hess et al., 1966). Often
the simplest and most direct methods are the most successful and glass bead
lysis was the method of choice during this work.
4.1.2 AMMONIUM SULPHATE PRECIPITATION
In S.cerevisiae the main substances that contaminate the soluble proteins
are cell debris and other solid material (45% dry weight of cells), lipid (10%),
RNA (5%) and DNA (0.4%). A variety of methods are available for the removal
of such contamination prior to the selective purification of the desired protein.
Protamine sulphate or polyethyleneimine have been used to complex nucleic acid
allowing their removal by filtration or precipitation. Clarification of cell lysate
solutions with sodium tetraborate (borax) has also been used, although this is
largely done on preparations of an industrial scale (Milbum et al., 1990).
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Centrifugation in the presence of relatively low concentrations of ammonium
sulphate (25-40% saturated w/v) is generally considered adequate to remove the
majority of the insoluble protein and cell debris. Ammonium sulphate also
serves to stabilize enzymes and to prevent proteolysis and bacterial action
(Scopes, 1987).
As can be seen from lanes 1 and 2 in Figure 46, the supernatant from a
40% saturated (w/v) ammonium sulphate precipitation (40S) does not have a
significantly different profile from that of the cell-free extract (CE). This
suggests that very few soluble proteins have been removed by this procedure.
However, a large pellet was precipitated by this treatment (40P) and this is
suggestive of the fact that insoluble matter, including cell wall fragments and
intracellular organelles, have been removed. The 40P profile (lane3, Figure 46)
shows a high background staining but few specific bands and, most
importantly, very little protein in the region corresponding to the position of
pyruvate kinase. This suggests that this precipitation step results in a general
removal of protein but which includes very little pyruvate kinase itself.
The further addition of ammonium sulphate to the 40S fraction to bring it
to 70% (w/v) saturation results in the efficient removal of the majority of
pyruvate kinase. A comparison of lanes 4 and 5 in Figure 46 demonstrates that
the majority of the protein that migrates close to authentic rabbit muscle pyruvate
kinase is removed by this precipitation step. A large proportion of the other
proteins remain in the supernatant (70S). In preliminary experiments it was
found that significant pyruvate kinase activity remained in the supernatant from a
60% saturated (w/v) ammonium sulphate precipitation.
4.1.3 GEL FILTRATION CHROMATOGRAPHY
The problem facing the experimenter at this stage is the quite high
proportion of remaining protein contaminants in the pellet from the second
ammonium sulphate precipitation (70P) and the residual salt concentration. Both
aspects can be addressed simultaneously by the use of gel filtration
chromatography. By judicious use of matrix a group separation of salt from
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protein can be effected combined with a significant resolution of individual
proteins.
The majority of the denatured contaminants in the 70P fraction (Figure
46, lane 5) have a molecular mass less than that of the individual pyruvate
kinase subunits. Thus, even in an oligomeric state, a large proportion of the
native protein contaminants will be smaller in size than pyruvate kinase. As a
result, addition of the 70P fraction to a chromatography column containing a gel
filtration matrix whose exclusion size is in the region of the native molecular size
of pyruvate kinase will result in the enzyme eluting at, or near, the void volume
for this type of column. Contaminating proteins will be retarded sufficiently to
allow separation. Lane 6 in Figure 46 shows that most of the contaminating
proteins both larger and smaller than the pyruvate kinase subunit have been
removed. A few contaminating bands are seen and these may be due to
degradation products of the enzyme or, more likely, to subunits of oligomeric
proteins of a size similar to, or larger than pyruvate kinase, which would elute
with the enzyme in the void volume of the column.
The matrix used in this study for the gel filtration step was Sephacryl
S200HR (High Resolution) (Pharmacia). Sephacryl is a cross-linked copolymer
of dextran and bisacrylamide. The fine particles of the HR grade (25-75mm)
pack better than coarse particles, giving less zone broadening and therefore
better resolution. The resolution of two separated zones in gel filtration increases
as the square root of column length. Long columns should, therefore, be used to
obtain the best resolution. In general the length of column is decided by the
resolution required and the diameter by the sample capacity. Where maximum
resolution is required the starting zone must be narrow relative to the length of
the column. A sample volume of 0.5-5% of the bed volume is recommended.
For the gel filtration step in this study, a 90cm x 1.6cm (id) column of
matrix was used, corresponding to a bed volume of 180cnA The redissolved
pellet from the second ammonium sulphate precipitation step was usually of the
order of 6-10cm^ corresponding to 3-6% of the bed volume.
Maximum resolution in gel filtration is obtained with long columns and
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low flow rates. A flow rate of 5-25 ml.cm^.hr"^ is suggested for such columns.
In this sudy a flow rate of 10 ml.cm^.hr"^ was used.
4.1.4 ION-EXCHANGE CHROMATOGRAPHY
The isoelectric point (pi) of yeast pyruvate kinase has been determined
as 6.6 (Hunsley & Suelter, 1969). This property, as well as the large size of the
enzyme, can be exploited to further purify the enzyme by ion-exchange
chromatography.
At pH values above the pi proteins will have a net negative charge due to
ionisation of acidic side groups. An anion-exchange matrix equilibrated to a pH
well above the pi for pyruvate kinase is unusual in that it does not significantly
bind the enzyme but will bind many contaminating proteins that are negatively
charged at this pH. Preliminary experiments showed that at pH 8.5, very little
pyruvate kinase binds to the matrix (DEAE-cellulose), whereas a high
proportion of the remaining contaminants are removed. At pH values above 8.5,
pyruvate kinase binding to the column was unacceptably high and below pH 8.5
the contaminating proteins did not bind efficiently.
The size of the native pyruvate kinase enzyme also facilitates its
purification from the anion-exchange matrix chosen as it elutes close to the void
volume of the column whilst other proteins are hindered to some degree.
Ion-exchange chromatography is usually performed on short broad
columns. The sample volume should be limited to 1-5% of the bed volume if the
required protein is to be eluted with the starting buffer. However, if
contaminants are to be adsorbed and the sample of interest allowed to pass
straight through, the sample size is less important than the amount of
contaminant which is present. As with gel filtration chromatography, maximum
resolution is obtained at rather low flow rates. Row rates of 10 ml.cm^.hr"* are
usually suitable for the resolution of protein mixtures.
In this study a 10cm x 2.7cm (id) column of matrix (DEAE-cellulose)
was prepared, corresponding to a bed volume of 60cmThe sample volume
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was in the range 3-6cm^, corresponding to 5-10% of the bed volume. The
sample was eluted by buffer flowing under gravity, corresponding to a flow
rate of 5 ml.cm^.hr"^.
The unusual binding properties of pyruvate kinase to ion-exchange
columns is not an isolated phenomenon. Under normal conditions proteins in a
buffer whose pH is greater than the pi of the protein would adsorb to an anion-
exchange column. Conversely, proteins in a buffer of pH less than the pi would
adsorb to a cation- exchange column. There are also "sticky" proteins that will
bind to both types of column in the same buffer, and "slippery" proteins that are
difficult to get to bind to any adsorbent within a stable pH range. These effects
are partly due to non-electrostatic interactions e.g. hydrophobic and van der
Waals forces and partly to uneven distribution of charges over the protein
surfaces.
The calculated pi for yeast pyruvate kinase determined using the
ISOELECTRIC POINT program (Devereux et al., 1984) is 7.66. The large
difference between this value and that observed in the purified enzyme may
indicate that several normally charged residues are obscured and are not
available to undergo charge interactions with the ion-exchange matrix, leading to
the anomolous binding behaviour observed. In this sense, yeast pyruvate kinase
can be categorised as an example of a "slippery" protein.
An examination of the computer model of yeast pyruvate kinase indicates
that several charged residues appear to be buried deep in the polypeptide
structure and would presumably be unable to participate in charge interaction
with the column matrix. Although apparently incompatible with the expectation
that all charged hydrophilic residues ought to be in contact with the solvent, this
finding is compatible with the observed pi difference and the anomalous
behaviour of pyruvate kinase on anion-exchange columns. Of particular interest
in this regard are residues Arg 18, 40 and 436 and Lys 412 (yeast numbering).
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4.1.5 COMPOSITION OF BUFFER
Another advantage of the modified purification scheme described here is
the possibility of using similar buffers throughout the entire procedure. Thus,
the same buffer was used for resuspending the cells after pelleting, washing the
glass beads after cell lysis and resuspending the protein pellet obtained from the
second ammonium sulphate precipitation. This buffer consisted of 50mM Tris-
HC1, pH 7.5, 3mM MgCl2, ImM DTT, 20% (v/v) glycerol and 0.04% (w/v)
sodium azide. All purification steps were carried out at room temperature. The
samples obtained from the gel filtration step were applied directly to an anion-
exchange column equilibrated with 50mM Tris-HCl, pH 8.5, 3mM MgCl2,
ImM DTT, and 20% (v/v) glycerol. The pyruvate kinase was eluted with an
identical buffer.
The slightly alkaline pH of the initial buffer prevents acid proteases
released upon cell lysis from being activated and maintains the enzyme in a less
active conformation. The enzyme is further protected from denaturation and
inactivation by the inclusion of magnesium ions and DTT. The magnesium ions
are essential for enzyme activity and help the enzyme keep an active
conformation during purification. The DTT maintains the cysteine thiol groups
in a fully reduced state during purification, in an attempt to mimic the conditions
experienced by the protein in the cytosol. The sodium azide protects the gel
matrix and the eluted fractions from bacterial contamination. It does not affect
the enzyme in any way. The operations are carried out at room temperature to
help prevent inactivation of the enzyme which is cold-labile. Stabilization of
labile enzymes can be assisted by attempting to mimic the conditions of low
water activity. The most widely used method is to use glycerol in the buffer
solutions. Glycerol forms strong hydrogen bonds with the water, effectively
slowing down the motion of the water molecules and so reducing the water
activity. It has been suggested that protein molecules preferentially bind water,
and the structure so formed is less able to unfold against the structured glycerol
solvent than it would be able to in water alone (Scopes, 1987).
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4.1.6 PROTEASE INHIBITORS
In order to prevent as much as possible the degradation of the pyruvate
kinase by proteolysis from enzymes released during yeast cell lysis, a variety of
protease inhibitors were used. These were added together to the pellet
immediately prior to lysis in order to maximise their effectiveness. Six broad
groups of proteases are known. The serine proteases can be inhibited by 3,4-
dichloroisocoumarin (DCIC) and phenylmethylsulphonylfluoride (PMSF). The
thiol proteases are inhibited by E64 (and to some extent by PMSF). The acid
proteases are best inhibited by working in alkaline conditions as much as
possible. Metalloproteases can be inhibited by 1,10-phenanthroline.
Carboxypeptidases are inhibited by benzamidine hydrochloride (and by PMSF).
Other proteases are also inhibited by benzamidine. The inhibition is due
primarily to covalent modification and active site competition of the indicated
enzymes and so once inhibited further addition is not usually required. The
concentration of each inhibitor was in the range 0.1-lmM, although
benzamidine was added up to 50mM (see Section 2.6 for details).
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4.2 ENZYME ASSAY CONDITIONS
Many different methods are available for analysing the catalytic activity
of pyruvate kinase. These include monitoring the loss of pyruvate from the
reaction media spectrophotometrically (Pon & Bondar, 1967), determining the
amount of ^C-pyruvate as it is formed from ^C-phosphoenolpyruvate
(Kaslow & Garrison, 1983), reacting the carbonyl groups of generated pyruvate
with 2,4-dinitrophenylhydrazone to produce a coloured product (Imamura &
Tanaka, 1982) and recording the loss of NADH as it is converted to NAD+ in a
coupled enzyme assay with lactate dehydrogenase (Bucher & Pfleiderer, 1955).
By far the most commonly used technique is the latter, i.e. coupling the reaction:
PEP + MgADP + H+ > Pyruvate + MgATP
to the simultaneous reaction:
Pyruvate + NADH > Lactate + NAD+
Conditions are chosen such that the pyruvate is converted to lactate as soon as it
is produced via the first reaction. The stoichiometry is such that the rate of the
second reaction, determined by the rate of decrease of absorbance at 340nm, is
equivalent to the rate of the first reaction.
4.2.1 GENERAL CONSIDERATIONS
Enzyme activity is affected by the concentrations of its substrates,
activators and inhibitors specific for the enzyme, non-specific effects of
compounds such as salts and buffers, pH, ionic strength, temperature and in
some cases interactions with other proteins or material that might be present.
Activity is nearly always greatest at the highest feasible substrate
concentration. For enzymes obeying Michaelis-Menten kinetics a substrate
concentration at least ten times the Km should be used. This ensures that zero
order kinetics for the reaction will be observed. At lOK^, the rate is 91% of the
theoretical rate at infinite concentration. There are two reasons for operating well
above the Km value. First, slight variation of concentration from one set of
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assays to another makes very little difference to the observed rate. Second,
consumption of substrate during the assay will make little difference to the rate
and, if products are accumulating, any inhibitory effect they may have is less if
the substrate concentration is high.
When dealing with multiply charged substrates such as ADP and PEP,
their effect on ionic strength should be considered. Physiological ionic strengths
are normally in the range 0.1-0.2M. As salt concentration increases above
0.2M, activity is often depressed. Temperature is also important. Enzyme
reaction rates, like almost every other chemical process, increase with
temperature, typically by a factor of between 1.5-2.2 for every 10°C rise. At a
mean value of 1.8, activity increases by 6% per degree Celsius rise in
temperature. As a result, accurate control of temperature to within + 0.5°C is
important.
Coupled enzyme assays require a large amount of coupling enzyme to be
sure that it is the enzyme being measured that is limiting. The basic principle is
that a steady state should be set up in which the rate of reaction of the coupling
enzyme is equal to that of the enzyme being measured. Theoretically this can not
be achieved; it will only be approached asymptotically. One must first define
how closely we wish this condition to be achieved and in what period of time. A
typical spectrophotometric assay will run for a few minutes, and the accuracy of
the pipetting and instrumentation is unlikely to be better than + 2%. If we set
our restrictions as 98% of the true rate one minute after the start of the reaction,
then the amount of the coupling enzyme needed is not so great. The minimum
amount of coupling enzyme required (in units) is five times the Kjyj of the
substrate of the coupling enzyme, measured under the conditions of the assay in
which it is to be used.
4.2.2. OPTIMISING THE ENZYME ASSAY
A variety of different assay conditions for the rabbit skeletal muscle and
S.cerevisiae enzyme are listed in Table 15. From a study of the literature, it can
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be seen that the properties of the yeast and the muscle enzyme are clearly
different with regard to their pH optima and kinetic constants for substrates and
cofactors. It is evident therefore, that the optimum assay conditions for the
yeast enzyme will be different from those for the muscle enzyme. The assay
conditions so far described in the literature for the yeast enzyme, and
summarised in Table 16, are unsuitable for a variety of reasons that are outlined
below.
4.2.2.1 BUFFER COMPONENTS
Cacodylate is unsuitable due primarily to its extreme toxicity. Less toxic
alternatives are readily available. Tris and triethanolamine are unsuitable as their
usable pH ranges lie outside the pH optimum of the yeast enzyme. Imidazole
can be used. However, pure imidazole is relatively expensive and the less pure
forms may contain compounds that interfere with the enzyme itself, the coupling
enzyme, or any of the other components of the assay. These impurities may also
affect the performance of other experiments e.g. fluorescence measurements.
Sodium phosphate is unsuitable as sodium cations compete with potassium for
binding to the enzyme and phosphate anions interfere with the binding of PEP
and ADP to the active site of the enzyme. MES is suitable as it has low toxicity
and has maximum buffering capacity in the region around the pH optimum of
the enzyme. It is also relatively inexpensive in a pure form. For these reasons
MES was chosen as the buffering component in the enzyme assay system used
in this thesis. The buffer counterion was tetrapropylammonium to allow
modification of the monovalent metal cation content in other experiments. The
pH was 6.5 which is close to the pH optimum for the yeast enzyme.
4.2.2.2. SUBSTRATE CONCENTRATION
A) PHOSPHOENOLPYRUVATE
The range of PEP used in the previous assays was O.lmM to lOmM. A
suitable concentration to use was 5.6mM as this was mid-way between the
previous values and was still several times the K^j for this substrate ensuring
that the enzyme was saturated at all times. It was also a convenient and
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economic amount of the salt used to measure out repeatedly (lOOmg/ml) and
avoided contributing excessively to the ionic strength of the assay media.
B) ADP
The range of ADP used in the previous assays was O.lmM to lOmM. A
suitable concentration to use in these assays was 2.4mM as this is several times
the Kj^j for this substrate ensuring that the enzyme was fully saturated
throughout the assay. High concentrations of ADP are known to be inhibitory to
yeast pyruvate kinase and so lower concentrations are preferable. There is also
an economic consideration. A convenient amount of the ADP salt to use was
lOOmg/ml. A lower concentration of ADP also resulted in a lower contribution
to the ionic strength of the assay media.
C) MAGNESIUM
Pyruvate kinase has a requirement for divalent cations, usually
magnesium. The most convenient salts to use are the chloride or sulphate. The
sulphate anions inhibit the enzyme, possibly by mimicking the y-phospho group
of ATP and thus interfering with the binding of PEP and ADP at the active site.
The chloride anion has not been reported to have any significant effect on
enzyme activity. However, magnesium chloride is very hygroscopic and tends
to absorb water vapour and so care must be taken when storing this compond
for long periods. The range of concentrations used in previous assays was 8-
25mM. A value of 15mM was chosen as being clearly in excess of the Kjyj for
this cation and to reduce its contribution to the ionic strength of the assay media.
D) POTASSIUM
The yeast pyruvate kinase also has a requirement for monovalent
cations, usually potassium. Previous assays used potassium chloride in the
range 50-150mM. A concentration of lOOmM was chosen as being intermediate
in value and yet sufficient to saturate the enzyme
4.2.2.3 NADH
Throughout most of the assays described previously, a concentration of
0.15mM NADH was used. This gives an absorbance at 340nm of 0.93. This is
sufficient for the sensitivity of most spectrophotometers to detect a change in
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signal due to enzymic oxidation of NADH by lactate dehydrogenase.
4.2.2.4. LACTATE DEHYDROGENASE
In early assays the coupling enzyme had to be prepared fresh whenever
it was required and so specific activities varied from preparation to preparation.
From examination of Table 16 it can be seen that a large excess of lactate
dehydrogenase was usually used corresponding to 20-37mg/ml. This would
have been equivalent to several hundred units per assay. This is a vast excess to
what is actually required and later workers used 4-14 units. Stable preparations
of lactate dehydrogenase are commercially available. The enzyme is stabilised in
3.6M ammonium sulphate. Unless desalted, where activity is rapidly lost, the
effect of the salt on pyruvate kinase activity must be considered. Ammonium
cations are a known activator of the enzyme and sulphate anions are a potential
inhibitor. In the assays used in this thesis, one unit of lactate dehydrogenase was
present. Not only is this sufficient for the reaction but it also minimises the
contamination of the assay with ammonium sulphate to ImM, which would not
have any significant effect on activity.
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4.3 MORPHOLOGICAL AND BIOCHEMICAL STUDIES OF THE
PARENT AND TRANSFORMED YEAST CELLS
The fact that an essential glycolytic enzyme has been mutated may
manifest itself as differences in some of the fundamental properties of the cells
expressing the mutant enzyme. Properties such as cell morphology and growth
rate can be investigated simply.
The cells overexpressing mutant protein are slower growing (doubling
time 3.6 hrs) than the same strain overexpressing wild-type enzyme (doubling
time 2.5 hrs), although both grow more quickly than the parental strain
containing the PYK1 disruption (doubling time 5.8 hrs). The slow growth of
the mutant enzyme expressing cells may be due to the deleterious effects of a
less efficient pyruvate kinase enzyme. One might postulate that a cell expressing
a mutant glycolytic enzyme but able to grow on glucose as the sole carbon
source was unaffected by the introduced mutation. However, this is not
necessarily the case. A cell expressing a completely non-functional pyruvate
kinase could grow on glucose if an alternative pathway to glycolysis existed.
Such an alternative pathway is present in yeast and is depicted in Scheme 1.
If sufficient DHAP is converted to glycerol-3-phosphate this could be
transported into the mitochondria and be reconverted to DHAP with the
concomitant production of reduced flavine adenine dinucleotide (FADH2). The
FADH2 can be oxidised via the oxidative phosphorylation pathway on the inner
mitochondrial membrane to generate ATP. If this pathway were the sole or major
route by which the cells expressing mutant protein were growing then inhibition
of oxidative phosphorylation by cyanide would result in a marked decrease in
the rate of growth of these cells compared to wild-type cells. Fig. 30 shows the
growth rates of the parental strain and the wild type and mutant-expressing
strains in the presence and absence of 10|lM KCN. The growth of the parental
strain is severely inhibited by cyanide. There is no decrease in growth rate of the
wild type or the mutant cells. This implies that there is sufficient active mutant
pyruvate kinase present in the cells to allow adequate growth on glucose. By
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implication there is also sufficient intracellular Fru-1,6-P2 to maintain the
activity of the effector-dependent mutant enzyme. A reduction in growth rate due
to an inefficient pyruvate kinase may manifest itself as a build-up of the
intracellular levels of the substrates PEP and Fra-1,6-P2- It was not possible to
measure the intracellular levels of PEP. This may be due to several factors. PEP
is labile in acid or alkaline conditions and so attempts to isolate enzyme-free
cellular extracts by acid or alkaline precipitation methods may have resulted in
the destruction of the PEP. Also, the levels of PEP may be below those
detectable with simple enzyme assays, especially as PEP is an important
intermediary metabolite in numerous biochemical pathways and as such would
not accummulate to any appreciable degree even in a cell where the pyruvate
kinase was not present.
Fig. 31 compares the intracellular levels of Fru-1,6-P2 between the
parent strain and the wild type and mutant overexpressing cells. Clearly there is
a significant difference in the levels of Fru-1,6-P2 between the different cells. A
build up of Fru-1,6-P2 in the parent strain is observed. This is probably due to
the reduced flux through the glycolytic pathway caused by the absence of
pyruvate kinase. The amount of Fru-1,6-P2 is nearly double that of the wild
type cells (except at early stages of growth) and nearly four times that of the
mutant expressing cells.The amount of Fru-1,6-P2 in the wild type expressing
cell is nearly twice that in the mutant enzyme expressing cell assayed under
identical conditions. The pattern of production of the effector molecule is the
same in all strains i.e. a peak of production in mid-log phase growth followed
by a decline to a basal level in late-log and stationary phases of growth. The
overexpression of an active pyruvate kinase may well be sufficient to explain the
large increase in the growth rates of the transformed strains over the parent
strain. Whether the difference in activity of the overexpressed enzymes is
sufficient to explain the differential production of Fru-1,6-P2 within those cells
is a subject for further investigation. In reality there are probably many factors
that contribute to this observed difference in the pool of intracellular Fru- F6-P2
and the difference in the activity of the overexpressed pyruvate kinases is but
one facet of this problem.
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The intracellular and extracellular morphology of the parent and
transformed cells are strikingly different (Fig. 29). The cells overexpressing
wild type and mutant pyruvate kinase appear normal in all respects. The parent
cells however, are smaller and irregularly shaped. The cell wall appears to be
more densely stained than the transformed cells. The intracellular regions are
less densely stained than either of the two transformed cells and also appear to
have a large number of vesicle-like inclusions. The disruption of PYK1 by the
insertion of URA3 might be expected to severely affect the growth of the
resultant cells. This is because PYK1 has also been identified as cdcl9 and is
therefore involved in the regulation of cell growth and division in some manner.
Many glycolytic enzymes have been found to bind DNA (Ronai, 1993).
Examples include lactate dehydrogenase, phosphoglycerate kinase, aldolase,
and glyceraldehyde-3-phosphate dehydrogenase. Although none of these
enzymes interact with a specific target DNA sequence, their association with
DNA may play a role in transcription and replication of DNA through general
stabilization of the nuclear matrix or chromatin structure. Although pyruvate
kinase was not specifically examined in this system, it is an intriguing thought
that this enzyme may also have a similar DNA binding function which would
help explain the severe deleterious effects observed in cells in which it is absent.
Many glycolytic enzymes have also been found to interact with tubulin
and microtubules in vitro (Walsh et al., 1989). Interactions between tubulin and
microtubules and the enzymes lactate dehydrogenase, glyceraldehyde-3-
phosphate dehydrogenase and pyruvate kinase probably occur in vivo (based on
calculated affinity constants for these components). These enzymes may,
therefore, play a structural role in the formation of the microtrabecular lattice. A
disruption of PYK1 , leading to the complete absence of pyruvate kinase, may
interfere with cell division due to the involvement of microtubules in
chromosomal separation. As tubulin is involved in the formation of components
of the cytoskeleton, cell morphology may also be disrupted. Pyruvate kinase has
also been found to associate with actin in separate studies, increasing the
liklihood of an important role for this enzyme in maintaining cell structure
(Walsh & Knull, 1988).
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4.4 PEPTIDE SEQUENCING
The mutant enzyme was purified and digested with cyanogen bromide.
This compound cleaves proteins on the C-terminal side of methionine residues.
It was expected, from an analysis of the amino acid sequence, that 11 peptides
would be produced by this procedure (Table 4). The peptides were dissolved in
4M guanidine hydrochloride and applied to a microbore reverse phase HPLC
column in order to separate them. The chromatogram produced is shown in
Fig.32. Clearly, several distinct peaks are visible. Some peaks were better
resolved than others. The peptides were detected by their absorbance at 220nm.
Absorbance in this region of the uv spectrum is due to the peptide bond and so
can be used to give an approximate measure of the amount of material present in
each peak. The peptide containing the serine 384 to proline mutation is the
largest (14.4kD) and most hydrophobic, as determined by a computer program
that analyses the properties of possible protein digestion products
(PEPTTDESORT; Devereux et al., 1984). The peak numbered 17 in the
chromatogram in Fig.32 was chosen as the likliest candidate considering the
suspected properties of the peptide and its resolution compared to the rest of the
peaks present. The peptide was isolated and subjected to 16 rounds of N-
terminal Edman degradation on an automated peptide sequencer. The degradation
products were separated by HPLC and compared to a standard chromatogram
containing all possible PTH-amino acid residues and reaction products. The
retention times of these products on the HPLC column are shown in Fig.33. The
chromatogram produced for the first round of Edman degradation is shown in
Fig.34. It shows an excess of aspartate, which is often a characteristic of the
first round of degradation, and also a clear excess of valine. Unfortunately, other
amino acids are also present in surprisingly large amounts, notably tyrosine,
isoleucine, leucine and alanine. This suggests that contaminating peptides are
also present in peak 17. A more comprehensive analysis of the data performed
by D.Lamont (Welmet) suggested the presence of up to seven contaminating
peptides (Table 6). A positive identification of the point mutation was not
possible by this method because the sequencing did not extend far enough into
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the peptide. The serine 384 to proline mutation is present 18 residues from the
N-terminus of peptide 11. As sequencing was suspended after 16 cycles, due to
multiple contaminating signals, the mutation could not have been detected. It is
sometimes possible to follow the sequence of a known protein when
contaminating peptides are also present. However, as the peptide containing the
mutation of interest was not well represented in the sample this procedure was
also impossible (Table 6). No other peptides from this separation were
considered as suitable for sequencing. Only one peptide gave a clear signal that
could be identified unambiguosly. That was peptide 5. A comparison of this
peptide with a computer database revealed a 100% match with yeast pyruvate
kinase (Fig.35). A better method for separating the peptides was not readily
available. The reverse phase microbore HPLC system is widely used and has a
range of preset elution programs for the purposes of peptide separation. It was
not economic in terms of time or expense to optimise elution conditions for this
particular digest or to purchase a column with a different matrix in order to try
and improve the separation. It may well be that the optimum separation had
indeed been effected by the system used and that time spent trying to improve
the separation would have been futile. As has been observed earlier, yeast
pyruvate kinase is an unusual protein in terms of its behaviour on ion-exchange
matrices. It may be that the unusual behaviour also extends to the individual
peptides on reverse phase matrices, resulting in poor resolution and a different
order of elution when compared to the predicted behaviour of the peptides using
the PEPTIDESORT program.
Due to the expense of the sequencing reaction, and the low liklihood of
obtaining an improved resolution of fragments from a repeat digestion and
HPLC purification, this approach was abandoned in favour of sequencing the
plasmid DNA used to overexpress the mutant protein.
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4.5 DNA SEQUENCING
To confirm that the overexpressed pyruvate kinase under study contained
the desired serine to proline mutation, a portion of the plasmid DNA containing
the site of the point mutation was sequenced. Two oligonucleotide primers were
designed to be exactly complementary to a short region 80-100bp either side of
the mutagenised region. The potential secondary structure of the
oligonucleotides was checked using the UWGCG programs CIRCLES and
SQUIGGLES. From Fig. 37 it can be seen that both oligonucleotides have the
potential to self-anneal and form stem-loop structures. The stability of these
structures is calculated to be about 2kJ/mol. Under the conditions in which these
oligonucleotides are used i.e. in PCR and sequencing reactions, it is unlikely
that such structures would exist, as the presence of an exactly complementary
template sequence would make oligonucleotide-template pairing much more
favourable thermodynamically.
The size of the oligonucleotides was confirmed by LDMS. This is a
relatively new technique and is used primarily for the determination of the
molecular mass of peptides and small proteins. It is not routinely used for
determining the size of DNA molecules. As a result, the lack of appropriate
DNA mass standards makes the error in DNA mass determination greater than
for protein work. However, an acceptable agreement (3.3-4.5%) between the
expected mass and that determined by LDMS was obtained. As can be seen from
Fig. 38, both oligonucleotides are substantially free from contaminants, either
precursor nucleoside triphosphates or prematurely terminated oligonucleotides.
The oligonucleotides were used to amplify a stretch of DNA from
double-stranded plasmid DNA by the polymerase chain reaction. From agarose
gel electrophoretic analysis, it can be seen that the PCR product is about 275bp
in size (Fig.39). This is a little larger than the expected size of 253bp. The
increase in apparent size is probably due to anomalous running of the PCR
product compared to the marker DNA . The markers used (lkb ladder, Gibco
BRL, UK) are polymers of a small repeating unit used to generate a nested set of
fragments of varying size (Fig. 40). As such their mobility in an agarose gel
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may well be different from that of a natural DNA sequence. An attempt to
confirm the mass of the PCR product by LDMS was not successful. The
estimated size of a 253bp ds DNA fragment is of the order of 160kD. This is
beyond the detection range of the LDMS equipment. This procedure however,
was able to confirm the absence of smaller DNA fragments. The PCR product
was purified by reverse phase HPLC prior to sequencing. As can be seen from
Fig.41, the DNA fragment is essentially free of any contaminants.
The PCR sequencing technique was not successful. In all attempts to
sequence by this method premature stops were observed in all four sequencing
lanes. This is usually indicative of a contaminated DNA template. After
purifying the template by a commercial ion-exchange method (PCR magicprep,
Promega) and repeating the process, still no sequence information was
obtainable. The PCR template, Taq polymerase, oligonucleotides and other
components were either used fresh or specially purified for each sequencing
reaction, and so the failure for readable sequence to be produced is even more
disturbing.
Other disadvantages of PCR sequencing include the random introduction
of incorrect nucleotides at a frequency greater than for other sequencing
strategies, the magnesium-dependent nature of the Taq polymerase reaction
requiring accurate titration of DNA template with MgCl2 and the need to use
glycerol-tolerant sequencing gels due to the formation of glycerol-boric acid
adducts in traditional sequencing gels. The latter problem is especially tiresome
as it means that small numbers of sequencing reactions must be run separately
from other reactions performed using the non-PCR sequencing method, adding
to the expense and inconvenience of this system. Another sequencing method
was therefore tried. Double-stranded sequencing using a genetically modified
form of T7 DNA polymerase (Sequenase, USB) was successful at the first
attempt. With slight modifications it allowed readable sequence up to 100 bp
either side of the point mutation to be produced.
The DNA sequence in the region of the serine to proline mutation is
shown adjacent to the wild-type sequence (Section 3.3, Fig.43). Although only
a portion of the PYK1 sequence was analysed in this way no spurious mutations
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were observed. The entire PYK1 sequence was determined when the
mutagenesis reactions were performed (McNally, 1989a; McNally et al., 1989b)
and there is no reason to believe that any spurious mutations have been
introduced into either sequence during propagation of the plasmids since that
time.
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4.6 PURIFICATION AND KINETIC CHARACTERISATION OF
WILD TYPE AND MUTANT FORMS OF PYRUVATE KINASE
The purification protocol for pyruvate kinase is shown in Scheme 2. The
wild type and mutant enzymes were purified in an identical manner. The elution
profile from the Sephacryl S200 gel filtration column for the wild type and
mutant enzymes are shown in Fig. 44. In both cases the activity peak is located
in the first protein peak to be eluted from the column. This peak elutes in the
void volume of the column, as determined by prior calibration with Dextran Blue
2000. It is possible to estimate the minimum size of the enzyme at this stage.
The column matrix excludes proteins greater than 200kDa in size. As a result
proteins larger than this are eluted in the void volume. The active enzyme,
therefore, must be larger than 200kDa. This is consistent with the idea that
pyruvate kinase is a tetramer of identical subunits each approximately 55kDa in
size (McNally, 1989).
The elution profile from the ion-exchange column is shown in Fig. 45.
A large peak elutes in the void volume of the column. The pyruvate kinase
activity is found to elute slightly behind this protein peak, indicating that the
enzyme does not bind significantly to the column matrix under the conditions
used. This is consistent with the enzyme being of a large size (and hence
excluded from the matrix) and having an isoelectric point (pi) significantly
below 8.5. This is consistent with previous findings. A pi of 6.6 for the wild
type enzyme has been reported (Yun et al., 1976).
The rate of reaction against the amount of enzyme was found to be linear
for both the wild type and mutant enzymes (Fig. 47). This demonstrates that no
significant inhibition of either enzyme occurs at high or low protein
concentrations, as has been recorded for other enzyme preparations (Cornish-
Bowden, 1981). Protein aggregation or dissociation could be responsible for
these phenomena but do not appear to be relevant to the pyruvate kinase
preparations produced here, when assayed under the stated conditions.
The effect of the positive allosteric effector fructose-1,6-bisphosphate
on the rate of the reaction catalysed by the wild type and mutant pyruvate kinases
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is shown in Fig. 48. The wild type enzyme shows a slight increase in rate in the
presence of the effector compared to the rate in its absence. The concentration of
effector does not influence the rate between l-5mM.
The effect of Fru-1,6-P2 on the mutant enzyme is more profound. The
relationship between reaction velocity and effector concentration shows an
apparent saturation effect over the range 0-5mM. The conclusion is that the
mutant enzyme is fully active only in the presence of high (5mM) concentrations
of effector, and is effectively inactive in its absence. The serine to proline
mutation seems to exert an effect on either the efficacy of effector binding or on
the mechanism by which the effector brings about a more active conformation of
the enzyme. As the mutation is thought to interfere in the transmission of the
allosteric effect across intersubunit contacts, the pronounced disturbance in the
mode of action of the effector is, perhaps, not surprising. The concentration of
Fru-1,6-P2 where the mutant displays half maximal activity was calculated as
1.9mM + 0. ImM. It has been reported that the pyruvate kinase from
S.carlsbergensis requires Fru-1,6-P2 in order to achieve optimum Vm values
(Hess & Haekel, 1967). This phenomenon may be related to that observed with
the mutant enzyme from S.cerevisiae. Unfortunately, the amino acid sequence of
the S.carlsbergensis enzyme is not known and so comments on its ability to bind
the effector, and the mechanism by which its adopts an active conformation in
the presence of the effector, are limited.
A plot of reaction velocity against PEP concentration for the wild type
enzyme is shown in Fig. 49. In the absence of the effector, the plot is strongly
sigmoidal. In the presence of ImM Fru- 1,6-P2 the plot is better represented by
an hyperbola. Transformation of these data into a Hill plot indicates that in the
absence of effector the Sq 5 PEP is 3.34mM. The value for the Hill coefficient
(npj = 2.67) suggests that a strong, positive homotropic interaction between
PEP binding sites occurs. This confirms data obtained by other workers (e.g.
Murcott, 1992). In the presence of ImM Fru-1,6-P2 t^e Sq 5 PEP is reduced to
0.17mM and the Hill coefficient to 1.0. This indicates that the binding of the
effector to the enzyme increases the affinity of the enzyme for substrate by a
factor of 20, and abolishes cooperativity between PEP binding sites.
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A plot of reaction velocity against PEP concentration, in the presence of
5mM effector, for the mutant enzyme was also sigmoidal. Note that in the
absence of effector the enzyme was inactive and so kinetic data for this case
were unobtainable by traditional enzyme assay methods. The data were
transformed into a Hill plot. In the presence of the effector, the Sq 5 PEP was
calculated to be 0.94mM with a Hill coefficient of 1.69. Thus the mutant enzyme
displayed a five-fold lower affinity for PEP than the wild type enzyme under the
same conditions, and the cooperativity between PEP binding sites was
increased.
A plot of the reaction velocity against ADP concentration for the wild
type enzyme is shown in Fig. 51 A. In the absence of effector, the plot is clearly
sigmoidal. Also, the maximum velocity appears only to be about one-third of
that observed in the presence of effector. In the presence of effector, the plot
becomes hyperbolic and the maximum observed velocity increases markedly.
This may indicate that the conformation of the active site, in the absence of
effector, is considerably different to that in the presence of effector, such that
ligands necessary for catalysis are not optimally orientated. When the Sq 5 ADP
is being determined kinetically, the reactions are started by the addition of an
excess of PEP. Conversely, when the Sq 5 PEP is being determined, the
reactions are started by an excess of ADP. The variation in maximum velocity in
the presence and absence of Fru-1,6-P2 is not observed when the Sq 5 PEP
determinations were performed. This suggests that, in the absence of effector,
an ordered addition of substrates to the enzyme is required for the formation of
the catalytically active complex, with ADP binding before PEP. The addition of
effector overcomes this requirement and, along with the increase in affinity and
abolition of cooperativity, may be one of the ways in which the effector activates
the enzyme. An ordered addition of substrates to yeast pyruvate kinase has been
claimed by other workers, although they determined that the order of substrate
binding was PEP first, followed by ADP then magnesium (Morris et al., 1984).
The data were transformed into a Hill plot (Fig.52). The Sq 5 ADP was
calculated as 0.39mM. The Hill coefficient was 1.16. This indicates that a slight
positive homotropic interaction between ADP binding sites occurs. This is
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consistent with data from other sources in which ADP appears to exhibit only a
small degree of cooperativity between binding sites (Hunsley & Suelter, 1969).
In the presence of effector the plot becomes hyperbolic, with Sq 5 reduced to
0.15mM and n^j reduced to 1.04. Thus, what little cooperativity existed is
abolished by the addition of effector, and further supports the claim that the
effector brings about a conformational change in the enzyme molecule upon
binding.
A plot of reaction velocity against ADP concentration for the mutant
enzyme is shown in Fig. 5IB. Note that these data are obtained in the presence
of 5mM Fru-1,6-P2- As the mutant enzyme was observed to be inactive in the
absence of effector, kinetic data were not obtainable. The data were transformed
into a Hill plot (Fig. 52B). The Sq 5 ADP was calculated to be 0.69mM and npj
was 1.46. This suggests that the point mutation causes a four-fold decrease in
affinity for ADP and a marked increase in cooperativity between ADP binding
sites.
A plot of reaction velocity against monovalent cation concentration for
the wild type enzyme, in the absence of the effector, is shown in Fig. 53A. The
enzyme is known to require monovalent cations for activity (Tietz & Ochoa,
1958). The data were transformed into a Hill plot (Fig.54A). The Sq 5 K+was
calculated to be 41.5mM with npj 1.8. This is indicative of a strong, positive
homotropic interaction between potassium binding sites and supports the
findings of other workers (Rhodes et al„ 1986).
A plot of reaction velocity against monovalent cation concentration for
the mutant enzyme, in the presence of effector, is shown in Fig. 53B. The plot
is weakly sigmoidal upto lOOmM. Above lOOmM the cation appears to inhibit
the enzyme. The data were transformed into a Hill plot (excluding the points
above lOOmM). The Sq 5 K+ was calculated to be 21.4mM with nj_j 1.37.
Thus, even in the presence of effector, there is observed to be a significant
positive homotropic interaction between potassium binding sites in the mutant
enzyme.
The effect of varying the monovalent cation on the activity of the wild
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type and the mutant enzymes, in the presence and absence of Fru-1,6-P2, was
determined (Fig. 55).
In the absence of effector, maximum activity in the wild type enzyme is
observed when ammonium ions are present as the activating monovalent cation
(Fig. 55A). Potassium and rubidium ions also strongly activate the enzyme.
Caesium barely activates the enzyme at all, and lithium and sodium do not have
any stimulatory effect whatsoever.
In the presence of the effector, potassium is observed to be the most
potent activator of the wild type enzyme. Rubidium and ammonium ions activate
equally well but produce only 50% of the activity as potassium. Caesium,
lithium and sodium all produce some activation but only extremely poorly. The
effect of ammonium to produce such a great activation in the absence of the
effector may be due to the stabilising effect of ammonium sulphate solutions
seen in many other systems (Scopes, 1987). The toxic effect of ammonium
compounds in cells means that these species never accumulate to any significant
extent and that this form of activation probably never occurs in vivo. The effect
of Fru-1,6-P2 is to select against ions other than potassium, possibly by
producing a conformation in which potassium binding is enhanced. The ability
of potassium to produce significant changes in conformation of S.cerevisiae
pyruvate kinase has already been noted (Kuczenski & Suelter, 1970).
The effect of monovalent cations on the mutant enzyme in the presence
and absence of Fru-1,6-P2 was also studied (Fig. 55B). In the absence of the
effector, none of the monovalent cations studied caused an activation of the
enzyme. In the presence of the effector, potassium and ammonium appeared to
produce about the same level of activation. Rubidium produced about two-thirds
of the activation as either potassium or ammonium. Lithium, sodium and
caesium were not able to activate the enzyme in the presence of the effector.
These results suggest that the conformational change induced in the wild type
enzyme by potassium and ammonium is not being produced in the mutant
enzyme, or, that the conformational change is insufficient to cause activation.
The conformational change induced by the effector allows potassium to function
and activate the enzyme. Thus the two species produce two different types of
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conformational change. The observed activation by ammonium is again probably
an experimental artefact and would not occur in vivo. The conformation of the
active site of the mutant enzyme in the presence of effector is probably slightly
different to that of the wild type enzyme under the same conditions. This is seen
in the different activation profiles of the two enzymes and reflects real
differences in the geometry of the active site and in particular ligands associated
with the binding of the monovalent cation.
The effect of divalent cations on the activity of the wild type enzyme was
studied. The results are displayed in Fig. 56A. In the absence of Fru-1,6-P2
magnesium and manganese ions activated the enzyme to the same extent. Cobalt
produced about two-thirds of the activity observed with magnesium. Calcium
and barium did not activate at all. In the presence of the effector, maximum
activation was observed with magnesium. Cobalt activation was unaltered,
whilst the effect of manganese was dramatically reduced. Calcium and barium
again had no effect on enzyme activation. Thus, Fru-1,6-P2 appears to select
against ions other than magnesium from activating the enzyme. Manganese and
cobalt have often been used to activate the wild type enzyme in NMR
experiments due to their paramagnetic properties (Nowak & Mildvan, 1972).
However, it may be that these cations do not fully mimic the effects of
magnesium. The conformational changes observed to occur upon effector
binding probably serve to affect the binding of all components in the reaction,
including the metal cations. If the divalent cation is required to form a substrate-
enzyme bridge complex, then the disposition of ligands and the dimensions of
the active site must neccessarily be altered upon effector binding. Cations able to
bind ligands in the absence of effector may not be able to do so in the presence
of effector.
The effect of divalent cations on the activity of the mutant pyruvate
kinase was also determined (Fig. 56B). In the absence of Fru-1,6-P2 none of
the divalent cations studied were capable of activating the enzyme. In the
presence of the effector, magnesium, manganese and cobalt all produced about
the same degree of activation. The selection against cations other than
magnesium in the wild type enzyme is not apparent in the mutant enzyme. This
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may indicate that the conformation of the active site of the mutant enzyme, in the
presence of effector, is different from that of the wild type enzyme. Ligands that
bind magnesium may not be as flexible in the effector-activated mutant as they
are in the wild type enzyme, leading to the ability of manganese and cobalt to
activate the mutant as potently as magnesium. Calcium and barium had no effect
on enzyme activation. The effect of calcium (and possibly also barium) may be
to produce an inactive enzyme-substrate-M^+ complex. The binding of calcium
may allow one catalytic cycle but then the prevention of the enzyme to release
product, or to relax sufficiently to bind further substrate molecules, produces an
inactive inhibited enzyme (Boiteux et al., 1983).
That these metal cation effects were not due simply to differential levels
of inhibition or activation of the coupling enzyme, lactate dehydrogenase, was
examined by assaying the coupling enzyme alone in the presence of the various
cations under investigation (Fig. 57). Apart from zinc, which completely
inhibited the coupling enzyme and which was not used in the resultant pyruvate
kinase assays, none of the metal cations studied had any significant effect on the
activity of the coupling enzyme. The inhibition of lactate dehydrogenase by zinc
may be due to the accessibility of the active site cysteine residue. Sulphydryl
groups have a high affinity for metal cations such as zinc. A similar effect might
be expected from cations such as Cu^+, Cd^+ or Hg^+ were they to be tested.
Some authors have reported the effect of zinc on pyruvate kinase as being
strongly inhibitory. In each case the pyruvate kinase was assayed with the
coupled enzyme method using lactate dehydrogenase. The result obtained is not
surprising if it is the coupling enzyme that is being inhibited and not the pyruvate
kinase. The authors do not specifically report the effect of the metal cation
additions on the coupling enzyme in separate control experiments e.g. Murcott,
1992.
The effect of pH on the activity of the wild type and mutant enzymes
was examined (Fig. 58). In the absence of Fru-1,6-P2 the wild type enzyme
shows a narrow pH profile, with maximum activity being displayed at pH 6.5.
This is in agreement with the data from a number of workers (e.g. Hunsley &
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Suelter, 1969). A rapid decrease in activity at higher pH values is observed. A
less dramatic decrease in activity is observed as the pH falls below 6.5. In the
presence of the effector, a broader pH profile is observed. The wild type enzyme
still has a pH optimum at 6.5 but becomes more active at higher pH values.
Thus, the effector may produce a conformational change at the active site that
allows the enzyme to retain activity as the pH increases. This may suggest a
more confined active site with a decreased accessibility of solvent. Such a
conformational change could favour catalytic activity as this would reduce the
possibilty of phospho transfer to water by providing a more hydrophobic
environment for the substrates. Any observed effect on the pH profile would
therefore be coincidental and of no particular benefit to the enzyme. Indeed, the
physiological benefit of a broader pH profile is unclear. Pyruvate kinase would
become more active under conditions of metabolic stress, where feedforward
activation by Fru-1,6-P2 would be possible. Under these conditions,
intracellular pH is often observed to decrease. The possibility remains,
therefore, that the observed broadening of the pH profile is an experimental
artefact with no physiological basis.
In the absence of Fru-1,6-P2 the mutant enzyme is very much
less active than in the presence of the effector (Fig. 58B). At pH 6.5, the kcat of
the mutant enzyme is 250-fold lower in the absence of effector than in its
presence. The enzyme is more active at pH values greater than 8.5. However,
even under these conditions it only displays 15% of the activity of the fully
activated mutant enzyme. In the presence of the effector, the mutant enzyme
shows a pH profile broadly similar to the wild type enzyme. The pH optimum is
6.5. The activity of the mutant enzyme at pH 5.5 is virtually zero, unlike the
wild type enzyme. The effect of pH on the mutant enzyme is difficult to explain.
At pH 5.5, and in the presence of effector, the conformation of the enzyme is
clearly different to that of the wild type enzyme. This either allows protonation
of the residues essential for catalysis rendering the enzyme inactive (Morris et
al., 1984), or results in a conformational change so severe that the binding of
substrates either cannot occur or does not induce further conformational changes
leading to activation. It has been suggested that salt bridges play an important
279
role in stabilising the conformation of pyruvate kinase (Walker et al., 1992). The
drop in pH would be expected to severely disrupt the component residues of salt
bridges by affecting the size and distribution of charge on their sidegroups.
N.B. It is possible that the differences in catalytic activity observed upon
changing the pH of the assay medium may be due to loss of enzyme by
denaturation rather than to any inferred conformational changes at the active site
or elsewhere on the enzyme. As the appropriate control experiments to determine
more fully this possibility were not performed in this study, it must remain
highly speculative whether the conformational changes suggested actually occur.
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4.7 FLUORESCENCE AND CIRCULAR DICHROISM STUDIES
The fluorescence emission spectra of the wild type and the mutant
enzymes were obtained in the region 305-400nm. The excitation wavelength
was 295nm, ensuring that the predominantly absorbing residue was the single
tryptophan present in each subunit. The emission spectra obtained in the absence
and presence of substrates and effectors are identical for both the wild type and
mutant enzymes. The fluorescence emission in each case is seen as a broad peak
with a maximum at 340nm. This is indicative of a tryptophan residue that is
quite exposed to the solvent. Upon the addition of the substrates PEP and ADP
to saturating concentrations, the intensity of emission decreases indicating that a
conformational change has taken place in the vicinity of the tryptophan residue.
As the emission maximum has not been altered by substrate binding, this
indicates that the quenching has occurred "internally" i.e. by residues adjacent to
the tryptophan. This effect is observed in both the wild type and mutant
enzymes (Fig. 59 and 60). The emission spectra obtained in the presence of the
effector Fru-1,6-P2 are quite different. Addition of Fru-1,6-P2 results in a
decrease in fluorescence intensity and a shift of the emission maximum to a
longer wavelength. The emission maximum is altered from 340nm to 360nm,
indicating that the tryptophan residue has become almost completely exposed to
the solvent. This indicates that a greater conformational change has occurred in
the environment of the tryptophan, in the presence of the effector, than in the
presence of either of the two substrates. This conformational change is observed
in both the wild type and mutant enzymes and is complete at effector
concentrations of 0.1 mM (Fig. 61). This seems to indicate that the change in
conformation affecting the tryptophan residue occurs at lower concentrations of
effector than is observed to be the case from analysing the data from the enzyme
assays. This could arise from the effects of other ligands on Fru-1,6-P2 affinity,
or possibly, from the fact that Fru-1,6-P2 affects some other feature of the
enzyme (or enzyme-substrate complex) which is important for its effects on
activity. The exposure of the tryptophan may be an unimportant indicator of the
state of enzyme activation but is suggestive of the fact that Fru-1,6-P2 exerts a
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profound influence on the enzyme. Certain minor conformational changes are
complete at a very low concentration of effector. Other conformational changes,
leading to the full activation of both the wild type and the mutant enzymes,
require much larger concentrations before they are complete.
Titration of the enzymes with Fru-1,6-P2 and measurement of the
fluorescence change allows the determination of the dissociation constant (Kd)
of the effector for the enzyme. The Kd for the wild type enzyme is 49.3pM (at
pH 8.5 and in the absence of other substrates) and that for the mutant enzyme
under identical conditions is 15.6|iM. The values for both enzymes suggests that
a very tight association of effector and protein occurs. The point mutation at the
subunit interface appears to increase the affinity of the mutant enzyme for
effector by a factor of more than three. The binding kinetics also change from
weakly sigmoidal in the wild type to strongly sigmoidal in the mutant. A
maximum fluorescence quench of about 40% is seen in both enzymes indicating
that the tryptophan has been exposed to about the same degree in both enzymes.
Other factors may influence the change in the mutant enzyme from an
inactive to an active conformation apart from the concentration of effector.
Possibilities may be:
1) A time-dependent conformational change.
2) An association/dissociation of subunits in the presence of effector.
3) An ionic strength-induced conformational change.
4) A contaminant of the effector solution causing the conformational change.
5) Fru-1,6-P2 is not the true effector and the conformational change is brought
about by similar but different compounds.
If the differential activity of the mutant enzyme observed to occur at
various effector concentrations were actually produced in a time-dependent
manner, then it should be possible to incubate the enzyme with a low
concentration of effector for a longer period and observe the same increase in
activity as was observed at higher effector concentrations. This was found not to
be the case. Mutant enzyme incubated in the presence of ImM effector for 10
minutes always showed lower activity than enzyme incubated with 5mM effector
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for one minute. Thus, although there may well be a minimum time for the
completion of the conformational change, it is the concentration of effector that
is the critical component in the observed transition.
It has been shown in mammalian cell cultures that Fru-1,6-P2 causes the
association of monomelic M2 pyruvate kinase (identified as a cytosolic thyroid
hormone binding protein) to a tetrameric form (Ashizawa et al., 1991). If this
were also true for the mutant enzyme, then various forms of the enzyme in
different stages of association between monomer and tetramer should be
detectable by cross-linking experiments using glutaraldehyde in the presence and
absence of effectors. The tetrameric, dimeric and monomelic forms would be
observed when analysed by SDS-PAGE. There was insufficient time to perform
these types of experiments under fully controlled conditions. The detection of
dimeric and tetrameric forms of pyruvate kinase by SDS-PAGE would be
difficult due to the high molecular mass of these forms (1 lOkD and 220kD
respectively) leading to their poor penetration and low resolution in even low
percentage polyacrylamide gels. This method of analysing the degree of
association of subunits has been successfully used with lactate dehydrogenase
and phosphoglycerate mutase (Hermann et al., 1981; White et al., 1993).
However, both of these enzymes are considerably smaller than pyruvate kinase
(subunit molecular mass 35kD and 27kD respectively) allowing easy
discrimination between tetrameric, dimeric and monomelic forms of these
enzymes.
The evidence from other sources is contrary to the hypothesis that the
effector promotes the assembly of inactive monomers of the mutant enzyme to
active tetramers. Mutant enzyme artificially denatured into its constituent
monomers is completely inactive. Also, the mutant enzyme is isolated in an
identical fashion to the wild type enzyme in a procedure where the concentration
of effector is negligible. The enzyme under these conditions is tetrameric with no
evidence of dimeric or monomelic forms existing in any significant amounts.
Thus the hypothesis that the effector functions by causing the association or
dissociation of subunits to activate the mutant enzyme is likely to be false.
The highly charged nature of the effector might lead one to believe that
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an ionic strength-induced conformational change could be produced. It has been
shown that the ionic strength of the media affects the interaction of the effector
with the enzyme (Speranza et al., 1990). However, as the combined ionic
strength of the components of the assay mixture is little altered by the
contribution of 5mM effector, it can be supposed that this hypothesis is not
correct.
A contaminant of the effector might be the true cause of the observed
conformational change. An examination of a sample of the effector by HPLC
failed to identify any contaminants. The effector was used as the trisodium salt.
It can be seen from the results of the monovalent cation activation experiments
(Section 3.4) that sodium fails to activate the mutant enzyme to any extent
If Fru-1,6-P2 were not the true effector it should be possible to activate
the enzyme with likely breakdown products or similar compounds that could
have contaminated the effector preparation. Fructose-1-phosphate, fructose-6-
phosphate and fructose-2,6-bisphosphate did not activate either the wild type or
the mutant enzyme. Fructose-2,6-bisphosphate is not likely to be an activator of
the yeast enzyme despite being a potent activator in the highly similar
trypanosome enzymes (Opperdoes, 1987). Trypanosome glycolysis is largely
confined to a subcellular organelle, the glycosome, where the majority of the
glycolytic enzymes are sequestered. Phosphofructokinase, the enzyme that
produces Fru-1,6-P2, is one of these enzymes, whereas pyruvate kinase (which
is not) is found in the cytoplasm. Access of Fru-1,6-P2 to the cytoplasm is
limited by the impermeability of the glycosomal membrane. Thus, regulation of
pyruvate kinase in trypanosomes is performed by the related compound Fru-2,6-
P2, which is produced in the cytoplasm by 6-phosphofructo-2-kinase. Other
eukaryotes that regulate their pyruvate kinases often do so via Fru-1,6-P2 over
other hexose-phosphates.
The remaining idea, that a concentration-dependent conformational
change is produced by the effector remains the most obvious and convenient
way of explaining the data. Despite saturation of the effector site at very low
concentrations there may be another low affinity site that must be saturated to
complete the conformational change. The point mutation may have left the
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primary site relatively unaltered but may have decreased the affinity of a
secondary site for the effector. Evidence against this hypothesis is that a
secondary site ought to be identifiable through the analysis of Fru-1,6-P2
binding data e.g. a Scatchard analysis. This would only be true, however, if
binding at the second site also produced a change in the property being detected -
in this case fluorescence emission. If not, one would need some other method
for detecting binding at the second site e.g. ^C-Fru-1,6-P2- Also, no
candidates for a secondary effector site have been proposed from analysis of X-
ray crystallography data. However, the only model for pyruvate kinase so far
available is from the non-allosterically regulated cat muscle enzyme and so this
does not necessarily exclude the possible existence of such a secondary site.
Recently, the effector site in the pyruvate kinase from Bacillus
stearothermophilus has been suggested to lie in a different position to that of the
cat muscle enzyme (Walker et al., 1992). The proposed new site is a pocket deep
between domains A and C, separated from the other pocket by close interdomain
contacts and accessed via an alternative channel in the protein structure. It ought
to be noted at this point that the most potent effector of the
B.stearothermophilus enzyme is ribose-5-phosphate, and not Fru-1,6-P2 and
that the various forms of pyruvate kinase have probably evolved mechanisms of
allosteric regulation precisely tailored to their regulatory requirements.
The conclusion that a concentration-dependent activation of the mutant
enzyme exists can be supported by proposing that the conformational change
observed, i.e. a change in tryptophan fluorescence that is complete at an effector
concentration of 0.1 mM, is not reflecting the full activation of the enzyme. The
tryptophan residue is already quite well exposed to solvent in the absence of
effector and only a small change in conformation, elicited by a low concentration
of effector, would be required to make it fully exposed. This low concentration
of effector is, however, insufficient to bring about full enzyme activation, which
requires a much greater effector concentration. Also, it is likely that the geometry
of the active site is highly ordered and that the correct orientation of ligands is
only obtained in the presence of all the substrates and cofactors. This may make
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it appear that the kinetics of binding of the various substrates studied by
fluorescence techniques were not in accord with those determined during
enzyme assays.
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ANALYSIS OF FLUORIMETRY BINDING DATA
A number of experiments were performed on both the wild type and
mutant enzymes, where the fluorescence emission at 340nm was monitored as a
function of ligand concentration. From these experiments, typical sigmoid and
hyperbolic ligand saturation curves were obtained. The data from these plots
could be used to produce Hill-type plots, from which Sq 5 and Hill coefficient
values (njj) could be determined for the various ligands. The data from these
experiments is summarised in Table 11.
1) BINDING OF Fru-1,6-P2 TO THE WILD TYPE ENZYME
At pH 8.5, and in the absence of other substrates and cofactors (except
magnesium), the binding of the effector Fru-1,6-P2 to the enzyme appears to be
weakly sigmoidal. The Sq 5 Fru-1,6-P2 under these circumstances is 49.3|iM,
which agrees well with the value obtained by other workers e.g. Murcott et al.,
1991. The degree of cooperativity of binding between effector sites appears to
be very much reduced. The Hill coefficient was calculated as 1.23. Previous
work indicates a much greater cooperative effect with a Hill coefficient of 2.25.
This indicates that the pH difference, the absence of potassium, or the absence
of any of the other substrates, all of which are known to affect the conformation
of the enzyme, are affecting the ability of the effector to modulate its own
binding to the enzyme.
2) BINDING OF Fru-1,6-P2 TO THE MUTANT ENZYME
The binding of Fru-1,6-P2 to the mutant enzyme was investigated under
exactly the same conditions as for the wild type enzyme. The Sq 5 Fru-1,6-P2
for the mutant enzyme was determined to be 15.6(iM with a Hill coefficient of
1.8. These values are significantly different to those for the wild type enzyme.
The introduction of the point mutation therefore appears to affect the binding of
effector, apparently tripling the affinity of the enzyme for effector and increasing
the cooperativity between effector binding sites. Apart from the significant
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changes in conformation due to the different buffer conditions, in terms of the
high pH and the lack of other substrates, the mutant enzyme appears to adopt a
conformation different to that of the wild type. This allows a tighter effector
binding, due perhaps to a different orientation of ligands in the effector site. The
increase in cooperativity indicates a difference in the way in which subunits
interact with each other. The mutation may cause stabilising salt bridges to form
that are not possible in the wild type enzyme or protect other contact regions
from being disrupted.
The great difference in the binding properties of the effector to both the
wild type and mutant enzymes is probably due more to the different buffer
conditions than on vast differences in conformation between the two enzymes.
The geometry of the active site in the absence of so many compounds essential
for catalytic activity may be reflected in the unusual fluorescence signals
produced. Assessing the binding properties of the effector in the presence of
substrates may produce different conclusions.
3) BINDING OF Fru-1,6-P2 TO THE WILD TYPE ENZYME IN
THE PRESENCE OF ADP
Before effector was added, the wild type enzyme was incubated with
saturating concentrations of the substrate ADP. As a result, the Sq 5 Fru-1,6-P2
was calculated to be 269.3(iM with a Hill coefficient of 1.08. Thus, the addition
of ADP has caused a five-fold reduction in affinity for the effector and converted
the weakly sigmoidal binding kinetics into an hyperbola compared to the enzyme
in the absence of ADP. This indicates that the effector site conformation is
significantly different in the presence of one of substrates. It also indicates that
the addition of substrate appears to abolish cooperativity between effector sites
on different subunits.
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4) BINDING OF Fru-1,6-P2 TO THE MUTANT ENZYME IN THE
PRESENCE OF ADP
The determination of the effect of ADP on the binding of the effector to
the mutant enzyme was carried out under exactly the same conditions as for the
wild type enzyme. The Sq 5 Fru-1,6-P2 was calculated to be 56.8|iM with a
Hill coefficient of 1.40. Thus, in the mutant enzyme, the affinity for the effector
has been reduced three-fold compared to the result in the absence of substrate,
and the cooperativity between effector sites has also been reduced slightly. This
broadly matches the effects seen in the wild type enzyme. The small decrease in
cooperativity indicates a slight disruption of intersubunit communication
between effector sites and may be attributed to a small conformational change
upon substrate binding.
5) BINDING OF Fru-1,6-P2 TO THE WILD TYPE ENZYME IN
THE PRESENCE OF PEP
The binding of Fru-1,6-P2 to the wild type enzyme was determined in
the presence of saturating concentrations of the other substrate, PEP. The Sq 5
Fru-1,6-P2 under these circumstances was 55.2|i.M with a Hill coefficient of
1.76. Thus, in the presence of PEP, the effector appears to bind the wild type
enzyme with about the same affinity as in its absence. The cooperativity between
effector sites increases significantly from 1.23 to 1.76. This indicates that the
addition of PEP causes a significant change in enzyme conformation. The
conformational change affects the communication between effector sites rather
than the ability of the enzyme to bind the effector molecule. The change in
conformation elicited by PEP is different to that produced by ADP.
6) BINDING OF Fru-1,6-P2 TO THE MUTANT ENZYME IN THE
PRESENCE OF PEP
The determination of the effect of PEP on the binding of the effector to
the mutant enzyme was carried out under identical conditions to that of the wild
type enzyme. The Sq 5 Fru-1,6-P2 in the presence of PEP was found to be
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15.3|iM with a Hill coefficient of 0.95. This indicates that the enzyme binds the
effector with about the same affinity as in the absence of substrate, but with a
much decreased degree of cooperativity between effector sites. This suggests
that the effect of substrate binding is to reduce communication between effector
binding sites. The effect in the mutant enzyme is different to that observed in the
wild type enzyme. Thus, the conformational change elicited by PEP is different
in the two enzymes.
7) BINDING OF ADP TO THE WILD TYPE ENZYME
The ability of the wild type enzyme to bind the substrate ADP was
followed by fluorimetric means. The conditions were the same as have been
described for the determination of Fru-1,6-P2 binding to the wild type enzyme.
The Sq 5 ADP was found to be 3.02mM with a Hill coefficient of 1.06. This
compares with the kinetically determined values of 0.39mM and 1.16
respectively. This indicates that the wild type enzyme can bind ADP under the
conditions used but with a much reduced affinity. This suggests that the
difference in pH, the absence of potassium and PEP produce a different enzyme
conformation that is not able to bind ADP very effectively. The cooperativity
between ADP binding sites is only slightly reduced. The ADP sites have been
found not to interact to any great extent by a number of workers (e.g. Hunsley
& Suelter, 1969).
8) BINDING OF ADP TO THE MUTANT ENZYME
The binding of ADP to the mutant enzyme was measured in exactly the
same way as for the wild type enzyme. The Sq 5 ADP was found to be 2.49mM
with a Hill coefficient of 0.96. A comparison with the values determined from
enzyme assays is not appropriate here due to the difference in conditions,
especially the presence of high concentrations of Fru-1,6-P2 required for
activation of the mutant enzyme. However, the results suggest that the
conformation of the mutant enzyme under the conditions used for assay and in
the absence of the other reaction components leads to the production of an
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enzyme conformation that is not conducive to the optimum binding of ADP. It
may be that the disposition of ligands at the active site are not well placed to
allow efficient substrate binding. The inflexibility of the active site may lead to
the reduction in the degree of cooperativity observed between ADP binding
sites.
9) BINDING OF PEP TO THE WILD TYPE ENZYME
The binding of PEP to the wild type enzyme was assessed by
fluorimetric means as described above. The Sq 5 PEP was determined as
93-OjlM with a Hill coefficient of 1.06. This compares to the kinetically
determined values of 3.34mM and 2.67 respectively. Thus, the affinity of the
enzyme for PEP has increased by a factor of 35 and the cooperativity between
PEP binding sites has been virtually abolished. This suggests that the change in
pH, or the lack of potassium or ADP, has altered the conformation of the
enzyme allowing much tighter binding of substrate and reducing the degree of
communication between binding sites on different subunits.
10) BINDING OF PEP TO THE MUTANT ENZYME
The binding of PEP to the mutant enzyme was determined by exactly the
same means as for the wild type enzyme. The Sq 5 PEP was found to be
0.17mM with a Hill coefficient of 1.0. Thus, despite the different assay
conditions, the point mutation results in a two-fold reduction in binding affinity
compared to the wild type enzyme. The cooperativity between PEP binding sites
has not been affected relative to the situation seen in the wild type enzyme. This
suggests that the conformation of the mutant enzyme is slightly different to the
wild type enzyme assayed under the same conditions and greatly different to




The data from the experiments described above is summarised in Table
11.
The conformation of the wild type and mutant enzyme, determined via
the fluorimetric method, are different to each other in many respects. Each
substrate affects the binding of the effector to different degrees, reflecting the
unique conformation adopted by the enzymes in their presence, and the subtle
influences this will have on the binding sites of the other components and the
ability of one subunit to communicate changes to the other binding sites on
different subunits. The conformations of the wild type and mutant enzymes in
the buffer used for the fluorimetric titrations are different from those adopted in
the standard assay buffer. The higher pH, the absence of potassium, and the lack
of the other substrates and effectors, all contribute to the final geometry of the
active site and the effector sites. This also affects the ability of one subunit to
communicate with the other subunits. There is little wonder therefore, that the
results obtained from the fluorimetric titrations are different from those obtained
by traditional enzyme assay. The different results serve to reinforce the concept
of the importance of different conformations in enzyme activity and the role of
individual compounds to affect, either subtlely, or quite dramatically, the ability
of the enzyme to bind compounds or to communicate change to other subunits in
the enzyme.
A point mutation in the active site of E.coli phosphofructokinase has
been observed to alter the cooperativity of the enzyme for substrates (Berger &
Evans, 1990). Cooperativity has also been induced in E.coli glutathione
reductase by a single point mutation located at the subunit interface (Scrutton et
al., 1992). It is possible that a mutation affecting intersubunit communication, as
has been produced here in the yeast pyruvate kinase, may interfere with
substrate binding at the active site. The great difference in the assay conditions
employed prevents a more precise discussion of the influence of the point
mutation on the various properties studied.
292
CIRCULAR DICHROISM STUDIES
Circular dichroism (CD) is a sensitive technique that can be used to
determine the secondary structure of proteins and peptides in solution. Circular
dichroism spectra for the wild type and mutant forms of pyruvate kinase were
collected in the region 260-190nm in the presence and absence of a number of
different ligands. To get reliable results it is important to understand the
limitations of the technique. Circular dichroism spectra of proteins may look
complicated, but the the long wavelength regions are dominated by the CD due
to any alpha helical structures present. As a result, the information content of a
protein CD spectrum is often lower than one might guess. In reality, CD data can
give statistically significant estimates of multiple classes of secondary structure
only if the data extend down to 184nm. If data extending only to 200nm are
used, alpha helix is the only secondary structure that can be determined with
confidence The situation is not much improved if data extending to 190nm are
used (Johnson, 1990).
The CD of proteins is primarily the CD of the amide chromophore.
Secondary structure, as measured by CD, counts amide-amide interactions. The
amide chromophore begins absorbing far into the uv region with the first
prominent peak at about 220nm. Absorption by alpha helix dominates in the
region 240-190nm, with an intense negative peak at about 222nm, another
reasonably intense negative peak at 208nm and an intense positive peak at
192nm. The beta sheet also has a fairly intense peak at 198nm, and random coil
has an intense negative peak at 198nm. Despite this, CD spectra measured to
190nm do not usually contain enough information to reliably allow calculation of
the secondary structural content other than the alpha helix content, which can
normally be predicted accurately with spectra truncated at 200nm.
Circular dichroism instruments can not make accurate measurements on
samples with an absorbance greater than 1.0. Solvent transparency is usually the
major problem requiring the use of low concentrations of buffer. Note that, in an
attempt to overcome the problems of solvent transparency in this work, the CD
( and fluorescence) measurements were performed with a buffer concentration of
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20mM Tris-HCl, rather than the 50mM used in the enzyme assays. Solvent
transparency problems can be partially overcome by using short pathlength
(0.02cm) cuvettes. At a scan speed of lOnm/min a single spectrum takes seven
minutes to produce. In order to increase the signal-to-noise ratio multiple scans
can be collected and averaged automatically. Another important factor for the
correct interpretation of CD spectra is the requirement for an accurate estimation
of the protein content of the sample. The protein content of the ion-exchange
purified fractions was determined by measuring the aborbance at 280nm (A2go)
compared to a suitable reference blank. The A2gg f°r a lmg/ml solution of yeast
pyruvate kinase has been calculated as 0.51 (Yun et al., 1976). It should be
noted that Lowry determinations are not sufficiently accurate to be used with CD
measurements (Johnson, 1990).
Figure 62 shows the CD spectra of the wild type and mutant enzymes. It
can be seen that there is no significant difference in the spectra in the regions
important for estimating secondary structure.
The interpretation of CD spectra is not straightforward and the
calculation of secondary structure is prone to many sources of error. The usual
method is to determine the CD spectra for polypeptides that are assumed to adopt
a single secondary structure in solution and then fit them to the CD spectra of the
protein being analysed. The fraction of each secondary structure is taken to be
the fraction of the corresponding polypeptide CD spectrum that is contained in
the protein spectrum. There are a number of problems with this approach:
1) The CD spectrum of an alpha helical polypeptide is for the infinitely long
structure, and only short helices are found in proteins.
2) Beta sheets come in parallel and antiparallel varieties, and it is not usually
known which variety the polypeptide assumes in solution.
3) There are various types of beta turn and their CD spectra have not been well
characterised.
4) There is disagreement over what conditions produce a true random coil in
solution and the CD spectra have not been well determined. Moreover, it is not
clear that "random" should be used for the residues that do not fall into the other
secondary structure classifications since they are not really "randomly"
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orientated.
The CD spectra in this work were analysed by the program CONTIN
(Provencher & Glockner, 1981). This program was developed by using
reference protein spectra measured 190nm. It has been stated that the best fit
with this program is for proteins containing a high alpha helical content, and this
is probably due to the general inadequacy of spectra truncated at 190nm for
determining other elements of secondary structure, as outlined earlier.
Circular dichroism can be used to follow changes in secondary structure
upon the binding of ligands. It is unusual for such dramatic changes in protein
conformation to be elicited by ligand binding. This is reflected in the spectra
presented in this work. The addition of the substrates PEP and ADP, and the
effector Fru-1,6-P2, to the wild type and mutant enzymes, do not appear to
cause any significant changes in the CD spectra produced, and hence no
difference in the secondary structure of these enzymes (Figures 63 to 68
inclusive).
The other data presented (fluorimetric, trypsin digestion, chemical
modification and thermal stability) all suggest that tertiary structural changes
occur readily upon ligand binding. The apparent significant change in secondary
structure content of the mutant enzyme over the wild type enzyme (Table 12)
may be an artefact due to difficulty fitting the CD spectra with the CONTIN
algorithm or inaccuracies in protein determination which are critical to the final
secondary structure estimation.
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4.8 TRYPSIN DIGESTION OF WILD TYPE AND MUTANT
ENZYMES
The analysis of conformational transitions using limited proteolysis has
been used successfully in a number of enzyme systems for assessing the extent
of conformational change induced in proteins by the binding of various
substrates and effectors (Arnone et al., 1992). A number of proteolytic enzymes
have been used in such studies. For this study trypsin was used as it has broad
substrate specificity, does not require any special incubation conditions that
might compromise the activity of the target enzyme, is relatively inexpensive and
can be completely and rapidly inhibited when required. The effect of trypsin
digestion on wild-type and S384P mutant pyruvate kinase activity was
investigated. The role of substrates and effectors in protecting the enzyme
against digestion was also studied. The results are summarised in Table 13.
The enzymes were incubated in standard assay buffer. Additions were
9.4mM PEP, 8.0mM ADP and l.lmM Fru-1,6-P2- Aliquots of the digestion
mix were taken at specific time points and incubated in the reaction mix to which
had been added ImM PMSF to inhibit the added trypsin. PMSF was observed
to have no significant effect on either pyruvate kinase or lactate dehydrogenase.
The PMSF was extremely labile and only porly soluble in water, and so was
dissolved in methanol immediately prior to use and stored on ice until required.
The substrates PEP and ADP significantly protect the wild-type enzyme
from trypsin digestion compared with the enzyme in the absence of substrates
(Fig.69). It should be noted that the assay buffer contains the essential metal
cations K+ and Mg^+ which, by themselves, do not appear to protect the
enzyme. The allosteric effector Fru-1,6-P2 offers little or no protection of the
wild-type enzyme and actually appears to enhance the destruction of the enzyme
at longer incubation times.
The same pattern of protection was observed with the mutant enzyme
(Fig. 70). Here, ADP appeared to offer more protection from trypsin digestion
than PEP. However, both ADP and PEP were significantly more effective in
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protecting the mutant enzyme than Fru-1,6-P2 which did not prevent trypsin
digestion to any extent.
The time taken for the enzymes to lose 50% of their activity can be
measured and used to compare the effect of the additions in protecting the
enzymes from trypsin digestion. When no additions were made, the wild type
enzyme lost 50% of its activity after 19.4 minutes. When PEP was present, this
time was extended to 120.8 minutes, a six-fold increase. ADP extended the
inactivation time to 99.1 minutes, over a five-fold increase. Conversely, the
presence of Fru-1,6-P2 decreased the inactivation time to 16.5 minutes.
For the mutant enzyme, the time taken for the enzyme to lose 50% of its
activity in the absence of substrates and effectors was 23.5 minutes. Addition of
ADP extended this time to 84.8 minutes, nearly a four-fold increase. Addition of
PEP resulted in a two-fold increase in the inactivation time to 47.5 minutes. The
effector, Fru-1,6-P2, caused a decrease in the observed inactivation time to 18.3
minutes. These data are summarised in Table 13.
These data can be taken to indicate that substrates and effectors induce
different conformations in the wild type and mutant pyruvate kinase enzymes
that are differentially susceptible to digestion with trypsin. PEP and ADP
significantly protect the enzymes from digestion indicating that a "closed"
conformation exists that prevents trypsin from gaining access to susceptible
bonds. It is important to note that the degree of extrapolation required to obtain a
50% inactivation time for PEP and ADP may exaggerate the degree of protection
actually offered by these compounds. Fru-1,6-P2 aPPears to offer very little
protection from trypsin digestion. This indicates that the enzyme is in a more
"open" or "relaxed" conformation where access by trypsin to susceptible bonds
is easier. PEP and ADP bind at effectively the same site and might be expected to
produce similar conformations of the enzyme. The allosteric activator binds at an
altogether different site from the two substrates and so might be expected to
produce an entirely different conformation in its presence. In fact, several
different studies suggest that Fru-1,6-P2 binding promotes a "looser"
conformation which would make accessibility of trypsin to cleavage sites easier
(Kapoor, 1976; Speranza et al., 1990). PEP and ADP may provoke a more
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closed conformaton in order to produce an environment in which the exclusion
of water from the active site is essential to allow an efficient phospho transfer
reaction to proceed.
An examination of the primary sequence of yeast pyruvate kinase in
conjunction with the computer model of the subunit tertiary structure, reveals the
location of a vast number of potential trypsin cleavage sites (61 in total). The
distribution of lysine and arginine residues in a single subunit is shown in Fig.
85. Of these residues, several appear at interdomain regions, where polypeptide
flexibility would be greater and accessibility by trypsin easier than in more
compact regions of the domain. A number of charged residues are suspected as
being important in ADP binding. In particular Arg 48,90 and 263 and Lys 85
are thought to be among those residues involved in binding the phospho groups
of ADP. The fact that ADP significantly protects both the wild type and mutant
enzyme from trypsin digestion suggests that these residues may be important
cleavage sites in the unprotected enzymes. ADP appears to protect the mutant
enzyme more than the wild type enzyme. This suggests that the conformation of
the mutant enzyme after binding ADP is significantly different to that of the wild
type enzyme. This conformational change may protect more lysine and/or
arginine residues that are near to the ADP binding site. Of particular interest in
this regard are residues Arg 215 and Lys 193 and 195, which are very close to
those charged residues at the active site and could be perturbed sufficiently on
binding ADP to be protected from trypsin cleavage.
Binding of the effector Fru-1,6-P2 to both the wild type and mutant
enzymes significantly increases the susceptibility of the enzymes to trypsin
digestion. The effector binding site has been identified in the E.coli enzyme by
the covalent attachment of pyridoxal-5'-phosphate to lysine residues (Speranza
et al., 1990). The equivalent residues in the yeast enzyme are 394-409. In this
region there are several charged residues, notably Arg 407 and Lys 392 and 394.
They could fulfill the same function as those positively charged residues at the
active site i.e. binding the negatively charged phospho groups of the effector.
Upon effector binding a significant conformational change occurs, resulting in
the exposure of more arginine and lysine residues than are exposed in the native
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unligated conformation. A small local perturbation might result in residues such
as Arg 424 and 458 and Lys 412 becoming exposed. A larger, global
conformational change could expose any number of charged residues. Of
particular significance would be residues located in the interdomain regions.
Such residues include Arg 408, 427,and 430 and Lys 235, 280 and 281, found
between domains B and C , and Lys 193, 195, 336 and 387, found between
domains A and B, which would be more prone to exposure than other charged
residues partly shielded in the more compact regions of the various domains.
The trypsin digestion data are more suggestive of altered conformations
of pyruvate kinase than the NEM inhibition studies because there are more
trypsin cleavage sites potentially accessible to trypsin than there are thiol groups
accessible to NEM. Hence, any observed difference in pyruvate kinase activity
during the trypsin experiments is more indicative of a global conformational
change induced by substrate or effector binding. Local perturbations caused by a
small number of NEM modifications may not be the primary cause of the
observed enzyme inactivation.
300
4.9 THE EFFECT OF NEM ON PYRUVATE KINASE ACTIVITY
The effect of the reagent N-ethylmaleimide on pyruvate kinase activity
was determined for both the wild-type enzyme and the S384P mutant enzyme.
NEM reacts specifically with the sulphydryl groups of cysteine residues in
enzymes often leading to their inactivation (Wieker & Hess, 1972; Plaxton et
al., 1990). The inactivation may be due to the prevention of substrates binding
to the active site of the enzyme by steric hindrance caused by the covalent
modification. Alternatively, NEM treatment may prevent the enzyme adopting an
active conformation by affecting the flexibility of the protein molecule.
The effect of 2mM NEM on enzyme inactivation was studied and the
role of substrates and effectors in preventing the covalent modification of the
enzyme was also investigated. The enzymes were incubated in standard assay
buffer. Additions included 9.4mM PEP, 8.0mM ADP and l.lmM Fru-1,6-P2*
The enzymes were allowed to react with the added substrates and effectors for
three minutes prior to NEM addition. The enzymes were assayed immediately
after NEM addition and at regular intervals up to 24 minutes later. The results
are summarised in Table 14. NEM addition did not immediately affect the
enzyme activity of either the wild type or the mutant enzyme. However, after the
incubation with NEM was allowed to continue, a significant difference in the
activity of both enzymes was observed.
A useful measure of the extent of protection offered by compounds
against this type of inhibition is the length of time required for the enzyme to
lose 50% of its activity (T50). The effect of NEM on the wild type enzyme, in
the presence and absence of various ligands is shown in Fig. 71. In the absence
of any substrates or effectors, the wild-type enzyme lost approximately 50% of
its activity after 8.1 minutes. Note that the essential cations K+ and Mg^+
present in the assay buffer did not prevent inactivation of the enzyme. The
presence of the substrates PEP and ADP protected the wild-type enzyme with
calculated T^q values of 58.7 minutes and 22.3 minutes respectively. The
allosteric effector Fru-1,6-P2 offered limited protection to the wild-type enzyme
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with a T^q of 31.9 minutes. The results with the mutant enzyme showed a
similar difference in the ability of substrates and effectors to protect against
NEM inhibition (Fig. 72). In the absence of substrates and effectors, the mutant
enzyme had a T^q of 6.7 minutes. The substrates PEP and ADP offered
significant protection of the enzyme, increasing the T^q to 14.7 and 13.8
minutes respectively. The allosteric effector Fru-1,6-P2 conferred limited
protection and increased the T^q to 8.6 minutes. The biphasic nature of the
observed inhibition with both enzymes may be indicative of the rapid reaction of
highly exposed cysteines followed by the slower reaction of less accessible
residues.
These results are consistent with the existence of different conformations
of the enzyme existing in the presence and absence of various substrates and
effectors. When the substrates PEP and ADP are present the enzyme adopts a
stable conformation markedly resistant to the presence of the thiol group
modifier NEM. This is indicative of a "closed" conformation where cysteine
sidegroups are not exposed to the solvent or are protected by nearby residues
preventing NEM from reacting with them. The conformation adopted in the
absence of substrates (but in the presence of the essential metal cations) is more
"relaxed" with cysteine sidegroups readily accessible to the solvent and hence to
NEM reaction. The allosteric activator Fru-1,6-P2 induces a conformational
change in which some of the thiol groups are exposed and some are protected,
thus accounting for the intermediate level of protection afforded in the presence
of NEM. The fact that the substrates PEP and ADP bind at essentially the same
place could explain why they protect the enzyme to the same degree. The
conformation in the presence of either substrate is likely to be very similar.
Conversely Fru-1,6-P2, by binding at a site distinct from either of the
substrates, induces a different conformation where different cysteine residues
are exposed or protected. Cysteine residues important in enzyme activity are
more readily exposed in the presence of the allosteric activator than they are in
the presence of the substrates.
The distribution of cysteine residues in the yeast pyruvate kinase
monomer was examined by reference to the computer model of the yeast enzyme
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based on the coordinates of the cat skeletal muscle enzyme (Clayden, 1987;
Murcott, 1990). There are seven cysteine residues per monomer, although none
appear to be well-placed to participate in substrate or effector binding (Fig. 86).
The proposed effector binding site, identified in the E.coli enzyme, and
corresponding to residues 394-409 in the yeast enzyme is quite close to only one
cysteine residue, Cys 425. A local conformational change induced by the
binding of the effector might expose this residue, leading to covalent
modification by NEM. A more extensive conformational change might allow
other cysteine residues to be exposed. The fact that this is indeed the
experimental observation supports this conclusion. In contrast, the large degree
of protection from NEM modification afforded by the substrates PEP and ADP
indicates that the cysteine residues are less exposed to the solvent and, as all the
cysteines are quite distant form the active site, a conformational change must
have occurred upon substrate binding to offer this protective effect. This
supports the trypsin digestion studies where PEP and ADP were seen to protect
the enzyme, perhaps by producing a more compact structure, and the effector
was seen to offer very little protection, indicating a looser overall structure for
the enzyme. It may be that in the tetrameric enzyme the disposition of the
cysteines may be different to that observed in the monomelic model. In
particular, cysteines nearer to intersubunit contacts might be more exposed when
the effector molecule is bound to the enzyme than when substrates are present.
However, it should be noted that the computer model of the monomer is based
on its disposition in the tetramer.
It has been observed on many occasions and with many different
pyruvate kinase enzymes that compounds known to react with cysteines and
other reactive side-chains can be prevented from doing so by substrates,
substrate analogues and effectors (Section 1.5). Assuming that the primary
sequence for the pyruvate kinase from the yeast Saccharomyces calsbergensis is
very similar to that of S.cerevisiae , it may be possible to identify some of the
cysteine residues postulated in earlier work (Wieker & Hess, 1972 and Fig 12).
These authors reported that the pyruvate kinase from S.carlsbergensis contained
six cysteine residues per subunit as opposed to seven in the S.cerevisiae
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Fig. 86 Yeast pyruvate kinase subunit showing location of cysteine
residues.
Polypeptide shown as a ribbon.
Cysteine residues shown as spheres.
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enzyme. Three of these cysteines were located on the surface of the protein, and
could be distinguished from one another by their reactivity towards DTNB. The
other three cysteines were less reactive and are probably buried in the
hydrophobic core of the enzyme. The most reactive cysteine was not part of the
active site or the allosteric effector site and may correspond to residue 370 of the
S.cerevisiae enzyme. The second most reactive cysteine was deemed to be part
of the active site and may correspond to residue 120 in the S.cerevisiae enzyme,
which is apparently located at the opening of the active site cleft. The third most
reactive cysteine was part of the allosteric site and, in the S.cerevisiae enzyme,
may be equivalent to Cys 425. Until the gene encoding the pyruvate kinase from
S.carlsbergensis is cloned and sequenced the location of the cysteines, and their
comparative position with respect to the S.cerevisiae enzyme, must remain
speculative.
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4.10 THERMAL STABILITY STUDIES
Many proteins are progressively inactivated by heating. This thermal
inactivation is often accompanied by denaturation and precipitation of the
protein. The introduction of point mutations into features of secondary structure
within a protein are often found to affect the ability of the protein to resist
thermal denaturation. Mutations can make the protein more or less resistant to
such treatment. One way to measure the effect of heating on an enzyme is to
determine the temperature at which 50% of the enzyme activity is lost (T^q).
This was done for the wild type and the S384P mutant pyruvate kinases and also
for the rabbit muscle enzyme. The results are shown in Fig. 73.
The rabbit muscle enzyme was found to be highly resistant to thermal
denaturation (T50 = 58°C). This result is in accordance with data previously
recorded (Potter, 1993). The wild type yeast enzyme had a T^q of 42°C, much
lower than the rabbit muscle enzyme. This reflects the different tertiary and
quaternary structures adopted by the two enzymes and is a consequence of their
different amino acid sequences. The S384P mutant pyruvate kinase had a T^q of
39°C, 7% lower than the wild type enzyme. The effect of the point mutation is
to disrupt the helix Ca2. This may well affect the overall structure of the
tetrameric enzyme. The mutation may expose residues to the solvent that are not
normally exposed and so catalyse thermal denaturation to some extent. The
secondary structure of the mutant enzyme, as measured by its CD spectrum, is
not significantly different from that of the wild type enzyme (Fig. 62). It may
not be possible to detect a small difference in alpha helical content between the
wild type and mutant forms of the enzyme. The large difference actually detected
(Table 12) may be an artefact due to inaccurate measurement or bias in the
CONTIN algorithm used to calculate secondary structure content This suggests
that the point mutation has not had a great influence on the secondary structure
of the enzyme. Thus, it is apparent that the altered response of the mutant
enzyme to a rise in temperature is due to a change in the quarternary and tertiary
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structure compared to the wild type enzyme. A "loosening" of intersubunit
contacts, or an increase in subunit flexibility, due to the introduction of the helix-
destabilising proline residue, might be sufficient to explain the reduced thermal
stability observed in the mutant enzyme. It has been shown that a difference of
1°C in melting temperature between wild type and mutant forms of a protein
corresponds to a difference in energetic stability of approximately 2.1kJ/mol.
Thus, in this case, the Ser 384 to Pro mutation would lead to a destabilisation of
the enzyme by 6.3kJ/mol.
The yeast enzyme is known to be cold-labile (Kuczenski & Suelter,
1970), indicating that associations between apolar groups (which are
significantly weakened at low temperatures) are an important feature in the
stabilization of the tetrameric enzyme. An increase in temperature, therefore,
might be expected to stabilize hydrophobic contacts over other forms of
intersubunit contact. Obviously, a point will be reached where prolonged
exposure to a denaturing environment will result in the loss of enzyme activity.
The point mutation in the mutant enzyme may have disrupted an important
hydrophobic contact contributing to the observed loss of thermal stability. The
alpha helix, Ca2, is a known intersubunit contact area and so the implication
that the mutation may have affected some physical property as well as the kinetic
properties is not surprising. The serine to proline mutation would have increased
the hydrophobicity of the Ca2 helix. As a result, it may be that an increase in the
strength of the hydrophobic contact region is sufficient to explain the observed
changes in kinetic and physical properties. An analysis of a range of point
mutations engineered into bacteriophage T4 lysozyme have shown that the most
successful ways of producing a more thermostable enzyme are: a) reducing the
difference in entropy between folded and unfolded protein, which in practice
means reducing the number of conformations in the unfolded state; b) stabilising
the alpha helices, and c) increasing the number of hydrophobic interactions in
the interior core.
The most obvious way of decreasing the number of unfolded
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conformations is to introduce novel disulphide bridges, based on a knowledge
of the tertiary structure of the folded protein. Where this is not possible, a
reduction in the conformational freedom of the unfolded states, and hence a
stabilisation of the native protein, may be produced by the introduction of
proline residues. Proline residues have less conformational freedom in unfolded
structures than any other residue since the proline sidechain is fixed by a
covalent bond to the main chain. Such mutations can only be made at positions
that neither change the conformation of the main chain in the folded structure nor
introduce unfavourable contacts with neighbouring side chains. The detrimental
effects of the introduced proline at residue 384 imply, therefore, that there have
been some main chain conformational changes, or effects on residues near the
introduced proline. This supports the desired intention of this residue change,
which was to alter intersubunit contacts sufficiently to produce measurable
effects in the kinetic or physical properties of the mutant protein.
In support of the conclusions expressed above, a point mutation at a
dimer interface (glycine 418 to tryptophan), analogous to that produced in the
mutant pyruvate kinase, has been observed to cause a significant lowering of the
thermal stability of the dimeric enzyme glutathione reductase from E.coli
(Scrutton et al., 1992). A pronounced destabilisation of yeast phosphoglycerate
mutase has also been produced by a lysine to proline substitution in a subunit
interface region (White et al., 1993).
The absorbance of the wild type and S384P mutant enzymes at 280nm
(A280) was monitored as a function of temperature, in the presence and absence
of the effector Fru-1,6-P2. In the presence of effector, the A280 of both the wild
type and mutant enzymes was greater than the corresponding unligated enzymes
at all temperatures studied (Fig. 74). This indicates that the the effector acts to
alter the conformation of each enzyme to expose more uv absorbing sidegroups
(e.g. Trp, Tyr and Phe) to the solvent. The absorbance at 280nm increased as a
function of temperature whether or not effector was present. This indicates that
rising temperature causes a progressive conformational change that also leads to
the exposure of uv absorbing groups to the solvent. The absorbance at 280nm
reached a maximum at higher temperatures for the wild type and the mutant
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enzymes before falling sharply. The maximum absorbance was observed at a
lower temperature for the mutant enzyme than for the wild type enzyme. The
maximum absorbance at 280nm was observed at a lower temperature for each
enzyme when Fru-1,6-P2 was present than when no ligand was added. The
sharp fall in absorbance at 280nm can be attribruted to the denaturation,
aggregation and precipitation of the enzymes which effectively removes
chromophoric groups from solution. The exposure of hydrophobic regions to
the solvent would facilitate the aggregation of proteins via these exposed areas.
The decreased ordering of water molecules around hydrophobic regions as the
temperature is increased may influence the rate and extent of aggregation. The
participation of water in the inactivation of pyruvate kinase is further suggested
by the stabilization of the enzyme in the presence of 20% (v/v) aqueous glycerol
solutions. Burying hydrophobic sidechains in the interior of the protein
molecule, thereby shielding them from contact with the solvent, is a major
determinant in the folding of proteins. Any treatment that results in the exposure
of hydrophobic residues to the solvent would be expected to increase protein
instability. The introduction of the helix destabilising proline residue may have
resulted in the increased exposure of previously buried stretches of hydrophobic
residues, thus contributing to the observed instability of the mutant.
Thus, in the presence of effector, both enzymes are in a more open
conformation in which chromophores are more exposed to the solvent than in
the unligated state. This leads to their more rapid denaturation as temperature is
increased. The wild type enzyme is more resistant to thermal denaturation than
the mutant enzyme.
A similar phenomenom has been observed in several other systems. An
increase in absorbance at 280nm has been recorded with glutamate
dehydrogenase from Pyrococcusfuriosus as a function of temperature (Klump
et al., 1992). Also, addition of Fru-1,6-P2 to the pyruvate kinase from E.coli
was observed to significantly increase its susceptibility to thermal denaturation,




A polyclonal antiserum against wild type pyruvate kinase from yeast was
raised in, and purified from, rabbits. The antiserum was used in a variety of
different experiments with varying degrees of success.
The antiserum was first used in Western blotting experiments to
determine the specificity and affinity of the preparation. A mixture of proteins
from a number of different sources were separated by electrophoresis on an
SDS-polyacrylamide gel. The proteins were electro-blotted onto a nylon
membrane and incubated with varying dilutions of the antiserum as described
earlier (Section 2.8). The optimum dilution of antiserum to use was found to be
1:1500. The polyclonal antiserum was found to react only with wild type yeast
pyruvate kinase (Fig. 75). It did not react with purified rabbit pyruvate kinase,
or with any of the proteins in cell extracts from E.coli, Bacillus subtilis,
Staphylococcus aureus or Thermoplasma acidophilum. Thus, it can be
concluded that the polyclonal antiserum prepared from the rabbits was specific to
the antigen it was raised against, did not cross-react with host enzyme, and
displayed a high affinity for the target antigen. One of the problems confronting
the producers of mutated enzymes is the effect of the mutation on catalysis. It is
possible to interfere with the catalytic mechanism of the enzyme very easily,
especially when the nature of the active site is not fully known. A procedure for
identifying inactive mutant forms of yeast pyruvate kinase, that may be produced
during site-directed mutagenesis experiments, is now available.
Immunodiffusion experiments were also attempted. The technique relies
on the diffusion of antigen and antibody towards each other from separate wells
cut into an agaose gel. When the two proteins meet, they combine and form a
precipitate. The distance of the precipitate from the wells depends upon the
concentration of the two components. Pyruvate kinase and other proteins were
allowed to diffuse towards a sample of either polyclonal antiserum or a control
well containing a sample of pre-immune serum. Under the conditions described
in the experimental protocol (Section 2.8.1) no precipitation was observed with
either the pre-immune serum or the polyclonal antiserum. There are several
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possible reasons for this lack of precipitation. One, or both, of the proteins
could have denatured during storage. The pyruvate kinase preparation was used
fresh from the final stages of purification and was found, during standard
enzyme assays, to be highly active. The antiserum was stored at -20°C. It has
been reported that impure samples of antiserum do not retain their activity for
long unless stored at -70°C. The antiserum used in this assay was purified
using a rapid method that relied on the binding of impurities to an anion-
exchange matrix. Hence, the possibility of residual contaminants eluting with the
non-retained antiserum cannot be discounted. Thus, the denaturation, or
proteolysis, of the antiserum during storage preventing the formation of an
antibody-antigen precipitate would be possible. Another way in which the
interaction of antibody and antigen could be disrupted is by the incubation of the
components in non-optimal conditions. The matrix for the interaction consisted
of pyruvate kinase assay buffer in which 1% (w/v) agarose had been dissolved.
This may not have been suitable for the formation of precipitates due, possibly,
to the high salt content interfering with the electrostatic interaction of antibody
and antigen. It has also been reported that sodium azide, commonly used to
prevent microbial contamination, interferes with the interaction of antibody with
antigen. The preparations of antiserum used in these experiments were stored in
the presence of 0.02% (w/v) sodium azide. It may also have been the case that
the range of concentrations of antibody and antigen used in these experiments
did not fall within the zone of maximum interaction that is commonly observed
with antibody-antigen precipitation studies. Either too much or too little of one
of the interacting components would result in the formation of soluble, rather
than insoluble, aggregates. Thus, although an interaction between antigen and
antibody had occurred, it would not have been observed.
A direct precipitation of pyruvate kinase from solution with varying
concentrations of polyclonal antiserum was attempted (Fig. 76). This
immunotitration experiment was also unsuccessful in that the activity of the
samples incubated in the presence of the polyclonal antiserum was not
significantly different from those incubated with the pre-immune serum. The
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reasons for the failure of these experiments appear to be different from those for
the failure of the immunodiffusion experiments. The denaturation of the
polyclonal antiserum is the most likely explanation. However, the antiserum in
this instance were stored at -70°C in the absence of sodium azide. The
incubation buffer was of sufficiently low ionic strength not to interfere with the
antibody-antigen interaction. The range of dilutions of antibody used was much
lower than that used in the immunoblotting experiments and so would have been
sufficient to cause some interaction with the enzyme. Thus, it appears that the
titre of anti-pyruvate kinase antibodies in the rabbit serum was extremely low
due, perhaps, to poor immunogenic responses from the host animals or, more
likely, to losses during purification and storage.
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4.12 COMPUTER PREDICTIONS OF SECONDARY
STRUCTURE
Several computer programs exist for analysing protein secondary
structure. The programs most readily available are those produced by the
University of Wisconsin Genetics Computer Group (UWGCG)(Devereux et al.,
1984) and the program PREDICT (Sawyer et al., 1988). The wild type and
mutant forms of yeast pyruvate kinase were analysed by a number of these
programs.
The program PEPPLOT displays a variety of data. The most useful are
the alpha helix/beta strand prediction plot (Chou & Fasman, 1978), the
hydrophobic moment plot (Eisenberg et al., 1984) and the hydropathy plot
(Kyte & Doolittle, 1982).
When the wild type and mutant pyruvate kinase enzymes were analysed
by these methods none of the plots drawn by this program showed any
significant difference between any of the calculated parameters for either of the
enzymes, i.e the secondary structure, the probability of certain residues being on
the surface of the protein or buried, and the exposure of certain residues to the
solvent were indistinguishable (Fig. 77 and 78).
The Chou and Fasman alpha and beta conformational potentials are
plotted as running averages of four adjacent residues. The horizontal lines across
the panel indicate the minimum levels for predicting alpha and beta structures.
The small hashmarks at the top of the panel classify each residue as forming,
breaking or indifferent for beta structures. Likewise the hashmarks at the bottom
of the panel classify each residue as alpha-forming, breaking or indifferent.
Maximum resolution of structures is best seen in small sections of the
polypeptide of interest (40-60 residues). The hydrophobic moment is a measure
of the "amphiphilicity" of a sequence that is helpful for identifying structures
located at the interface between hydrophobic and hydrophilic regions of a
protein. Thus, segments of secondary structure that are located so that one side
faces the hydrophobic interior of the protein and the other faces the exterior or
solvent have high hydrophobic moments (i.e. greater than 0.4). The
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hydrophobic moment may also be useful for helping locate transmembrane
segments which typically have low hydrophobic moments and high
hydrophobicities. This plot therefore allows one to predict whether the
secondary structures predicted by the Chou and Fasman method are located on
the surface of the protein, are transmembrane segments, or are within the
globular core of the protein. The hydropathy profile is frequently used to find
intra-membrane regions of proteins. It is also commonly used to try to predict
the positions of antigenic sites on proteins. The hydropathy profile is calculated
using a window nine residues wide. Peaks in this panel indicate hydrophobic
(interior) regions, and valleys hydrophilic (surface) regions. Globular proteins
typically produce hydropathy plots with hydropathy values ranging from +2 to
-2. Trans-membrane segments of proteins usually produce much higher
hydropathy scores (typically in the +3 to +4 range).
Another program, PEPTIDESTRUCTURE, shows a very
significant difference between the secondary structure of the wild type (Fig. 79)
and mutant (Fig. 80) forms of the enzyme. The output from this program seems
to indicate that the serine 384 to proline mutation disrupts the alpha helix in
which it is situated compared to the structure seen in the wild type enzyme. This
is supported by the expermental evidence of the different properties exhibited by
the mutant enzyme and the known behaviour of proline as a helix disrupting
amino acid. Further, a CONTIN analysis of the secondary structure of the wild
type and mutant enzymes indicates that the mutant enzyme has lost some alpha
helical structure and gained some beta sheet structure (Table 12).
The interpretation of these plots is often difficult. The plots themselves
are often crude and simplistic and do not accurately reflect the real situation. The
vast array of possible conformations available to a protein in solution can not
realistically be represented by a computer program. The programs themselves
are quite old, e.g. Chou and Fasman (1978), Kyte and Doolittle (1982), and
although the algorithms on which they calculate the potential secondary structure
are based on real data obtained from protein sequence databases, they cannot
readily be updated or improved as our knowledge of protein secondary structure
increases. As a result, the output from these plots is perhaps less sophisticated
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than other, more recent, programs in terms of accuracy in calculating the
secondary structural elements of proteins.
In an attempt to overcome any inaccuracy produced by analysing
sequences by only one algorithm, the PREDICT program was also used to
determine the secondary structure of the wild type and mutant enzymes (Fig. 81
and 82). This program is essentially a combination of eight different secondary
structure prediction programs. The output from the program is a series of panels
in which the helix, beta strand and coil elements are displayed against the
number of programs that predict their occurrence within a particular sequence.
As a result, an element of secondary structure scoring highly indicates a greater
probability of that structure being present than if it had a lower score. A low
score does not mean that that element of secondary structure would not form,
just that the confidence limits of one being able to say that it does occur are
lower. The PREDICT plot for the wild type enzyme shows a very strong
probability of there being an alpha helix in the middle of the given sequence
(Fig. 81). This region corresponds almost exactly to helix Ca2, and shows that
the PREDICT algorithm is sufficiently sensitive to allow interpretation of
secondary structural features associated with small sections of sequence. The
PREDICT plot for the mutant enzyme however, is not much different to that of
the wild type enzyme (Fig. 82). A small difference at the N-terminus of the
alpha helix is observed. The substitution of the serine with a proline has caused
a reduction in the number of programs attributing a helix structure to that part of
the sequence. The difference however, is only small and is not what was
expected. A much larger destabilising effect of proline was anticipated, resulting
in a dramatic reduction in the attribution of a helical structure to the affected part
of the sequence by the prediction programs. It is often the case however, that a
single proline residue present within a strong helical region does not have the
expected destabilising effect when assessed by a number of secondary structure
prediction programs (MacArthur & Thornton, 1991). The most dramatic
destabilising effect is observed when the residue(s) immediately prior to the
proline are within beta strand structures. Proline residues within helices are
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tolerated by the prediction programs when the residues immediately preceding
the proline are hydrophobic and when the proline is close (within 3-4 residues)
of the N-terminus of the helical region. From the given sequence it can be seen
that the proline substitution is the sixth residue of a 13-residue helix and that the
three residues preceding the proline are the hydrophobic residues valine and
alanine. Thus, it is not surprising that the destabilising effects of proline are not
observed with any of the computer prediction methods. This does not mean, of
course, that the proline substitution does not have any effects on the enzyme in
vivo.
In a sense these programs are not designed to provide accurate data,
merely to act as an aid to interpretation. After all, there are very few examples of
proteins where all that is known about them are their amino acid sequences, thus
requiring computer programs to provide information not otherwise available.
There are now accurate physical techniques for determining the secondary
structure of proteins e.g. circular dichroism, and so reliance on these programs
for this sort of information may soon no longer be necessary.
Having said that, plots of structural measurements like PEPPLOT and
PREDICT can be of significant value for detecting similarity between sequences.
Similarity that is often difficult for the human or the computer to recognise in the
primary sequence may generate patterns of secondary structure measurements
that are recognisably similar when plotted.
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4.13 SEQUENCE COMPARISON OF PYRUVATE KINASES
The complete primary amino acid sequences of all pyruvate kinases
known to date are shown in Table 1. In this respect it is the most comprehensive
compilation of pyruvate kinase sequences yet prepared. Sequence information is
available from most types of organisms found in nature-bacteria, fungi,
protozoa, plant, bird and mammal. Various tissues within these organisms are
also represented e.g. the sequences for mammalian blood, liver and muscle
isoenzymes and plant cytosolic and plastidic isoenzymes are available. From the
alignment it can be seen that the sequences are clearly related to each other.
The greatest variation in the sequences lies in the size and composition of
the N-terminal region. This region forms a small flexible domain that is thought
to interact with the other domains and contribute to intersubunit communication
(Fig.3). The higher eukaryotes show the highest degree of similarity in this
region. However, differences do exist-the most significant being in the presence
of a phosphorylation site on a short N-terminal extension found in rat and
human liver and rat erythrocyte forms but absent in the muscle forms. The only
region of secondary structure in the N-terminus, identified from X-ray
crystallographic studies on the cat muscle enzyme, are two short alpha helices.
The great variation in sequences makes it impossible to positively attribute these
features to the other enzymes. Undoubtedly secondary structural features exist
but their identification must await more detailed analysis of the other enzymes.
The flexibility of the N-terminal region in the cat muscle makes precise
predictions of its behaviour difficult. Its contribution to intersubunit
communication is supported by the great variation observed in this region across
the enzymes so far sequenced. The implication is that sequence variability is in
some way contributary to variety of function. The great length of the N-terminal
region in the plant enzymes and information provided by Dr.S.Blakeley
(Queen's University, Kingston, Canada) suggest that such sequences may be
involved in transport across intracellular membranes e.g. the outer and inner
chloroplast membranes. Evidence that such sequences are found in other
enzymes comes from studies on pyruvate phosphate dikinase from maize (Zea
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mays) (Matsuoka et al., 1988). These workers found that an N-terminal
sequence composed of three separate modules functioned in transporting the
enzyme across the chloroplast membrane. An alignment of the putative signal
from maize with the plant N-terminal regions of pyruvate kinase shows only a
poor correlation between sequences (Table 18). This may indicate that other,
previously unidentified chloroplast translocating signals exist in these enzymes.
A more convincing chloroplast signal peptide is found in the tobacco and castor
seed isoenzyme A. These enzymes show partial identity to a signal peptide
found in the small subunit of ribulose-l,5-bisphospha e from Chlamydomonas
(Mishkind et al., 1985) (Table 18). The signal peptide from this enzyme is also
comprised of three blocks or domains. An N-terminal block rich in serine and
threonine residues comprises domain I. This is followed by a
glycine/leucine/lysine-rich block in close proximity to several proline residues.
Domain in consists of a region rich in serine residues. In tobacco and castor
seed isoenzyme A all these elements can be found. The series of four asparagine
residues in this sequence may form the signal peptide cleavage site (Blakeley et
al., 1991). Three adjacent asparagine residues are also found in the tobacco G
isoenzyme in a similar position and so may also indicate the site of cleavage of a
signal peptide. It is worth commenting that the first 100 residues of all of the
chloroplast sequences shown in Table 18 are rich in hydrophobic residues which
would facilitate transport across intracellular membranes.
A remarkable number of residues are conserved across all the sequences.
These are likely to be involved in substrate binding and orientation and in
preserving essential interdomain and intersubunit contacts. Domains A and C
appear to be the most conserved, with domains B and N being less well
conserved respectively. The extreme C-terminal regions, forming part of domain
C, are also highly variable. Like domain N, they may function in inintersubunit
communication and so contribute to the variety of kinetic properties displayed by
the pyruvate kinases. It is interesting to note that an examination of the computer
model of the yeast pyruvate kinase subunit reveals that portions of the last 50
residues of domain C are in very close proximity to domain N and so together
might form the means of intersubunit interaction.
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H-U , U , _!!!_
Tb.pA SQALNFFVSSSSRSPATFTISRPSVFPSTGSLRLLVKKSLRTLWEASSAAASDIDEPQS
Cs.pA SQSLHF-SPNLTFAKQPFP-KLPLPFPTSNS-RYPVNN-YKSLSIKASTSPSSS-SDPQ-
Cs . pB A VWKDLEEAVRVWLAVLRDMEWWLVTAVMGWt3)J*JV-ARXNHCHGTOEWHR
Tb. pG A-TMN-LPTGLHVAAKPASLNRLSSAKNVGDLFFSDSRHRKRVNTSNQIMAVQSIJEHIH—
Bn. pG LSPNGGSAS TRSDKFLKPASFRVKVLGNEAKKSGRVSVRGGRKVDTTVR
PPDK MAA SVSRAICVQKPGS KCTRDREATSFARRSVAAPRPPHAKA
• : 1 i 1
Tb.pA SPVLVSENGSG—GVLSSATQEYGRNAAPGTDSSSIEVDTVT
Ca.pA —VLVADNGTGNSGVLYNNNN KSVTVSDPSSIEVDAVTETELKENGFR
Cs.pB SVIERVRR LNEEKGFAVAIMMDTEGSE IHMGDLGGASSAKAEDGE




Table 18 N-terminal sequences of plant plastidic pyruvate kinase isoenzymes
compared with maize pyruvate, phosphate dikinase (PPDK) signal
sequence.
Underline = domains of maize PPDK signal sequence (Matsuoka et
al., 1988). ,t ,
Overline = blocks sharing similar motif to Chlamydomonas nbulose-
1,6-bisphosphatase signal sequence (Mishkind et al., 1985).
Cs.pA/pB = castor seed pyruvate kinase plastid isoenzymes A and B
Tb.pA/pG = tobacco pyruvate kinase plastid isoenzymes A and G.
Bn.pG = Brassica napus pyruvate kinase plastic isoenzyme G.
Cartoon depicts domain structure of Chlamydomonas ribulose-1,6-
bisphosphatase signal sequence. Arrow indicates putative signal
sequence cleavage site.
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The plant plastid sequences show some interesting features apart from
the extreme length of the N-terminus. A deletion of some seven residues in the
castor seed plastid isoenzyme B effectively removes the majority of an alpha
helix (Aal). The consequences of this on the behaviour of this enzyme with
respect to the other plant enzymes cannot be predicted. It is worth noting at this
point that a similar deletion is seen in the same region of the Yarrowia lipotytica
enzyme, corresponding to the complete removal of the helix Aal. A detailed
study of the X-ray crystal structure of the cat muscle enzyme did not suggest that
Aal played any critical role in enzyme activity (Muirhead, 1987). However, any
mutation that affects the integrity of a highly conserved structure such as the
alpha/beta barrel of domain A is likely to have a pronounced effect on the kinetic
properties of such an enzyme. A comparison of the X-ray structure and/or
kinetic parameters of this enzyme with the otherwise highly similar enzyme from
S.cerevisiae would be of interest.
The plastidic A and B isoenzymes from castor seed and tobacco all show
a seven residue insertion in domain B corresponding to an extension of a beta
strand (B{37) or, more likely, forming a flexible loop between two adjacent beta
strands (B|37 and B(38) (Table 1). The beta strand Bp7 has been implicated in
forming a subunit interface. The plastidic G isoenzymes from Brassica napus
and tobacco do not share this feature. Thus, there exists the possibility that the A
and B isoenzymes have different regulatory properties compared with the G
isoenzymes because of this structural difference. Unfortunately, no kinetic data
are available for the three different isoenzymes to confirm this hypothesis. The
G isoenzymes appear to be a quite distinct group and are as unrelated to the A
and B isoenzymes as they are to other prokaryote and eukaryote enzymes.
The sequence LDTKGPEIRT (corresponding to residues 111-120 of the
cat muscle enzyme) is well conserved across all the sequences and appears to be
involved in binding the substrate ADP. In particular, residues Lys 114, lie 118
and Arg 119 are important in this respect. This sequence has even been found in
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a partial sequence from the archeabacterium Thermophilus acidophilum (Potter,
1993).
Other important regions conserved across most of the enzymes are the
residues FASFIR (corresponding to residues 239-244 of the cat muscle
enzyme), the conserved lysine 269 (presumed to be the proton-donating catalytic
residue), residues MVARGDLG (corresponding to residues 290-297 of the cat
muscle enzyme) and residues PTRAE (corresponding to residues 339-343 in the
cat muscle enzyme) (Table 1).
The sequence FASFIR forms a beta strand (A(34) and a small loop. This
region is in a critical part of the active site and is involved in providing ligands
for the binding of both PEP and ADP. The PEP binding site is located in the
loops that connect strands A(33 and A(34-6 to domain B and helices Aa4-6
respectively (Muirhead, 1985). In particular, Ser 242 serves in orientating PEP
and Phe 243 provides a hydrophobic contact for the adenine ring of ADP. The
sequence MVARGDLG forms a beta strand (A[36) and part of an alpha helix
(Aa6). This region is essential for a number of reasons. First, the helix Aa6 is
an important intersubunit contact. Second, this region also provides ligands for
binding substrates at the active site, especially Arg 293 which is involved in
ADP binding. Third, the A(36/Aa6 region provides ligands for the enzyme-
bound divalent cation. The sequence PTRAE forms part of the helix Aa7. This
helix is also an important intersubunit contact area.
The alpha helices Ca 1 and Ca2, thought to be critical in communicating
the allosteric effect in the M2 isoenzyme, are not well conserved across the
sequences. In fact, no single residue is absolutely conserved in these areas. In
particular, Cal is quite poorly conserved with the plant plastid A and B
isoenzymes having an insertion in this region and the G isoenzymes having a
deletion. Indeed, a comparison of the yeast enzyme with the cat muscle enzyme
reveals that the sequence corresponding to helix Cal is actually better
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represented as a beta strand (Muirhead, 1987). This can clearly be seen in a
secondary structure prediction plot of the relevant portion of the enzyme
(Fig.79). The fact that these alpha helices are poorly conserved may indicate that
they are capable of imposing a variety of properties on the enzymes that possess
them, as opposed to the rigid conformations and limited flexibility of function
imposed by having a large number of identical residues. The relevance of
differences in the sequences of these alpha helices becomes apparent when it is
noted that the only difference between the allosterically regulated M2 isoenzyme
and the non-regulated Ml isoenzyme from rat muscle lies largely within these
two alpha helices.
The effector site, identified in the E.coli enzyme (Speranza et al., 1990)
and corresponding to the cat muscle residues 423-438, is more conserved across
the sequences than either of the alpha helices Cal and Ca2.
It comprises a beta strand (C(31), an alpha helix (Ca3) and the sequence in
between. The presence of such sequence similarity in this area may indicate the
presence of a functional, or vestigial non-functional, effector site in many of the
enzymes sequenced. Many are in fact known to be regulated by allosteric
effectors. This site has been identified in the non-allosterically regulated cat
muscle enzyme as a potential secondary nucleotide binding site (Muirhead,
198 ). It is impossible to predict the identity of potential ligands or the effect of
their binding to the enzyme by simply comparing primary amino acid sequences.
It is also dangerous to interpolate the potential structure of these regions from the
known structure of the only enzyme so far crystallised, the non-regulated cat
muscle enzyme. However, it is clear, from what has been said before about the
composition of Ca 1 and Ca2, that the primary sequence of these regions need
not be similar for them to participate in ligand binding and contributing to
transmitting an allosteric effect across the subunits. Other studies involving
computer modelling of the effector site in the cat muscle enzyme suggests that
totally different residues are involved in effector binding (Clayden, 1987).
Hydrogen bonding between enzyme and effector could be facilitated by Val 468,
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Pro 470, Arg 42, Leu 41 and Ser 66 (cat muscle numbering). Potential ligands
for the two phospho groups of Fru-1,6-P2 were identified as Arg 42 and Arg
105. However, not all of these residues are conserved in the yeast enzyme. The
most important changes in the yeast enzyme involve Ser 66, which is changed to
Ala, the absence of Arg 102 and the addition of a negative charge from Glu 498
(which is Ala in the cat enzyme).
It is far from certain that the site identified in the cat muscle enzyme as a
second nucleotide binding site functions as a Fru-1,6-P2 binding site in the yeast
enzyme. There are substantially fewer potential ligands correctly orientated in the
yeast enzyme that would be able to bind the effector. Crystals of an allosteric
pyruvate kinase, formed in the presence of the effector, have never been
prepared in a form suitable for high resolution X-ray diffraction studies. Also, it
can not be stated with certainty that conformational changes originating in this
region of the enzyme would be able to produce the observed changes in kinetics.
The effector site in the E.coli enzyme was identified by the labelling of a
reactive lysine (residue 366) by pyridoxal 5'-phosphate in the presence of the
effector. That this lysine is even close to the actual site of effector binding must
also remain conjecture. A conformational change on effector binding could lead
to the burying of a lysine sidechain, and hence its protection from reaction with
pyridoxal 5'-phosphate, some distance from the effector site itself. A better way
of identifying the ligands involved in the binding of the effector molecule, in the
absence of X-ray crystallographic data, would be the preparation of a series of
radioactively-labelled Fru-1,6-P2 analogues with different reactive functional
groups, that are capable of covalent attachment to the sidegroups of suspected
ligands in the binding site. A similar series of experiments with a variety of ADP
analogues has helped elucidate the ligands involved in nucleotide binding
(Vollmer & Colman, 1990).
A comparison of the cat muscle and B .stearothermphilus sequences
identified a region that was proposed to form a loop at the entrance of the
allosteric site (Walker et al., 1992). This region, corresponding to residues 97-
102 of the cat muscle sequence, was absent in the B .stearothermophilus and the
other allosterically regulated enzymes then sequenced. The absence of the loop
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from the allosteric forms suggested that the effector binding pocket was flexible
and could adopt a variety of alternative conformations. The binding of the
effector molecule was proposed to hold the pocket open resulting in the
formation of the active conformation. Conversely, in the non-regulated forms,
the presence of the loop was proposed to hold the pocket permanently open
locking the enzyme in the active conformation. However, from the more
extensive sequence records now available, this same loop region can be
identified in the vertebrate M2, R and L isoenzymes. All of these isoenzymes are
allosterically regulated. In the M2 isoenzymes from human and rat, the loop
sequence is identical to that from the cat muscle enzyme. In the R and L
isoenzymes the loop is highly similar. The presence of the loop sequence in
these isoenzymes suggests a more complex behaviour and /or function for the
loop structure. The ability of the R and L isoenzymes to be phosphorylated may
negate or modulate the effect of the loop. The M2 isoenzymes are not
phosphorylated yet still clearly display allosteric properties. The loop region
may, therefore, be unimportant in determining the conformation of the effector
site. It should be noted that the most potent effector of the
B.stearothermophilus enzyme is not Fru-1,6-P2 but ribose-5-phosphate. Thus,
the loop may have a specific function in this enzyme but be redundant or
ineffectual in the other enzymes.
An interdomain salt bridge between Asp 356 (located in A(38) and Arg
444 (located between Ca3 and C(32) has been identified (Walker et al., 1992).
This feature is proposed to stabilize the active R conformation of the enzyme. It
is interesting to note that these two residues are conserved in all the pyruvate
kinase enzymes listed in Table 1, except the two E.coli isoenzymes. This
suggests that the proposed salt bridge is very likely to be an important structural
feature.
The C-terminal regions of the enzymes are almost as varied as the N-
terminal regions. The longest C-terminal tail is found on the
B.stearothermophilus enzyme. This may have something to do with the thermal
stability exibited by this enzyme. However, confirmation or refutation of this
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hypothesis will have to await the sequencing of other pyruvate kinases from
thermophilic organisms. The proximity of the N and C termini of the cat muscle
pyruvate kinase suggests that the region occupied in the tetramer by the N-
terminal domain might be substituted by the C-terminal extension. It is
interesting to note that all the bacterial enzymes so far sequenced have short N-
terminal domains and longer C-termini, thus adding weight to this hypothesis.
The plant cytosolic enzymes show a 13 residue insertion in the region
between a beta strand (C(32) and an alpha helix (Ca4) that is absent in all the
other sequences. This sequence could form a loop between these two elements
of secondary structure. This potential loop is composed of residues with bulky,
hydrophobic sidegroups e.g. phenylalanine, tryptophan and valine, and may
thus have a role in maintaining hydrophobic contacts between subunits or
domains, or in shielding some region from the solvent. The region is highly
conserved amongst the cytosolic enzymes and so may well perform some
essential function in these enzymes.
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4.14 ALIGNMENT AND PHYLOGENETIC ANALYSIS OF
PYRUVATE KINASE SEQUENCES
Two phylogenetic trees are presented (Fig. 83 and 84). Both have been
constructed by computer analysis of the primary sequences shown in Table 1.
The first tree (Fig. 83) has variable branch lengths which gives evolutionary
distances in PAM units. Evolutionary relationships between amino acid
sequences are expressed as "accepted point mutations per 100 residues"
(PAMs). This parameter, which was calculated according to Dayhoff (1978),
takes into account the back mutations and multiple hits that may have occurred
during evolution. This tree however, is only one of many possible trees that can
be generated using the same data. Tree topologies may vary slightly with the
order in which species are added to a tree (the order of the alignment). One way
to get information about the tree topology is to do a bootstrap analysis. Here,
columns in a multiple alignment are sampled at random and new nonsense
alignments of identical length are created. If mutations occurred at random
within a sequence, the tree topology should not change. The second (consensus)
tree, with identical branch lengths, is the most probable tree after 100 bootstrap
analyses (Fig. 84). It can only provide information about the liklihood of a
specific branching point. It contains no information about evolutionary
distances.
The clustering of sequences in the first tree corresponds to the taxonomic
heirarchy of the organisms from which they originate. Thus, the vertebrates
occupy one distinct branch along with the other eukaryotes represented in this
tree - the fungi and protozoa. The plants and bacterial sequences occupy their
own separate branches. This reflects the distinct Kingdoms of organisms found
in nature. Among the eukaryotes, the vertebrate isoenzymes form a very tight
cluster. The mammalian R and L isoenzymes are separate from the Ml and M2
isoenzymes. This indicates that they have only recently diverged from a common
vertebrate ancestor. The fungal enzymes are all clearly related, being also only
recently diverged from a common ancestor. The protozoan enzymes also cluster
together. The tree indicates that the protozoa / vertebrate divergence occurred
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after the protozoa / fungi divergence and accords well with our current
knowledge of evolutionary relatedness.
Plant cells evolved from symbiotic associations that included (at least) a
nucleocytoplasmic host cell, a mitochondrial ancestor, and a chloroplast ancestor
(Woese, 1987). From protein and nucleic acid sequence studies it is now
possible to identify with relative certainty the taxa from which these ancestors
came. Mitochondria are descended from a group of purple sulphur bacteria, and
chloroplasts from cyanobacteria. The origin of the nucleocytoplasmic host cell is
less certain, but appears to be from sulphur metabolizing archaebacteria. It has
been proposed that the chloroplast ancestor oxidised H^S by using it as an
electron donor during photosynthesis (Searcy, 1992). Sulphur is particularly
suitable for such symbiotic associations because, compared with oxygen, it is
less toxic, more versatile in its chemistry and easily trapped and recycled within
each association.
The plant cytosolic enzymes form another tight grouping and appear
distinct from the plant plastidic enzymes. This indicates that the plant cytosolic /
plastidic divergence occurred a very long time ago. However, the clustering of
the plant cytosolic sequences may merely be an artefact of the way the tree is
drawn. The angle of the plant cytosolic enzyme branch, and the precise location
of its root, may bias its final position and give the false impression that it is more
distantly related to the bacterial and fungal branches than it actually is.
The bacterial and plant plastidic enzymes form the most diffuse
grouping. This may simply reflect the small range of organisms sampled.
Although all the bacteria apparently share a common ancestor, the sequences
shown appear to have diverged markedly. This is also true of the plant plastidic
isoenzymes. The unusual and anomolous placing of the pyruvate kinase
isoenzyme II from E.coli (kpy2 ecoli), on the plant plastidic branch, may give
support to the theory that chloroplasts are derived from the descendents of
endosymbiotic bacteria that invaded early eukaryotic cells. It should be noted
that a lateral transfer of the pyruvate kinase gene from a cyanobacterium to
E.coli may also account for the unusual position of this sequence in the tree.
The consensus tree (Fig. 84) only provides information about the point
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of divergence of sequences, not on their evolutionary relatedness. The unrooted
tree allows one to determine the order in which sequences appear to diverge
from common ancestors. Again, a distinct clustering of sequences is observed.
Vertebrate, fungi, protozoa, bacterial, plant cytosolic and plastidic zones can be
clearly defined. An example of the usefulness of this kind of tree can be seen
when one considers the vertebrate isoenzymes. In the vertebrate zone, the R and
L isoenzymes and the Ml and M2 isoenzymes clearly share a common ancestor.
Not surprisingly, the rat and human R and L isoenzymes appear to have
diverged from an ancestral enzyme that is different from the ancestor from which
the rat and human Ml and M2 isoenzymes have diverged. Although no estimates
of the time of such a divergence can be calculated from this sort of tree in terms
of millions of years, a temporal ordering of successive divergences can be
inferred.
More interestingly perhaps, in this particular consensus tree, is the
confirmation of the unusual position occupied by the isoenzyme II of E.coli. It
appears that all the plastidic isoenzymes share a recent common ancestor with the
E.coli isoenzyme n. The plant cytosolic / plastidic ancestor is very much older.
Thus, it is more probable that the plant plastidic enzymes have descended from a
bacterial endosymbiotic invader of a protoeukaryote than from a cytosolic
enzyme that has subsequently been sequestered into an intracellular organelle.
There remains, however, a query over the construction of the tree itself.
What parameters govern the direction and angle a particular branch makes with
any other? This factor is presumably accounted for in the algorithm used in
constructing the tree but its appropriateness is beyond the scope of this
discussion. One should be aware that the position of a particular branch in close




This thesis has described the purification and characterisation of a novel
form of the enzyme pyruvate kinase from the organism S.cerevisiae that was
produced by site-directed mutagenesis. In an alpha helix considered as essential
for the transmission of the allosteric effect across intersubunit contact zones, a
serine residue (Ser 384) was mutated to a proline. The proximity of serine 384
in subunits 1 and 2 to the corresponding serine 384 in subunits 3 and 4
respectively, was likely to increase the helix-destabilising effects of the proline
substitution. As a result, a variety of effects upon substrate binding properties,
response to allosteric effectors, thermal stability and overall protein
conformation were expected. Several studies to probe these, and other, aspects
of the mutant protein and to compare them with the wild type protein were
undertaken. From the results obtained, a number of conclusions can be drawn.
1) PURIFICATION
A revised purification protocol has been devised that improved upon
previous methods in terms of:
1) speed-pure protein, ready for a variety of kinetic studies, could be prepared in
under 36 hours.
ii) high yield-up to 15mg of pure enzyme could be produced from one litre of
culture.
iii) purity-an homogeneous enzyme preparation, greater than 98% pure, could be
generated.
iv) reproducibility-the procedure was highly robust and was reproducible over
the course of the project.
v) convenience-a minimum of purification steps ensured speed and high stability
of the preparation.
2) KINETIC PROPERTIES OF THE MUTANT ENZYME
The mutant enzyme was active only in the presence of high
concentrations of the positive allosteric effector fructose-1,6-bisphosphate. In
the absence of this effector the enzyme had a kcat 250-fold lower than the wild
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type enzyme. The fully activated mutant enzyme had a approximately 68%
of the wild type enzyme. This indicates that the point mutation introduced into
the enzyme has affected either the ability of the mutant protein to bind substrates
and effectors, or to catalyse the kinase reaction as efficiently as the wild type
enzyme, or both.
3) CHANGES IN CONFORMATION INDUCED BY LIGANDS
Large conformational changes have been detected upon substrate and
effector binding, in the wild type and the mutant enzymes, by a variety of
techniques. The conformational change in the mutant enzyme is different to that
undergone by the wild type enzyme. This is shown by the differential response
of the two enzymes to digestion by trypsin, inhibition by NEM, thermal stability
and changes in fluorescence emission. These changes can be quantified in terms
of T50 values for the digestion, inhibition, and thermostability studies and Sq 5
and npj values for the kinetic and fluorescence studies.
4) ALTERED CONFORMATION OF THE MUTANT ENZYME
It appears that in the absence of the effector, the mutant enzyme cannot
adopt the conformation required for full catalytic activity. The effector changes
the conformation of the enzyme, allowing residues important in catalysis to
adopt the correct orientation, or to allow flexing of parts of the molecule
involved in intersubunit communication. This interpretation is compatible with
independent findings that point mutations are capable of disrupting catalysis,
intersubunit communication and protein conformation.
5) SECONDARY STRUCTURE PREDICTIONS
An attempt has been made to determine the extent of the disruption
caused by the point mutation by reference to generally available secondary
structure prediction programs. One method in particular indicated that the serine
to proline mutation would reduce the length of the important alpha helix, Ca2, at
its N-terminal region and convert it to a length of beta strand. Changes in
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secondary structure were monitored by circular dichroism spectroscopy. The
results from these experiments indicated that, in the mutant enzyme, the amount
of alpha helix was decreased relative to the wild type enzyme and the amount of
beta strand was increased. However, the overall secondary structure was not
significantly different between the two forms and so indicates that the two
enzymes adopt a generally similar folded conformation. Greater changes in the
quarternary and tertiary structure were observed with the fluorescence, trypsin
digestion and NEM inhibition studies.
6) SEQUENCE ALIGNMENT
The most comprehensive collection of pyruvate kinase sequence data yet
assembled indicated that the most conserved residues were involved in substrate
binding and maintaining the conformation of the active enzyme. Residues
involved in effector binding or intersubunit communication were less well
conserved. This indicates that the degree of interaction between subunits, and
the overall conformation adopted by the enzymes listed, may vary considerably.
There are more allosterically regulated enzyme sequences known than there are
sequences from non-allosterically regulated enzymes. However, the only X-ray
crystallographic data for the quaternary structure of the enzyme comes from the
non-regulated cat muscle enzyme. This reflects the difficulty of isolating crystals
of the allosterically regulated forms. The implication is that allosterically
regulated enzymes are more flexible and have a more varied range of
conformations than do the non-regulated forms. Thus, the model of the cat
muscle enzyme may not be the most suitable for analysing the other enzymes
considering their range of activity, the mode of their regulation, and the range of
organisms from which thay have been isolated.
7) IDENTIFICATION OF RESIDUES FOR FURTHER
MUTAGENESIS STUDIES
Several obvious targets for site-directed mutagenesis can be identified.
Considering that so few residues are conserved across all the sequences
analysed, those that are must contribute some essential function. It may be
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possible to alter the specificity of the active site by changing the ligands involved
in substrate binding e.g. Lys 269, Glu 271, Ser 242 and Phe 243. The precise
location of the effector site is in doubt. The effect of point mutations in the
suspected areas on the binding parameters and structural changes induced in the
enzyme by such modifications may help to delineate the site further. Salt bridges
have been idenified as important for maintaining the conformation of the active
enzyme. The introduction, or destruction, of salt bridges by site-directed
mutagenesis may help to determine more precisely the contribution of these
structures to the activity of the enzyme. Tryptophan residues could be introduced
into parts of the protein and used as probes of the conformation of the enzyme
under various conditions by monitoring the fluorescence emission of the mutated
enzyme. Cysteine residues could be introduced and the effect of thiol modifying
groups monitored by trypsin digestion or NEM-inhibition studies after exposing
the enzyme to various ligand and effector molecules.
8) PRODUCTION OF ANTI-PYRUVATE KINASE ANTISERA
A high specificity, high affinity polyclonal antiserum against wild type
yeast pyruvate kinase was produced. This would allow the identification of
inactive forms of pyruvate kinase were they to be produced during further site-
directed mutagenesis experiments. Analysis of the properties of the antisera
against the mutant form of the enzyme produced during this work was hampered
by the apparent instability of the antiserum preparations during storage.
9) PHYLOGENETIC ANALYSIS
An analysis of the 31 pyruvate kinase sequences was used to prepare a
phylogenetic tree for the enzyme. This allows the identification of important
branching points in the evolution of the enzyme and could be used to infer levels
of similarity between the enzymes of organisms that have yet to be sequenced. It
can also be used to identify unusual enzymes, such as the E.coli isoenzyme II
which is apparently closely related to the plant plastidic enzymes. As a result,
this seems to indicate that plant plastidic enzymes have evolved from a bacterial
endosymbiotic invader rather than from a sequestered cytosolic enzyme.
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uvate kinase (EC 2.7.1.40) is of particular importance in
cofysis for controlling the flux from fructose-1,6-bisphosphate
)ugh to pyruvate. It catalyses the essentially irreversible
tversion of phosphoenolpyruvate to pyruvate by the addition of a
-ton and the loss of a phospho group which is transferred to ADP.
tsphoenolpyruvate ♦ MgADP + H+ » pyruvate + MgATP
3 enzyme from most sources is a tetramer of identical subunits
*i about 500 residues in length. The enzyme has an absolute
uirement for monovalent and divalent cations (usually K+ and
2+) which act to coordinate and orientate the substrates prior to
alysis. A number of isoenzymes of pyruvate kinase are found to
st in vertebrate tissues. Their kinetic and regulatory properties
ect the metabolic requirements of the tissues in which they are
iressed. The L, M2 and R isoenzymes from liver, kidney and red
od cells respectively are all allosterically regulated by a number
iffectors such as fructose-1,6-bisphosphate, ATP and
coneogenic amino acids. These isoenzymes display a sigmoid
itionship of reaction rate with respect to substrate PEP. This
itrol is essential to prevent futile cycling of substrates in tissues
t can undergo glycolysis and gluconeogenesis. The M1 isoenzyme
n skeletal muscle is not allosterically regulated and displays
>erbolic Michaelis-Menten type kinetics. The yeast S.cerevisiae
> a single allosterically regulated form of the enzyme and has been
juenced in this lab (1). Intersubunit contact zones are thought to
important in mediating the allostenc transition. Two major types
ntersubunit contact are present in pyruvate kinase. Interactions
ween subunits 1 and 2 and between subunits 3 and 4 do not
itribute significantly to the enzyme's response to allosteric
jctors. However, the interactions between subunits 1 and 3 and
ween subunits 2 and 4 are considered to be largely responsible
the enzyme's altered kinetic properties upon effector binding.
»tetrameric enzyme could almost be considered to be a dimer of
lers (see Fig.1). The cat skeletal muscle enzyme has also been
(uenced and crystallised, allowing its 3-dimensional structure to
resolved to 2.6A (2). The main difference between the
t-regulated cat muscle enzyme and the yeast enzyme have been
alised to two alpha helices (Cal and Ca2) that form the 1,3 (and
) intersubunit contacts. Work is under way on two aspects of the
ist pyruvate kinase activity. Examination of the crystal structure
i led to the identification of lysine 239 as the ultimate proton
lor during catalysis. The effect of altering the position of the
itive charge on catalysis is being measured by mutating the
ne to both an ariginine and a histidine by site-directed
tagenesis. Other mutations have been introduced into one of the
ha helices responsible for maintaining the intersubunit contacts
cribed above. Serine 384 in subunits 1 and 2 lie directly
»site serine 384 in subunits 3 and 4 making this residue a
'able target for mutagenesis. Their proximity to one another can
exploited to maximise any alteration in kinetic properties. These
ine residues have been mutated to the charged residues arginine
i histidine and to the helix-destabilising residue proline. These
tations are expected to alter significantly the catalytic activity
s 239) and the response to allosteric effectors (Ser 384) of the
yme. These effects can be detected and measured by standard
jtic techniques. Of particular importance are any conformational
nges induced on binding the various effectors. These changes can
detected by methods such as tryptophan fluorescence, CD
ctroscopy and equilibrium dialysis. The effect of these mutations
Fig. 1 A TETRAMER OF PYRUVATE KINASE
Individual subunits are labelled (S1-S4).
The broken line shows the 1,3 (2,4) inter¬
subunit interface.
The alpha helices Ca1 and Co2 are indicated.
may be to inactivate completely or even to cause the dimerisation of
the enzyme. If this is the case, purification of the mutants will be
more difficult as enzymic activity can not be used to monitor the
progress of the purification. A high affinity polyclonal antisera
against wild-type pyruvate kinase has been raised and purified from
rabbits. This could prove very useful in aiding the identification and
punfcation of mutant forms of the enzyme. An improved
purification protocol has been devised that enables rapid
purification of large amounts of protein for study.
An expression and mutagenesis system based on the pVT-L
phagemid (3) is being developed to enhance the production and
purification of mutant protein.
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